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ABSTRACT 
The Self-Regulation Model (Leventhal, Nerenz & Steele, 1984) 
highlights the roles of patients' illness representations, coping, emotional 
reactions and appraisal of coping in the progression of chronic disease. This 
thesis incorporates previous literature on adherence, panic-fear and self-
management interventions into the model in order to (a) investigate coping 
with asthma and (b) develop an intervention aimed at improving asthmatic 
control. 
New measures of asthmatic control and illness representations of the 
consequences of having asthma were developed in order to operationalise the 
model. 
A cross-sectional study investigated factors influencing asthmatic 
control in a sample of 35 adult asthma sufferers recruited through a single 
general practice. Coping was poor, adherence being low and less than 50% of 
participants reporting current Peak Flow monitoring or medical contact 
during the previous 12 months. Good coping appeared to be a response to 
poor asthmatic control, rather than prophylactic. Good asthmatic control was 
associated with low perceived consequences, recent medical contact, moderate 
panic-fear and low general avoidance coping. These results imply that 
asthmatic control may be improved by encouraging sufferers to maintain 
regular contact with outpatient services and to implement prophylactic 
coping. 
Since epidemiological and clinical evidence suggested asthmatic 
control to be poor in young adults, an intervention was developed to 
improve asthmatic control in this group by modifying illness representations, 
coping and panic-fear. The intervention was evaluated in a randomised 
controlled study of 50 student asthma sufferers identified initially through an 
epidemiological screening of 2,979 students. It led to increased Preventer 
medication use and Peak Flow monitoring and decreased distress over the 
condition. However, the coping process changed and asthmatic control 
improved even in the control group, perhaps because self-monitoring of 
v 
asthmatic control for the study constituted a change in coping. This 
unanticipated result was entirely compatible with the Self-Regulation Model. 
The thesis dearly demonstrates value of the Self-Regulation Model in 
understanding asthma self-management and developing clinical 
interventions. 
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PART 1: 
INTRODUCTION AND LITERATURE 
REVIEW 
2 
CHAPTER 1: INTRODUCTION 
1.1. Overview 
This thesis is concerned with the application of a psychological model 
of coping with chronic disease to: 
(1) Investigating the coping process in individuals suffering from asthma. 
(2) Intervening in order to improve asthma self-management within a 
specific clinical population: young adult asthma sufferers. 
The concepts behind the thesis came about as a result of both 
theoretical and clinical interests. On the one hand, Health Psychologists have 
recently shown a strong interest in the coping process in individuals suffering 
from chronic disease and have begun to build theoretical models postulating 
the relationships between physiology, cognitions and behaviour. 
Simultaneously, clinical concern over the impact of asthma due to poor self-
management has grown. The thesis attempts to gain insight into the 
processes involved in asthma self-management by utilising psychological 
models of coping with chronic disease. 
1.2. Historical Background 
Throughout the nineteenth century, and for the greater part of this 
century, the biomedical model of health and illness almost exclusively guided 
health care. Mind and body were considered to be two entirely separate 
entities, and it followed that all disease or physical disorder could be 
explained in purely physiological terms and treated accordingly. This 
remains the dominant model in medicine today and has been central to the 
advancement of modern-day medicine. 
However, it is becoming increasingly acknowledged that the outcomes 
of health care are not, in fact, purely biomedical, but can also be affected by 
social and psychological factors. For example, a person's health may be 
influenced by their lifestyle, personality, upbringing or beliefs, and so 
identical biomedical conditions may have different medical outcomes in 
3 
different individuals. Health Psychology emerged as a discipline primarily 
concerned with investigating the roles of such factors in illness and health. 
Health Psychologists have become concerned with health care at the 
primary (general preventative) level, the secondary level (aiming at those 
possessing risk factors for certain diseases) and the tertiary level (dealing with 
those already in a state of illness). This thesis will be concerned with tertiary 
care in that it deals with how patients who have already developed a chronic 
condition cope with that condition in their everyday lives. 
Much previous psychological research into chronic disease has taken a 
psychosomatic approach, investigating how various personality traits may 
precipitate the development of certain diseases (eg. French & Alexander, 
1941; Jones et al., 1976; Purcell & Weiss, 1970). However there are several 
problems now widely recognised with this approach (e.g. Creer, 1986; Earll, 
Johnston & Mitchell, 1993). First, the empirical data to date has shown 
conflicting results, some results supporting the hypothesised relationships 
and some opposing them. Second, causality is difficult to establish since the 
majority of studies were carried out with individuals who were already sick. 
Finally, the approach allowed no scope for clinical intervention, since 
personality traits are, by definition, stable and not amenable to change. The 
present research therefore rejects this view and is concerned instead with 
how individuals actually use their pre-existing resources and adapt them in 
response to their illness. Hence an interactive approach is taken, rather than 
the more traditional causal one. 
1.3. Aims Of The Thesis 
This thesis aims to use the Self-Regulation Model of coping with 
chronic disease (Leventhal, Nerenz & Steele, 1984) in order to investigate 
psychological factors involved in coping with asthma and to develop an 
intervention which is evaluated in a randomised controlled trial. 
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1.4. Outline Of The Thesis 
Part 1 of the thesis contains critical reviews of the literature on coping, 
adherence to recommended medication regimens and previous research into 
the role of emotions in asthma and brings together these bodies of research to 
form a comprehensive theoretical model which guides the ensuing empirical 
studies. 
Part 2 is concerned with the preparation necessary to carry out the 
empirical studies and contains three chapters. The first summarises the 
model developed in the introduction and outlines the research questions 
derived from it. The second chapter discusses the operationalisation of the 
model (using pre-existing measures where possible and describing the 
development of new measures where this was necessary) and the final 
chapter describes and critically compares the different methods of recruiting 
participants for the two studies. 
Part 3 reports on the empirical studies themselves: a cross-sectional 
study investigating the model's predictive value in a group of adult asthma 
sufferers and an intervention study aimed at improving disease outcome in a 
specific subgroup of asthma sufferers: young adults. 
The final section (Part 4) concludes the thesis by summarising the main 
results of the studies as a whole and discussing their theoretical and clinical 
implications and possible directions for future research. 
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CHAPTER 2: COPING WITH CHRONIC CONDITIONS 
2.1. Introduction 
Chronic conditions are, by definition, ongoing once developed and 
hence require lifestyle changes and constant medical attention throughout 
the course of the sufferer's life. However, they are often controllable and 
hence need not necessarily be permanently symptomatic. They form 
U ••• a stable part of the self regardless of their symptomatic nature ... " 
(Nerenz and Leventhal, 1983). 
Examples are asthma, diabetes, cancer, rheumatoid arthritis or 
permanent disability resulting from accidents, heart attack or stroke. 
In contrast, acute conditions are symptomatic and curable, while cyclic 
conditions are symptomatic but recurrent, with periods of remission being 
experienced in-between periods of aggravation. 
This chapter gives an overview of one paradigm - that of stress and 
coping - which has evolved out of a more general literature on coping and 
which has, more recently, been applied in the context of chronic disease. 
Particular reference is made to asthma where appropriate, but see Chapter 3 
for a comprehensive overview of this condition. The chapter critiques some 
general models of coping which have been developed, using previous 
psychological research into various chronic conditions as examples. Future 
chapters will look at how one of these general models, in particular, might be 
combined with other strands of research - both with asthma patients and in 
other areas - to form a basis for the ensuing investigations into coping with 
asthma. 
2.2. The Stress And Coping Paradigm 
An increasingly popular and useful way of investigating how 
individuals deal with chronic conditions concerns the concepts of stress and 
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coping identified and defined by Lazarus (1966), the founder of coping 
research. 
2.2.1. Definitions Of Stress And Coping 
Lazarus originally proposed the definition of coping as follows: 
" ... constantly changing cognitive and behavioural efforts to manage specific 
external and/or internal demands..... a person's efforts to manage demands, 
whether or not these efforts are successful. No a priori assumptions are made 
about what is good or bad coping." 
(Lazarus & Folkman, 1984). 
This definition is useful because it views coping as a process, 
incorporates any attempts to manage demands and focuses on the 
management of, rather than the abolition of, those demands. However, for 
the purposes of this thesis, the definitions used are those of Sarafino (1990), 
which follow on from this original definition. These definitions were chosen 
because they more comprehensively describe the various terminologies often 
used to describe the coping process, and distinguish between cause, process 
and outcome more precisely. The definitions are as follows: 
Stress is" the condition that results when an individual perceives a 
discrepancy between the demands of a situation and his or her own biological, 
psychological or social resources." 
Hence the amount of stress caused by a certain situation depends on the 
balance between (a) the individual's resources and (b) his/her perceptions of 
the demands of the situation. 
A stressor is "the stimulus which causes stress." 
With respect to chronic conditions, the most common stressors are 
diagnosis, the condition itself, symptoms of the condition and various aspects 
of the treatment regimen. Taylor and Aspinwall (1990) also list adverse 
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emotional reactions such as depression or anxiety, the impact of disease on 
one's social network, work or leisure-related losses/limitations and threats to 
self esteem as associated stressors. Chapter 3 presents asthma as an 
unpredictable condition with a complex, variable treatment regimen, all of 
which are potential stressors for sufferers. 
Strain is "the individual's physiological and psychological response to a 
stressor. " 
Thus strain is what lay-people generally refer to when they report that 
they 'feel stressed'. 
Coping is "any process by which the individual tries to manage the 
perceived discrepancy between the demands and resources they perceive in a 
stressful situation." 
Hence the term coping refers to any response which the individual 
carries out in an attempt to reduce stress, and in this way corresponds closely 
to the Lazarus definition. 
In the early coping literature, coping tended to be classified as 
"adaptive" or "non-adaptive" (e.g. Weisman and Sobel, 1979), but more 
recently it has become accepted that most strategies may be "adaptive" in 
certain situations but less" adaptive" in others. 
The early literature excluded various types of response from the 
definition of coping - for example, 
"physiological and emotional reactions which lack a purposive element, such 
as crying or subjective feelings of anxiety, are not included within this 
framework. " 
(Ray, Lindop & Gibson, 1982), 
However, the above definition has developed to include a wide variety 
of coping efforts, which need not necessarily lead to a direct solution of the 
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problem. For example, coping may involve correcting or mastering the 
problem, altering the perception of the discrepancy between demands and 
resources, tolerating the threat or avoiding the situation (Lazarus and 
Folkman, 1984). Carver, Scheier and Weintraub (1989) endorse this view, 
using giving up efforts to attain the goals which are impeded by the stressor as 
an example of a coping strategy. They state that although such strategies are 
not central to the original Lazarus model, they are not incompatible with it. 
In both these ways, and as suggested by both the Lazarus and Sarafino 
definitions, evaluation of the outcome of coping is irrelevant to the 
definition of coping itself. The central, defining feature of coping is the 
function it is intended to serve, i.e. reduction of stress. 
2.2.2. Functions Of Coping 
Lazarus and Folkman (1984) have maintained that coping can serve 
two main functions: reducing stress or changing the emotional response to 
the stressor. 
Problem-focused coping is aimed at reducing the perceived discrepancy 
between the demands of the situation and the individual's resources. This 
can be done either by reducing the stressor (e.g. by changing the situation) or 
by increasing the resources available for dealing with it (e.g. by learning new 
skills). 
Emotion-focused coping is aimed at controlling the emotional 
response to the stressor. 
Both functions of coping may be fulfilled by either cognitive means or 
behavioural means, or by some combination of the two. For example, 
somebody who has no money may cope by either persuading himself that 
happiness is more important than money (cognitive problem-focused coping) 
or by finding an extra job (behavioural problem-focused coping). An 
individual who is anxious following a disagreement with a friend may aim to 
reduce this anxiety by either reassuring himself that his view is right and that 
the other person is not important anyway (cognitive emotion-focused coping) 
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or by writing to or visiting the friend In order to rectify the situation 
(behavioural emotion-focused coping). 
Emotion-focused and problem-focused coping strategies can be used 
either separately or together, since any stressor may invoke stress in more 
than one way. 
2.2.3. Types Of Coping 
Another general classification of coping strategies is into approach and 
avoidance strategies (e.g. Holahan & Moos, 1985; Ray, Lindop and Gibson, 
1982). These terms refer to 
"Cognitive and emotional activity that is oriented either toward or away from 
threat. " 
(Roth & Cohen, 1986, p.813). 
Approach and avoidance strategies hence fall at either end of a 
continuum, along which all possible methods of coping lie. Many other 
researchers have supported this distinction, although the phenomenon has 
been named rather differently: e.g. as blunting-monitoring (Miller & Mangan, 
1983), attention-avoidance (Holmes & Stevenson, 1990) or repression-
sensitisation (Bell & Byrne, 1978; Gudjonsson, 1981). Most coping 
measurement tools incorporate this concept, containing items to measure 
both approach and avoidance coping (see Chapter 7 for a discussion of such 
measures). 
Studies concerning the relationship between approach or avoidance 
coping and adjustment have shown varied results. In general, however, 
studies concerned with coping with chronic disease have found avoidant 
coping to be associated with poor adjustment. For example, Felton and 
Revenson (1984) found various approach coping strategies to be associated 
with good emotional adjustment (i.e. lower negative affect) while avoidant 
coping was associated with indicators of poor adjustment. These findings 
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held for patients with each of four chronic conditions: blood cancer, 
hypertension, diabetes and arthritis. 
However, the nature of the stressor may influence the relative 
effectiveness of the two types of coping. For example, Roth and Cohen (1986) 
have suggested that the effectiveness of approach or avoidance coping 
depends on the controllability of the stressor, approach coping being best for 
controllable conditions such as asthma, diabetes and some cancers while 
avoidance coping is more effectiveness for uncontrollable conditions such as 
paralysis. 
Suls and Fletcher (1985) compared avoidant and non-avoidant (rather 
than "approach") coping strategies in a meta-analysis of 43 previous studies 
and their results agreed with those of Holmes and Stevenson. Overall, 
avoidant strategies showed more favourable outcomes when used to cope 
with short-term stressors, while enduring stressors were best coped with 
using approach strategies. For example, it may be best to ignore a mild, 
headache, since headache is often transitory and a visit to the doctor might be 
wasted if there was nothing they could do about it. However, if the headache 
persists for any length of time, especially if it increases in intensity, then the 
more adaptive strategy would be to visit a doctor in order to determine any 
underlying cause before permanent damage becomes a possibility. 
Holmes and Stevenson (1990) have provided evidence that the 
persistence of the stressor is also important. In their study of 30 chronic and 30 
recent-onset pain patients, the use of approach coping strategies was more 
adaptive than use of avoidance coping strategies for the chronic patients but 
not for the recent-onset patients. 
2.2.4. Coping Strategies 
There are many possible strategies by which approach and avoidance 
coping can be carried out to fulfil both problem-focused and emotion-focused 
functions. Researchers have thus found it useful to go beyond the simple 
dichotomy of problem-focused and emotion-focused coping (Taylor and 
11 
Aspinwall, 1990). From many lines of previous research, some common 
coping strategies have been found (Sarafino, 1990), including the following: 
Direct action involves doing something specific to cope with a stressor. 
This method of coping is approach-based and generally serves a problem-
focused function. For an asthma sufferer, direct action might involve getting 
rid of a pet which causes an allergic reaction, for example. 
Seeking information involves searching for information about the 
stressor in order to understand it better and perhaps allow for a new 
perspective on the problem, and can fulfil either problem-focused or 
emotion-focused functions. This, too, is an approach method of coping. 
Hence an asthma sufferer might approach a GP for information leaflets 
concerning the physiological, practical or emotional aspects of the illness. 
Turning to others is an approach method of coping which can fulfil 
both problem-focused and emotion-focused functions, since individuals may 
be approached for either practical or emotional support. Asthma sufferers 
might, for example, join an organisation such as the National Asthma 
Campaign in order to gain some support from other sufferers. 
Resigned acceptance occurs when the individual simply learns to live 
with the stress caused by a situation. This is an avoidance strategy which can 
be especially useful in serving an emotion-focused function in cases where a 
situation is unchangeable and brings about emotional discomfort, s discussed 
above. 
Emotional discharge is demonstrated when people express their 
feelings to reduce tension - for example, by screaming out loud or making 
jokes. Such coping strategies would have been discounted by early coping 
researchers on the grounds that they "lack a purposive element". However, 
for present purposes such responses are valid coping strategies since they 
relieve emotional stress. Other methods of coping in this way are the 
behavioural strategies alcohol and non-therapeutic drug consumption (e.g. 
Carver, Scheier & Weintraub, 1989). 
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Intrapsychic processes refer to the use of cognitive strategies to 
reappraise stressful situations. So, for example, people may redefine their 
problem by making downward comparisons to others who are worse off 
(Taylor and Aspinwall, 1990), denial (first described by Freud, as a defence 
mechanism), intellectualisation or suppression - the deliberate attempt to put 
something out of mind. These strategies form the most common avoidance 
strategies of coping, although avoidance strategies may also be behavioural in 
nature - for example, taking one's mind off a stressor by going to the cinema 
etc. (Carver, Scheier & Weintraub, 1989). 
2.2.5. Coping Styles 
Sarafino (1990), in his review and summary of previous literature, 
notes two important findings on the way individuals cope with stress: 
(1) Individuals tend to be consistent in the way they cope with a particular 
type of stressor. 
(2) Individuals' efforts to cope with a stressor typically involve a combination 
of strategies. 
Therefore each individual possesses his or her own unique coping 
style, comprising the combination of coping skills available and utilised in 
different circumstances. 
2.2.6. Measurement Of Coping Strategies 
The measurement of coping strategies is discussed fully in Chapter 7. 
2.3. Models Of Coping With Chronic Conditions 
The original model proposed by Lazarus (1966) maintained that stress 
comprises three sequential processes: primary appraisal, secondary appraisal 
and coping. During primary appraisal, threat is perceived towards the self. 
Secondary appraisal follows, and involves selecting a potential response to 
the threat. Finally, coping is the behavioural process of carrying out the 
planned response. An additional process occurs following the carrying out of 
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coping strategies: reappraisal, i.e. re-assessment of the situation and of how 
effective the coping strategies have been. This basic model has been updated 
by many researchers in order to apply it to chronic disease. 
2.3.1. Crisis Theory (Moos. 1982) 
Crisis theory describes factors which may influence an individual's 
adjustment to the first phase of a crisis, which may include the diagnosis of a 
chronic condition, or adjustment to a new treatment regimen. A schematic 
diagram of this process is shown in Figure 2.1. The outcome of a crisis is 
hypothesised to depend on the coping process, which in turn depends on the 
individual's illness and personal, developmental, physical, social and 
environmental factors. For example, the seriousness of the illness and the 
visibility of its symptoms may affect how the individual copes, as might the 
person's medical history, family background, resistance to illness and social 
support systems. 
The model proposes the coping process itself to consist of three 
components, the relative importance of each being unique to the individual: 
(1) An appraisal of the illness. The individual decides exactly what the 
illness means to him/herself. This could involve the necessity for dealing 
with the symptoms and the limitations they impose, adjusting to the 
treatment regimen and developing and maintaining relationships with 
medical practitioners. On an emotional level, the individual may perceive a 
need for maintaining emotional balance, self-image, and social relationships 
while preparing for an uncertain future with the illness. This stage 
corresponds to primary appraisal in the Lazarus model. 
(2) Formation of adaptive tasks. The individual decides how to go about 
tackling the problems caused by the illness. This stage corresponds to 
secondary appraisal in the Lazarus model. 
(3) Coping skills. The individual uses his coping skills to perform these 
adaptive tasks. This stage corresponds to coping in the Lazarus model. 
Figure 2.1: Crisis Theory (Moos, 1982). 
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Crisis Theory is useful in that it specifies how the coping process may 
influence the outcome of a crisis. However, it is a general model which has 
not extensively been applied to health research, it focuses only on acute crises 
or the early stages of chronic stressors and it does not specifically define the 
role of emotions in the coping process after the initial appraisal stage. Hence 
it was not suitable for use in the current research. 
2.3.2. The Self-Regulation Model (LeventhaL Nerenz & Steele, 1984) 
Perhaps the most comprehensive and extensively researched model of 
coping with chronic disease, and the one upon which the remainder of this 
thesis will be based, is the Self-Regulation Model. This model shares some of 
the important features of the Lazarus model and Crisis Theory, but is more 
detailed and treats coping as a continuous, dynamic process. The research 
behind the model first began with an investigation into the effects of fear 
messages on preventive health behaviours (e.g. Leventhal, 1970; Leventhal, 
Singer & Jones, 1965) and short-term adaptation to noxious stimuli and 
attempts were then made to apply the same principles to acute illness 
episodes and, finally, chronic illness. The model has previously been referred 
to as the "Parallel Processing Model", an "Information Processing Model" and 
a "Commonsense Model of Illness Representations" (Nerenz and Leventhal, 
1983). 
a. Underlying assumptions of the model. 
The Self-Regulation Model is based on four assumptions (Leventhal, 
Nerenz and Steele, 1984): 
Active processing. Behaviour and experience are assumed to be shaped 
by an underlying information processing system which integrates current 
stimulus information with memories in an episodic manner. 
Parallel processing. It is assumed that the processing system is divided 
into two pathways - one concerned with the individual's perceptions of the 
objective features of the condition and one with the emotional responses the 
condition evokes - which occur simultaneously but are also capable of 
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interacting. Note that this is in line with the distinction between problem-
focused and emotion-focused coping made by Lazarus, and more explicitly 
defines the appraisal stage in Crisis Theory and primary appraisal in the 
Lazarus model. 
Stages in processing. The coping process occurs in stages, at both 
objective and emotional levels. 
Hierarchical processing. All processes may occur at either abstract or 
concrete levels. Each process may be conceptualised as a series of layers going 
from highly abstract material at the top to more concrete, situationally bound 
material at the bottom (Nerenz & Leventhal, 1983). Concrete levels are 
formed from perceptual memories combined with information, while 
abstract levels are generally more interpretative in nature and the two levels 
may either support each other or may contradict each other and lead to yet 
more stress. With asthma, this distinction may be best demonstrated by the 
example of the patient who, despite being diagnosed as having asthma and 
accepting this diagnosis, feels no symptoms for the majority of the time. At 
an abstract level, the patient may know he or she has asthma, and that this is 
an ongoing condition, yet feels well, and this conflict in information may 
cause further stress. 
b. Summary of the Self-Regulation Model 
The first stages of the model involve the individual first perceiving the 
situation (as in the models of Lazarus and Moos), then integrating this 
perception into memories of previous experience. 
Two conscious processes are then initiated, each consisting of a series of 
three stages, and corresponding to problem-focused and emotion-focused 
functions and, to a degree, to the two aspects of appraisal in Crisis Theory. On 
a practical level, the individual builds a conscious representation of the 
medical condition as he/ she perceives it, then uses this representation to plan 
appropriate coping responses. Once these responses have been carried out, 
the impact of the coping is assessed and the process is amended and repeated 
to take into account the new state of affairs. 
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Meanwhile, on an emotional level, the individual becomes aware of 
his/her emotional reaction to the condition and plans and executes coping 
strategies to deal with this reaction, then, as in the objective case, evaluates 
the impact of the coping and re-assesses the new emotional situation. 
Although the model has previously been termed the "Parallel 
Processing Model", it is becoming increasingly acknowledged that the 
emotional and objective pathways are not independent; rather, the outcome 
of one may affect the other and vice versa (e.g. Leventhal, Diefenbach & 
Leventhal, 1992; Leventhal, Nerenz & Steele, 1984). Emotions may influence 
responses to illness in several ways, including (a) affecting the onset and 
progress of the disease (an indirect effect), (b) increasing the difficulty of self-
diagnosis and the decision to seek care by adding emotional symptoms to the 
physical ones, (c) altering attention to/interpretation of somatic states and (d) 
affecting behavioural decisions (Leventhal, Diefenbach & Leventhal, 1992). 
At the same time, each component of the illness representation may induce 
its own emotional response, at either an abstract or a concrete level. 
However, there appears to be some uncertainty and contradiction regarding 
the existence of this relationship: Leventhal (1990) states that 
"Studies .... strongly suggest the partial if not complete separation of the 
mechanisms and processes underlying the generation and control of emotion 
and the processes involved in the generation of perception and cognition for 
the control of danger." 
(p.29). 
Hence research is required into the exact nature of the relationship 
between the two pathways proposed by the model (see also p.34). 
The model can be seen in its full form in Figure 2.2. The individual 
components will now be discussed in greater detail, with particular reference 
to how they might relate to the coping process in asthma sufferers. 
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c. Components of the Self-Regulation Model 
The components of the model will now be discussed more fully, in 
turn. Previous research findings will be described where appropriate and 
possible scenarios for asthma sufferers will be used by way of example. 
Component 1: Perception of the illness. The individual who is 
suffering from a medical condition will perceive certain bodily symptoms and 
signs. These will depend on the objective details of the condition as well as 
previous illness experiences, both with the same condition and with other 
conditions. Two people with exactly the same objective condition may thus 
perceive it very differently. 
Component 2: Integration of perceptions with memory. The 
individual's perceptions will be incorporated into their existing schema. This 
process will again be affected by the individual's past experience with illness, 
and also by factors such as information previously obtained from medical 
professionals, family, friends, health education campaigns etc. 
Components 1 and 2 are hypothesised to be pre-attentive, i.e. not under 
conscious control of the individual. Perhaps because of the difficulty in 
assessing such unconscious processes, they are generally not taken account of 
in research using the Self-Regulation Model and there is very little 
understanding of the mechanism of these processes and their roles in the self 
regulation process. 
Component 3: Representation of illness in conscious awareness. For 
any illness, the individual, whether suffering the illness personally or not, 
constructs a mental representation of the condition, i.e. gathers together all 
the information available concerning the condition so that it can be assessed. 
The resulting set of beliefs is termed the illness representation. 
Illness representations have been the subject of extensive 
investigation, both by the proposers of the model and by subsequent 
investigators (Croyle & Barger, 1993). They have been investigated primarily 
using semi-structured interviews including open-ended questions about 
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various illnesses and' analysing the responses obtained. They have often been 
referred to as "commonsense", or "implicit" models of illness and Leventhal 
and his colleagues have investigated these models in patients with conditions 
such as hypertension (Meyer, Leventhal & Gutmann, 1985) and cancer 
(Nerenz et al., 1984; Nerenz, Leventhal & Love, 1982). Following these 
studies, they identified four basic components of peoples' representations of 
disease (see Leventhal & Nerenz, 1985 for full details of the various 
methodologies used): 
Identity, consisting of the symptoms of the illness plus the label given 
to it. For example an individual who wheezes intermittently may label his or 
her condition as asthma or may simply see it as a breathing problem. It 
should be noted that in many cases the label will be derived following a 
consultation with the doctor; however a label may also be given if the other 
components of the illness representation match the illness representation of a 
condition suffered previously, either by oneself or by acquaintances. 
Cause. The illness representation includes the patient's hypotheses 
about the cause of the condition. In the case of asthma, patients might hold 
beliefs about causes of (a) the condition and (b) exacerbations. So, for example 
an individual might believe that his/her condition was originally caused by 
catching a common cold at an early age, and that symptoms are provoked by 
cold weather. Cognitive representations of the causes of illness have, over 
recent years, become of interest to researchers in their own right in the field of 
causal attributions. A full review of the causal attribution literature is beyond 
the scope of this thesis because this variable is only one of a large set of 
variables of interest; for a comprehensive review the reader is referred to 
Croyle and Barger (1993) and Gudmundsdottir (1995). 
Consequences. The patient generally holds beliefs about what the 
short- and long-term consequences of the illness might be: for example, an 
asthma sufferer may believe that sport is never possible with asthma, or that 
all pets must be avoided. 
Time line forms part of the illness representation, i.e. individuals tend 
to hold implicit ideas about how long an illness takes to develop and whether 
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it is acute, chronic or cyclic. This can be particularly interesting with asthma, 
since it can be asymptomatic for periods of time, so many believe it to be a 
short-lived but recurrent condition, rather than chronic. 
Lau and his colleagues attempted to replicate these five illness 
representation components and found that in a group of 270 undergraduates, 
illness representations of the last time they were sick (the exact definition of 
'sick' not being given) did fall into the same domains that Leventhal had 
described, but also into a fifth domain - that of cure (Lau, Bernard & 
Hartman, 1989; Lau & Hartman, 1983). Goldman et al. (1991) have verified 
that these same five components also hold true for children in a study of 27 
children asked pre-structured questions about these aspects of common colds 
and fevers. These findings are likely to be due to acute, rather than chronic 
conditions being the focus of each of these studies. 
The illness representation an individual holds of a particular illness is 
proposed to be the product of several influences (Leventhal, Meyer and 
Nerenz, 1980; Leventhal, Nerenz and Steele, 1984), including: 
Bodily experiences connected with the illness or other current 
activities. 
Personal illness experience. An individual's previous experiences with 
illness (both personal and that of others) will influence the illness 
representations held. Hence illness representations may be influenced by 
episodic memory (Leventhal & Cameron, 1987). 
General information current in the individual's culture. The 
individual will develop beliefs about illness which are influenced by general 
cultural beliefs and mayor may not be correct. For example, cultural attitudes 
towards diseases such as AIDS may influence individuals' illness 
representation of this condition. In this way, semantic memory can also 
influence illness representations (Leventhal & Cameron, 1987). 
Social communication can operate in a number of ways to influence 
illness representations, but mainly involve the individual sharing the details 
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of an illness with others and information being exchanged. As well as family 
members and others in the individual's social circle, the doctor-patient 
relationship may be important in this area, as may the media and the views 
represented therein. 
Bishop and his colleague have investigated relationships between 
illness representations of different conditions (Bishop, 1991a; Bishop, 1991b; 
Bishop & Converse, 1986; Bishop et al., 1987). Their work has shown that 
individuals tend to categorise illnesses in terms of features such as 
contagiousness and seriousness and that certain conditions are seen as 
prototypes of each category. Hence when a new condition is encountered, the 
resulting illness representation will be based on illness representations 
already held concerning the prototype illnesses. 
Once formed, illness representations can change over time, through 
new experiences of any of the above influences. Most research has been 
carried out on changes in illness representations due to either time or 
personal experience (either first-hand or in others) of the condition of 
interest. For example, there is evidence that most illnesses are seen as being 
acute up to and immediately after diagnosis, although later on a more chronic 
model may be adopted (Nerenz and Leventhal, 1983). 
Marteau (1985) found that parents' illness representations of various 
chronic conditions (asthma, diabetes and epilepsy) were changed by their own 
child suffering from one of the conditions. Parents viewed the condition 
their own child suffered from as less serious than the other two conditions; 
hence the experience of illness appeared to modify the illness representation. 
Johnston et al. (1990) describe a series of studies examining changes in 
perceptions of seriousness and perceived controllability of an illness suffered 
by a close family member. In a cross-sectional study of 130 parents of 65 
children aged between 5 and 16 years old, parents perceived the condition to 
be more serious the longer the time since diagnosis. The seeming anomaly 
between this and the results of the Marteau (1985) study is not irreconcilable 
since the former study assessed differences between illness representations of 
different conditions (however long the relevant condition had been suffered 
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by the child) while the latter included only illness representations of the same 
condition and investigated the effects of time since diagnosis. 
Recently, innovative new directions have been taken in investigating 
influences on illness representations. For example, some U.s. researchers 
have begun to use experimental research designs, where individuals are 
informed, following a saliva test (administered as part of a battery of research 
tools), that they possess a risk factor for a pancreatic condition (this risk factor 
is, in fact, fictitious). Illness representations of this condition are then elicited 
by questionnaire. By randomly allocating participants to different diagnoses 
(at risk/not at risk) and giving them different information about the 
condition prior to the saliva test, the effects of such variables can be 
examined. Croyle and his colleagues (Croyle & Ditto, 1990; Croyle & Jemmott, 
1991) report on a series of such experiments, which show that altering the 
perceived prevalence of the condition influences the illness representation 
formed of that condition (perceived seriousness of the condition was greater 
if the individual had been led to believe that its prevalence was low). 
In addition to changing over the course of an illness, and as a result of 
knowledge obtained about a condition, illness representations, coping and 
appraisals are hypothesised to change as an individual moves between places 
and between roles. 
Nerenz and Leventhal (1983) report that a person's illness 
representation may be incorporated into the self-system in at least three ways. 
For some, the disease and the self may be completely inseparable, every aspect 
of the individual's life incorporating the illness. For others, the condition 
may be merely a component of the self, while there are disease-free 
components too. This is seen to be the most desirable state in most cases. In a 
third group, the self faces the constant threat of outbursts of acute, 
symptomatic illness and many of the individual's actions are carried out in 
order to minimise the constant threat of impending illness. This is the most 
desirable state in chronic conditions such as asthma. 
Component 4: Coping with the objective features of the illness. 
Coping is the next stage in the Self-Regulation ModeL The individual's 
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illness representation influences the coping strategies carried out (Nerenz and 
Leventhal, 1983). 
A general example from asthma research could be tbat individuals 
who believe that a consequence of having asthma is that life will always be 
restricted may be less likely to use various coping responses when they find 
their life restricted by their condition. Another example is that those who 
believe asthma to be controllable may be more likely to take the prescribed 
medication than those who do not. 
Component 5: Appraisal of the objective impact of coping. Once the 
individual has assessed the situation and taken what are considered to be 
appropriate coping actions, the situation must be reappraised in order to 
evaluate whether the coping responses have brought about the desired 
outcome (Le. reduced the stress), or whether some or all of the procedure 
must be modified or repeated. This evaluation process may lead either to a 
modification of the illness representation, or to the use of a different coping 
strategy. An example could be the asthmatic patient who believes asthma to 
be an acute illness. When a period of exacerbated symptoms is experienced, 
the patient may take the prescribed medication and expect that the illness will 
go away. Because of the chronic nature of asthma, the symptoms may be 
temporarily relieved, but eventually they will return. This requires the 
individual to reappraise the situation, and it may be accepted that asthma is a 
chronic condition, after all (Le. the illness representation becomes modified); 
alternatively, the original illness representation may persevere but the 
individual may try taking higher doses of medication, or consulting the 
doctor more often, in an effort to control the symptoms. 
Note that appraisal in this sense is a very different concept to primary 
appraisal in the original Lazarus model. In this case, it refers to the appraisal 
of outcomes of coping, while in the Lazarus model it referred to appraisal of 
options for coping, (the corresponding process to Leventhal's appraisal being 
reappraisal ). 
Component 6: Emotional reaction to illness. As well as coping with 
the stress caused by the objective features of their illness, patients also 
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experience emotional reactions to the condition which are a further source of 
stress and hence must be coped with. Less research has been done into this 
branch of the model; however, it is assumed that the individual becomes 
aware of these emotional responses and plans coping responses accordingly. 
Component 7: Coping with the emotional reactions to the illness. Just 
as they are used to cope with the perceived objective features of the illness, 
coping strategies are also employed in an attempt to alleviate the emotional 
reactions evoked by the condition. For example, an individual who becomes 
distressed due to symptoms may decide to visit the doctor, even if he or she 
feels fairly confident of the diagnosis in advance. Such coping would serve 
an emotion-focused function. 
Component 8: Evaluation of the change in distress. As for the 
objective coping, the impact of the coping responses aimed at reducing 
emotional reactions to the illness is appraised and a decision taken as to 
whether the coping efforts were adequate, or whether further action is 
needed. Again, this appraisal might lead to an alteration in the emotional 
reactions themselves, or to the implementation of an alternative coping 
strategy. 
Interactions and feedback loops. Every stage of the coping process can 
influence almost every other stage, as suggested by the feedback loops between 
the above components of the model. 
So, for example, an appraisal of the self-regulatory system as inadequate may 
lead to updating of either the illness representation or the coping strategies 
used. Similarly, the process of implementing a new coping strategy to deal 
with the emotions caused by illness may reduce the emotions or, even if it 
does not, may cause the individual to appraise the coping more positively. 
c. Critique of the Self-Regulation Model. 
Several aspect of the Self-Regulation Model - both positive and 
negative - warrant further discussion: 
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Coping is viewed as a process. As with Lazarus' original formulation, 
the Self-Regulation Model considers coping as a continuous process, rather 
than a series of independent events. Hence the model is of clinical use 
because it offers many possible targets for intervention in the coping process. 
The model is compatible with previous bodies of research. The Self-
Regulation Model has developed from the strong, broader basis of coping 
literature, viewing chronic diseases as particular types of stressor. It 
incorporates earlier coping theories - for example, it incorporates the earlier 
concepts of problem-focused and emotion-focused coping. It is also 
compatible with general theories of cognition, since it proposes illness 
representations to be structured according to environment, experience, etc. 
(Skelton & Croyle, 1991) and to be involved in determining how the 
individual interacts with the world. Hence the model has the advantage of 
fitting into the more general psychological literature as well as into general 
coping theory. 
Supporting experimental evidence. A great strength of the Self-
Regulation Model is that there is a significant amount of evidence supporting 
the hypothesised relationships between variables. Several anecdotal 
examples have already been given above, by way of illustration of various 
aspect of the model; research findings will now be discussed. By far the 
majority of the research has been carried out into the "objective" pathway of 
the model, and in particular into illness representations - hence the focus of 
this discussion. It should also be noted that almost all the studies have been 
cross-sectional in design; where longitudinal methodology has been used, this 
is made clear. 
Leventhal and his colleagues have produced a wealth of evidence to 
support the hypothesised relationships between the variables in their model, 
and in particular between illness representations and coping. For example, 
Meyer, Leventhal and Guttman (1985) studied 230 hypertensive patients and 
found that those who held an acute illness representation of their condition 
were less likely to cope by continuing with the recommended treatment than 
those who believed it to be chronic. 
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Nerenz, Leventhal & Love (1982) studied 61 patients with malignant 
lymphoma who were being treated by chemotherapy. They found that the 
number of side effects an individual associated with the chemotherapy was 
significantly related to coping efforts, although they do not specify more 
clearly how coping was assessed. 
Prohaska et al. (1987) carried out an experimental study with a sample 
of 1,280 adults. Participants were asked how they would cope in several 
hypothetical scenarios concerning symptoms with varying severity, duration 
and label. Coping was measured by their own measure. The results showed 
that perceived severity had the most significant effect on coping, being 
associated with higher levels of self-care behaviours (rest and relaxation) and 
use of health services (calling a doctor for an appointment/using emergency 
services). Symptoms of longer duration were also associated with an increase 
in seeking medical care. Having a label for the condition had no significant 
effect on coping, however. 
Hampson, Glasgow and Toobert (1990) found that in a group of 46 
women (mean age 64 years) with non insulin dependent diabetes mellitus, 
recruited through general practices, perceived seriousness and importance of 
treatment was associated with coping by self-reported exercise and restricted 
diet over the seven days prior to the interview. 
Payne (1990) found that beliefs about treatment and causes of breast 
cancer in a group of 268 healthy women were related to coping as measured 
by self-reported breast self-examination. This study is slightly different in that 
it deals with a potential health threat, rather than an illness which has 
already developed, but since it is concerned with a chronic disease it was 
considered worthy of mention here. 
Lau, Bernard & Hartman (1989) demonstrated that, for a range of 
common illnesses, those who possessed strong identity and cure components 
in their illness representation were more likely to cope by consulting a doctor 
when ill. It could, conversely, be hypothesised that those who believe there is 
no cure for their condition might tolerate many more symptoms before 
visiting a doctor. 
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In a longitudinal study carried out with 233 chronic fatigue syndrome 
patients (Moss-Morris, Petrie & Weinman, 1995; Weinman, 1994a; Weinman, 
1994b; Weinman et al., 1995), several significant relationships between illness 
representations (measured using the IPQ; see Chapter 7) and coping 
(measured using 12 of the COPE scales; see Chapter 7) were found. These 
relationships are summarised in Table 2.1. In addition, the study found 
perceived identity and consequences of CFS to be predictive of the number of 
non-scheduled visits to the GP during the subsequent 3 months (Weinman et 
al., 1995). 
Table 2.1.: Significant correlations between illness representations and 
coping in the CFS study by Moss-Morris, Petrie & Weinman (1995). 
ILLNESS COPING STRATEGY (COPE) r 
REPRESENTATION 
COMPONENT (lPQ) 
Chronic timeline Suppression of competing activities O.IS** 
Behavioural disengagement -0.22*** 
Emotional attributions Behavioural disengagement 0.19** 
Strong identity (i.e. belief in Venting of emotions 0.24*** 
many associated symptoms) Behavioural disengagement 0.20** 
Planning 0.22** 
Serious consequences Venting of emotions 0.20** 
Mental disengagement 0.24** 
Suppression of competing activities O.IS** 
Seeking of social support for emotional 
reasons O.IS** 
Planning 0.22** 
Internal controIl cure Active coping 0.34*** 
Planning 0.30*** 
Positive reinterpretation 0.25*** 
Behavioural disengagement -0.22*** 
** ~<0.01 *** ~<0.001 
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Weinman et al. (1995) report on a study of M.l. patients which 
demonstrated significant correlations between the number of non-scheduled 
visits to the GP in the previous 3 months and (a) number of symptoms 
believed to be associated with the condition, (b) perceived timeline of the 
condition and (c) perceptions of the consequences of the M.L 
Earll and Johnston (1994) carried out two longitudinal studies of 
multiple sclerosis sufferers and found that a strong "identity" for the 
condition 6 weeks after diagnosis was positively correlated with coping by 
seeking information and social support 12 months after diagnosis. Similarly, 
the initial belief that the disease had strong consequences was significantly 
. correlated with coping by taking positive actions at the latter time point. 
Studies concerning the relationship between emotional reactions to 
illness and coping with asthma are discussed in Chapter 4. Little research has 
been carried out on appraisals of coping, either concerning coping with the 
objective features of the illness or coping with the emotional reactions it 
provokes. 
Lack of outcome measures. One weakness of the Self-Regulation 
Model is that it does not explicitly state how illness outcomes and emotional 
adjustment are incorporated into the coping process. In order to hypothesise 
a place for such variables within the model, it is necessary to turn to previous 
research findings on their relationships with the variables of the Self-
Regulation Model. The results of such studies have demonstrated links 
between (a) illness representations and illness outcomes / emotional 
adjustment and (b) coping and illness outcomes/emotional adjustment. 
Again, the majority of these studies are cross-sectional unless otherwise 
stated. 
For example, Partridge and Johnston (1989) demonstrated the former 
relationship by showing perceived personal control over recovery to be 
predictive of residual disability in longitudinal studies of both stroke and 
wrist fracture patients. Morrison, Johnston and MacWalter (1994) replicated 
this finding in a larger sample of stroke patients. 
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Meyer, Leventhal & Guttmann (1985) carried out a longitudinal study 
and found a predictive relationship between coping and illness outcome. 
Individuals with hypertension who reported taking their medication as 
recommended were more likely to have their blood pressure controlled six 
months later than those employing other coping strategies. Furthermore, 
both coping and illness outcome were associated with illness representations 
(see p.26). 
Frenzel et al. (1988) found that high levels of coping (both approach 
and avoidance) were associated with poor glycemic control in a cross-sectional 
study of 39 adults with insulin-dependent diabetes mellitus. Coping was 
assessed using the Coping Responses Indices (Moos et al., 1983) and glycemic 
control from two sources: blood samples and self-administered glucose test 
results recorded by patients in a diary. The authors therefore suggest that 
increased coping may be the result of poor glycemic control, rather than the 
cause. 
Rosenstiel & Keefe (1983) carried out a study of 61 individuals with 
lower back pain and found that the coping strategies cognitive coping and 
suppression and diverting attention and praying (derived by factor analYSis 
of eight coping strategies identified from previous research) were associated 
with functional capacity as assessed by an activities of daily living 
questionnaire. 
Maes and Schlosser (1987; 1988a) examined the influence of asthma-
specific coping strategies (measured using the Asthma Coping Questionnaire; 
see Chapter 7) on various outcome measures in a sample of 397 asthma 
patients aged between 16 and 74 recruited through four hospitals. They found 
that coping by reacting emotionally in attack situations and maintaining a 
restrictive lifestyle explained a significant proportion of the variance in the 
number of days absent from work due to asthma. Maintaining a restrictive 
lifestyle was also associated with the amount of medicine taken per day and 
coping by focusing on asthma contributed to the explanation of the number 
of hospital visits during the past year. In all cases the coping variables 
contributed to the explanation of the outcome variable in addition to the 
reported level of asthma symptoms. 
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Taylor, Lichtman & Wood (1984) have shown associations between 
illness representations and emotional adjustment in a sample of 78 women 
with breast cancer. Beliefs about control over the condition were significantly 
associated with adjustment: those who believed the condition to be 
controllable (either by oneself or by others) showed better adjustment than 
those who perceived the condition as uncontrollable. In this study, 
adjustment was measured using a scale derived from items from 10 different 
measures of various types of adjustment, using factor analytic techniques. 
Weinman et al. (1995) found significant correlations between illness 
representation (assessed using the Illness Perceptions Questionnaire; see 
Chapter 7) and both disability (measured using the Sickness Impact Profile; 
Bergner et al., 1981) and health distress in a sample of M.l. patients. High 
levels of disability were associated with a strong identity to the condition (Le. 
associating many symptoms with it) and belief in severe consequences to the 
condition. Health distress was associated with the same two variables and 
also with the perception of M.l. as chronic. 
Felton, Revenson and Hinrichsen (1984) studied individuals suffering 
from either hypertension, diabetes, blood cancer or rheumatoid arthritis and 
found that different coping strategies (measured using an adapted version of 
the WOCC; see Chapter 7) were associated with different levels of emotional 
adjustment (measured using the Bradburn Affect Balance Scale; Bradburn, 
1969). Cognitive coping strategies were associated with positive affect while 
emotional coping strategies were associated with negative affect. 
Dunkel-Schetter et al. (1992) found that coping through social support, 
focusing on the positive or distancing was associated with low emotional 
distress in a sample of 603 cancer patients. Coping by cognitive or 
behavioural escape/avoidance was associated with higher distress levels. 
Coping was measured using a version of the WOCC (see Chapter 7) adapted 
for use with cancer patients and distress with the bipolar version of the 
Profile of Mood States (Lorr & MCNair, 1982). 
Nerenz, Leventhal & Love (1982) found that individuals in their 
malignant lymphoma study who believed that their nausea was associated 
32 
with the cure, (chemotherapy) rather than the condition, showed higher 
levels of distress. In a larger study, including 121 individuals with either 
metastatic or adjuvant breast cancer or malignant lymphoma, the number of 
perceived side-effects of treatment was associated with distress levels, those 
perceiving more side-effects reporting more distress (Nerenz et al., 1984). In 
particular, perceptions of vague, ongoing side-effects (e.g. tiredness) were 
more likely to be associated with high distress than were perceptions of more 
specific side-effects such as nausea and hair loss in the malignant lymphoma 
and metastatic breast cancer patients. In this study, coping with the side-
effects of treatment was also related to distress: the overall number of coping 
strategies used was correlated with distress, as was the number of coping 
strategies which had been tried which were perceived to have failed. 
Bombardier, D'Amico & Jordan (1990) carried out a study of 101 
patients with various chronic conditions (including primarily neurological, 
cardiovascular, gastroenterological and psychiatric complaints) to examine 
the relationship between coping (assessed using a revised version of the 
WOCC) and depression (measured by the Carroll Depression Rating Scale; 
Carroll et al., 1981). Their results showed that emotion-focused coping was 
associated with poor psychological adjustment and high levels of depression. 
Hence it is postulated for the purposes of the current research that 
illness outcomes and emotional adjustment are the result of coping efforts. 
Earll and Johnston (1994), Johnston (1994) and Weinman (1994a; 1994b) have 
also taken this approach in their recent work, carried out since the current 
studies were planned. This addition is in line with Crisis Theory (see p.13) 
and can be seen in the adapted version of the Self-Regulation Model 
presented in Chapter 6. Following from this, it would then appear logical to 
postulate that illness outcomes and emotional adjustment may guide the 
individual's appraisals of the coping efforts. 
However, very recent studies by the above authors, using such an 
updated version of the model and examining all four of these variables 
(illness representations, coping, illness outcome and emotional adjustment), 
have found rather surprising results. Instead of supporting the hypothesis 
that illness representations predicted coping, which in turn predicted illness 
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outcomes/ emotional adjustment, three studies have found the direct 
relationship between illness representations and illness outcomes/emotional 
adjustment to be greater than the relationship between coping and these 
variables. 
In the first study, already mentioned above, Moss-Morris, Petrie and 
Weinman (1995) found the four components of illness representations 
(measured using the IPQ; see Chapter 7) to be significantly predictive of 
physical dysfunction (measured using the Sickness Impact Profile; Bergner et 
al., 1981) in chronic fatigue syndrome patients, predicting 37% of the 
variability in a multiple regression. Coping, measured using the COPE scales 
(see Chapter 7) was, in comparison, predictive of only 19% of the variance in 
this variable. 
In the Earll and Johnston (1994) longitudinal multiple sclerosis study, 
illness representations and coping were assessed using structured interviews, 
the results of which were coded by two raters and all showed inter-rater 
reliability of 0.89 or above. Illness outcome (disability) was measured using 
opes guidelines and emotional adjustment using the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983). When both concurrent 
and predictive correlations between the variables were examined, no 
significant associations were found between coping and disability/emotional 
adjustment, but many significant correlations were found between illness 
representations and these outcome variables. The strongest result found was 
that identity and perceived consequences were significantly positively 
correlated with both disability and emotional adjustment. Those who had 
the correct label for their condition were less disabled and less emotionally 
distressed than those who did not know what their condition was. 
Individuals who scored high on the 'consequences' component of their 
illness representation were also likely to show better outcomes. Since this 
study included longitudinal data, it is suggestive of a causal time pattern, in 
that not only are these variables associated, but illness representations precede 
outcomes. 
A further study by the same authors has demonstrated similar results. 
Earll, Johnston & Mitchell (1993) investigated the relationship between illness 
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representations and coping in a sample of 50 individuals suffering from 
motor neurone disease. Measurement of illness representations and coping 
was carried out using the semi-structured interviews developed in the 
multiple sclerosis study. Individuals who believed their condition to have 
very serious consequences showed significantly higher levels of anxiety and 
depression (measured using the HADSi Zigmond & Snaith, 1983) and 
significantly lower well-being (measured using the Bradburn Well-being 
affect/balance scale; Bradburn, 1969) than those perceiving their condition to 
have less serious consequences. 
Feedback loops. The extensive use of feedback loops in the model 
means that the relationship between any two (or more) variables may be 
investigated. This has both advantages and disadvantages. The advantage is 
that it allows many different relationships between variables to be explored. 
For example, recently interest has been taken into the relationship between 
illness representations and emotional outcomes (see above) - processes which 
the original model postulated to be independent (parallel) processes (see p.17). 
Weinman (1994ai 1994b) has made this progression explicit by further 
adapting the Self-Regulation Model to include more feedback loops, between 
components of the model at the same stage on each of the objective and 
emotional processes (e.g. between illness representations and emotional 
reactions to the illness; between coping with the objective features of the 
condition and coping with the emotional reactions it evokes and between 
appraisals of the two processes). He postulates relationships between the 
objective and the emotional paths of the model, so that the model no longer 
contains two independent paths, but every component may potentially 
influence the others. 
The possible interactions between the two coping processes are 
reflected, to some extent, in the fact that coping measures (see Chapter 7) 
generally include scales assessing both problem-focused coping (coping with 
objective features of the condition) and emotion-focused coping (coping with 
the emotional reactions it evokes). Hence investigation of the two paths of 
the model may be carried out using a single questionnaire. 
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Hence the model used to guide the empirical studies takes account of 
this possibility (see Chapter 6). The disadvantage of this interaction between 
objective and emotional pathways, however, is that the model loses some of 
its theoretical clarity and ability to postulate causal links between variables. 
Use for guiding research. Leventhal himself points out that the Self-
Regulation Model is not a theory, but a model or a framework, used to guide 
research from which specific theories can be derived (Leventhal, 1990). In this 
way the model guides researchers towards the type of variables they should be 
investigating and is not intended to be testable in its entirety. There are no 
specific measures specified and hence it can be operationalised to suit the 
condition of interest. Because of this is it widely applicable to the 
investigation of a wide variety of conditions, coping strategies and appraisal 
methods. 
Further critique of the Self-Regulation Model will be presented in the 
discussion sections of the empirical chapters of this thesis. 
e. Application of the Self-Regulation Model to asthma research. 
The Self-Regulation Model is the best-developed and most specific 
model of chronic disease available at present and despite (or perhaps because 
of) its complexities, and despite its drawbacks, it is a useful and thorough 
model for guiding Health Psychology research. Vinck (1994) proposes the use 
of the model in such a context. 
Although the model provides a comprehensive framework for 
investigating the coping process in the context of chronic disease, work 
applying it to asthma has never, to date, been published. Furthermore, the 
model has generally been applied partially - for example, illness 
representations have been studied alone, or in relation to coping - but the 
model has rarely (and only since the beginning of this study: Earll & 
Johnston, 1994; Earll, Johnston & Mitchell, 1993) been operationalised fully in 
a single study. Finally, the model has not been used as a basis for intervening 
with patients with chronic disease by attempting to alter illness 
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representations and coping behaviour, apart from by Pimm et al. (1994), 
whose work was carried out since the outset of this study. 
Hence it was decided to use the Self-Regulation Model to investigate 
the process of asthma self-management and to develop an intervention 
aimed at improving outcomes in this chronic condition. 
Chapter 3 will now introduce more details about asthma and asthma 
care, with emphasis on why this condition is ideal for study within the 
framework of the Self-Regulation Model. Chapter 4 focuses on the concept of 
adherence to medical recommendations as a strategy for coping with the 
objective features of an illness. Chapter 5 then discusses some previous 
psychological work into emotional reactions to asthma which may also be 
incorporated into the Self-Regulation ModeL 
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CHAPTER 3: ASTHMA 
3.1. Introduction 
This chapter introduces asthma as a chronic condition, suitable for 
studying within the framework of the Self-Regulation Model. After defining 
asthma and its clinical features, influencing factors and current treatment 
guidelines are summarised and the concept of asthmatic control, which is a 
central point of this thesis, is discussed. Throughout, the importance of self-
management (self-regulation) is stressed. The chapter concludes with data on 
the epidemiology of asthma which point to the clinical importance of 
studying this condition, particularly in young adults. 
3.2. Definition And Pathophysiology 
So many definitions of asthma have been made over the years that it is 
difficult to choose the 'best' one for the purposes of research (Creer, 1983; 
Gross, 1980; Warner, 1992). However, for the purposes of this thesis, asthma 
is defined as: 
" A lung disease with the following characteristics: 
1) Airways obstruction (i.e. narrowing) that is reversible, either 
spontaneously or with treatment. 
2) Airways inflammation. 
3) Airways hyperresponsiveness to a variety of stimuli." 
(National Heart, Lung & Blood Institute Of The National Institute Of Health, 
Bethesda, 1991) 
Chronic inflammation of the airways is present and leads to 
hyperresponsiveness of the airways which, in turn, can cause airways 
obstruction (or bronchocons triction ). 
The central feature of asthma is the reversibility of these responses (e.g. 
Farr, 1985). Reversibility of the airway obstruction means that asthma 
symptoms generally occur episodically, while reversibility of the airway 
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inflammation means that asthma can be controlled in the long-term. If non-
reversible reactions are seen, or irreversible lung damage found, then other 
diagnoses such as chronic bronchitis or chronic obstructory pulmonary 
disease (COPD) are more appropriate. 
The changes in lung function are seen on a day-to-day basis as well as 
on a longer time-scale. Asthma sufferers are characterised by an exaggeration 
of the daily morning-to-evening variation in lung function which is found to 
some degree in all individuals. Hence the symptoms experienced tend to be 
more obvious on waking than later in the day. Even when this diurnal 
variation is reduced by medication (see below), an individual with asthma 
may be prone to acute symptoms, triggered by one of several possible factors 
(see Section 3.4.). 
It should be noted that throughout this thesis, the term "attack" is not 
employed; rather "symptoms", "exacerbations" and "times when symptoms 
are felt" are referred to. This is because many sufferers do not suffer what 
they would term "attacks" and the term is now seen to be somewhat dated. 
The only exceptions to this rule are when quotes are taken from other 
authors verbatim. 
3.3. Symptoms 
The physical symptoms of asthma which result from the decrease in 
lung function vary between individuals, but generally include varying 
degrees of tightness in the chest, shortness of breath (dyspnoea), wheezing, 
'chesty' cough and mucous congestion. It should be noted, however, that this 
list is not definitive. Any of the symptoms may also result from causes other 
than asthma, i.e. their presence does not necessarily indicate a diagnosis of 
asthma; conversely, the absence of one or more of the symptoms need not 
necessarily exclude a diagnosis of asthma. 
3.4. Contributing Factors 
Many factors can contribute to the development and symptoms of 
asthma, including the following: 
39 
3.4.1. Heredity 
Individuals with a family history of asthma are more likely to develop 
the condition themselves. Anderson (1992) reports that twin studies indicate 
concordance for asthma to be 19% in identical twins and 4.8% in fraternal 
twins, i.e. a heritability of approximately 15%. 
Other evidence for a genetic component to asthma comes from cross-
cultural studies of the prevalence of asthma. Different countries are known 
to have different prevalence rates - for example, prevalence is less than 1% in 
Gambia and Japan but approximately 5% in the United Kingdom and the 
Netherlands (Kaptein et al., 1988) - and it is likely that at least part of this 
variation is genetic, rather than environmental, in origin. Kaptein et al. 
report on a case where individuals from England landed on the island of 
Tristan de Cunha and the prevalence of asthma in the island's inhabitants 
increased drastically over the next three centuries. This increase was 
presumed to be the result of genetic mixing, as in-breeding occurred. 
However, the mode of transmission is still not fully understood and 
geneticists continue to search for the "asthma gene". 
3.4.2. Allergy 
Allergy to certain substances is a contributing factor to asthma in many 
cases. Allergens may be inhaled (e.g. pollen, house dust mite), ingested (e.g. 
food additives, aspirin), injected (e.g. injection solutions) or come into 
contact with the body (e.g. household substances). In asthma, the most 
common allergens fall into the first two categories, reactions being triggered 
by such diverse things as house dust mites, feather pillows, lemon squash and 
nuts (Valman, 1987). 
Allergens affect asthma sufferers to different extents. One popular 
classification (although in declining use) is between extrinsic asthma, where 
allergic reactions are present, and intrinsic asthma, where such reactions are 
absent (Pearson, 1990). Intrinsic asthma is thought to be linked with family 
history of asthma and presence of other allergic conditions (e.g. eczema or 
hayfever), while extrinsic asthma is not. 
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3.4.3. Atopy 
Individuals who are classed as atopic, i.e. prone to conditions such as 
eczema, hayfever and rhinitis, are likely to additionally suffer from intrinsic 
asthma (Anderson, Pottier & Strachan, 1992). 
3.4.4. Viral infections 
Infections such as colds and other upper respiratory tract infections are 
common triggers of asthma symptoms; indeed, Valman (1987) states that this 
is the most important precipitating cause of exacerbations. 
3.4.5. Reflex Factors 
Vagus nerve responses to extreme air temperatures or humidity may 
affect lung functioning. Hence asthma sufferers can experience symptoms on 
stepping outside on a cold day, or on entering a warm building. Laughing, 
coughing and hyperventilation all increase the amount of cold air inhaled 
and hence may induce asthma symptoms (Pearson, 1990). 
3.4.6. Exercise 
Aerobic exercise or sudden, strenuous exercise, can encourage asthma 
symptoms because it increases demand on the lungs and it has hence 
traditionally been discouraged in sufferers. However, more recently the 
benefits of exercise for sufferers have been acknowledged and promoted. 
With the correct preparation in terms of medication beforehand, regular 
exercise is now encouraged because of its contribution to general fitness and 
many patients report that with this improvement, their asthma causes fewer 
problems (Levy, Hilton & Barnes, 1993). 
3.4.7. Psychological Influences 
Psychological factors such as stress, anxiety, depression, guilt, anger, 
frustration, anticipatory pleasurable excitement and joy (Cohen & Lask, 1983) 
are generally referred to in medical texts as contributing factors to asthma, 
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although more specific details of the mechanisms are often omitted (e.g. 
Rendle-Short, Gray & Dodge, 1985). It is possible that the effect occurs, in 
some cases, due to hyperventilation, but this is not always the case (Pearson, 
1990). The role of such factors in the absence of hyperventilation is 
controversial and little consensus has been reached between researchers to 
date (Creer, 1992). 
Cohen & Lask (1983) report on experimental findings demonstrating 
that emotional states such as stress can increase sensitivity to allergens, and 
claim that 
"without a 'basic substrate of immunophysiological vulnerability', no 
amount of emotional distress will provoke an attack of asthma, but ... given 
this substrate, emotional factors play a major part In determining whether 
attacks occur". 
(p.186). 
The results of laboratory studies have also supported roles for 
suggestibility (e.g. MCFadden et al., 1969) and conditioning (e.g. Dekker, PeIser 
& Groen, 1957) in precipitating exacerbations of asthma symptoms. 
Other researchers have argued, however, that there is no evidence at 
all that psychological stress exacerbates asthma (e.g. Creer, 1978). More recent 
evidence has suggested that, in fact, the relationship may be the reverse, i.e. 
that emotions such as anger and anxiety are a result of suffering from 
asthma, rather than vice versa (Farr, 1985; Kaptein et al., 1988). 
In reality, it is likely that psychological factors and asthma mutually 
influence each other; hence the mixed results in determining causality. A 
transactional model of asthma, incorporating both these causal routes, is 
therefore becoming more and more common in asthma research (Creer, Stein 
et aI., 1992). 
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3.4.8. Non-specific irritants 
Some substances do not cause specific allergic reactions but can irritate 
the lungs (even in non-asthma sufferers) if present in high enough 
concentrations. They include cigarette smoke, powders and fumes (Pearson, 
1990) and sensitivity is generally enhanced in asthma sufferers. 
3.4.9. Hormonal factors 
Although the role of female hormones in asthma is not fully 
understood, many women report that their asthma symptoms are worse at 
certain stages of their menstrual cycle, e.g. at the start of menstruation. Some 
menopausal individuals may present with asthma for the first time, or 
individuals with an early history of asthma may find that it recurs at this 
time (Davidson, 1995). Pregnancy may influence the course of asthma but 
this phenomenon is, at present, poorly understood because in some 
individuals symptoms become less pronounced while in others they increase 
(Pearson, 1990). 
3.5. Treatment 
3.5.1. Goals Of Treatment: Asthmatic control 
The goals of asthma treatment are commonly accepted to be: 
(1) Minimal symptoms, ideally none. 
(2) Normal activities of daily living (i.e. no disability). 
(3) Reliever medication needed not more than twice daily; ideally, none. 
(4) Minimal side effects from medications. 
(5) Airflow rates normal or near normal at rest. 
(6) Airflow rates normal after using Reliever medication. 
(7) Daily ... variation (in lung function) minimal. 
(Hargreave, Dolovich & Newhouse, 1990; Mendoza, 1991). 
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In more acute cases, prevention of death is also a goal (British Thoracic 
Society et al., 1990). The exact interpretation of (3) deserves further 
discussion. Many physicians (e.g. St Andrews Health Centre, 1992a) 
recommend two puffs of Reliever medication per day as the upper limit. 
Since most asthma sufferers take two puffs of Reliever medication at a time, 
it is unclear whether the above refers to two puffs or two occasions, i.e. four 
puffs per day. Hence this thesis employs the guideline of one occasion, i.e. 
two puffs per day as a conservative recommendation on the assumption that 
it is best to encourage Reliever medication use to be minimised as much as 
possible. 
If these goals are attained then the asthma is said to be well controlled, 
i.e. asthmatic control is good. 
In practice, it is generally reasonably easy for most patients to attain 
minimal symptoms and normal activities of daily living, while the 
remaining goals may be attained with a more thorough treatment regimen. 
Since many factors are involved in asthma, treatment regimens include 
several components, in varying degrees, tailored to the individual's needs. 
The following is a summary of the advice generally given to patients, 
although it should be noted that individuals will follow the advice to varying 
degrees (see Chapter 4). 
Although asthma treatment throughout history has involved methods 
such as acupuncture and bleeding as well as drugs as diverse as 
anticonvulsives, opiates, coffee, herbal mixtures, adrenergic substances and 
theophyllines (Brewis, 1991a), contemporary treatment regimens typically 
comprise four components: medication, avoidance of known triggers of 
symptoms, exercise and monitoring (e.g. National Heart, Lung & Blood 
Institute Of The National Institute Of Health, Bethesda, 1991). 
3.5.2. Medication 
There are two main types of treatment generally prescribed for asthma 
and other, more intense treatments which are used at times when severe and 
persistent symptoms are experienced. The summary below is based on 
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information reported by the British Thoracic Society et al. (1990), Levy, Hilton 
and Barnes (1993), the National Asthma Campaign (1990) and Valman (1987). 
a. Reliever Medication 
Reliever medications (medically termed bronchodilators) contain ~2-
agonists which relax the bronchial muscles rapidly when they are constricted 
and are used to give almost instant relief at times when asthma symptoms 
are experienced (i.e. part 1 of the asthma definition). They are generally 
prescribed to be used PRN (i.e. as required) and administered in inhaler form, 
although tablet and syrup forms of some drugs do exist. Although effective 
in relieving symptoms in the short-term, there is evidence that over-
dependence on Reliever medication may lead to higher morbidity levels in 
the long-term because they suppress the subjective need for Preventer 
medication (Van Schayck, 1993). Hence daily use of less than one puff of 
Reliever medication is recommended. 
If the patient has difficulty co-ordinating inhaler use, it may be taken 
from the inhaler via a spacer device - a large, plastic 'bottle' with a valve at 
the mouthpiece. The device holds the medication and allows it to be taken in 
in several breaths, evenly, rather than in one short blast and hence more of 
the medication reaches the lungs, rather than sticking in the back of the 
throat. 
Nebulising treatments contain ~2-agonists which are broken up into 
small droplets which can be inhaled via a face mask attached to a compressed 
air supply to allow more intense and effective delivery to the lungs. They 
may be used in emergencies or for individuals who are unable to use inhalers 
for some reason and are almost always prescribed for short-term, intensive 
use (i.e. three or four times daily for a short period) in conjunction with a 
course of oral steroids. 
b. Preventer Medication 
Preventer medications are designed to be used regularly and 
continually (i.e. not only when symptoms occur) in order to prevent 
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symptoms from being experienced. They are generally prescribed for a period 
of at least three months, initially, and are used on a "step-up/step-down" 
basis, i.e. once good asthmatic control is achieved, Preventer medication 
intake is systematically decreased to a minimal level and if asthmatic control 
decreases then the dosage can be increased again. 
Two forms of Preventer medication exist. Corticosteroids reduce 
mucous secretion and airways inflammation (i.e. part 2 of the asthma 
definition). They are generally prescribed in inhaled form, so that lower 
doses can be used (as delivery is straight into the lungs) and hence the 
possibility of side effects is reduced (Barnes, 1989). Although corticosteroids 
are the most effective drugs (National Heart, Lung & Blood Institute Of The 
National Institute Of Health, Bethesda, 1991) and therefore generally the 
medication of first choice, anti-allergic drugs may be used as an alternative for 
patients who prefer not to use steroid preparations. This class of drugs have 
similar effects to corticosteroids, but work by decreasing airways 
hyperresponsiveness (i.e. part 3 of the asthma definition) and are hence 
particularly effective for those with extrinsic asthma. 
Preventer medication may also be taken through a spacer device, either 
to co-ordinate inhaler use or in cases where side effects (e.g. thrush) are 
caused by the impact of the medication on the back of the throat. Such 
problems can also be counteracted by rinsing the mouth with mouthwash 
after inhaler use. 
Short courses of oral steroids may be used to treat asthma when one of 
the following situations arises: 
(1) Symptoms and 'Peak Flow (see Section 3.5.5.) are deteriorating 
progressively each day. 
(2) Peak Flow falls below 60% of the patient's best ever result. 
(3) Sleep is frequently disturbed by asthma. 
(4) Morning symptoms persist until mid-day. 
(5) All other treatments are ineffective in controlling asthma. 
(6) Emergency nebulised Reliever medication is needed. 
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Short courses of oral steroids are administered in tablet form and 
perform multiple functions: relaxing bronchial muscles, decreasing 
inflammation and increasing sensitivity to the other two types of drug, which 
are continued at the same time. 
Recently, "long-acting Relievers" (also called "Protectors") have 
become available. While taking effect in a similar fashion to Reliever 
medications, the effects of these drugs are more long-term so they can be 
prescribed in a similar regimen to Preventer medications. At present, the use 
of these drugs in asthma treatment is still contentious. 
See Appendix 2 for a complete list of currently prescribed Reliever and 
Preventer medications. 
3.5.3. Avoidance Of Known Triggers Of Symptoms 
Patients with asthma are generally advised to change their immediate 
environment or habits in order to avoid known allergens. For example, they 
may consider moving house to a less industrial area or decide not to keep pets 
or to avoid smoky rooms, depending on the particular triggers for their 
asthma. 
3.5.4. Exercise 
As previously discussed, many physicians recommend a careful fitness 
training programme in conjunction with medication and avoidance of 
allergens so that general fitness (including lung function) may be improved 
(Levy, Hilton & Barnes, 1993). 
3.5.5. Monitoring 
Since poorly controlled asthma may lead to extreme symptoms, severe 
disability and even death, it is desirable for patients to detect when lung 
function is deteriorating and action is needed. Most physicians agree that 
variation in the level of treatment according to the state of the lungs is 
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necessary in order to minimise symptoms and at the same time minimise the 
risks of side-effects of treatment (Brewis, 1991b). 
However, this is very difficult in practice, for several reasons. Firstly, 
since asthma may be influenced by many variables, changes in lung 
physiology can be extremely unpredictable and often quite rapid in onset. 
Secondly, changes in lung physiology may be asymptomatic at the early stages 
of deterioration. Finally, previous research has suggested that patients' 
perceived symptoms may not accurately reflect the underlying 
pathophysiology at all levels, i.e. that patients often cannot accurately detect 
underlying variation in their condition using symptoms alone (Barnes, 1992; 
Kendrick et al., 1993; Lancet editorial, 1983; MCFadden, Kiser & deGroot, 1973; 
Pennebaker, 1984; Rubinfield & Pain, 1976). For example, Rubinfield and Pain 
(1976) identified patients who claimed their asthma symptoms were in 
remission when, in fact, their lung function was decreased by more than 50%. 
They also found that 15% of a sample of 61 asthma outpatients were unable to 
detect when their lung function was less than 50% of that predicted (by age 
and sex) in an experiment where decreased lung function was induced by 
administration of metacholine solution. In a sample of 255 adult asthma 
patients recruited from 11 general practices in England, Kendrick et al. (1993) 
found that 60% were poor at assessing the severity of their asthma symptoms 
compared to an objective measure (Peak Flow - see below). 
As early as 1942, medical researchers realised that a quantitative 
measurement of lung capacity was invaluable as an index of asthmatic 
control and could be used in diagnosis and treatment planning (see Wright & 
MCKerrow, 1959). For many years, cumbersome, expensive and often 
inaccurate pieces of machinery were used to take such measurements, which 
were mainly used for physiological research purposes. Today, however, 
convenient monitoring methods, which patients can carry out for 
themselves, are available and there are several types of measurement which 
can be taken (see Chapter 7 for a full review). At this stage, only the most 
commonly used of these measures in clinical management of asthma - Peak 
Flow - will be discussed. 
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a. The Mini-Wright Peak Flow Meter 
In 1959 Wright designed the Peak Flow Meter, which revolutionised 
asthma care and is still in use, in modified form, today. Almost 20 years later, 
a mini form of the meter - portable and much cheaper - was designed 
(Wright, 1978). Patients could use these cheaper, portable meters for self-
monitoring and hence they are becoming more common in asthma care, 
although many physicians are still to be persuaded of their usefulness. 
The meter is tubular with a spring-loaded piston and a longitudinal 
slot through which air escapes. The patient inhales as deeply as possible then 
blows sharply into one end of the tube and the device measures the volume 
of air expired in the first 0.1 seconds, a scale along the side of the tube 
displaying this measure (converted to litres/minute). The highest reading of 
three blows is generally taken, to allow for random errors in technique. 
Miller, Dickinson and Hitchings (1992) have investigated some of the 
properties of Mini-Wright Peak Flow Meters, using a computer-driven pump 
to generate different levels of airflow. Test-retest reliability was demonstrated 
to be almost 100% within the limits of reading the scale by eye (i.e. within 5 
1/ min) and readings between instruments were reliable to within 8.5 1/ min. 
Readings were not affected by holding the meter horizontally or at 45° below 
horizontal or by temperature changes between 6°C and 25°C. However, 
unused meters were found to over-read by up to 80 1/min in the mid-range of 
300 to 500 1/ min and meters which had been used for longer than six months 
were found to significantly under-read. Despite such doubts about the 
absolute accuracy of the Mini-Wright meter (Higgins et al., 1989; Wright, 
1978), the general clinical consensus is that it remains a useful tool in 
assessing variation in lung functioning over time (Cross and Nelson, 1991). 
Population norms for Peak Flow measurements have been calculated, 
and regression equations for predicting an individual's Peak Flow rate, given 
their age, sex and height, are available (Nunn and Gregg, 1989). These 
regression equations were derived from Peak Flow data obtained from 225 
male and 228 female non-smokers. However, for the purposes of assessing 
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asthmatic control, it is variability of Peak Flow which is of interest, as 
explained in Section 3.1. 
b. Uses of the Mini-Wright Peak Flow Meter 
The meter has four main uses: 
Diagnosis of asthma. Diagnosis is possible by calculating the maximum 
daily variability of Peak Flow over a period of several days. Daily variability 
of more than 15-20% has been suggested to strongly indicate the possibility of 
asthma (Cross and Nelson, 1991; Levy & Hilton, 1993; Levy, Hilton & Barnes, 
1993; Pearson, 1990). 
Assessment of treatments. As asthma is brought under control by 
drugs, Peak Flow variability decreases and this decrease is generally 
accompanied by an overall increase in Peak Flow (as chronic inflammation 
decreases). Treatment efficacy can therefore be assessed by measuring either 
the overall increase in Peak Flow or the decrease in Peak Flow variation 
brought about by the use of the drug under test. Objective comparisons of 
different treatments are therefore possible. 
Identification of triggers of symptoms. Regular two-hourly Peak Flow 
monitoring in different environments may help determine asthma-inducing 
allergens - for example, in cases where occupational asthma is suspected 
(Cross & Nelson, 1991). 
As an aid to self-management. As discussed above, it is desirable for 
patients to be able to assess their own, variable, condition in order that they 
can adjust their medication accordingly. Several studies (e.g. Bellia et al., 
1985) have demonstrated that home monitoring of Peak Flow leads to 
improved self-management of asthma. One recent study (Charlton et al., 
1990) found no advantage of including Peak Flow monitoring in self-
management plans (in terms of number of GP consultations subsequently 
required and oral steroid use). However it is likely that this result was 
obtained because the control group received a very intensive self-
management programme including consultation with a specially trained 
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nurse practitioner, longer consultation times, review of inhaler technique, 
regular follow-up, self-management plans, education and more appropriate 
use of inhaled steroids, whereas in the other studies the control group 
received no extra asthma care. 
If home Peak Flow monitoring is to be of use, rigorous procedures 
should be followed in order for any benefits to be seen (Vathenen and Cooke, 
1991). A baseline of the patient's best attainable Peak Flow and Peak Flow 
variability must first be established, using short courses of oral steroids to 
establish the former if initial readings are more than 20% below those 
predicted (from norms). Patients are generally shown when and how to use 
the meter and how to record their results, and given clear instructions about 
the action they should take when the variability in their Peak Flow 
measurements is of differing degrees. Monitoring is usually recommended 
twice daily - before taking medication in the morning and evening - and each 
reading recorded in a table or graph, often alongside other details of the 
asthma, such as symptoms felt and resulting disruption to daily life (see 
Appendix 1 for an example). 
3.5.6. Sharing Of Responsibility For Treatment Between Patient And GP 
Asthma management is now generally viewed as a shared 
responsibility between patient and GP (Clark, Gotsch & Rosenstock, 1993; 
Reinke & Hoffman, 1992; Warner, 1992). Hindi-Alexander, Throm and 
Middleton (1987) describe such a process as collaborative self-management, 
where the patient adapts the advice of health professionals in order to apply it 
in everyday life. The onus is thus on the patient to control their condition 
adequately on a day-to-day basis, but due to the variable nature of asthma it is 
still recognised that there may be times when this is impossible and 
professional help should be sought. In addition, it is generally recommended 
that GP-initiated consultations should be included in the treatment plan. 
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3.6. Assessment Of Asthmatic Control 
3.6.1. Indices Of Asthmatic Control 
As well as the individual needing to monitor his or her own asthma, 
many health professionals now assess at regular intervals how well an 
individual's asthma is controlled. In both cases the following factors may be 
taken into account (e.g. St Andrews Health Centre, 1992a): 
(1) Night-time awakening with wheeze/cough. 
(2) Early morning tightness in chest/wheeze/ cough. 
(3) Use of Reliever medication. 
(4) Peak Flow measurements. 
(5) Symptoms during exercise. 
3.6.2. Peak Flow Measurements As An Index Of Asthmatic Control 
Since lung function varies naturally on a daily basis, being lower in the 
morning than at night time, relatively small daily variations in Peak Flow 
(i.e. less than 10% from the best ever Peak Flow measurement) do not 
indicate poor asthmatic control. However, variations larger than this do 
indicate that asthmatic control is less than optimal. 
Figure 3.1. shows Peak Flow diary records giving examples of what may 
be considered good, poor and deteriorating asthmatic control. 
3.6.3. Research Measures Of Asthmatic Control 
Chapter 7 discusses the assessment of asthmatic control for research 
purposes in detail. 
3.6.4. A Note On The Concept Of The 'Severity' Of Asthma 
The concept of 'severity' of asthma, although frequently referred to in 
clinical practice, is problematic because there are at least two senses in which 
the word could be used. Firstly, severity could refer to the worst an 
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Figure 3.1.: Examples of asthmatic control as indicated bv Peak Flow 
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(c) Deteriorating asthmatic control. 
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individual's asthma could get. It is practically and ethically impossible to 
measure this, since diagnosed asthma sufferers are generally prescribed 
medication in order to ensure that this state is never reached. Additionally, 
in theory, this point would be death in all cases. Secondly, and more 
realistically, the term 'severity' can be used to refer to the frequency, 
chronicity and severity of asthma symptoms (Warner, 1992). Hilton et al. 
(1982) found that this is the data which medical practitioners tend to use 
when requested to assess the severity of their patients' asthma. However, due 
to the changeable nature of asthma, severity in this sense is difficult to 
measure. Indeed, in one study (Williams, 1992), when GPs and asthma 
nurses were asked to rate the severity of patients' asthma from medical notes 
and personal contact with the patient, they were unable to do so as they stated 
that severity could vary within an individuaL They were prepared only to 
give three separate assessments for each patient - one of 'current severity', 
one of 'worst ever severity' and one of 'overall severity'. The correlations 
between these ratings (for the same rater) ranged from 0.51 to 0.74, and 
correlations between raters' ratings (for the three different measures) ranged 
between 0.41 and 0.84. These figures indicate that severity of asthma was not 
a unitary or a valid concept, at least for these particular health professionals. 
Other researchers (e.g. Creer, 1983; Creer and Winder, 1991) support this view 
of severity of asthma as a complex issue. 
Within the framework of asthmatic control which has been introduced 
thus far, the concept of severity becomes redundant, however. If the premise 
is accepted that "all acute attacks should be regarded as preventable" 
(Tattersfield, 1991), i.e. that asthma can be controlled so that lung function is 
indistinguishable from that of a non-asthma sufferer, then the only possible 
meaning of 'severity' is based on the amount of treatment which is necessary 
to bring this change about. For example, some individuals' asthma may be 
adequately controlled by simply avoiding animals, others may require 
Reliever medication occasionally while yet other cases will require one or 
more Preventer medications in order to maximise asthmatic control. For 
these reasons, the term 'severity' will not be used further in this thesis, but 
instead asthmatic control will be of central importance. 
54 
3.7. Epidemiology 
3.7.1. Prevalence /Incidence 
a. Current Prevalence Figures 
There are several problems inherent in assessing the prevalence of 
asthma (Costello, 1991). Firstly, there is variability in diagnosis, both over 
time, between practitioners and between studies and secondly, different types 
of prevalence data may be reported in different studies (e.g. point data, 
cumulative data or period data). Hence comparisons between studies and 
assessment of overall rates present difficulties. 
A summary of some recent studies is shown in Table 3.1., which clearly 
demonstrates that the definition of asthma used can greatly affect prevalence 
measures, and that prevalence may vary considerably between studies, even 
where the samples are similar. 
Table 3.1.: Summary of three studies of prevalence of (a) self-reported 
asthma and (b) self-reported wheeze. 
STUDY SAMPLE USED % REPORTING % REPORTING 
ASTHMA IN PAST WHEEZE IN PAST 
12 MONTHS 12 MONTHS 
Littlejohns, Ebrahim 40-70 year-olds Males 4.7 Males 18.0 
& Anderson (1989) Females 3.3 Females 15.0 
Burney et al. (1991) 74,006 men aged 20-
44 in 21 English 
L.A. Districts Mean=3.4 Mean=ll.4 
Pereira (1993) 6,000 men aged 20-
44 in 8 postal areas 
of Fife, Scotland 5.0 28.4 
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A general guideline is that on average about 5% of the population of 
the United Kingdom will have a current diagnosis of asthma and 10-15% will 
have received such a diagnosis at some time in their lives (Alexander, 1981; 
Martin, Meltzer & Elliot, 1989, p.29). Hence it is estimated that there are 
currently approximately 2.5 million asthma sufferers in the United Kingdom. 
Anderson, Pottier & Strachan (1992) carried out a longitudinal study of 
7,225 individuals born in 1958, following them up at age 7, 11, 16 and 23 years. 
The annual incidence of new cases was found to be 2.6% between ages 0-7, 
1.1 % between ages 8 and 11, 0.71% between ages 12 to 16 and 0.76% between 
ages 17 and 23. 
b. Changes In Prevalence Over Time 
Burney, Chinn and Rona (1990) report from longitudinal data collected 
on primary school children in England between 1973 and 1986 that the 
prevalence of asthma increased during this period, and not simply because of 
changes in diagnostic fashion, since the increase in prevalence of asthma was 
greater than the decrease in the prevalence of bronchitis. 
3.7.2. Mortality 
Although no data for Scotland alone are available, approximately 2,000 
individuals die from asthma each year in the England and Wales, mostly due 
to acute attacks in those with poorly controlled asthma (Burney, 1986). 
Indeed, Pearson (1990) states that over 80% of these cases were due to 
preventable factors and Levy and Hilton (1993) support this view, suggesting 
that 86% of asthma deaths in 1979 were potentially preventable. The British 
Thoracic Association (1982) also states that 53% of a sample of 90 individuals 
who died as a result of their asthma in two regions of England in 1979 had 
shown poor self-management during the previous year. In addition, 55% had 
not sought medical help, even during the fatal exacerbation. These figures 
strongly suggest a role for poor self-management in mortality due to asthma. 
Figure 3.2. shows data on mortality rates in England and Wales by age 
and sex in 1985. Anderson (1992) concludes from these figures that asthma 
56 
mortality increases with age, and that although infant mortality rates are low, 
deaths begin to increase exponentially at age 15-19. There are no significant 
sex differences in mortality at any age. 
Figure 3.2.: Asthma mortality by age and sex. England and Wales, 1985. 
Taken from Anderson (1992). 
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Figure 3.3. shows trends in asthma deaths in England and Wales over 
the last 15 years, by age group. The figures suggest that mortality during this 
period has changed differentially in patients of different ages. Mortality rates 
have remained relatively stable in children, slowly risen in young adults 
(aged 15-34) and showed a less clear trend for older adults (aged 35-54). There 
is an overall increase in mortality which is in contrast to trends in other 
common treatable conditions (Charlton & Valez, 1986). Sears (1991) presents 
similar data confirming this trend world-wide, and particularly in young 
adults. He claims that the increase is not simply due to changes in diagnostic 
labels. Burney, Chinn and Rona (1990) believe that increases in mortality can 
be completely accounted for by the recent increase in prevalence, although 
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others claim that this factor alone cannot account for such an increase. 
Inadequate self-management may have a role to play in this phenomenon: 
for example Barnes (1989) suggests that, since mortality is increasing despite 
developments in treatment and an increase in asthma therapies prescribed, 
currently available therapies are either inadequate or are not being used 
optimally. 
Figure 3.3.: Trends in asthma deaths in the last 15 years. England and 
Wales. Taken from Anderson (1992). 
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In summary, mortality rates in asthma sufferers are high, particularly 
in young adults, and have been increasing in this age group over recent years. 
In many cases, death is preventable by correct management of the asthma. 
Hence asthma self-management is a particular issue in young adults. 
3.7.3. Morbidity 
Two of the most commonly used indices of morbidity due to asthma 
are hospital admissions and consultation rates. 
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Hospital admissions can be seen as a coping response to severely 
uncontrolled asthma, in most cases. Hospital admissions show almost the 
opposite pattern to mortality: Figure 3.4. demonstrates that admissions have 
increased in all age groups in recent years (Anderson, 1992; Costello, 1991), but 
this increase has been least in the age-group 15-34. This suggests that the 
action taken in any case is not necessarily appropriate to the level of asthmatic 
control. For example, children are more likely to be hospitalised and less 
likely to die while young adults are less likely to be hospitalised and more 
likely to die because of their asthma. Hence the action taken to control 
asthma in this group (as well as in older adults) is important. 
Mitchell (1989) states that, as for prevalence, the increase in morbidity 
seen over recent years cannot be explained simply by either changes in the 
International Classification of Diseases coding or diagnostic transfer. He takes 
this increase to be due to poor self-management as well as increase in 
prevalence over these years. 
Figure 3.4.: Trends in hospital admissions for asthma. England and 
Wales. Taken from Anderson (1992). 
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Consultation rate data, although available (Hay & Higgenbottam, 1987; 
Higgenbottam & Hay, 1990), are more difficult to interpret in terms of their 
implications for asthma management, since consultations may be for the 
purposes of giving advice, monitoring, minor problems or emergencies and 
may in addition be initiated by either the patient or the practitioner. An 
increase in consultations for routine advice and monitoring may be desirable, 
whereas an increase in consultations for emergency treatment of 
uncontrolled asthma is not. Data which distinguish between consultations 
for different purposes are not currently available and hence this morbidity 
index is not presented here. 
3.8. Summary. 
Asthma is a complex chronic condition, with diverse symptoms which 
may be influenced by many different factors. Both symptoms and influencing 
factors may vary between individuals and even within the same individual, 
on different occasions. Hence the personal experiences of asthma sufferers 
will vary immensely and the resulting illness representations may be 
correspondingly quite different. In addition, the amount and type of medical 
advice received, which also influences the illness representation, may vary 
widely between patients. 
However, the central defining feature of asthma is that it is 
controllable, with the correct management. Such management requires 
vigilance, self-monitoring and daily health care on the part of the sufferer and 
includes exercise, avoidance of triggers and the use of Preventer medication, 
even at times when the asthma is asymptomatic. All these activities are 
forms of coping and can hence be incorporated into the Self-Regulation 
ModeL Patients are becoming increasingly responsible for tailoring their own 
treatment according to the current state of their asthma and hence the 
individuals' representation of his or her asthma, and the resulting coping, are 
of importance. 
In recent years the prevalence of asthma in the UK has been increasing, 
and currently about 5% of the general population have a current diagnosis of 
asthma. Despite recent advances in treatments and self-monitoring, asthma 
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continues to be a significant health problem, especially in young adults, 
where illness outcomes are particularly poor and deteriorating rapidly. 
Mortality rates begin to significantly increase at 15-19 years and have increased 
more in the 15-34 year age-group than any other age-group over recent years. 
Despite an overall increase in the number of hospital admissions, however, 
the lowest increase in hospital admissions due to asthma in recent years has 
also been in this age group. This evidence suggests that self-management is 
not optimal in 15-34 year olds, in particular, and that an understanding of the 
self-regulation process is desirable. 
It is clearly of clinical importance to investigate asthma self-
management within the framework of the Self-Regulation Model in order to 
identify specific, modifiable factors which might influence asthma sufferers' 
self-management. This is the aim of this thesis. 
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CHAPTER 4: ADHERENCE TO RECOMMENDED TREATMENT REGIMENS 
AS A COPING RESPONSE TO CHRONIC DISEASE 
4.1. Introduction 
As discussed in the previous chapter, asthma is a complex condition 
requiring a multi-faceted treatment regimen including the use of both 
Reliever and Preventer medications, avoidance of allergens, exercise and 
self-monitoring in order to maximise asthmatic control. Medical advances in 
recent years mean that, theoretically at least, total asthmatic control is 
possible. 
While it is the responsibility of medical experts to ensure that the 
correct treatment (according to current medical knowledge) is recommended, 
how the patient actually goes on to behave is of paramount importance in 
controlling this condition. Hence Creer (1993) states that 
"the reality (is) that better medications (do) not necessarily ensure improved 
management of asthma." 
(p.303) 
and the concept of adherence to medical recommendations - an area in 
which extensive research has previously been carried out - is important in 
understanding asthmatic control. 
In this chapter, the term adherence is defined and discussed and 
adherence rates found in previous studies are presented. The relationship 
between adherence and illness outcomes is discussed in some detail and 
previous work on determinants of adherence outlined. It is argued that (a) 
adherence to recommended asthma Preventer medication regimen is an 
important influence on asthmatic control, (b) several features of asthma 
contribute to the low adherence rates found in patients suffering from this 
condition and (c) adherence may be seen as a coping response within the 
framework of the Self-Regulation Model. 
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4.2. Definitions 
The terms adherence and compliance both refer to the degree to 
which a patient carries out the behaviours and treatments recommended to 
them by health professionals (Sarafino, 1990). However, although the two 
words are often used interchangeably, and their definitions and use have now 
diversified (e.g. Chambers Dictionary, 1994), there are, in fact, subtle 
differences in the original definitions and interpretations of the two words. 
The definitions used in this thesis are as follows: 
Compliance is "acting in accordance with rules, wishes etc;.being 
obedient to." 
Adherence is "following closely or exactly." 
(Collins English Dictionary, 1989). 
Most contemporary psychological researchers prefer to use the term 
"adherence", since "compliance" implies that the practitioner uses an 
authoritarian style and that the patient is expected to obey reluctantly 
(Sarafino, 1990; Voyles & Menendez, 1983). Deviation from the 
recommendations is thus viewed as a form of disobedience. Hulka (1979) 
sums up this objection by stating that 
" ... The term ('non-compliance') implies a pejorative affect towards 
patients, who are presumed to be at fault." 
(p.63). 
The definition of adherence, however, implies no fault. The patient is 
permitted to have independent beliefs about the recommended treatment, 
and to question or adapt the regimen, rather than blindly following the 
"rules" of the practitioner, who is not exempt from errors of judgement. For 
example, physicians may on occasion make errors in diagnosis, give 
erroneous advice, or prescribe treatment which is inappropriate or not fully 
effective for the condition (Cochrane, 1992). A patient who stops taking his 
medication because it makes him feel ill (perhaps the physician has prescribed 
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too high a dose, or the medication is causing an allergic reaction) would 
therefore be described as "non-compliant" but could still be "adherent". 
A further distinction between adherence and compliance is the 
element of intent. Thus Gordis (1979) states that 
"non-compliance implies an intent not to follow instructions." 
(p.2S). 
Adherence, on the other hand, may include other reasons for not 
taking medication such as forgetting, inability to afford them etc. For these 
reasons, the convention throughout this thesis will be to refer to 
"adherence", even where the source papers employ other terms. This is 
unusual, however: in practice, despite recent acknowledgement of the 
difference between the two terms, they continue to be used interchangeably by 
psychologists, while medical research still tends to prefer the term 
"compliance" . 
4.3. Adherence Behaviour 
It is important to note that adherence is not an unidimensional 
construct. The degree of adherence to each component of a multi-faceted 
regimen may differ: for example, Johnson et al. (1986) found five independent 
components of adherence to recommendations for diabetes self-management: 
exercise, injections, diet type, frequency of eating/ glucose testing and diet 
amount. A further study (Johnson et al., 1990) identified an additional factor: 
consumption of concentrated sweets. In a study of patients with either 
asthma or hypertension, adherence to recommended lifestyle changes was 
uncorrelated with adherence to recommended medication (Ford et al., 1989). 
Adherence to each individual component of a recommended 
treatment regimen comprises a continuum ranging from total adherence to 
total non-adherence (Creer, 1993). Hence there are individuals who adhere 
totally, partially and not at all (Partridge, 1992). Different factors may be 
involved in different degrees of adherence (see Section 4.7.). 
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Patients may show poor adherence to a component of the 
recommended treatment regimen in various ways (Cochrane, 1992). For 
example, adherence to the recommended medication regimen may be due to 
the omission of doses, use of a drug for the wrong reasons, over- or under-
use, incorrect timing of doses or early discontinuation of therapy. 
The remainder of this chapter will focus on adherence to 
recommended medication regimens. 
4.4. Measurement Of Adherence 
The measurement of adherence to recommended medication regimens 
is described fully in Chapter 7. 
4.5. Adherence Rates 
This section reports on adherence rates to treatment regimens in 
general, and in particular to adherence rates found in previous asthma 
studies using a variety of the assessment methods. It should be borne in 
mind that there are no figures defining "good" and "poor" adherence. 
However, Cochrane (1992) has suggested that any patient who follows over 
80% of the recommended regimen may be considered adherent. 
4.5.1. General Adherence Rates 
There is no consensus as to exact levels of adherence. It is suggested 
that, overall, only about 50-60% of patients follow their GP's 
recommendations "reasonably closely" (Sackett & Snow, 1979). Adherence to 
recommended medication regimens ranges between 18% and 89% (Epstein 
and Cluss, 1982), with a mean of around 50% (Ley, 1982). Adherence to 
recommended changes in lifestyle are generally even lower than this 
(Sarafino, 1990). 
However, caution should be employed in interpreting the figures since 
the samples used are generally volunteer samples and are hence likely to 
consist of individuals who are more highly motivated to adhere than those 
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who decline to take part. In addition, overall measures of adherence may 
give no insight into the different ways in which a patient may be non-
adherent (Cochrane, 1992), or into differential adherence to different 
components of the recommended treatment regimen. 
4.5.2. Adherence Rates In Asthma 
Research findings to date are best summarised best by Taytard (1992), 
who states that: 
"it is generally accepted that (adherence) is poor in asthma, although, perhaps, 
not poorer than for other chronic diseases." 
(p.125). 
Dekker et aI. (1992) found that in a sample of 150 Dutch patients 
diagnosed with asthma and recruited through a general practice, 24% reported 
taking no medication at all when they felt symptoms, while a further 44% 
took their medication inappropriately. A recent British study, employing self-
report, returned capsules, canister weighing and "spot checks" of urinary 
Reliever medication concentrations as measures of adherence, found that 
general practice asthma patients were more likely to adhere to 
recommendations for Reliever medication than for Preventer medication 
(66% adherence as compared to less than 50%) (Horn, Clark & Cochrane, 
1990). Similar findings were obtained for patients in a hospital asthma clinic 
(Horn, 1986). These findings are not surprising since Reliever medication is 
generally prescribed to be taken PRN in response to symptoms, the only 
stipulation being not to exceed a certain number of puffs per day (usually 
one). Hence non-adherence to Reliever medication is generally taken to be 
indicated by the percentage of days on which the maximum recommended 
number of doses was exceeded. Preventer medication, in contrast, is 
prescribed to be taken on a regular basis, whether the asthma is symptomatic 
or not, and influences asthmatic control in the long-term. Hence the main 
clinical problem concerns adherence to Preventer medication regimens. 
Cochrane and Hom (1991) report that over-use of Reliever medication 
in a sample of asthma patients recruited through general practice tended to 
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increase over a nine-month period, while adherence to Preventer medication 
did not change significantly over this period, remaining stable at around 50%. 
This result suggests that asthmatic control was deteriorating due to poor 
adherence to Preventer medication, leading to over-reliance on Reliever 
medication and emphasises that adherence to recommended Preventer 
medication regimen is vital for good asthmatic control. Increasing such 
adherence is hence the main challenge for asthma research. 
Kleiger and Dirks (1979) found that 54% of a sample of 100 hospitalised 
adult asthma sufferers self-reported non-adherence to the recommended 
medication regimen. 52% of non-adherence was due to under-use of 
medication and 28% due to over-use. The remaining 20% of poor adherers 
reported both under-use and over-use on occasions. 
4.6. The Relationship Between Adherence And Illness Outcomes 
4.6.1. General Relationships 
The central assumption of the medical model - that better medications 
improve disease control in chronic conditions - is not necessarily correct. For 
example, Sackett and Haynes (1976) stress that the concordance between 
adherence to recommended preventative treatment and illness outcomes is 
not 100%: on occasion a condition may disappear without treatment, while at 
other times symptoms might remain despite total adherence (see Table 4.1.). 
Table 4.1.: Correlations between adherence and illness outcomes 
(treatment goal) (Sackett & Haynes, 1976). 
TREATMENT GOAL 
. ACHIEVED NOT ACHIEVED 
HIGH Ideal Inadequate therapy 
ADHERENCE 
Self-limited illness; cure Patient has quit LOW without adherence treatment 
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In the case of asthma, the above table can be applied to the symptoms, 
but not the condition itself, since asthma is chronic in nature. Good 
asthmatic control is the treatment goal and the medical model states that 
taking Preventer medication will lead to the attainment of this goal. In 
general it would be expected that not taking Preventer medication would lead 
to a decrease in asthmatic control; however, at times, asthmatic control may 
be good despite non-adherence to Preventer medication. Medical 
recommendations would be that at such times, regular Peak Flow monitoring 
is carried out in order to determine when lung function may be deteriorating 
and hence to re-commence Preventer medication in order to re-establish good 
asthmatic control. If such monitoring is not carried out then it would be 
recommended that the patient continues taking Preventer medication as a 
preventive measure against asthmatic control deteriorating. At other times 
a patient may adhere fully to the recommended Preventative treatment yet 
the asthma may not be brought under control. It is therefore important that 
he or she recognises the stage at which it is wiser to consult a GP than to 
struggle on alone. 
The view taken in this thesis is that of not questioning the accuracy of 
medical science, but instead focusing on the patients' behaviour as it relates to 
current medical knowledge and recommendations. Therefore since, by the 
medical model of illness, poor adherence to medical recommendations is 
associated with poorer disease outcomes (e.g. Cluss et al., 1984; Horn, Clark & 
Cochrane, 1990; Ley, 1990), it is important to identify factors which may affect 
how closely a patient follows the treatment regimen recommended. 
Gordis (1979) suggests a model to account for instances where 
adherence may not be reliably related to illness outcome. This model is 
depicted in Figure 4.1. 
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Figure 4.1.: Factors influencing illness outcome (Gordis, 1979). 
external 
factors 
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The model suggests that, in addition to adherence, other factors of 
medical care (e.g. sympathy received from the GP) and external factors such as 
cultural factors, occupational exposure, etc. may also influence illness 
outcomes. However this thesis remains concerned only with adherence to 
recommended medication regimens. 
4.6.2. Relationships In Asthma 
Siafakas & Bouros (1992) report several consequences of poor 
adherence in asthma (see Table 4.2.). These consequences fall into three broad 
categories. The first is asthmatic control, as defined in Chapter 3 (1, 2, 3, 4, 7, 
10, 12 & 13). The second concerns emotional consequences (5 & 6), which it 
could be hypothesised result from poor asthmatic control and the third 
involves economic consequences (8 & 9). Drug toxicity is a consequence 
which appears to stand on its own and presumably refers to toxic effects due 
to over-use of drugs. 
69 
Table 4.2.: The consequences of poor adherence in asthma. 
1. Failure to become symptom free. 
2. Failure to live a normal life. 
3. Failure to participate in physical exercise. 
4. Prolonged and severe attacks. 
5. Increased emotional stress (personal/family). 
6. Psychological imbalances. 
7. Missing days from work/school. 
8. Prolonged treatment. 
9. Increased expenses (personal/public). 
10. Frequent visits to emergency departments. 
11. Drug toxicity. 
12. Life threatening attacks. 
13. Death. 
Horn, Clark and Cochrane (1990) reported that poor asthmatic control 
in a prospective study of 160 general practice patients was the result of poor 
adherence in 25% of patients (these patients tended to over-use Reliever 
medication, as measured by urine assays). Cluss et al. (1984) found in their 
study of 22 asthmatic children that those exhibiting poor adherence wheezed 
more during the two-week study period and showed poorer Peak Flow 
variability (see Chapter 3) - again, outcomes representative of poorer 
asthmatic control. 
4.7. Factors Influencing Adherence 
Since adherence rates overall are low and poor adherence is at least 
partly responsible for poor illness outcomes, psychologists have become 
concerned with determining factors which might influence adherence 
behaviour, and in particular those factors which are potentially modifiable. 
Such factors include aspects of the underlying condition and its treatment, the 
individual's representation of it and the coping strategies available for dealing 
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with the illness. In the following discussion, particular reference is made to 
asthma where possible. 
4.7.1. Demographic Variables 
Glanz et al. (1984) found that sex, race and marital status were not 
related to adherence in a sample of 97 asthma sufferers aged between 15 and 
45, but that those reporting high adherence (by self report) were significantly 
older than those reporting low adherence. Partridge (1992) found a similar 
result and noted that, in particular, adolescents tend to become disillusioned 
when regular treatments fail to cure the condition and to show poor 
adherence. Johnson et al. (1986; 1990) found in two separate studies that 
adolescent diabetes sufferers (aged 16-19 years) were less adherent than 
children in all areas of recommended diabetes care. 
4.7.2. Illness Factors 
Haynes (1979) concluded from the results of 81 previous studies of 
relationships between illness factors (diagnosis, severity, symptoms, degree of 
disability, duration, previous bouts, recency of last attack, previous 
hospitalisation, length of stay in hospital, positive family history, clinical 
improvement, concurrent conditions) and adherence that illness factors were 
not correlated with adherence, with the following exceptions: 
(1) Psychiatric patients show lower adherence. 
(2) Increasing symptoms are associated with decreased adherence. 
(3) Increased disability is associated with increased adherence. 
These results, however, imply nothing about causality, i.e. whether the 
illness factors are precipitating factors or consequences of adherence. In 
addition, Haynes noted that adherence differed between different treatments 
for the same condition, indicating that treatment factors must also be taken 
into account (see Section 4.7.3.). However, the evidence is conflicting: Ley 
(1990) cites two reviews of studies which demonstrate that adherence is no 
lower in psychiatric patients than in other patient groups. 
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Other research has suggested that adherence is lower in chronic 
conditions than in acute conditions (Partridge, 1992). Exact figures reported 
are about 78% for acute illnesses treated with short-term regimens and 
around 54% for chronic illness (Sarafino, 1990; Epstein and Cluss, 1982). 
Concerning asthma, Glanz et al. (1984) found that neither duration of 
asthma, attack frequency, previous hospitalisation, family history of asthma 
or number of attacks during the previous 30 days was associated with 
adherence (measured by self report). 
Taytard (1992) and Voyles and Menendez (1983) speculate that the non-
adherence found in asthma sufferers is caused partly because it is a chronic 
condition which can fluctuate between an asymptomatic state and death. 
4.7.3. Treatment Factors 
There is some evidence that the more complex, inconvenient, 
expensive, prolonged or disruptive of normal lifestyle a treatment regimen is, 
the less likely it is to be followed (Sackett and Haynes, 1976). More recently, 
two separate components of complexity have been identified and studied: 
number of medications in the recommended regimen and recommended 
daily frequency of doses of those medications. 
Regarding the number of drugs in the regimen, Coutts, Gibson and 
Paton (1992) found that the more times a day patients were recommended to 
take their drugs, the less adherence they displayed. Hulka (1979) has found 
similar results: for a combined group of patients suffering from either 
diabetes or congestive heart failure and prescribed up to 14 different drugs 
each, both over- and under-use of medication increased with increasing 
number of prescribed drugs. Other studies (e.g. Cramer et al., 1989) have 
drawn similar conclusions. 
However, Glanz et al. (1984) have reported the converse effect, those 
prescribed more complex medication regimens tending to be more adherent. 
Still other studies, such as six of the eleven reviewed by Blackwell (1979), 
have demonstrated lower adherence rates only once three or four different 
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medications have been added to the regimen. It is likely that the differences 
between these studies may be due to different methods of assessment of 
adherence. 
There is only slight evidence for an influence of the frequency with 
which drugs are recommended to be taken on adherence: for example, Hulka 
(1979) found a trend towards higher adherence rates when all drugs were 
prescribed to be taken once a day only, regardless of the overall number of 
medications in the recommended regimen. Partridge (1992) has suggested 
that a reduction in adherence appears only when medication is 
recommended more than twice daily, while Cochrane (1992) found this effect 
only occurred after the fourth daily dose was introduced. Either of these 
effects could perhaps be due to the fact that up to three daily doses of 
medication can be tied to particular daily events, such as getting up and going 
to bed, or meal times, while above this it becomes more difficult to 
remember. Alternatively, the reduction in adherence may be due to a sense 
of rebellion or "giving up" once the regimen is perceived to be too 
demanding. 
Taytard (1992) suggests that because Reliever medications relieve 
immediate symptoms but do not control asthma in the long-term, while 
Preventer medications have the opposite effect, adherence may be expected to 
be low in asthma sufferers. Van Schayck (1993) and Voyles and Menendez 
(1983) support this view. 
Side-effects of medication (such as the bitter aftertaste of some non-
steroid Preventer medications or hoarseness/sore throat due to inhaled 
steroids) may be expected to influence adherence (Creer, 1992; Partridge, 1992). 
However, some studies have shown that anticipated side effects, rather than 
actual ones, lead to lower levels of adherence (Sbarbaco, 1990). Hence the 
individual's representation of the treatment recommended may be equally as 
important as medical facts in determining adherence. Asthma patients often 
perceive steroid Preventer medications to carry adverse side effects, due to 
recent publicity about the use of anabolic steroids in sport, despite the fact that 
there is no evidence to support this belief, the low dosages and inhaled 
method of administration used for asthma treatment being associated with 
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minimal risk (Levy, Hilton & Barnes, 1993). It is possible, however, that such 
erroneous beliefs might lead to low adherence to steroid Preventer 
medications. 
Since asthma treatment regimens are ongoing and often complex, with 
occasional side-effects, it is expected that adherence could be a particular issue 
in investigating coping responses to asthma. In addition, the differing modes 
of action and recommended regimens of Reliever and Preventer medications 
may lead to poor adherence in asthma (Voyles and Menendez, 1983). 
4.7.4. Understanding, Memory And Satisfaction 
Ley (1990) suggests that an individual's understanding, memory and 
satisfaction with the consultation will influence adherence (see Figure 4.2.). 
Figure 4.2.: Factors influencing adherence (from Ley, 1990). 
UNDERSTANDING 
However, the definition of "understanding" has varied between 
studies, variously being taken to mean understanding of the treatment 
regimen, understanding of the rationale for treatment, understanding of the 
illness or some combination of these factors. Ley reports that only the former 
type of understanding has been found to influence adherence. Similarly, 
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satisfaction can either refer to satisfaction with the consultation as a whole or 
with the communication during the consultation. Furthermore, memory 
and adherence have been assessed by different methods in different studies. 
However, despite these inconsistencies, the results of studies have shown 
remarkable consistency (although the number of studies is not sufficient to 
allow comparison of the different methods of operationalisation of the 
model). 
Using the results of 29 previous studies carried out by various authors, 
Ley provides evidence that all the relationships predicted by the above model 
are significant. The mean correlations found between each pair of variables 
are displayed in Table 4.3. 
Table 4.3.: Mean correlations between understanding, memory, 
satisfaction and adherence in 29 studies (from Ley, 1990). 
MEMORY SATISFACTION ADHERENCE 
UNDERSTANDING 0.34 0.58 0.36 
MEMORY - 0.20 0.29 
SA TISF ACTION - 0.26 
Hulka (1979) found that, for patients with congestive heart failure, 
adherence was significantly different between groups of patients expressing 
different levels of satisfaction with communication with the GP. Individuals 
who were most satisfied with communication were more likely to adhere to 
the recommendations made. However this finding did not hold for patients 
with diabetes. 
4.7.5. Setting 
Griffith (1990), in her review, found that patients in general practice 
tend to show poorer adherence than those in acute settings. This is 
presumably because the latter group are supervised and are in critical 
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situations. Hence adherence in general practice patients who do not require 
acute care for their asthma is an extremely important issue. 
4.7.6. Illness Representations 
The Leventhal group (Leventhal & Cameron, 1987; Leventhal, Meyer 
& Nerenz, 1980) have argued that adherence may be viewed as a coping 
response within the framework of the Self-Regulation Model, and there is 
empirical evidence to support this view. For example, Becker and Rosenstock 
(1984) discovered that while the physician's assessments of the severity of an 
individual's condition did not relate to adherence, the patient's perception of 
seriousness was indeed predictive of their adherence to the recommended 
treatment regimen. Blackwell (1979) supports this result, quoting seven 
studies which have found high perceptions of severity to be associated with 
good adherence. 
Meyer, Leventhal & Guttmann (1985) found that individuals with 
hypertension who believed that treatment had beneficial effects on their 
symptoms were more likely to report high adherence to recommended 
medication regimens than those who did not hold such beliefs. 
Partridge (1992) has suggested that poor understanding of what 
successful treatment may achieve (i.e. poor understanding of the concept of 
asthmatic control) and hence an expectation that asthma will necessarily 
restrict one's life indefinitely (incorrect representation of consequences) may 
lead to over-reliance on Reliever medication and poor adherence with 
Preventer medication. In one study, 64% of patients tolerated waking on at 
least three nights per week due to their asthma (Turner-Warwick, 1989) -
perhaps because they believed that nothing could alter this situation. 
Leventhal, Diefenbach & Leventhal (1992) suggest that adherence is 
likely to be optimal when GP and patient share a common illness 
representation, agree upon appropriate treatment and share criteria for 
outcome appraisal. However, patients are often not given sufficient 
information about their condition and its treatment to develop an accurate 
illness representation (Partridge, 1992). For example, Partridge reports that in 
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a poll of 1,490 members of the National Asthma Campaign, 25% did not 
understand at the time of diagnosis that Preventive medication constituted 
part of treatment (i.e. left the consulting room with an incorrect 
representation of cure). 
It follows that successful treatment of a condition involves replacing 
an individual's self-regulatory system which, although perhaps coherent, 
may be incorrect, with one which is both coherent and biologically valid (i.e. 
in line with current medical knowledge). 
4.7.7. General Coping Strategies 
A longitudinal study carried out by Sherbourne et al. (1992) using 
patients with three chronic disease (hypertension, diabetes and heart disease) 
found that individuals who relied heavily on avoidant coping strategies 
(measured using the Ways Of Coping Questionnaire; Billings & Moos, 1981 -
see Chapter 7) tended to show poor adherence to their doctor's 
recommendations, both in general and specifically related to their health 
problem. 
4.7.8. Emotional Reactions 
Ley (1990) suggests that anxiety may decrease adherence because of its 
influence on memory. While there is evidence for a relationship between the 
three variables, its exact nature is unclear. Some have suggested it to take the 
form of an inverted V-shape (those with moderate anxiety remembering and 
adhering more than those with extreme anxiety in either direction), while 
others suggest a linear relationship, higher recall (and adherence) being 
associated with higher anxiety. Research carried out in Poland by Heszen-
Niejodek (1994) supports the former hypothesis: in a sample of 61 individuals 
with hypertension, those with moderate levels of anxiety were found to show 
higher adherence than those with either low or high levels. It is interesting 
to note the similarity between these results and those found between the 
emotional reaction panic-fear and other coping strategies (see Chapter 5). 
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4.8. Incorporating Adherence Into The Self-Regulation Model 
Leventhal and his colleagues (Leventhal, Diefenbach & Leventhal 1992; 
Leventhal, Meyer & Guttman, 1980) have suggested that adherence to 
recommended treatment regimen may be viewed as a coping response, 
carried out to ameliorate the perceived effects of the condition. The findings 
reported above concerning the associations between illness representations, 
emotional reactions to asthma, adherence and illness outcomes support this 
view. Hence it is possible to incorporate this variable into the Self-Regulation 
Model. Because figures suggest that adherence to recommended treatment 
regimens is not optimal in asthma sufferers, this is particularly desirable in a 
study of coping with asthma. 
Frenzel et al. (1988) demonstrated that adherence to recommended 
glucose testing and insulin injections was independent of other, 
questionnaire-based, coping methods. It therefore seems intuitively 
reasonable to measure adherence as a behavioural coping response, i.e. 
separately from theoretically-derived coping strategies. 
4.9. Possible Strategies For Improving Adherence 
The above review suggests that there are three potentially modifiable 
determinants of adherence to recommended medication use in asthma 
patients, leading to three potential methods of intervention: 
(1) Altering treatment regimens to more simple ones. 
(2) Educating patients in order to give them more medically accurate illness 
representations. 
(3) Improving the quality of doctor-patient interactions so that the patient 
understands and remembers more and is more satisfied with the 
consul ta tion. 
Altering treatment regimens is the responsibility of clinicians and 
pharmacologists. Improving the quality of doctor-patient interactions, 
although a procedure on which psychologists may be able to advise, also 
depends on the co-operation of clinicians and is outwith the scope of this 
78 
thesis. However, altering illness representations is exactly the kind of 
cognitive intervention with which psychologists are traditionally concerned 
and is the method of choice for the intervention study described in Chapter 
10. 
4.10. Summary 
Adherence may be viewed as a coping response to chronic illness and 
has been demonstrated to be influenced by illness representations and 
emotional reactions, among other factors. The use of Preventer medication is 
particularly important for good asthmatic control, as discussed in Chapter 3; 
hence adherence to medical recommendations for taking Preventer 
medication can therefore be incorporated into the Self-Regulation Model as a 
coping response. 
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CHAPTER 5: PREVIOUS PSYCHOLOGICAL RESEARCH INTO EMOTION 
AND ASTHMA 
5.1. Introduction 
Although there is an ever-increasing amount of investigation into the 
physiological aspects of asthma, and into potential new cures, research on the 
psychological aspects of this condition is relatively scarce. As a demonstration 
of this fact, although the National Asthma Campaign funded £3.5 million of 
research during 1991, none of the 50 projects supported included any 
psychological measures (National Asthma Campaign, 1991). 
Some interest in the psychological factors involved in asthma has been 
established in recent years, however, and as interest in chronic conditions has 
developed, research teams all over Europe have begun to investigate the 
condition. Originally, most work followed the psychosomatic tradition, 
concentrating on identifying personality factors that seemed to be common to 
asthma sufferers, and hence defining the "asthmatic personality", i.e. the 
person who was most likely to develop the disease. This approach was 
"deficit-centred" (Eiser, 1990) in that it searched for "psychological deficits" 
which were precursors of chronic illnesses. Although some disciplines 
continue to use this approach, Health Psychology has rejected it, since it does 
not allow for intervention, but instead leaves the asthma sufferer "at the 
whim" of his or her personality. 
Instead, Health Psychology research has focused on sufferers' responses 
to their asthma, on how various other constructs (e.g. coping strategies, locus 
of control and self-efficacy) relate to outcome, and on what the intervening 
variables in such processes might be. Hence, instead of being seen as 
"deviant", those with chronic diseases are viewed as ordinary people coping 
with exceptional circumstances. 
This chapter does not aim to discuss all recent research in the area, but 
instead focuses on the classic asthma research of Kinsman and his colleagues, 
carried out using over 600 asthma patients admitted to the National Jewish 
Hospital and Research Centre, Denver, Colorado between 1971 and 1977 
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Gones et al., 1979) and to incorporate this research into the framework of the 
Self-Regulation Model. 
5.2. The Context Of The Kinsman Group's Work 
As early as the 1960s, research was being carried out into emotional 
reactions to asthma symptoms, although much of the evidence concerning 
specific emotions was conflicting. For example, while Knapp and Nemetz 
(1960) reported that asthma was associated with depressed mood, Weiss (1966) 
found that children became more fearful and anxious at the times when their 
asthma was aggravated. Results such as these prompted the Denver team to 
study more systematically the relationship between emotions and asthma. 
5.3. The Work Of The Kinsman Group: Relating Asthma Symptomatology 
To Medical Outcomes 
Kinsman and his colleagues originally began their work with an 
investigation of the subjective symptomatology of asthma, i.e. how people 
perceive their own asthma symptoms (Kinsman, Luparello et al., 1973). They 
aimed to design a tool for assessing a wide range of asthma symptoms, for 
both diagnostic and evaluative purposes. It was also hypothesised that such a 
tool could be used to assess sufferers' perceptions of symptoms during 
exacerbations, i.e. the perceived stressor. This concept is entirely compatible 
with the illness representations proposed by the Self-Regulation Model, 
where perceived symptoms form one component of the illness 
representation. However, the team also aimed to include emotional, as well 
as somatic symptoms, and so this was the first work to directly and 
systematically evaluate the emotions felt by sufferers at the times when 
symptoms are felt. 
The group developed and evaluated a scale - the Asthma Symptoms 
Checklist (ASC) - based on a set of 77 symptoms derived from interviews with 
29 adult asthma patients. A sample of 100 adult inpatients (76% of whom 
required steroid Preventer medications upon subsequent discharge) indicated 
the frequency with which they experienced each symptom, using the 
follOWing scale: 
1 
Never 
2 
Almost 
never 
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3 
Sometimes 
4 
Almost 
always 
5 
Always 
Key cluster analysis of the results yielded 36 items measuring the 
relative frequency of occurrence of five clusters of symptoms associated with 
asthma attacks: two describing mood states (panic-fear with 7 items and 
a=0.93 and irritability with 6 items and a=0.90), two describing somatic 
symptoms (hyperventilation-hypocapniaa with 9 items, a=0.83 and 
bronchoconstriction with 10 items, a=0.83) and the final one concerning 
fatigue (with 4 items and a=0.85). 
In order to assess the consistency of this solution, the sample was split 
into two subgroups and analysis performed on the two resulting data sets. 
The results were the same in both cases and hence deemed to be reliable. See 
Appendix 3 for a complete listing of the items. As predicted, somatic 
symptoms were the most commonly reported, 91% of patients reporting the 
frequent occurrence Calmost always' or 'always') of bronchoconstriction 
symptoms and 92% experiencing hyperventilation symptoms at least 
occasionally (but only 9% of these frequently). Fatigue was the most common 
non-somatic symptom during asthma attacks, almost twice as many patients 
(78%) reporting such symptoms as occurring 'frequently' than panic-fear 
(42%) or irritability (34%). Bronchoconstriction was not associated with mood 
states (r=0.20 with panic-fear and r=0.18 with irritability) but hyperventilation 
was more strongly associated with these variables (r=0.38 and r=0.39 
respectively). Kinsman et al. ended this paper by suggesting that the ASC be 
used to form typologies of response to asthma for individual patients, by 
looking at the relative frequency of each of the subjective symptoms. 
Furthermore, it was suggested that such typologies may be related to coping 
responses, although this hypothesis was not investigated experimentally. 
Kinsman, O'Banion et al. (1973) administered the ASC to a further 
group of 75 inpatients and combined the results with those from the earlier 
a Henceforth in this thesis, 'hyperventilation-hypocapnia' will be referred to simply as 
'hyperventilation' (since nowhere did the Kinsman group define the term 'hypocapnia'). 
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study (Kinsman, Luparello et al., 1973). The bronchoconstriction scale was re-
labelled 'airways obstruction' to allow for the fact that some of the items 
reflected origins other than the bronchioles, e.g. mucous congestion. The 
results regarding relative frequency of occurrence of each symptom were 
replicated. When subgroups of asthma patients were formed based on age, 
sex, age at onset of asthma, duration of illness and drugs subsequently 
prescribed at discharge (2-6 months later), it was found that females reported 
more panic-fear and fatigue symptoms than males No differences in 
subjective symptomatology were found between individuals of different age, 
age at onset or duration of illness, but those who were prescribed steroid 
Preventer medication upon subsequent discharge from hospital reported 
higher levels of panic-fear symptoms but no difference in any other type of 
symptoms. 
Kinsman et al. (1974) went on to identify typologies (i.e. combinations 
of the different types of symptoms reported) in the original sample of 100 
patients, using object cluster analysis. Fifteen patterns of subjective 
symptomatology were identified into which 97% of patients fitted. The 
investigation into discharge drug regimens was repeated using both mood 
symptom categories (panic-fear and irritability): individuals reporting high 
levels of either one of these symptoms were compared to those reporting (a) 
low levels of either symptom and (b) moderate levels of both symptoms. The 
earlier results were replicated in that individuals reporting low levels of 
mood symptoms were less likely to be prescribed steroid Preventer 
medication upon subsequent discharge than were those reporting moderate 
or high levels of mood symptoms. 
Hence the importance of panic-fear, as opposed to any other subjective 
symptoms of asthma, was indicated and this variable became the primary 
focus of the group's subsequent studies. It was suggested that patients' 
emotional responses to asthma exacerbations might influence treatment 
decisions made by physicians and the results therefore led the group to 
attempt to identify coping strategies which might mediate this relationship. 
In the resulting studies, the concept of typologies was abandoned and a 
specific focus on panic-fear returned to. 
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Kinsman et al. (1977) used a slightly adapted version of the ASC to 
study the relationship between subjective symptomatology and medical 
outcomes in a sample of 374 inpatients. Scores on each ASC variable were 
converted to Z-scores and patients were categorised into three groups (45 and 
55 forming the cut-off points). Of the 10 symptom scales, only panic-fear 
showed a significant relationship to prescribed steroid Preventer regimen at 
discharge, individuals reporting low panic-fear being prescribed less intensive 
regimens than those reporting moderate or high panic-fear. Panic-fear was 
not related to objective measures of lung function; reported panic-fear 
symptoms and objective pulmonary function were, in fact, orthogonally 
related to discharge steroid Preventer regimens at almost the same level. It 
was hence speculated that panic-fear could influence medical decisions 
regarding discharge drug regimens by influencing the patients' coping 
behaviour. The fact that the relationship was strongest for patients of 
physicians rated high in sensitivity by their peers provided a degree of 
support for this hypothesis. 
The research next carried on to investigate whether panic-fear might be 
related to use of Reliever medication as well as of Preventer medication. In 
an inpatient setting, Reliever medication can be taken as required (i.e. PRN) 
but it must be requested from the medical staff. Reliever medication use can 
be conceptualised as a behavioural coping strategy, often considered as an 
index of the effectiveness of the medical treatment programme (see Chapter 
3). This was of importance since it was hypothesised that such a coping 
strategy might mediate the relationship between patients' panic-fear levels 
and physicians' prescribing patterns. Dahlem, Kinsman and Horton (1977) 
investigated requests for PRN Reliever medication (in nebulised, inhaled, 
oral or injected form) in a sample of 88 adult inpatients. The results 
confirmed that panic-fear and pulmonary function level were not directly 
associated and demonstrated that panic-fear was more strongly associated 
with requests for Reliever medication (see Figure 5.1.). Patients reporting low 
panic-fear scores were least likely to request Reliever medication, regardless of 
their pulmonary function level, while patients reporting high levels of panic-
fear symptoms requested high levels of Reliever medication, regardless of 
their objective pulmonary state. It was proposed that requests for medication 
were a coping response aimed at relieVing distress. Only those with moderate 
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ASC panic-fear scores (and this group did comprise the majority of the 
patients) made progressively more Reliever medication requests as their 
pulmonary function worsened. 
Figure 5.1.: Percentage of days when Reliever medication was 
requested according to panic-fear and pulmonary function levels (Dahlem. 
Kinsman & Horton. 1977). 
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These results suggested that a moderate amount of panic-fear in 
response to asthma symptoms was optimat while extreme panic-fear 
responses in either direction led to different behavioural coping strategies, 
which may ultimately result in different illness outcomes (see also 
Staudenmayer et al., 1979). It was suggested that, since PRN Reliever 
medication use is generally taken to indicate treatment efficacy by physicians, 
this coping strategy (which was now known not to relate directly to 
underlying physiological state, in fact, but rather to panic-fear) may influence 
their subsequent treatment of patients' asthma. 
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The group extended their study (Dahlem, Kinsman & Horton, 1979) 
and supported this hypothesis by demonstrating that requests for PRN 
Reliever medication were related to two medical decisions (prescribed 
medication regimen and length of hospitalisation), regardless of the patient's 
objective medical condition. There was a linear relationship between PRN 
Reliever medication requests and both these variables. Hence there was 
evidence to support the hypothesised link between coping by PRN Reliever 
medication requests (which had been shown to be influenced by panic-fear 
levels) and medical decisions in an inpatient setting. 
Staudenmayer et al. (1979) studied the relationship between physiology 
(airways hyperreactivity, assessed by histamine challenge), panic-fear and a 
medical outcome outwith the hospital setting (rehospitalisation within six 
months) in a sub-sample of 196 inpatients who had taken part in the previous 
studies. Individuals reporting low levels of panic-fear were more likely to be 
rehospitalised than those reporting low panic-fear, despite similar levels of 
airways hyperreactivity in the two groups (37% compared to 18%). 
Individuals with low panic-fear symptomatology and high airways 
hyperreactivity were the most likely of all to be rehospitalised. The authors 
concluded that better outcomes seen in patients with high panic-fear may be 
due to higher levels of vigilant (approach) coping in this group. 
Despite its wide use with inpatient populations, the Denver team 
never extended their research to outpatient populations and it was not until 
relatively recently that the scale was validated for use with this clinical group. 
Brooks et al. (1989) administered the ASC to a sample of 132 adult outpatients, 
48% of whom had visited an emergency room for respiratory problems in the 
previous year. Exploratory factor analysis of the results supported the validity 
of the ASC - and particularly of a slightly modified panic-fear scale - in this 
population. The panic-fear scale contained nine items and showed an 
internal reliability of 0.93. Panic-fear was found to be significantly correlated 
with hospitalisation due to respiratory problems during the previous 12 
months, but not with number of calls or visits to a physician or emergency 
room visits. However, only linear correlations were used here and since 
previous research had suggested a non-linear relationship between panic-fear 
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symptomatology and medical variables, perhaps further investigation would 
have been advisable. 
Hyland et al. (1993a) studied the relative roles of emotional reactions at 
the time when asthma symptoms were felt (using the ASC) and in everyday 
life (using the Living With Asthma Questionnaire; Hyland, 1991) in a sample 
of 42 outpatients. Only the ASC variables panic-fear and irritability were 
associated with the physician's prescription of steroid Preventer medications, 
together accounting for 32% of the variance in this variable. Based on these 
results, and the work of the Kinsman group, Hyland thus supported the 
earlier suggestion by the Kinsman group: that individuals reporting high 
panic-fear symptomatology exhibit approach coping which, in the long-term, 
might lead to better asthmatic controL 
Although, 20 years after their initial publications, the Kinsman group 
have published numerous studies on outpatient populations of asthma 
sufferers (e.g. Mawhinney et al., 1993), they no longer use the ASC as a 
measure of emotional reactions to asthma. Instead they have reverted to 
their original interest of studying personality factors (assessed using the 
MMPI) and their relationship to the coping process. 
5.4. Summary 
The relationship between panic-fear and the coping process has been 
extensively investigated in inpatient populations of asthma sufferers. Panic-
fear at times of asthma exacerbations has been shown to be associated with 
coping (assessed by requests for PRN Reliever medication) which has, in turn, 
been shown to influence medical decisions made by physicians and hence 
illness outcomes (release from hospital and prescribed steroid Preventer 
medication regimen at discharge). Different levels of panic-fear were found 
to influence the coping process in different ways: high levels were associated 
with approach coping, low with lack of (or at least delayed) coping and 
moderate levels with appropriate coping (i.e. coping adapted to suit the 
objective physiological state of their asthma). 
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There has been less research into such processes in outpatient 
populations, however. Panic-fear has been demonstrated to be associated 
with illness outcome (hospitalisation) and physicians' medical decisions 
(prescription of steroid Preventer medication), but its relationship to coping 
itself has not been investigated. These results suggest that the coping process 
may be similar to that found in hospitalised samples, and deserves further 
investigation. However, the studies to date have only investigated linear 
relationships between variables, rather than the non-linear ones found by the 
Kinsman group. 
5.5. Incorporating The Kinsman Group's Work Into The Self-
Regulation Model 
The Kinsman group have reported a wealth of asthma-specific work 
which may be incorporated into the Self-Regulation Model in that the panic-
fear scale of the ASC measures an emotional response to asthma episodes. 
There is ample evidence that this response is related to coping strategies 
which, in turn, would be expected to influence asthmatic control. The ASC 
construct panic-fear may be considered as an emotional response to asthma 
symptoms within the Self-Regulation Model which has been shown to 
influence the coping process. Hence emotional responses to asthma in the 
context of the Self-Regulation Model may be operationalised as panic-fear. 
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PART 2: 
THE BACKGROUND TO THE EMPIRICAL 
STUDIES 
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CHAPTER 6: SUMMARY OF THE ADAPTED SELF-REGULATION MODEL 
AND RESEARCH QUESTIONS FOR THE EMPIRICAL STUDIES 
6.1. Summary Of Introduction 
The Self-Regulation Model (Leventhal, Nerenz & Steele, 1984) is a 
theoretically-based model of coping with chronic disease which is supported 
by much empirical evidence. It specifies roles for the sufferer's illness 
representation, coping responses and emotional reactions in the self-
regulation process. Although the role of illness outcomes is not specified, 
when these are added into the model, based on the results of previous 
research, it is a strong framework within which to investigate the coping 
process in individuals suffering from chronic disease. 
Asthma is a chronic condition which is influenced by numerous 
factors (which may vary between individuals) and requires a complex 
treatment regimen comprising several components. The efficacy of medical 
treatments has advanced considerably in recent years, with the result that 
asthma can largely be controlled by drugs self-administered by the patient and 
by adaptation of other behaviours. Asthma may be considered as a stressor, 
placing considerable demands on the patient, both physically and 
psychologically and the treatment regimen may be stressful in itself. Since 
the condition is variable and often unpredictable, the stress caused may be 
enhanced even further. 
The prevalence of asthma is increasing and hence this condition is 
becoming a considerable public health concern. Despite recent advances in 
asthma care, outcomes remain poor, especially in young adults. In this group, 
mortality rates are high and have increased over the past 25 years, while a 
corresponding increase in hospital admissions has not been found. These 
findings suggest that self-management may be poor and that insight into the 
self-regulation process is essential. 
The Self-Regulation Model was hence chosen as a framework for 
investigating the coping process in asthma and, based on the results of 
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previous research, the following factors were incorporated into the model 
was desirable: 
(1) Adherence to the recommended treatment regimen, which is an 
important factor in establishing good asthmatic control. Previous research 
findings have demonstrated that adherence is not optimal in asthma 
sufferers, perhaps due to the complex nature of the recommended treatment 
regimen, which incorporates at least two types of drug which perform 
different functions and are used in different ways. Adherence may be 
influenced by illness representations and emotional reactions to illness, 
among other factors, and can hence be incorporated into the Self-Regulation 
Model as a behavioural coping strategy. 
(2) The emotional reaction panic-fear, which has been found to relate to 
several outcomes in hospitalised asthma patients, possibly through its 
influence on patients' coping strategies. Although there is some evidence 
that similar relationships between panic-fear and the coping process exist in 
outpatient populations, the exact nature of this relationship has not been 
thoroughly investigated and only coping by Reliever medication use has been 
studied to date. 
(3) General coping strategies, which have been found to influence adherence 
and can thus be incorporated into the model. 
6.2. The Adapted Self-Regulation Model 
The Self-Regulation Model was adapted to include these factors and the 
adapted version can be seen in Figure 6.1. This model can be used to generate 
research questions concerning the relationship between cognitions (illness 
representations), behaviour (coping), emotional reactions and asthmatic 
control. 
Figure 6.1.: The adapted version of the Self-Regulation Model used to guide the empirical studies. 
\.0 
....... 
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6.3. The Research Questions For The Empirical Studies 
The model was used to guide two empirical studies investigating the 
coping process in asthma sufferers. Two studies were planned: one cross-
sectional and one intervention. The research questions addressed in each 
study are summarised below. 
6.3.1. The Cross-Sectional Study 
(1) (a) What illness representations do individuals with asthma hold of 
their condition? 
(b) How do the components of illness representation relate to each 
other? 
(c) Which demographic/illness factors might influence illness 
representations? 
(2) (a) How do individuals with asthma cope with their condition in 
terms of behaviours which are recommended by the medical 
profession? 
(b) How might adherence to recommended Preventer medication 
regimens as a coping response to asthma be assessed? 
(c) Are there relationships between different asthma-specific coping 
strategies? 
(3) Is the Self-Regulation Model of use in understanding the relationships 
between the variables proposed to be involved in asthmatic control? More 
specifically: 
(a) Are illness representations associated with coping with asthma? 
(b) Is panic-fear associated with coping with asthma and if so, is the 
relationship linear or curvilinear? Also: Is the relationship between 
panic-fear and prescribed Preventer medication regimen curvilinear? 
(c) Is asthma-specific coping related to asthmatic control? 
(4) Do (a) illness representations and (b) panic-fear show a direct relationship 
to asthmatic control? (c) If (a) and (b) are supported, are these relationships 
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stronger than those between asthma-specific coping and asthmatic control? 
(d) Does panic-fear moderate the relationship between asthmatic control and 
medica tion use? 
(5) What is the role of general coping strategies in the process of coping with 
chronic disease? In particular: 
(a) Are general coping strategies related to asthma-specific coping 
strategies? 
(b) Are general coping strategies related to asthmatic control? 
(c) If so, which (general or asthma-specific) coping strategies show the 
greatest association with asthmatic control? 
(6) Are illness representations and emotional reactions to asthma 
independent, or intercorrelated? 
6.2.2. The Intervention Studv , 
(1) How do young adult asthma sufferers cope with their condition? Does 
this sample show poor asthmatic control, and poor coping, as predicted? 
(2) What are the psychological and medical effects of a intervention aimed at 
improving asthmatic control in young adult asthma sufferers and based on 
the Self-Regulation Model? More specifically: 
(a) Does the intervention lead to an improvement in asthmatic 
control? 
(b) Is any improvement in asthmatic control associated with changes 
in illness representations, coping and emotional reactions, as suggested 
by the Self-Regulation Model? 
(c) Do any benefits found remain three-months later? 
Specific hypotheses for the intervention study are given in Chapter 10. 
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CHAPTER 7: OPERATIONALISATION OF THE MODEL FOR USE IN THE 
EMPIRICAL STUDIES 
7.1. Introduction 
In order to operationalise the model presented in Chapter 6 for use in 
the empirical studies, it was necessary to carefully select measures of each 
relevant variable. Existing measures were available for some variables, but 
others have been less extensively researched and therefore possess no such 
measures. In addition, a measure of disease outcome in asthma was required 
in order to test the hypotheses generated by the extended version of the 
model. 
This chapter first describes the development of the disease outcome 
measure of asthmatic control. It then discusses the measurement of illness 
representations and coping (general coping and adherence), critiquing existing 
measures for use and describing the development of an additional measure of 
illness representations for the purpose of this thesis. A discussion of the 
measures selected in each case concludes the chapter. Other measures which 
were used in the studies are described in the relevant empirical chapters and 
in Chapter 5 (measurement of emotional reactions to asthma). 
7.2. Measurement Of Disease Outcome: Asthmatic Control 
Although clinically defined, no objective measure of asthmatic control 
was available so it was necessary to develop one for the purposes of this 
thesis, based on the clinical concept. 
7.2.1. Introduction 
a. The clinical concept of asthmatic control 
As stated in Chapter 3, good asthmatic control is indicated by: 
(1) Minimal symptoms, ideally none. 
(2) Normal activities of daily living (i.e. no disability). 
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(3) Reliever medication needed not more than once (two puffs) per day; 
ideally, none. 
(4) Minimal side effects from medications. 
(5) Airflow rates normal or near normal at rest. 
(6) Airflow rates normal after using Reliever medication. 
(7) Daily ... variation (in lung function) minimal. 
Many general practices have a standard information sheet which they 
complete at regular intervals for each asthma patient and keep in the medical 
notes (e.g. St Andrews Health Centre, 1992a). These forms generally include 
information on symptoms reported by the patient, sleep disruptions, days off 
work/schoot lung function and medication use in addition to other things 
such as family history, exercise taken and assessed inhaler technique. The GP 
or asthma nurse assesses asthmatic control from this collective information. 
b. The research concept of asthmatic control 
The clinical concept of asthmatic control has been interpreted in 
various ways in previous research. A review of seven previous asthma 
studies which assessed the relationship between psychological factors (e.g. 
knowledge, coping strategies, attitudes to asthma) and asthma outcomes 
reveals that asthmatic control was measured in several ways (see Table 7.1). 
There are several physiological measurements indicative of lung 
function and different devices have been developed to measure each one. 
The most commonly used measures are Forced Expiratory Volume in one 
second (FEVl) and Forced Vital Capacity (FVC), both measured in litres, and 
Peak Flow Rate (PEFR), measured in litres/minute. PEFR is the measure of 
choice in most clinical applications at present, and it is easily measured by 
simple, portable Peak Flow Meters (PFMs; see Chapter 3). 
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Table 7.1.: Indices of asthmatic control used in seven studies assessing 
the relationship between psychological factors and outcomes of asthma. 
STUDY INDICES OF ASTHMATIC CONTROL 
Beasley, Cushley & • Lung function (FEVl/FVC) 
Holgate (1989) • Nocturnal wakening 
• Absences from work/school 
• Medication use 
Cluss et al. (1984) • Level of wheeze 
• Lung function variability (PEFR) 
Harding & Modell (1985) • Medication use 
• Lung function (PEFR) 
Hilton et al. (1986) • Avoidance of activities due to asthma 
• Absences from work/school 
• Hospital admissions 
• Disturbed nights due to asthma 
• Frequency of wheezing/attacks/severe attacks 
Maes & Schlosser (1988b) • Hospital admissions 
• Medication use 
• Absences from work 
Sibbald (1989) • Symptoms (wheezy attacks/nocturnal attacks/ 
overall) 
• Exercise dyspnoea 
• Absences from work/ school 
• Use of medical services (home 
visits / casualty /hospital admissions) 
White et al. (1989) • Asthma symptoms (breathlessness/wheeze/ 
cough) 
• Disturbed nights due to asthma 
• Absences from work/ school 
• Home visits by GP 
• Disruption of activities due to asthma 
• Medication use 
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The above summary demonstrates seven possible methods of assessing 
asthmatic control, with several indices representing each measure (see Table 
7.2.). 
Table 7.2.: Measures of asthmatic control and their indices. 
ASTHMATIC CONTROL MEASURE EXAMPLES OF INDICES 
Symptoms Cough, wheeze, shortness of breath, 
asthma attacks, severe attacks, 
night attacks, exercise dyspnoea 
Lung function PEFR, FVC, FEV 1, variability 
Medication use 
Avoidance/ disruption of activities 
Absences from school/work 
Use of emergency medical services Hospital admissions, horne visits 
requested, casualty attendance 
Disturbed nights due to asthma 
The above discussion suggests that indices of asthmatic control can be 
further categorised into three domains: physiological (lung function), medical 
(symptoms) and behavioural (e.g. medication use, use of medical services, 
absence from school/work, avoidance/disruption of activities, disturbed 
nights). Some of the indices might alternatively be classified as impairment 
(lung function, symptoms), disability (sleep disruption, avoidance/disruption 
of activities) and handicap (days off work/school) as defined by the World 
Health Organisation (1980). 
Two points should be noted about the indices of asthmatic control 
previously utilised. Firstly, although every study reviewed employed more 
than one index of asthmatic control, the indices have always been used as 
independent outcome variables (often with no a priori reasoning for 
choosing one above another) and never combined into a single index. 
Secondly, they have rarely been referred to (either collectively or 
individually) as representing "asthmatic control". The concept of "asthmatic 
98 
control" is, at present, one generally held by health professionals rather than 
researchers. 
The current study aimed to devise a single index of asthmatic control 
based on a combination of the indices already utilised in both research and 
clinical care so that it would have external validity in addition to statistical 
validity. 
Five indices of asthmatic control were chosen for the purposes of this 
study: lung function variability, medication use, symptoms (cough, wheeze 
and shortness of breath), sleep disturbance due to asthma, disturbance of 
others' sleep due to asthma and work/ college days missed due to asthma. 
The fact that these indices are taken to reflect good asthmatic control does not 
necessarily imply that the correlations between them will be perfect, however. 
For example, a discrepancy is often seen between lung function and subjective 
symptoms (see Chapter 3), or patients may report symptoms yet use no 
Reliever medication, or vice versa. 
The objectives of the current study were: 
(1) To investigate the factor structure of the indices of asthmatic controL 
(2) To assess the reliability (inter-rater and test-retest) of clinical assessments 
of asthmatic control. 
(3) To identify the relationship between clinical assessments of asthmatic 
control and the indices. 
(4) To identify a suitable measure of asthmatic control for use in the 
empirical studies. 
Many of the methods used are taken from Marteau's (1985) work on 
developing a measure of diabetic control using health professionals' ratings 
based on various indices taken from patients' medical notes. 
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7.2.2. Method 
a. Participants 
Data from the 27 participants in the cross-sectional study who returned 
completed monitoring diaries were used in this analysis (see Chapter 9). 
b. Procedure 
Participants each attended a session where they completed 
questionnaires for the cross-sectional study. Following this session they were 
asked to keep a diary containing various details of their asthma for the next 
seven daysa. The information requested was: 
Lung function measurements, The objective measure of lung function 
variability used in this study was derived from Peak Flow measures - the 
most common clinical measures of asthmatic control (see Chapter 3). 
PFM readings were taken first thing in the morning and last thing at 
night, before using Reliever medication (so that lung function was not 
artificially improved)b. Three readings were taken on each occasion and the 
highest was recorded either in a chart or on a graph, or both, as preferred by 
the participant. It was stressed to participants that if they forgot to complete 
their diary at any point during the study week, they should leave a blank for 
that day rather than fabricating information. 
Details of medication use. Records of the number of puffs of both 
Reliever and Preventer medication used each day and night were kept. A list 
of Reliever and Preventer medications was attached to the diary and 
participants were requested to indicate which ones they were taking, to ensure 
that no confusion over terminology was encountered. 
a This diary was based on a commonly used diary produced by Astra. 
b All participants possessed their own Peak Flow Meter, or had one on loan from the 
general practice, and had had its use demonstrated by a health professionaL 
100 
(N.B. Only Reliever medication use was an index of asthmatic control. 
Preventer medication use is a precursor of asthmatic control, rather than a 
consequence of it. However, Preventer medication use was recorded as a 
variable in the study diaries because it was of interest in its own right in the 
cross-sectional study. Since the information was therefore available to the 
health professionals rating the diaries in this study, this variable was included 
in the analysis. However, it was not expected to be significant in the 
assessment of asthmatic control.) 
Self-report of symptoms felt during each day. Cough, wheeze and 
shortness of breath were each rated on the following scale: 
RATING SYMPTOM 
a None 
1 Mild: aware of symptom but easily tolerated 
2 Moderate: symptom caused occasional interference with 
normal activities 
3 Severe: symptom caused constant interference with 
normal activities 
Sleep disturbance due to asthma. This was recorded either as present 
or absent for each night of the study week. 
Disturbance of sleep of anyone living with participant during the study 
week because of that participant's asthma. This was recorded as either 
present, absent or not applicable. 
Number of work/college/school days (including half days) missed 
because of asthma during the study week. 
The diary can be seen in Appendix 1. Each element of the diary was 
explained and an opportunity to ask questions given before the participant 
took the diary away. The diaries were returned by participants at the end of 
the study week, either by hand at a specified time or by mail (reminder letters 
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were sent where necessary). All diaries were retained, regardless of whether 
they had missing information or not. Untidy diaries or diaries which had 
additional information written on them (such as "I had a cold this week" or 
"I saw the doctor on day three") were copied out onto a new diary with this 
information omitted and it was ensured that all Peak Flow data were recorded 
on both the graph and the table. A photocopy of each diary, identifiable only 
by participant number, was sent to each of four health professionals involved 
with asthma patients, who acted as raters. Raters 1 and 2 were respectively a 
GP and an asthma nurse in the general practice through which the patients 
were recruited and raters 3 and 4 were a GP and an asthma nurse in a separate 
practice in another town. The raters were asked to rate asthmatic control 
from the information in each diary using the following scale: 
(v. poorly 
controlled) 
1 2 3 4 5 6 ( excellently 
controlled) 
All raters were blind to each others' ratings, even where they worked 
in the same general practice. 
c. Research questions 
Data were analysed in order to address the following questions: 
(1) Is asthmatic control a unitary concept, or is there a dimensional structure 
to the indices? 
(2) Do health professionals use the rating scale of asthmatic control in the 
same way? 
(3) Is inter-rater reliability of the rating scale of asthmatic control satisfactory? 
If not, how can it be improved? 
(4) Is the test-retest reliability of the scale satisfactory? 
(5) What is the relationship between asthmatic control and the indices 
proposed to related to it? 
(6) What is the best measure of asthmatic control to be used in future 
studies? (See Discussion). 
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d. Data analysis 
Data were entered using SPSS PC Data Entry and transferred to the 
mainframe SUN computers for analysis. All analyses were carried out using 
SPSS Version 4 for SUN. 
7.2.3. Results 
The results of the analysis addressing each of the above issues will be 
reported and discussed in turn. A general discussion follows at the end of the 
chapter. 
a. Research Question 1: Is there a dimensional structure to the asthmatic 
control indices? 
The dimensional structure of the indices of asthmatic control was 
investigated using Principal Components Analysis. 
There were several necessary steps in this analysis. It was first 
necessary to transform the data from the diaries into a suitable form and to 
check the distribution of each variable. Although assumptions of normality 
need not be met for exploratory Principal Components Analysis (Tabachnick 
& Fidell, 1989, p.603), it was necessary that each variable assume a reasonable 
range of values for inclusion in the analysis. Principal Components Analysis 
with Varimax rotation was then performed. Since the number of variables 
was less than 30 and the mean communality was greater than 0.7, Kaiser's 
Criterion was used in determining which factors to consider, i.e. factors with 
eigenvalues greater than 1 were retained. Variables with factor loadings 
above 0.3 following rotation were used to describe the factors. These two 
criteria followed the recommendations of Bryman & Cramer (1990, p.260). 
Lung function variation over the course of the week was quantified by 
calculating the Amplitude Percent Mean (APM), using the formula 
APM = 100 (Max PEFR - Min PEFR) 
Mean PEFR 
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This measure is the one assessed by Higgins et al. (1989) as being the 
most valid index of lung function variability in terms of distinguishing 
between individuals diagnosed as suffering from asthma and reporting 
wheeze and those without such a diagnosis or symptoms. Since the goal of 
asthmatic control is to maintain lung function variation as close as possible to 
that of non-sufferers, this measure was seen to be valuable in quantifying 
lung function variation for the purposes of investigating asthmatic control. It 
should be noted, however, that Higgins et al. based their calculations on Peak 
Flow readings taken at 2-hourly intervals over a seven-day period, in contrast 
to the twice-daily readings used in this study. 
The mean APM was 14.7 (s.d. 10.92; range 3.0-41.7) and this variable was 
suitable for inclusion in the analysis. 
Amount of Reliever and Preventer medication used during the study 
week were calculated simply by summing the number of puffs of each type of 
medication taken over the seven day period. 
The mean number of puffs of Reliever and Preventer medication 
taken during the study week were 7.3 (s.d. 12.2; range 0-64) and 14.3 (s.d. 16.2; 
range 0-42) respectively. Both variables were suitably distributed for inclusion 
in this analysis. 
The severity of asthma symptoms (cough, wheeze and shortness of 
breath) during the study week were calculated by summing the ratings for 
that symptom over the seven days. The mean levels of each symptom were 
2.0 (range 0-7), 2.4 (range 0-12) and 3.5 (range 0-16) respectively; all three 
variables was included in the analysis. 
Since the mean number of disturbed nights due to asthma was only 0.3 
(range 0-2), and the mode was zero, this variable was excluded from the 
analysis due to poor distribution. 
Disturbance of others' sleep due to the participant's asthma was a 
dichotomous variable and no participants reported that this had happened 
during the study week, so this variable was excluded from the analysis. It is 
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possible that many of the sample were single or slept alone, although data 
was not available to confirm this. 
Similarly, no participants reported having had time off work or college 
during the study week because of their asthma, so this variable was also 
discarded. 
Hence the variables which were included in the Principal Components 
Analysis were APM, Reliever and Preventer medication use, and levels of 
cough, wheeze and shortness of breath. 
Two factors were obtained in the Principal Components Analysis, with 
eigenvalues of 1.99 and 1.64. They accounted for 33% and 27% of the variance 
respectively. Following rotation, three variables were found to load >0.3 onto 
each factor. The results of this analysis are summarised in Table 7.3. 
Table 7.3.: Results of Principal Components Analysis of the six 
asthmatic control indices. 
SUBSCALE LOADING ONTO LOADING ONTO 
FACTOR 1 FACTOR 2 
Wheeze 0.83 -0.30 
Shortness of breath 0.78 0.18 
APM 0.70 0.15 
Pre venter medication use 0.24 0.87 
Reliever medication use 0.01 0.85 
Cough 0.25 -0.30 
It was concluded that asthmatic control was not a unitary concept, but 
involved two independent factors. The first included lung function 
variability and levels of wheeze and shortness of breath and could be labelled 
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"lung function variation and symptoms", while the second included 
medication use (Reliever and Preventer) and level of cough (which loaded 
negatively onto this factor) and could be seen to primarily represent level of 
medication use. 
The finding that cough and wheeze were not in.terdependent is 
consistent with previously published findings (Lancet editorial, 1988). The 
results imply that level of medication use is independent of both objective 
and subjective symptoms of asthma. It is possible that medication use is 
based on aspects of the sufferer's illness representation other than perceived 
symptoms. 
b. Research Question 2: Do health professionals use the rating scale of 
asthmatic control in the same wav? , 
The distributions of each rater's ratings of asthmatic control are shown 
in Figure 7.1. 
Figure 7.1.: Distributions of the ratings of asthmatic control made by 
each of the four raters. 
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Only one of the four raters (rater 4) used every point on the six-point 
rating scale; the other three raters all failed to use the lowest point and rater 1 
did not use point three. Raters 3 and 4 showed a much more even 
distribution of ratings than did raters 1 and 2. 
Since only the two extremes of the rating scale were labelled, and the 
other points were numbered (i.e. were defined as equally spaced) it could be 
considered an interval scale. When normality was examined using kurtosis 
and skewness values, rater l's ratings were found to be significantly 
negatively skewed. However, since the four sets of ratings were normally 
distributed in every other respect, parametric tests were suitable for this data. 
The mean ratings of control made by each rater are shown in Figure 
7.2. A one-way ANOV A was performed, and showed that there were no 
significant differences between the mean ratings made by each of the four 
raters (F3, 104=2.40, ns). 
Figure 7.2.: Mean ratings of asthmatic control made by each of the four 
raters. 
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c. Research Question 3: Is inter-rater reliability of the rating scale of asthmatic 
control satisfactory? If not, how can it be improved? 
The percentage agreements between the ratings of each possible pair of 
raters are displayed in Table 7.4. 
Table 7.4.: Percentage agreements between ratings of each pair of raters. 
RATER 2 3 4 
1 48 41 41 
2 56 30 
3 56 
Percentage agreements were low between every pair of raters. 
Additionally, in only 5 cases (19%) was complete agreement between all four 
raters seen. Thus inter-rater reliability of the six-point scale of asthmatic 
control was unsatisfactory. 
The ratings of asthmatic control were next classified dichotomously as 
either poor (1-3) or good (4-6) in an attempt to improve reliability. Although 
this methodology would result in decreased sensitivity, it is based on the fact 
that for research purposes, disease control is often treated as a dichotomous 
variable, taking values of either good or poor, rather than a continuous 
variable (see Marteau, 1985). However, Marteau classified ratings as good or 
poor based on their position relative to the other ratings made by that rater 
(in other words, a rating was classified as good when it fell into the top half of 
the rater's ratings and poor when it fell into the lower half). This 
methodology was rejected in the current study for three reasons. Firstly, it 
was desired to assess the properties of the scale, regardless of the way 
individual raters used it. Secondly, due to the odd number of participants 
(n=27) one subject would have been lost in each case, which is not ideal given 
the already small sample size. Finally, each rater had several ratings at their 
middle value; Marteau excluded such ratings but again, because of the current 
sample size, this was not desirable. It was therefore decided instead to group 
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ratings of asthmatic control based on whether they fell into the upper half or 
the lower half of the rating scale. The resulting distributions of ratings for 
each rater can be seen in Figure 7.3. 
Figure 7.3.: Number of diaries rated as showing good and poor 
asthmatic control by each rater, based on dichotomous grouping. 
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Significant differences in the ratings of asthmatic control made by 
different raters were found (Cochran's Q3=16.67, 12.<0.01). Sign tests were 
carried out between the ratings of all possible pairs of raters in order to 
investigate where these differences lay. The results of these tests are 
summarised in Table 7.5., which also shows the new percentage agreements 
between each pair of raters ("ties"). Rater 1 rated asthmatic control as 
significantly better than raters 3 and 4 and rater 2 rated more highly than rater 
3; there were no further significant differences between raters. 
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Table 7.5.: Results of sign tests carried out to examine differences in the 
overall ratings of good and poor asthmatic control between each pair of raters. 
RATER A RATER B -ve DIFFS +ve DIFFS TIES SIGNIFICANCE 
(A>B) (A<B) 
1 2 2 2 24 (89%) ns 
1 3 8 0 19 (70%) ** 
1 4 7 0 20 (74%) * 
2 3 7 0 20 (74%) * 
2 4 7 1 19 (70%) ns 
3 4 1 2 24 (89%) ns 
All three of the observed differences lay between raters working in 
different practices; there were no differences between raters working in the 
same practices (i.e. raters 1 and 2; raters 3 and 4). There are various possible 
explanations for this discrepancy. It could be that raters 1 and 2, being aware 
that they were rating patients from their own practice (even though they 
could not identify individual participants), were more likely to be biased 
towards assessing them as having good asthmatic control. Another 
possibility is that raters 3 and 4 were simply more conservative in assessing 
asthmatic control, perhaps because they encountered worse asthmatic control 
in patients within their own practice. Alternatively, individuals working in 
different practices may hold different concepts of asthmatic control, i.e. may 
use different information from the diaries to make their assessments. It was 
not possible to investigate the former two possibilities in this study, but the 
latter is investigated below. 
Agreement between pairs of raters now varied between 70% and 89%, 
as compared to 30-56% with the original 6-point rating scale. The highest 
agreement was between raters working within the same practice (i.e. raters 1 
and 2; raters 3 and 4). This is likely to be due to similar training and 
experience with patients between raters working in the same practice. 
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All four raters agreed on 17 ratings (63%) based on this dichotomous 
coding; compared to the previous 19% agreement, this was a vast 
improvement and indicated a reasonable degree of inter-rater reliability. 
d. Is test-retest reliability of the scale satisfactory? 
Approximately 14 months after the raters were first requested to rate 
the diaries, they were asked to repeat the task. The Pearson correlation 
coefficients between ratings at Time 1 and ratings at Time 2 are shown in 
Table 7.6. 
Table 7.6.: Test-retest reliability for each of the four raters. 
RATER CORRELATION BETWEEN 
RATINGS AT Tl AND T2 
1 0.65** 
2 0.53** 
3 0.80** 
4 0.51 ** 
Although all the test-retest correlations are highly significant, only one 
of them (Rater 3 - one of the GPs) reaches the level of 0.8 which has been 
recommended as acceptable by statisticians such as Bryman & Cramer (1990). 
The time lapse between the two ratings was long, however, and the fact that 
asthma knowledge and treatment is constantly evolving may have 
contributed to these poor levels of reliability. The GPs ratings of asthmatic 
control were more reliable over time than the asthma nurses' ratings. 
e. What is the relationship between asthmatic control and the indices 
proposed to relate to it? 
The same variables as used in the Principal Components Analysis were 
entered as independent variables in stepwise multiple regressions with 
111 
asthmatic control ratings as the dependent variable (separate multiple 
regressions were carried out for each of the four raters). 
Since the ratio of independent variables to cases (6:27 or 1:4.5) was only 
just below the recommended minimum requirement of at least four times 
more cases than variables (Tabachnick & Fidell, 1989), it was decided to enter 
only those independent variables which showed significant raw correlations 
with any of the dependent variables, to keep this ratio as high as possible yet 
to still allow comparison of the total amount of variance explained by the set 
of independent variables for each rater. Correlation matrices between each 
raters' ratings of asthmatic control and the six asthmatic control indices were 
therefore constructed (see Table 7.7.). 
Table 7.7.: Correlation matrix of asthmatic control indices with each 
rater's ratings of asthmatic control. 
RATER 1 2 3 4 
APM -0.86** -0.72** -0.51 ** -0.43* 
Reliever medication use -0.04 -0.01 -0.15 -0.34 
Preventer medication use -0.20 -0.13 -0.20 -0.26 
Cough -0.07 -0.27 -0.56** -0.49** 
Wheeze -0.64** -0.74** -0.71 ** -0.51 ** 
Shortness of breath -0.53** -0.63** -0.54** -0.40* 
* 12.<0.05 ** 12.<0.01 
Four independent variables (APM and levels of cough, wheeze and 
shortness of breath) were significantly correlated with at least one rater's 
rating of asthmatic control and were therefore entered into each regression, 
giving a variables:cases ratio of approximately 1:7. (Note that three of these 
variables comprised Factor 1 in the Principal Components Analysis). 
Inspection of the four plots of predicted values of the dependent variable 
against the residuals showed that the assumptions of normality, linearity and 
homoskedasticity were violated slightly for the independent variable (APM). 
However, since (a) the other variables were satisfactorily distributed, (b) 
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transformation was undesirable due to problems with interpretation of 
results and (c) failure to meet the assumptions does not invalidate but merely 
weakens the results of multiple regression (Tabachnick & Fidell, 1989) the 
analysis was carried out using the original data. 
Tables 7.8., 7.9., 7.10. and 7.11. show the results of the stepwise multiple 
regression analyses for each of the four raters. They display the 
unstandardised regression coefficients (B) and intercept, the standardised 
regression coefficients (Beta), the semipartial correlations (sr2), and R2, 
adjusted R2 and F for the resulting equation. 
Table 7.8.: Multiple regression of asthmatic control indices onto rater 
l's ratings of asthmatic control. 
INDEPENDENT VARIABLE B 
APM 
Shortness of breath 
Wheeze 
Constant=6.3572 
R2=0.800441 
F2,22=44.12** 
-0.09 
-0.09 
** 12.<0.01 
Adjusted R2=0.78230 
BETA sr2 
-0.77** 0.51 
-0.27* 0.06 
ns -
1 Unique variability = 0.51+0.06=0.57; Shared variability = 0.80044-0.57=0.23 
R for the regression was significantly different from zero (F2,22=44.12, 
p'<0.01). Two of the independent variables contributed significantly to the 
prediction of rater l's ratings of asthmatic control: Amplitude Percent Mean 
alone accounted for 51 % of the variance, level of shortness of breath 
accounted for 6% and in combination the two variables accounted for a 
further 23% in shared variability. Altogether, 80% (78% when adjusted) of 
the variance in rater 1's ratings of asthmatic control could be predicted from 
the scores on these two independent variables. 
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Table 7.9.: Multiple regression of asthmatic control indices onto rater 
2's ratings of asthmatic control. 
INDEPENDENT VARIABLE B BETA sr2 
APM -O.OS -0.S7** 0.28 
Shortness of breath -0.12 -0.44** 0.17 
Wheeze ns -
** Note: R<O.Ol 
Constant=S.S821 
R2=0.694801 Adjusted R2=0.66706 
F2 22=2S.04 ** , 
1 Unique variability = 0.28+0.17=0.45; Shared variability = 0.69480-0.45=0.24 
R for the regression was significantly different from zero (F2,22=2S.04, 
p-<0.01). As for rater 1, two of the independent variables contributed 
significantly to the prediction of rater 2's ratings of asthmatic control: 
Amplitude Percent Mean alone accounted for 28% of the variance, level of 
shortness of breath accounted for 17% and in combination the two variables 
accounted for a further 24% in shared variability. Altogether, 69% (67% when 
adjusted) of the variance in rater 2's ratings of asthmatic control could be 
predicted from the scores on these two independent variables. 
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Table 7.10.: Multiple regression of asthmatic control indices onto rater 
3's ratings of asthmatic control. 
INDEPENDENT VARIABLE B BETA sr2 
Cough -0.35 -0.58** 0.33 
APM -0.05 -0.39** 0.13 
Shortness of breath -0.14 -0.40** 0.14 
Wheeze ns -
Constant=5.8475 
R2=0.741171 Adjusted R2=0.70420 
F3,21 =20.05** 
1 Unique variability = 0.33+0.13+0.14=0.60; Shared variability=0.74117-0.60=0.14 
R for the regression was significantly different from zero (F3,21 =20 .05, 
p.<0.01). Three of the independent variables contributed significantly to the 
prediction of rater 3's ratings of asthmatic control: level of cough alone 
accounted for 33% of the variance, Amplitude Percent Mean alone for 13% of 
the variance, level of shortness of breath accounted for 14% and in 
combination the three variables accounted for a further 14% in shared 
variability. Altogether, 74% (70% when adjusted) of the variance in rater 3's 
ratings of asthmatic control could be predicted from the scores on these three 
independent variables. 
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Table 7.11.: Multiple regression of asthmatic control indices onto rater 
4's ratings of asthmatic control. 
INDEPENDENT VARIABLE B 
Cough 
APM 
Wheeze 
Shortness of breath 
Constant=5.4741 
R2=0.449731 
F222=8.99** , 
-0.35 
-0.07 
Adjusted R2=0.39971 
BETA sr2 
-0.51 ** 0.26 
-0.46** 0.21 
ns -
ns -
1 Unique variability = 0.26+0.21=0.47; Shared variability = 0.44973-0.47=-0.02 (N.B. 
this figure could be slightly negative due to rounding of decimal places, or could be genuine - see 
Tabachnick & Fidell, 1989, p.1S1) 
R for the regression was significantly different from zero (F2,22=8.99, 
12<0.01). Two of the independent variables contributed significantly to the 
prediction of rater 4's ratings of asthmatic control: cough alone accounted for 
26% of the variance and Amplitude Percent Mean alone accounted for 21% of 
the variance. In combination the two variables accounted for no further 
variability. Altogether, 45% (40% when adjusted) of the variance in rater 4's 
ratings of asthmatic control could be predicted from the scores on these two 
independent variables. 
Table 7.12. lists the rank order of the independent variables 
contributing to each rater's rating of asthmatic control according to their 
respective Beta weights obtained from the multiple regression analyses. It 
also compares the total (adjusted) amount of variance in each rater's ratings 
explained by the independent variables entered into that rater's equation. 
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Table 7.12.: Rank order of the independent variables contributing to 
each rater's ratings of asthmatic controL according to their Beta weights. 
RANK RATER 1 RATER 2 RATER 3 RATER 4 
1 APM APM Cough Cough 
2 s.o.b. s.o.b. APM APM 
3 s.o.b. 
(% variance 
explained 78 67 70 40) 
Note: s.o.b=Shortness of breath. 
Focusing on the first two variables which contributed to asthmatic 
control, all four raters placed much weight on lung function variability. In 
addition, raters 1 and 2 appeared to use information concerning shortness of 
breath while raters 3 and 4 used information about levels of cough. Only 
rater 3 considered a third variable in assessing asthmatic control from 
participants' diaries and this variable was shortness of breath. Hence only 
raters 3 and 4 used information from both the factors resulting from the 
Principal Components Analysis when making their ratings of asthmatic 
control. None of the raters used any information about medication use in 
assessing asthmatic control, indicating that they perceived non concordance 
between asthmatic control and coping by medication use. Perhaps 
surprisingly, no rater used participants' reports of wheeze in rating asthmatic 
control, suggesting that they also perceived non concordance and patients' 
perceived wheeze. The overall percentage of variance in each rater's ratings 
predictable from the variables varied between 40% (rater 4) and 78% (rater 1). 
7.2.4. Summary And Discussion 
Asthmatic control is a clinical concept which is generally assessed by 
health professionals from diaries kept by patients which include 
physiological, medical and behavioural indices. The clinical indices of 
asthmatic control in fact comprise two separate factors: lung function 
variability / symptoms and medication use. Unfortunately it was not possible 
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to include the behavioural indices of asthmatic control in this analysis since 
they were not suitably distributed; if it had been then it is possible that they 
would have formed a third factor. 
The original six-point Likert-type rating scale of asthmatic control 
showed unsatisfactory inter-rater reliability, but when ratings were classified 
dichotomously as 'good' or 'poor', reliability increased. Inter-rater reliability 
was always greater between raters working in the same general practice than it 
was between raters working in different practices. Although there were no 
overall significant differences between raters, raters 3 and 4 showed a more 
even distribution between 'good' and 'poor' ratings than raters 1 and 2, 
perhaps because they were not rating patients from their own practice. The 
ratings were not satisfactorily reliable over a 14 month period; this is an 
unusually long period to use for assessments and it is possible that medical 
opinions concerning asthmatic control may have changed slightly over this 
period. 
When the information used by the each health professional to make 
the ratings of asthmatic control was examined, some striking similarities 
between raters were found. All four raters focused on lung function 
variation and a single symptom when assessing asthmatic control, apart from 
rater 3 who also took a second symptom into consideration. Raters 1 and 2 
(from one general practice) used information on level of shortness of breath 
while raters 3 and 4 (from a second practice) used level of cough (rater 3 also 
using level of shortness of breath to some degree). Only rater 3 used 
information from each factor of asthmatic control in making ratings. Less of 
the variance in the ratings of asthmatic control made by rater 4 was accounted 
for by the variance in the indices than for the other three raters. 
7.3. Measurement Of Illness Representations 
7.3.1. Existing Measures 
The original work of the Leventhal group on illness representations 
was primarily carried out using qualitative measures (semi-structured 
interviews; see Leventhal & Nerenz, 1985). However, none of the published 
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papers to date include strict guidelines for coding the data obtained from 
open-ended questions, and the group did not develop quantitative measures 
from the results of their studies. Hence researchers working within the 
theoretical framework of the Self-Regulation Model have been forced to 
develop their own measures (either quantitative or qualitative) and to use 
their own coding methods to operationalise the model. To date, no generally 
accepted, standardised measures have been found; this has led to difficulties 
with comparing data from different studies, due to a lack of coherent 
measures. 
Weinman (1994b) believes that it is important to develop quantitative 
measures of illness representations, since individuals often have difficulty 
expressing their concepts of illness in response to open-ended questions. In 
his study, for example, 37% of 50 diabetics interviewed about their condition 
produced only negligible amounts of information in semi-structured 
interviews. Quantitative measures also allow comparison of the results of 
different studies and this is particularly interesting if it is possible to adapt the 
measures for use with different patient and non-patient groups. For the 
current studies, it was desired to use a quantitative method of assessing 
illness representations, for several reasons. Firstly, it was desired to use 
measures with known reliability and validity and to compare data to the 
results of previous studies using the same measures. Second, it was required 
to use assessment methods which did not require too much of the 
partiCipants' time, since a large battery of measures were to be administered, 
participation in the studies was voluntary and it was desired to keep attrition 
to a minimum. Finally, repeated measures were used for the intervention 
study and it was felt that in such a case comparison of data was most easily 
accomplished using quantitative measures since participants would know 
that pieces of information they had given in previous waves of the study 
were still of interest at follow-ups. (If open-ended questions were used then it 
is possible that participants would deliberately try to give different pieces of 
information at each follow-up of the study, believing that information given 
early in the study would not be of interest at later time points). 
To date, no Single, psychometrically sound quantitative measure 
entirely consistent with Leventhal's original open-ended work on illness 
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representations has been developed. Only in one study (Prohaska et al., 1985) 
did the Leventhal group attempt to develop such a measure. This 
questionnaire included scales to assess perceived severity, emotional 
response, vulnerability, time appraisal (timeline) and self-effectance 
(controllability) and was used to elicit illness representations of several 
conditions from 396 general population adults. However, no reliability or 
validity statistics for the scales were reported and the questionnaire has not 
been used in any subsequent published studies. Instead, individual 
researchers have developed their own questionnaires for use with specific 
patient groups. For example, Payne (1990) has developed a questionnaire for 
assessing perceived cause and treatment of breast cancer, while Hampson, 
Glasgow & Toobert (1990) have developed a similar measure for use with 
diabetes sufferers, based on the results of open-ended questions. 
Two other research groups have developed measures of illness 
representations, based on the work of Leventhal and his colleagues, which 
can be applied to different clinical and non-clinical groups, have been 
psychometrically evaluated and have been used in empirical studies. These 
will now be discussed in turn. 
a. The Implicit Models Of Illness Ouestionnaire (Turk Rudy & Salovey, 1986) 
Turk and his colleagues set out to examine the dimensional structure 
of illness representations, using 38 items based on the work of Lau & 
Hartman (1983), Leventhal, Meyer and Nerenz (1980) and Taylor, Lichtman 
& Wood (1984). They also sought to examine the consistency of illness 
representations over different conditions and actual illness experience. The 
questionnaire was administered to a sample of 165 participants (diabetes 
educators, diabetes sufferers and college students; mean age 31.9), who were 
asked to rate two illnesses - one personally relevant (diabetes or influenza) 
and one not (cancer) - on various dimensions. Responses were given on a 9-
point Likert-type scale anchored at both ends (l=strongly agree; 9=strongly 
disagree). 
The methodology for this study was rather complex. Two sub-samples 
(N=35) were formed by random sampling. The results based on the salient 
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illness from one group were added to the results from the non-salient illness 
from the other group and Principal Components Analysis with oblique 
rotation applied to the resulting data set. Both Kaiser and scree criteria were 
used to determine which factors to retain; both methods led to the same 
result, which was then cross-validated using the remaining data. The 
resulting 28-item questionnaire comprised four subscales: seriousness (9 
items; a=0.92), personal responsibility (8 items; a=0.91), controllability (5 
items; a=0.79) and changeability (2 items; a=0.68). 
High scores on each of the subscales were interpreted as follows: 
Seriousness: Belief that the condition is contagious, difficult to cure, chronic 
and requires medical attention. 
Personal Responsibility: Belief that many things which are under the control 
of the individual (e.g. stress, diet) cause the condition. 
Controllability: Belief that the condition is controllable by the individual. 
Changeability: Belief that the illness changes over time. 
The validity of the IMIQ was demonstrated in two ways: (a) it 
discriminated between individuals with different levels of experience with 
the condition under study and (b) the two illnesses were rated differently 
overall. 
Because of the methodology behind its development, the IMIQ can be 
used for assessing illness representations of various conditions, whether 
personally relevant or not. However, to date it has not been used in asthma 
studies. 
Although the original items were based partly on the work of 
Leventhal and his colleagues, the resulting subscales do not correspond with 
those originally proposed by the Self-Regulation Model. This is likely to be 
because Turk et al. measure statistically defined dimensions, while 
Leventhal's original work was concerned with conceptually defined 
components of illness representations (Lau, Bernard & Hartman, 1989). In 
other words, the IMIQ domains are construct valid while Leventhal's 
components are content valid. Hence the Turk et al. domains merely 
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comprise re-groupings of items measuring Leventhal's original components, 
i.e. there is no evidence that Leventhal was wrong in his conceptualisation -
just that the items comprising his components can be grouped together in 
new ways. For example, the items in the seriousness scale could all be fitted 
into one or other of Leventhal's existing domains. Similarly, personal 
Responsibility is concerned with cause and cure and changeability can be 
related to timeline. Hence, although Turk et al. claim that their results 
oppose Leventhal's findings, in fact they merely seem to be re-grouped or re-
labelled, construct valid combinations of items representing the content valid 
components which Leventhal originally proposed. 
Lau, Bernard and Hartman (1989) expand on this point by suggesting 
that the dimensions approach, which entails factor analytic techniques, 
examines differences in illness representations of different conditions, while 
the components approach is concerned with shared features. Hence Bishop 
(1991a) asserts that the two approaches are merely concerned with assessing 
complementary aspects of the same phenomenon. 
b. The Illness Perceptions Questionnaire 
The second, more recently developed, questionnaire for assessing 
illness representations is the Illness Perceptions Questionnaire (IPQ; 
Weinman, 1993; Weinman, 1994a; Weinman, 1994b; Weinman et al., 1995). 
This questionnaire was theoretically derived, using data obtained from 
structured interviews with individuals suffering from either rheumatoid 
arthritis (N=22) or diabetes (N=88). From the interview responses, selection 
of 28 items was carried out by two independent researchers using the 
theoretical basis of the five illness representation components originally 
proposed by Leventhal and his colleagues. Hence the scales were content 
valid. 
The resulting subscales were labelled and high scores interpreted as follows: 
Emotional attributions: Belief that stress and other people were responsible 
for the onset of the condition. This subscale was derived from the Leventhal 
component cause, but includes only emotional aspects of this component. 
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Symptom quality: Belief that the condition is distressing, changeable and 
puzzling. This subscale corresponds to the Leventhal component identity. 
Consequences: Belief that the condition significantly disrupts life. 
Control/cure: Belief that the condition is controllable. 
Timeline: Belief that the condition is chronic. 
Participants respond using the following scale: 
1 
Strongly 
agree 
2 
Agree 
3 
Neither agree 
nor disagree 
4 
Disagree 
5 
Strongly 
disagree 
The items were used in a pilot study and adjusted where necessary, to 
improve comprehensibility. The resulting questionnaire consisted of 17 
items. In addition there was a list of 12 symptoms, with a yes/no answer 
format, designed to elicit the identity of the condition (although Weinman et 
al. (1995) suggest that an illness-specific symptom list be used in place of this 
list, where desired). The questionnaire in this form was administered to the 
original participants and the responses to these items showed good 
correlations with the open-ended responses where both were obtained 
(Weinman, 1994b). 
Table 7.13. shows the six scales of the IPQ along with Weinman's 
assessment of their internal reliabilities in a group of 288 Chronic Fatigue 
patients and test-retest data over a 4-week time period using a group of 32 
patients with chronic renal disease. 
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Table 7.13.: The six IPO scales and their internal reliabilities (Weinman, 
1993). 
SCALE NO. OF ITEMS a. TEST-RETEST 
RELIABILITY (r) 
Identity 12 0.83 0.84** 
Timeline 3 0.60 0.49* 
Control! cure 5 0.69 0.68** 
Consequences 4 0.63 0.68** 
Symptom quality 3 0.56 0.75** 
Emotional attributions 2 0.61 0.46* 
** 12<0.01 
The IPQ has since been adapted slightly (Weinman et aI., 1995) to fit 
better with the Leventhal conception of illness representations. The 
symptom quality scale has been dropped (since it contained only 2 items and 
showed relatively low internal reliability), one item ('My illness will improve 
in time') has been transferred from the timeline scale to the controI/cure 
scale and additional items have been added to the cause and consequences 
scales (the cause scale now contains more than simply emotional 
attributions; in addition there are hereditary, medical and behavioural 
attribution items). However the original version of the questionnaire 
remains used in some studies (e.g. Moss-Morris, Petrie & Weinman, 1995). 
Because the IPQ items were selected on the basis of their content validity, 
rather than their construct (i.e. statistical) validity, the scales are not 
independent, but intercorrelated. For example, Weinman (1994a) found 
significant correlations between the following pairs of variables in a sample of 
asthma sufferers: 
(1) Identity and (a) timeline, (b) cause and (c) consequences. 
(2) Timeline and (a) consequences and (b) cure/control. 
(3) Cause and cure/ control. 
(4) Consequences and cure/ control. 
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Those who held a strong identity to their asthma (i.e. believed many 
symptoms to be associated with it) tended to have more explanations for the 
cause of the asthma, believed that the condition was chronic and that it had 
worse consequences for their lives than those who associated less symptoms 
with their asthma. Individuals who believed their asthma to be chronic also 
believed it to have more severe consequences and that it could not be 
cured/ controlled than those holding an acute representation. Those who had 
many explanations for the cause of their asthma were least likely to think that 
it could be cured/controlled and those who believed there was no cure 
available and that the condition could not be controlled were more likely to 
believe that there were extreme consequences due to the illness. Hence it is 
clear that components of the illness representation assessed using this 
measure are not independent. However, it would be expected that these 
correlations would differ between sufferers of different conditions. 
The validity of the new scales has been shown in several ways 
(Weinman et al., 1995). Concurrent validity was demonstrated by significant 
correlations with disability (measured using the Sickness Impact Profile; 
Bergner et al., 1981), the Recovery Self Efficacy Scale (Partridge & Johnston, 
1989) and the Multidimensional Health Locus of Control Scale (Wallston, 
Wallston & DeVellis 1978). Discriminant validity was demonstrated by the 
fact that the IPQ profiles from samples of chronic fatigue, chronic pain, 
rheumatoid arthritis and diabetes patients were significantly different. 
This questionnaire is another which can be adapted for use with 
different clinical and non-clinical groups. As well as the patient groups 
mentioned above, the IPQ is also currently being used in a long-term 
longitudinal study of asthma sufferers (Weinman, 1995), but only 
preliminary results from this study are available to date. 
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7.3.2. Development Of A New Measure: Representations Of Consequences Of 
Asthma For Ouali ty Of Life 
a. Introduction 
The Leventhal group's extensive work on illness representations has 
suggested that some of the beliefs individuals hold about specific medical 
conditions concern the consequences of suffering from the condition. 
However, at the start of these studies, the IMIQ was used and it did not assess 
beliefs about consequences of illness. Hence for the purposes of that study it 
was necessary to develop a measure of illness representations of the 
consequences of having asthma. 
A thorough search of the literature and contact with various asthma 
researchers across the UK and abroad revealed only one measure concerned 
with beliefs about the consequences of having asthma: the Expectations 
Questionnaire (Hyland, 1992). This measure requests asthma sufferers to 
report how they expect their asthma will affect them in certain areas of life 
(e.g. sleep, limitation of activities) when it is (a) better than normal and (b) 
bad. However, there were several problems with this tool. Firstly, it had 
never been conceptualised, validated or published as an illness 
representations measure. Secondly, since illness representations are held by 
all individuals, regardless of whether they suffer the condition of interest or 
not, a measure of any component of the representation should be general and 
not dependent on personal experience of the condition, as the Expectations 
Questionnaire is. 
The aim of this study was to develop and validate a tool for 
measuring illness representations of the consequences of asthma which could 
be used with populations with differing levels of experience of asthma and 
was suitable for use in the empirical studies. 
The "consequences of having asthma" were interpreted conceptually as 
the ways in which the condition affects the quality of sufferers' lives. Hence it 
was decided to measure representations of the "expectations of Quality of 
Life". From this conceptual starting point, it was necessary to include items 
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concerning a wide range of areas of life affected by asthma in order to assess 
how individuals believe each area to be affected. It was therefore intuitive to 
base the measure on existing validated measures of Quality of Life with 
asthma. The criteria for choosing such a measure were (a) that it should 
cover as wide a range of areas of life as possible and (b) it should be validated 
in its original form, so that the areas covered reliably represent those relevant 
to asthma sufferers. 
There is a distinct lack of validated measures of Quality of Life 
specifically concerned with asthma, although scales for patients with general 
chronic airflow limitation do exist (e.g. Guyatt et al., 1987; Jones, Quirk & 
Baveystock, 1991; Maille et al., 1994). Such measures are not specific enough 
to asthma, and hence more specific measures were sought. 
A review of the literature revealed only three published asthma-
specific scales which had been extensively developed and psychometrically 
tested. The first was a 20-item self-administered questionnaire for adults 
with asthma developed by Marks, Dunn & Woolcock (1992). This 
questionnaire included subscales assessing breathlessness, mood disturbance, 
social disruption and concerns for health which were factor-analytically 
derived from an initial set of 69 Likert-type items derived from focus groups 
with asthma patients and administered to 283 asthma sufferers. Test-retest 
reliability was 0.80 and internal reliability 0.92-0.94. A certain degree of 
construct validity was reported to be demonstrated by correlation with 
medical markers of asthma severity, although the exact correlations were not 
reported but were said to be 'weak'. All the items in this questionnaire were 
negatively worded, i.e. high scores represented lower Quality of Life. Hence 
response bias would be expected to influence results. 
The second scale was the Living With Asthma Questionnaire (Hyland, 
1991; Hyland, Finnis & Irvine, 1991): a 68-item questionnaire with Likert-type 
response format, also factor-analytically derived from items identified by 
focus groups. This scale was designed to be a broadly focused tool, with a 
view to developing it and reducing its focus in subsequent studies, e.g. to 
allow its use as an outcome measure for clinical trials. Originally, 101 items 
were chosen by the author to fit into 11 domains: social/leisure, sport, sleep, 
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holidays, work and other activities, colds, mobility, effects on others, 
medication use, sex and dysphoric states and attitudes (high scores 
represented good Quality of Life). However, several Principal Components 
Analyses using various groups of asthma sufferers indicated that responses to 
the items were unifactorial, based on a scree plot. The first factor accounted 
for between 26.2% and 29.8% of the variance in participants' responses in the 
various samples. Only items loading >0.3 on this factor were retained and 
items demonstrating highly skewed response distribution (>70% of 
participants responding in the same way) were excluded, leaving 68 items in 
the final version of the scale. Validity of the scale was demonstrated by its 
high correlations with the Sickness Impact Profile (Bergner et al., 1981; 
r=0.66), steroid prescriptions (r=0.35) and Peak Flow measurements (r=-0.44). 
Discriminant validity was demonstrated by the scale's ability to distinguish 
between asthma sufferers recruited through GPs and those recruited through 
the Asthma Society and test-retest reliability was assessed at 0.9. The scale 
includes both positively and negatively-worded items, in order to minimise 
response bias. 
The third scale for measuring Quality of Life with asthma was the Life 
Activities Questionnaire for Adult Asthma (Creer, Wigal et al., 1992). The 70 
items for this scale were derived from letters to 90 adult asthma sufferers and 
fell into seven conceptual categories: physical, work, outdoor, emotions and 
emotional behaviours, home care, eating and drinking and 'miscellaneous'. 
Test-retest reliability was 0.80, and internal reliability 0.96-0.97. For each item, 
individuals were required to report the amount of restriction experienced, i.e. 
high scores represented greater restriction as in the questionnaire of Marks, 
Dunn & Woolcock. 
The Living With Asthma Questionnaire was selected as the preferred 
basis for development of the measure of representations of consequences of 
asthma for Quality of Life, primarily because of its broad focus of 11 domains 
of life (it was thought that these could be relevant when considering 
expectations, despite their non-independence in actual Quality of Life; also, 
when factors with eigenvalues> 1 were retained in Hyland's original analysiS, 
as opposed to using the scree test, six factors were in fact obtained, indicating 
that Quality of Life may be considered as multidimensional, depending on 
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the criterion employed). Also, the mixture of positively and negatively-
worded items was seen as an advantage, in that it would minimise response 
bias. In addition to the 68 items in the final version of the scale, four items 
which were dropped at the penultimate stage of its development were used, 
since the criterion for dropping them was unclear in the original paper. 
The resulting questionnaire was evaluated in order to investigate 
whether illness representations of consequences of asthma for Quality of Life 
comprised a unitary concept, or whether there was evidence for the validity 
of independent domains in the measurement of expectations of Quality of 
Life with asthma. 
b. Method 
Adaptation of the Quality of Life measure c. Several options for 
adapting the question format were considered. One was to rephrase each item 
to make it non-personal (e.g. "I can take part in any sport I want" would 
become "With asthma, you can take part in any sport you want") then to ask 
for the level of agreement with each statement, using a Likert-type response 
format. However, this approach was considered too general because of the 
wide variety in degree of restriction found in asthma sufferers. It was decided 
instead to leave each item phrased as in the original Quality of Life 
questionnaire and to ask for an estimate of the percentage of all asthma 
sufferers who would be expected to be restricted in the way described by the 
statement. 
The 72 items of the Living With Asthma Questionnaire were therefore 
taken and the following instructions added: 
"We would like to ask you about how you think life is, in 
general, for people who suffer from asthma. Below are 72 
statements concerning everyday activities which mayor may not 
be affected by asthma. We would like you to imagine that each 
c Many thanks are due to Dr Michael Hyland for the early discussions which led to the 
choice of this method. 
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statement is given to 100 people, chosen at random, from the 
total population of people who suffer from asthma, and to 
indicate in the box beside each statement the number of these 
people (out of 100) who would say that the statement was TRUE 
of them, because of their asthma. 
So, for example, if an item reads 'I cannot go to the cinema 
because of my asthma' and you think that 10 out of 100 people 
with asthma would say that this is true - they cannot go to the 
cinema because of their asthma - then write '10' in the box beside 
that item. Please do this for all 72 of the items.d 
You should write a single number (from 1 to 100) in each box)." 
In addition to completing the questionnaire, participants were 
requested to provide information about their level of experience with 
asthma, in order to investigate whether the sample was heterogeneous in this 
respect. Eight questions with yes/no response formats were asked, concerning 
personal experience of asthma and chest problems (current and previous), 
family members with asthma, close friends with asthma, 
flatmates/neighbours in residence with asthma and more distant 
acquaintances with asthma. 
The questionnaire can be seen in full in Appendix 1. 
Participants. The questionnaire was administered to 121 participants 
(43 male and 76 female), all of whom were psychology undergraduates at the 
University of St Andrews and aged between 17 and 40. Such a sample was 
chosen (a) because the intervention study was to focus on student asthma 
sufferers and (b) because large numbers of participants were hence possible. 
Participants were recruited in one of two ways. The first group 
consisted of first and second year students who were asked to complete the 
d Due to an administrative error, item 49 was inadvertently omitted from the 
questionnaires; hence only 71 items were actually administered. 
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questionnaire during laboratory classes. 70 students were given the 
questionnaire and 67 returned it completed, giving a response rate of 96%. 
The mean age of this group was 19.4 years. The three students who did not 
complete the questionnaire took it away and never returned it. A further 
paper was spoiled and was excluded from the analysis, leaving a final sample 
size of 66. 
The second group were third and fourth year honours students whose 
names were obtained from the honours class lists through the School of 
Psychology secretariat. Each student was sent a questionnaire via their 
pigeonhole, along with an explanatory letter requesting them to complete it 
and return it to a box placed beside the pigeonholes. 101 students were 
contacted in this way. Seven questionnaires were never removed from the 
pigeonholes; of the remaining 94, 55 were completed and returned, giving a 
response rate of 58.5%. The mean age of this group was 21.3 years, i.e. 
significantly higher than that of the first and second years (t119=-5.13, 12.<0.05), 
as expected. 
Overall, 121 questionnaires out of 164 were completed and returned: a 
response rate of 74%. The responses to 13 of the questionnaires (10 from the 
first group and 3 from the second) were incomplete and since this was an 
exploratory study, there were no a priori guidelines for substituting missing 
values so these participants were lost from some of the analyses. 
The mean age of the participants was 20.1 years. Classifying each 
individual according to their closest experience with asthma, 14 individuals 
(12%) had no experience of asthma at all. 62 (51 %) had a friend, flatmate or 
neighbour (for those living in student halls of residence) who suffered from 
asthma and 25 (21 %) had a relative with asthma. 11 (9%) had been diagnosed 
as suffering from asthma themselves at some point during their lives and a 
further 9 (7%) as suffering from 'other chest complaints'. Hence there was a 
wide range of experience with asthma among the total sample as required. 
Statistical procedure. Responses to the positively worded questions 
were subtracted from 100, meaning that a high score for any question meant 
expectations of high degree of disruption of life due to asthma. The 
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distributions of responses to the 71 items were found by examination of 
kurtosis and skewness values to be normally distributed, i.e. parametric 
statistics were appropriate. Participants recruited by the two methods did not 
differ significantly in their overall scores on the scale (tl06=1.38, ns); hence it 
was reasonable to combine the two samples for analysis purposes. 
It was not possible to perform exploratory factor analysis on the 
responses to the 71 items with a sample size of 121, since the variables:cases 
ratio did not reach the 1:5 recommended by Tabachnick & Fidell (1989). 
Alternative methods of investigating the possible factor structure of the scale 
were hence developed, based on the 11 original domains of the Quality of Life 
scale. 
Eight independent judges placed each item into one of Hyland's 
original 11 domains, to form the basis for 11 subscales. Judges were permitted 
to indicate a "not placeable" response for the items which they considered not 
to fall into any of the 11 domains. The eight sets of results were then 
compared and items where five or more judges (i.e. >50%) agreed on the 
domain were placed into the corresponding subscale. Internal reliabilities of 
the resulting 11 subscales were assessed using Cronbach's alpha. Correlations 
between the total scores for each of the 11 subscales were calculated in order to 
investigate whether the subscales were independent and Principal 
Components Analysis was then performed on the total scores of the 11 
subs cales to investigate whether the subscales were indeed independent or 
whether Expectations of Quality of Life was a unidimensional construct. 
c. Results. 
55 of the 72 items were placed into the same domain by at least five of 
the eight judges. The number of items which were placed into each domain, 
and Cronbach's alpha for each of the resulting subscales, can be seen in Table 
7.14. This table also includes details of the number of items which Hyland, 
Finnis & Irvine (1991) proposed to be included in each of the original 11 
domains, for comparison. With the exception of dysphoric states and 
attitudes, the eight judges classified the same number of items into each 
subscale, to within two items, as Hyland did in his original report. It seems 
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likely that Hyland classified several items which the eight judges did not 
agree on as dysphoric states and attitudes, although since he did not specify 
the actual items he placed into each scale, this hypothesis cannot be explored. 
Table 7.14.: Classification of items into 11 subscales by judges, and 
internal reliabilities of the resulting subscales. 
SUBSCALE NO. OF ITEMS ex NO. OF ITEMS 
(Hyland et al.) 
1 Dysphoric states & attitudes 14e 0.87 23 
2 Colds 6f 0.84 5 
3 Mobility 5 0.76 6 
4 Sport 3 0.71 3 
5 Holidays 3 0.69 3 
6 Sex 2f 0.62 1 
7 Sleep 2 0.61 4 
8 Effects on others 3 0.60 5 
9 Medication use Sf 0.60 6 
10 Social/leisure 5 0.56 6 
11 Work & other activities 7 0.52 6 
(Not classified 17) 
The internal reliability (coefficient alpha) for the entire scale was 0.95. 
Bryman and Cramer (1990) recommend 0.8 as a high level of internal 
reliability, although in practice, levels above approximately 0.6 are accepted as 
reasonable. Using this criterion, all but two of the scales showed reasonable 
internal reliabilities. 
The correlations between the 11 subs cales, and the significance of each 
correlation, are displayed in Table 7.15. All but two pairs of the subscales were 
significantly intercorrelated and it should be noted in particular that the first 
e Including item 49. 
f All eight judges agreed on categorisation of all items. 
Table 7.15.: Correlations (lmver half of table) and significance of correlations (upper half of table) 
between the 11 subscales. 
SUBSCALE 1 2 3 4 5 6 7 8 9 10 11 
1 Dysphoric states & attitudes * * * * * * * * ** * * * * * * * * * * -
2 Colds 0.59 - * * * * ** * * * * ** * * * * * * 
3 IvIobility 0.50 0.40 - ** * * * * ** ** * * * * * 
4 Sport 0.30 0.25 0.24 - * * * ** * * ns ** 
5 Holidays 0.44 0.36 0.41 0.48 - ** * * * * * * * * * * 
6 Sex 0.44 0.33 0.27 0.21 0.42 - * ** * * * * * * 
I-' 
7 Sleep 0.43 0.37 0.48 0.44 0.43 0.20 * * * * * * * * - ~ 
8 Effects on others 0.43 0.36 0.44 0.22 0.47 0.33 0.40 - ** ns * * 
9 -Medication use 0.71 0.37 0.41 0.23 0.41 0.39 0.38 0.48 ** * * -
10 Social/leisure 0.38 0.29 0.19 0.11 0.26 0.25 0.24 0.01 0.29 - * * 
11 "Vork & other activities 0.53 0.53 0.59 0.41 0.66 0.45 0.51 0.62 0.45 0.27 -
-- ------- ----------'-- ---- -- ------ ---------
Note: * 12<0.05 * *12<0.01 
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four subscales, which displayed the highest internal reliabilities, were highly 
intercorrelated. 
With 11 subs cales, the number of subscales to participants was 11:121, 
or 1:11. Examination of kurtosis and skewness values indicated that all the 
subscale scores apart from scale 2 (colds) and scale 6 (sex) fulfilled the 
assumptions of normality. Two violations out of 22 would only be expected 
to minimally degrade the results of exploratory Principal Components 
Analysis (Tabachnick & Fidell, 1989, p.603) and so Principal Components 
Analysis of the subscale scores was carried out in order to investigate whether 
the subscales were in fact statistically unidimensional, i.e. non-independent, 
as suggested by the raw correlations. Factors with eigenvalues greater than 
one were considered and Varimax rotation was used (see Table 7.16.). 
Table 7.16.: Results of the Principal Components Analysis of the 11 
subscales. 
SUBSCALE LOADING ONTO LOADING ONTO 
FACTOR 1 FACTOR 2 
Dysphoric states & attitudes 0.81 0.29 
Medication use 0.80 0.14 
Effects on others 0.67 0.18 
Sex 0.59 0.12 
Colds 0.58 0.36 
Mobility 0.56 0.39 
Social/leisure 0.51 0.48 
Sport -0.02 0.84 
Holidays 0.39 0.71 
Sleep 0.33 0.68 
Work & other activities 0.56 0.62 
Two factors were found, with eigenvalues of 5.2 and 1.1, accounting for 
47% and 10% of the variance respectively. Following rotation, seven 
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subscales were found to load onto factor 1 and four onto factor 2. Six of the 
subscales loaded >0.3 onto both of the factors and showed similar loadings 
onto each factor. 
d. Discussion 1 
Although all 11 subs cales, as classified by eight independent judges, 
demonstrated reasonable internal reliability, only three subscales showed 
high internal reliability (above 0.8) and the subscales were highly 
intercorrelated. 
The interpretation of the Principal Components Analysis results was 
unclear since the two factors obtained could not be labelled in any meaningful 
way. In addition, more than 50% of the subscales loaded significantly onto 
both factors, so the results of the analysis were inconclusive. 
Hence the evidence suggested that the 71 items formed a 
unidimensional scale, with high internal reliability (0.95). This indicates that 
individuals expect that asthma influences all areas of life equally, rather than 
causing different levels of restriction in different areas of life. However, it 
was apparent that the complete scale was very long and extremely time-
consuming and tedious for participants to complete; it was therefore desirable 
to reduce the number of items. 
e. Shortening The Scale: Method 
It was decided to explore two methods of shortening the scale: 
(1) Version A: The 20 items with the highest correlations with total scale 
scores were retained. 
(2) Version B: The two items from each subscale which correlated most 
highly with the total scale score were retained, to form a 22-item scale 
including items covering different areas of life. 
The resulting scales were compared in terms of internal reliability and 
variety of items. 
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f. Shortening The Scale: Results 
The items selected for inclusion in each of the shortened versions of 
the scale, the subscale they were derived from and their correlations with the 
total 71-item scale scores, are displayed in Table 7.17. Both shortened forms of 
the scale demonstrated satisfactory internal reliability - Version A at 0.89 and 
Version B at 0.87. Only 10 items were included in both versions of the 
shortened scale. Version A contained at least one item from every subscale 
with the exception of subscales 4 (sport) and 6 (sex). It was, however, heavily 
biased towards items from scales 1 (dysphoric states and attitudes), 2 (colds) 
and 11 (work and other activities). 
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Table 7.17.: The items selected for inclusion in each of the shortened 
versions of the scale. 
ITEM CORRELATION SUBSCALE INCLUDED IN INCLUDED IN 
WITH TOTAL TAKEN FROM VERSION A? VERSION B? 
SCALE SCORE 
3 0.53 5 v-
4 0.51 7 v-
7 0.46 8 v-
13 0.58 5 v- v-
IS 0.65 11 ../ v-
16 0.59 2 v- v-
17 0.58 3 ../ v-
18 0.48 8 v-
23 0.47 4 v-
24 0.46 4 v-
26 0.54 11 ../ v-
27 0.57 2 v-
29 0.59 1 v-
30 0.56 1 v-
34 0.62 7 v- v-
35 0.53 11 ../ 
36 0.56 2 v-
38 0.50 10 v-
42 0.52 3 ../ 
44 0.65 1 v- v-
52 0.55 10 v-
53 0.55 9 v- v-
54 0.59 9 v- v-
56 0.45 6 v- v-
57 0.54 1 ../ 
58 0.62 1 ../ v-
59 0.56 1 v-
60 0.62 1 v-
69 0.42 6 v-
70 0.57 2 v- v-
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g. Discussion 2 
The two shortened versions of the scale both showed satisfactory 
internal reliability. Since Version B contained a wider balance of items from 
different subscales, however, it was decided to forfeit a small amount of 
internal reliability in favour of a more varied and interesting questionnaire 
covering a wider range of areas of life affected by asthma. Hence a 22-item, 
unidimensional scale assessing representations of consequences of asthma for 
Quality Of Life, suitable for use with asthma sufferers in the cross-sectional 
study and also with non-asthma sufferers, had been created. This scale was 
named the Expectations of Quality of Life scale (EQOL) and can be seen in 
Appendix 1. 
7.4. Measurement Of Coping 
A measure of general coping strategies was required for the cross-
sectional study (for asthma-related coping strategies used in this study, see 
Chapter 9). By the time the intervention study was at the planning stage, an 
asthma-specific coping questionnaire had been published in English and this 
is also discussed below. In addition the measurement of adherence to 
recommended treatment regimens (see Chapter 4) is discussed. 
7.4.1. General Coping 
To a large extent, the measurement of coping has developed in parallel 
with coping theory (see Chapter 2). 
a. Early measures 
The measurement of coping began with individual researchers 
developing their own measures based on intuitive ideas about the types of 
coping individuals might use. For example, Sidle et al. (1969) developed a list 
of situationally non-specific coping strategies and Pearlin & Schooler (1978) 
carried out open-ended exploratory interviews with 2,300 healthy 
individuals. The latter study assessed coping with specific crises, e.g. marriage 
or job stress, and a list of 17 concrete coping strategies resulted. Although 
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these measures were potentially adaptable to a variety of situations, they 
lacked explicit theoretical structure (Ray, Lindop & Gibson, 1982). With the 
advancement of coping theory, however, increasingly sophisticated measures 
have been developed. The most significant and widely used of these 
measures will now be discussed. 
b. The Ways of Coping Checklist (Folkman & Lazarus, 1980) 
Lazarus, the founder of coping research, developed the first measure of 
coping - the Ways of Coping Checklist (WOCC) - based on the theoretical 
concept of problem-focused and emotion-focused coping. The WOCC consists 
of 68 items designed to assess problem-focused and emotion-focused coping 
strategies for dealing with a specific chronic stressor. Each item is responded 
to using a simple yeslno format. Principal Components Analysis with 
Varimax rotation indicated that 68% of the problem-focused items loaded 
significantly onto the first factor and 78% of the emotion-focused items onto 
the second. Internal consistency of the two subscales was indicated by 91% 
agreement between 10 expert raters asked to categorise the items. In addition, 
test-retest reliability was 0.80 for the problem-focused scale and 0.81 for the 
emotion-focused. 
Several problems concerning the use of the WOCC have since become 
apparent, however. Firstly, the items of the WOCC do not appear to be 
comprehensive and of high face value. For example, Ben-Porath, Waller and 
Butcher (1991) administered the WOCC to 326 college students and asked 
them to identify items which were not relevant to the particular stressor they 
were assessing. They found that all items were inapplicable in at least some 
cases (item figures ranging from 2.1 % to 83.9%), the mean inapplicability over 
all the items being 21.5%. Even Lazarus and his colleagues have found the 
WOCC to have some "redundant and unclear items" (Folkman & Lazarus, 
1985, p.157) and have hence chosen to omit or re-word some items and to add 
extra items. In other studies, researchers have found it necessary to add items 
to certain scales in order to make them more comprehensible (e.g. Scheier, 
Weintraub & Carver, 1986) or to use only some of the items, in conjunction 
with items derived from other sources (e.g. Felton, Revenson & Hinrichsen, 
1984; Stone & Neale, 1984), in order to form a comprehenSive list of items 
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which participants are willing and able to complete. The need for such 
amendments is not surprising in view of the fact that the items which did not 
load significantly onto either factor in the Principal Components Analysis 
were not discarded, but left as part of the scale. 
Secondly, the yes/no response format has been found too simple by 
several researchers and has subsequently been updated to a four-point Likert 
scale (e.g. Folkman & Lazarus, 1985; Scheier, Weintraub & Carver, 1986). 
Finally, and perhaps most importantly, subsequent research has 
suggested that the dichotomous categorisation of the WOCC items (into 
problem-focused and emotion-focused coping) was over-simplistic and that 
coping actually formed several factors. For example, Vitaliano et al. (1985) 
administered the WOCC to a sample of 425 medical students and factor 
analysis revealed six factors with eigenvalues greater than one. Four of these 
factors were labelled problem-focused coping, self blame, wishful thinking, 
seeking of social support and the final two factors were not labelled because 
less than four items loaded onto each and these items loaded more highly 
onto earlier factors. 
Scheier, Weintraub & Carver (1986) asked 291 undergraduates to 
describe how they had attempted to cope with the most stressful situation 
they had encountered in the previous two months, using the WOCc. Factor 
analysis of the resulting data, using oblique rotation, revealed seven factors: 
denial/distancing, problem-focused coping, self-blame, acceptance/ 
resignation, positive reinterpretation, escape through fantasy and social 
support. 
Dunkel-Schetter et al. (1992) factor-analysed data obtained from a 
group of 603 cancer patients using the WOCC and identified five coping 
strategies covered by the WOCC items. The five strategies were social 
support/direct problem solving, distancing, positive focus, cognitive 
escape/avoidance and behavioural escape/avoidance. 
Folkman and Lazarus (1985) themselves revised the original WOCc. 
They used 57 of the 66 WOCC items they had retained in their revised scale 
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and changed the response format to a 4-point Likert-type scale. Factor 
analysis of the results obtained from students coping with exams showed that 
the items clustered into six factors (following oblique rotation 15 items still 
did not load onto any of these and were discarded, leaving a 42-item scale). 
One of the factors was labelled problem-focused coping. Four were concerned 
with various emotion-focused strategies, but one of these was subsequently 
split into three separate scales since it 
"contained three distinguishable sets of emotion-focused items .... (which) 
were rationally assigned to three factors to provide greater theoretical clarity." 
(p.157). 
The resulting six factors were wishful thinking, distancing, 
emphasising the positive, self-blame, tension reduction and self isolation. 
The final factor contained a mixture of problem-focused and emotion-focused 
coping strategies and was labelled seeking social support. 
The revised version of the WOCC was named the Ways of Coping 
Questionnaire (WCQ). The internal reliabilities of the factor scales ranged 
between 0.56 and 0.85. The data used for this analysis were, however, 
somewhat unusual in that they included repeated measures data collected 
from the same participants at three time points across a two-week exam 
period and this inter-dependence was not allowed for in the analysis. In 
addition, the dividing of a single factor-analytically derived scale into three 
smaller scales goes against the fundamental aims of factor analysis. 
Common to all these studies was the finding that problem-focused 
coping formed a single scale, while the original emotion-focused strategies 
were found to split into at least two distinct subscales (and several in all 
studies but one). There were also similarities between the remaining factors 
found in the studies (see Table 7.18). Distancing, positive reinterpretation and 
seeking social support were factors which were identified in each of the three 
most recent studies. Although social support was classed as a problem-
focused strategy in the Scheier, Weintraub and Carver study, examination of 
the items indicates that it included seeking social support for emotional 
Table 7.18.: A comparison of the results of factor analysis of the \,yOCC items in four studies. 
I BILLINGS & MOOS FOLIOifAN & VITALIANO ET At. SCHEIER, DUNKEL-SCHETTER! 
(1981) LAZARUS (1985) (1985) \,yEINTRAUB & ET AL. (1992) 
CARVER (1986) 
Problem-focused Problem-focused Problem-focused Problem-focused Social support / direct 
problem solving 
Emotion-focused \,yishful thinking Wishful thinking 
Distancing Denial/ distancing Distancing 
Emphasising the Positive Positive focus 
positive reinterpreta tion 
....... 
Self-blame Self-blame Self-blame ~ 
Tension reduction 
Self isolation 
Acceptance / resigna tion 
Escape through fantasy Cognitive escape/ 
avoidance 
Behavioural escape / 
avoidance 
Seeking social support Seeking social support Social support Social support/ direct 
problem solving 
Appraisal-focused 
-
_ ....... -
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reasons, too. Hence this factor appears to be the only one to straddle the 
originally proposed boundary between problem-focused and emotion-focused 
coping strategies. 
The differences between the factors obtained in these studies may be 
explained by the differences in the nature of the stressors studied. For 
example, coping with a predominantly uncontrollable, chronic stressor would 
be expected to differ in form from coping with an acute, sudden-onset 
condition (Taylor & Aspinwall, 1990). However, the studies clearly 
demonstrate that Lazarus's original dichotomous view of coping was too 
simplistic. 
Despite this mixed support for the reliability and validity of the coping 
scales, the WOCC and the WCQ have been used extensively in coping 
research. Endler & Parker (1990), following their review, summarise the 
situation thus: 
"(they) have been used by other researchers far more than the psychometric 
properties of the scales would warrant." 
(p.846). 
c. The COPE (Carver, Scheier & Weintraub, 1989) 
Because of the difficulties they, and others, had found with the WOCC 
in its various forms, Carver, Scheier and Weintraub developed a new scale -
the COPE - which incorporates measures of thirteen conceptually distinct 
coping methods and may be used to elicit general ('dispositional') coping 
strategies or situation-specific ('situational') coping strategies. 
The COPE is a 60-item coping inventory comprising 15 scales of 4 items 
each, derived partly from the coping theory of Lazarus (including the WOCC) 
and partly from behavioural self-regulation research carried out by the 
authors over a number of years. The original 72 items were designed to cover 
the following 13 aspects of coping (as defined by the authors): 
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Active coping: Taking active steps to try to remove or circumvent the 
stressor, or to ameliorate its effects. 
Planning: Thinking about how to cope with a stressor. 
Suppression of competing activities: Putting other projects aside; trying to 
avoid becoming distracted by other events; letting things slide a little, if 
necessary, in order to deal with the stressor. 
Restraint coping: Waiting until an appropriate opportunity to act presents 
itself; holding oneself back and not acting prematurely. 
Seeking of social support for instrumental reasons: Seeking advice, assistance 
or information. 
Seeking of social support for emotional reasons: Seeking moral support, 
sympathy or understanding. 
Focusing on and venting of emotions: Focusing on whatever distress or 
emotion one is feeling and ventilating these feelings. 
Behavioural disengagement: Reducing one's efforts to deal with the stressor, 
even giving up the attempt to attain goals with which the stressor is 
interfering. 
Mental disengagement: This is a variation on behavioural disengagement, 
postulated to occur when conditions prevent behavioural disengagement. It 
occurs through a wide range of activities that serve to distract the person from 
thinking about the behavioural dimension or goal with which the stressor is 
interfering. 
Positive reinterpretation and growth: Thinking about the stressor in the best 
light possible. 
Denial: Refusal to believe that the stressor exists, or trying to act as if the 
stressor is not real. 
Acceptance: The opposite of denial, i.e. engagement in the attempt to deal 
with the situation. 
Turning to religion: The tendency to turn to religion in times of stress. 
Completion of the scale requires indicating the frequency with which 
that method is used, on the following four-point scale: 
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1 2 3 4 
I USUALLY DON'T I USUALLY DO THIS I USUALLY DO THIS I USUALLY DO THIS 
DO THIS AT ALL A LITTLE BIT A MEDIUM 
AMOUNT 
The development of the COPE was as follows: 
A LOT 
An initial Principal Components Analysis (with oblique rotation) 
carried out on data collected from 978 American undergraduates yielded 11 
factors, two of which incorporated two of the originally proposed coping 
strategies. Although the paper reporting the scale's construction does not 
make it clear, the original scales would appear to have been retained in these 
cases (if this is the case, then the Principal Components Analysis 
methodology appears to have been flawed). In addition, one item 
(concerning alcohol and drug use) was retained on its own as it did not load 
significantly onto any of the other factors, despite originally being intended to 
represent mental disengagement. The factors formed the basis for scales and 
tended to inter-correlate in two distinct clusters: theoretically 'adaptive 
strategies' (active coping and planning, suppression of competing activities, 
restraint coping and positive reinterpretation and growth) and theoretically 
'less adaptive' strategies such as denial, behavioural disengagement, focusing 
on and venting of emotions and alcohol/drug use. Seeking of social support 
(for both instrumental and emotional reasons) correlated significantly but 
weakly with both of these clusters. 
At a later date, three more items were added to form an alcohol and 
drugs scale and a further scale was added to assess coping by the use of 
humour. The authors are reported to regard these two scales as exploratory, 
although they have now formed part of the scale and been used in research 
for approximately six years. The post-hoc addition of these scales presents a 
further problem for the methodology. 
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Internal and test-retest reliabilities (based on a sample of 89 of the 
original undergraduates who re-completed the scale eight weeks after its first 
completion) for each of the 15 COPE scales were generally acceptable (see Table 
7.19.). 
Table 7.19.: The 15 scales of the COPE and their reliabilities. 
SCALE TEST-RETEST ex 
RELIABILITY (N=89) 
(N=978) 
Active coping 0.62 0.56 
Planning 0.80 0.63 
Suppression of competing activities 0.68 0.46 
Restraint coping 0.72 0.51 
Seeking social support for instrumental reasons 0.75 0.64 
Seeking social support for emotional reasons 0.85 0.77 
Focusing on & venting of emotions 0.77 0.69 
Behavioural disengagement 0.63 0.63 
Mental disengagement 0.45 0.58 
Positive reinterpretation & growth 0.68 0.48 
Denial 0.71 0.54 
Acceptance 0.65 0.63 
Religion 0.92 0.66 
Alcohol! drug use - 0.57 
Humour - -
The COPE is adaptable to a wide range of conditions and has been 
extensively used in health research over recent years - for example, with 
patients with myocardial infarction (Gudmundsdottir et al., 1994; Moorthy et 
al., 1994; Weinman et al. 1995) and chronic fatigue syndrome (Moss-Morris, 
Petrie & Weinman, 1995; Weinman, 1994b). 
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7.4.2. Asthma-Specific Coping Measures 
Since the above measures are not suitable for use in assessing coping 
with a condition such as asthma, which has no sudden onset, alternative 
methods of assessing asthma-specific coping were required. 
a. The Asthma Coping Questionnaire (ACQ) 
This questionnaire was originally written in Dutch form (Maes, 
Schlosser & Vromans, 1986), was described by Maes and Schlosser (1988b) and 
was first published in English by Schlosser (1992). 
The ACQ consists of two scales - The Asthma Coping Trait List (ACT), 
which is concerned with day-to-day coping with asthma, and the Asthma 
Coping State List (ACS), which measures coping specifically at times when 
asthma symptoms are experienced. Items were derived by operationalisation 
of 21 coping mechanisms identified in a factor analytic study by MCCrae (1982). 
The resulting questionnaire was administered to 397 adult asthma patients 
recruited through four hospitals in the Netherlands. Principal Axis Analysis 
with Varimax rotation revealed that the ACS comprised three further 
subscales and Principal Components Analysis with Varimax rotation that the 
ACT also comprised three scales (the reasons for using different statistical 
methods in each case were not discussed). The scales and their subs cales are 
summarised in Table 7.20., along with the number of items and their 
reliabilities, as reported by Maes and Schlosser (1988b) and Schlosser (1992). 
All the scales showed satisfactory reliability. In addition it was important to 
assess coping both at times when symptoms were felt and inbetween, since 
both may be expected to influence asthmatic control. 
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Table 7.20.: The six ASC scales and their internal reliabilities (from 
Schlosser, 1992). 
SCALE/SUBSCALE NO. OF ITEMS a. 
ACf 
Maintaining a healthy lifestyle 10 0.74 
Focusing on asthma 10 0.63 
Hiding asthma 10 0.73 
ACS 
Minimising the seriousness of the attack 17 0.84 
Reacting emotionally 10 0.69 
Rational action 12 0.82 
7.4.3. Measurement Of Adherence To Recommended Medication Regimen 
See Chapter 4 for a discussion of the concept of adherence to 
recommended medication regimens. 
There are several methods (both direct and indirect) of assessing how 
much medication a patient has taken; however, each method has its 
problems and to date no perfect method has been found, nor is it likely to be. 
The principal problem is that individuals who are aware that their 
medication consumption is under observation are more likely to succumb to 
social desirability effects, either by being more adherent than normal or by 
over-reporting adherence (especially if their own GP will know the results). 
Hence it is difficult to take a valid measure of the amount of medication 
generally taken. Measuring the timing of the doses taken presents even 
further difficulties but some methods which attempt to overcome them have 
been designed and are discussed below, along with more basic methods. 
Clinicians' ratings. In clinical practice, it is normal for adherence to be 
assessed by the clinician. However research has shown that such estimates 
are unreliable compared to measures such as pill counts (see below). There 
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are several reasons why this might be the case. Firstly, patients may be 
especially reluctant to admit less than optimal adherence to their own GP, 
who has made the medical recommendations and with whom an ongoing 
relationship is likely. Secondly, the exact questions used to assess adherence 
may vary and hence elicit very different responses. Thirdly, there is evidence 
that more than two-thirds of GPs simply do not ask their patients whether 
they adhere to the treatment regimen they have recommended or not 
(Kleiger and Dirks, 1976) and hence cannot be expected to provide valid 
information. For these reasons, Dunbar (1980) is almost certainly accurate in 
stating that clinicians' ratings "are of no value" (p.61) and "should not be 
used as an (adherence) indicator, either in the research or the clinical setting" 
(p.74-75). 
Direct observation. While direct observation methods have previously 
been employed in studies of adherence to recommended appointment 
attendance, it is impractical to directly observe an individual's medication 
consumption. 
Self-report. On the assumption that the patient him/herself is in the 
best position to assess adherence, self-report data is desirable and in fact is the 
most commonly used method of assessing adherence in asthma sufferers 
(Creer, 1993). The patient can simply be asked whether the GP's 
recommendations on specific aspects of treatment are adhered to: in may 
cases it will be confessed that guidelines are less than completely followed, 
especially if the patient is permitted to justify the response given. This 
procedure has the advantage that it can be carried out either during an 
in terview or by questionnaire. 
There now exist scales for assessing adherence by self-report. For 
example, Morisky, Green & Levine (1986) describe a structured four-item self-
report measure with reasonable internal reliability (a=0.61) in a sample of 400 
hypertensive patients. The four items were selected from five derived from a 
previous study (Green, Levine & Deeds, 1975) on the basis that they formed a 
single factor in Principal Components Analysis. The items concern non-
adherence for different reasons (forgetting, being careless, feeling better and 
feeling worse) and hence once more allow the patient to justify the responses 
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given. Each item is responded to in a yes/no fashion and the total number of 
'yes' responses is calculated, high scores indicating poor adherence. 
Concurrent and predictive validity in the sample were demonstrated by 
comparing scores to blood pressure control, both concurrently, six months 
later (r=0.43) and 42 months later (r=0.58). 
Research has shown, however, that interviews tend to lead to over-
estimates of adherence in comparison with other methods, including 
clinicians' ratings (Dunbar, 1980). A particular problem can arise here if the 
interview is carried out by the patient's own GP (see above). Self-report using 
written questionnaires has also been shown to over-estimate adherence by up 
to 30% compared with more sophisticated measures (Partridge, 1992). Such 
reporting errors may be due to intentional deception, memory failure, lack of 
understanding of the treatment regimen or social desirability effects. 
Partridge argues, however, that despite their sometimes low reliabilities, self-
report measures remain clinically useful, especially when non-
confrontational phrasing of questions is used. However, for research 
purposes such measures are generally taken in conjunction with more 
sophisticated, more reliable ones since they are easily obtainable and come 
from the patient him/herself. 
Illness outcome. Ley (1990) reports that some studies employ illness 
outcomes as a measure of adherence. However, as discussed in Chapter 4, 
factors other than adherence (such as efficacy of the recommended treatment) 
can influence illness outcome and hence this measure has poor validity. 
Patient diaries. Requesting patients to keep diaries recording 
medication use results in data from the full time period over which the 
behaviour actually occurs (Dunbar, 1980). The use of patient diaries 
minimises potential memory biases/inaccuracies since the period to be 
reported on at anyone time is relatively short. The data obtained from 
diaries can also give insight into whether a patient departs from 
recommendations systematically or erratically, possibly indicating whether 
non-adherence may be intentional or accidental and suggesting possibilities 
for intervention. 
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A problem with patient diaries is that they require the patient to 
consciously monitor medication use and hence may influence the normal 
pattern (Dunbar, 1980). Hence, whenever possible, minimal attention should 
be drawn towards the variables of interest. For example, medication use 
could be included as only one of the measures recorded in the diary so that 
the patient is less explicitly aware that this information is of specific interest. 
For example, in asthma studies a general diary can be requested, including 
Peak Flow measurements, symptoms, effects of illness on day-to-day 
activities, mood and other measures along with medication use. It should be 
noted that requesting the completion of diaries requires further adherence on 
the part of the patient and therefore paradoxically increases the scope for non-
adherence. 
Recently, electronic diaries have been developed (e.g. Hyland et al. 
1993a). One advantage of such diaries is that they are portable, and hence 
more likely to be completed at the requested times. In addition, the 
information requested at anyone time is committed to the computer's 
memory, so that at each completion time the previous data are not seen and 
hence monitoring effects are minimised. In addition, electronic diaries can be 
time-coded and hence allow detection of retrospectively recorded data. This 
has two advantages. Firstly, if individuals know of this procedure, then they 
are more likely to complete the diary at the requested times and retrospective 
data (which is more likely to be unreliable due to memory effects) can be 
detected and removed from analysis. Secondly, researchers must question 
whether an individual who is non-adherent to requests to complete a diary 
(completing it all at the end of the week) is really likely to be adherent to their 
medical treatment regimen on a daily basis. However, due to the high costs 
involved, electronic diaries have not been widely used to date. 
Prescriptions. A more quantifiable measure of medication use - and 
especially of medications prescribed on a long-term basis - is the number of 
prescriptions which an individual is given. GPs' notes should hold records of 
exactly how much many prescriptions have been written for a patient, and 
when, and this can be compared to the number expected if adherence was 
100%. 
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There are multiple problems with this measure as an indicator of how 
much medication the individual actually uses, however. Firstly, 
prescriptions written by the doctor are not necessarily collected from (or even 
taken to) the pharmacy. Secondly, there is no guarantee that the medications 
which are collected from the pharmacy are actually used. In the case of 
asthma, sometimes an inhaler might be lost, a "spare" may be kept or the 
patient may give or loan their inhaler to someone else on the same 
medication or discard old inhalers before they are empty. Thirdly, the 
number of prescriptions requested over a given time period might be affected 
by factors other than medication use. For example, a patient with a pre-
payment or exemption certificate may "stock up" near to the expiry date, in 
order to save money. The medication may not actually be taken during the 
period of interest, however. The only certainty of this method is that the 
number of prescriptions written is the maximum amount which the patient 
can have taken. However it would be necessary to ensure that medical 
records were 100% accurate in order to assert this completely. 
Perhaps a more accurate method is to use pharmacy records to identify 
the number of prescriptions uplifted by the patient. However, this method 
relies on individuals constantly using the same pharmacy, which is not 
necessarily the case. Furthermore, the problem of what the individual 
actually does with the medication once it is collected from the pharmacy 
remains unsolved. 
Medication measuring. Pill counts (or, in the case of asthma, inhaler 
weighing) can be used to assess how much medication has been taken by an 
individual during a certain period. For pill counting, the number of 
remaining pills in the bottle are compared to that predicted if adherence was 
100%. In the case of inhaler weighing, the standard weight of one actuation of 
each type of inhaler is required in order to determine the number of 
actuations a patient has made during the period of interest (e.g. Tashkin et al., 
1991). For powder-type "Spinhalers" or blister-pack tablets the patient can be 
requested to bring back all their empty and partially used packets at the end of 
the observation period. 
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Once more, in general, these methods take no account of patients 
taking the correct amount of medication but at the wrong time, or removing 
the medication from its container but never taking it at all. Even discounting 
the opportunity for "cheating", not all medication removed from the 
container is necessarily taken by the patient - for example, many patients 
"test" their inhalers periodically by activating them into the air. Patients are 
required to bring their medication containers to interviews (a further request 
for adherence) and if they do not then the assessment is lost. More specific 
problems to inhaler weighing are (a) that patients may have more than one 
inhaler, so care must be taken to ensure that either all inhalers are weighed or 
only one of them is used during the period of observation and (b) that 
patients may not fully actuate their inhalers every time (although this is a 
factor which is supposedly allowed for in the design of inhalers). 
Computerised medication dispensers. Perhaps the most accurate 
method of assessing patient medication use is by using computerised 
dispensers. These generally take the form of a container which can record the 
exact time that each dose is removed from the container and are hence very 
precise. For pills, a special bottle may be used with a digital memory which 
records the number of pills removed from the bottle, along with the time 
when they are removed. In the case of inhalers, a special casing can be used to 
dispense the medication from the canister. Examples are the "Nebuliser 
Chronolog" (Spector, 1985) and the "Turbohaler Inhaler Computer" (Van Es 
et al., 1994). Once again, the casing contains a micro-computer which records 
the number of actuations made and the time of each one. Spector reports that 
adherence as measured by this device was uncorrelated with adherence 
measured by patient diaries in a sample of 19 patients prescribed Preventer 
medication four times daily. 
Such electronic devices are generally used by drug companies 
conducting drug trials, since it is very important in such cases to know exactly 
how much of the medication under testing has been taken by each 
participant. They have the advantage of detecting those individuals who may 
not take the drug as recommended during the study period, but "dump" their 
pills or empty their inhalers immediately prior to returning them to the 
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investigator to make it appear that they have in fact been taking their 
medication. 
However, the devices still possess disadvantages. Individuals who are 
determined to hide poor adherence may still "cheat" by activating the 
mechanism at the correct time and removing the correct dose, but discarding 
it. In addition, the devices are very expensive and not available for every type 
of medication. They still rely on a single inhaler or pill container being used, 
unless one device is supplied for each which is very expensive. Finally, 
reliability is questionable: to date there have been high malfunction rates in 
the Nebuliser Chronolog (Creer, 1993) and the Turbohaler Inhaler Computer 
has been found to have a technical fault (Van Es et al., 1994). 
Biochemical tests. All the measures of adherence discussed so far are 
indirect, i.e. it is impossible to establish with certainty that the medication has 
actually entered the patient's body. Blood or saliva tests and urine assays are 
currently the only methods which can actually measure the amount of a drug 
the patient has taken, as opposed to had access to or removed from the 
container. Some drugs can be traced in their original form in the blood or, 
more commonly, the urine (e.g. penicillin: Karoly, 1985) while others must 
have tracers added to them to enable detection. Tracers may be added to all of 
the medication and adherence assessed by noting the proportion of tests 
which contain the tracer. Alternatively, for financial reasons, tracers can be 
added to only a proportion of the total number of doses and packaged in a 
known order within the medication supply. For example, Cluss et al. (1984) 
used a Riboflavin tracer (vitamin B2) in childrens' asthma medication and 
measured the concentration of this substance in daily urine samples to assess 
adherence. 
There do remain problems with these methods, however. Tracers 
must be chosen carefully to be inert, non-toxic, non-cumulative, unaffected by 
urine, easily extractable and easily detectable and they require special 
equipment and ethical approval for use. The tests can be very expensive and 
difficult to implement: especially where blood is required or the experimental 
procedure does not require other biochemical tests to be carried out, the 
procedure may be unacceptable to many patients. Most of the tests are still 
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unable to detect precisely the amount of medication used (Dunbar, 1980) as it 
is now recognised that there are differences in absorption, metabolism and 
excretion of drugs between (a) different samples of the same drug and (b) 
different individuals (Gordis, 1979). Furthermore, drugs taken in 
combinations can be metabolised at different rates compared to when taken 
alone. Once more, the time at which the medication was taken was taken is 
not precisely determinable. However, the advantage of such tests is that they 
do permit the assessment of adherence without the patient necessarily being 
aware of this, if blood or urine samples are required for other reasons. 
However, the ethical aspects of such a procedure are debatable. 
Ley (1990) reports on the relative frequencies of use of assessment 
methods of adherence in research to medical recommendations (including 
adherence to recommended medication regimen) carried out between 1977 
and 1983. 66% of studies employed only one method of assessment, 66% of 
this group using self-report and 9% using illness outcome. In the total 
number of studies, 68% used self-report measures, 40% illness outcomes, 14% 
direct observation (time-keeping), 12% medication measures, 10% 
computerised medication measures and 6% biochemical assays. 
7.4.4. A Comparison Of Adherence Rates In Asthma Obtained By Different 
Methods Of Assessment 
Several studies have been carried out to compare the many different 
methods of assessing adherence in asthma patients. One recent study has 
suggested that adherence measurement by inhaler weights is no different 
from that obtained by self-report (85% compared to 87%, Tashkin et aL, 1991). 
This study further suggested that adherence as assessed by electronic 
measuring devices is far lower than that indicated by either of these methods 
(52%). Another study comparing computerised dispensers to patient diaries 
found adherence to be up to 50% lower by the former method (Coutts, Gibson 
and Paton, 1992). 
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7.5. Measures Selected For The Empirical Studies 
7.5.1. Asthmatic control 
The clinical rating scale was not found to be a sensitive, reliable and 
valid method of assessing asthmatic control in either its full or its 
dichotomous form. Since all four raters placed high importance on the lung 
function variability measure (APM) in making their assessments of asthmatic 
control, this measure was chosen to represent the outcome variable asthmatic 
control for the purposes of the empirical studies. Creer and Winder (1991) 
advocate the use of such objective measures in assessing outcome in asthma. 
7.5.2. Illness representations 
Both the IMIQ and the IPQ were suitable for use in the studies and 
demonstrated satisfactory psychometric properties, but the IPQ was more 
specifically compatible with the Leventhal concept of illness representations. 
However, at the time of planning the cross-sectional study, the IPQ had not 
been developed and so the IMIQ was selected. In order to adapt this scale for 
use with asthma patients, the words "made worse" and "made better" were 
used instead of "caused" and "cured" - in other words, perceived personal 
responsibility for controlling, rather than curing the condition was assessed. 
Since no measure of consequences is included in this scale, the Expectations 
Of Quality Of Life With Asthma Questionnaire (EQOL) was developed (see 
Section 7.3.2.). 
However, by the time the intervention study was carried out, the IPQ 
was in the process of development and was being widely used in Self-
Regulation research with different patient groups. For this study it was hence 
decided to include both the measures, so that (a) IMIQ data from the two 
studies could be compared and (b) data obtained from the same sample using 
the two measures could be compared. Since the IPQ contained a measure of 
consequences, the EQOL was not used in this study. In addition, the 
symptoms scale was replaced by four scales of the Asthma Symptoms 
Checklist (see Chapter 5) to allow closer examination of the specific symptoms 
associated with asthma. 
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7.5.3. General coping 
It is evident that both the WOCC and the COPE have their empirical 
shortcomings and neither is ideal as a measure of general coping strategies. 
However, they are the best available at present and for the purposes of the 
cross-sectional study, it was decided to use the more recently developed, 
theoretically-based scale covering a wide range of coping strategies, i.e. the 
COPE. 
7.5.4. Asthma-specific coping 
The COPE was not suitable for use in assessing coping with asthma by 
the use of its specific instruction format, since its items refer to a single 
stressor with an acute, and relatively recent, onset. This is clearly not the case 
with asthma, where more than one stressor exists, onset may have been 
gradual and diagnosis may have been several years ago. The Asthma Coping 
Questionnaire was the only available measure of asthma-specific coping at 
the time of planning of the intervention study. Its psychometric properties 
were satisfactory and so it was selected for use, alongside some of the other 
measures of asthma-specific coping which had been employed in the cross-
sectional study (see Chapters 9&10). 
7.5.5. Adherence To Recommended Prescribed Medication 
Each of the methods available carried its own disadvantages. In reality, 
practicality, convenience and validity of data must be considered in selecting 
measures. Clinical ratings do not show sufficient reliability, but funding and 
equipment were not available for the more reliable and valid electronic 
diaries or biochemical tests. It was not practical to use an electronic device for 
assessing adherence since none was available that was not medication-
specific, i.e. only compatible with one brand of drug. It would have therefore 
been necessary to either restrict entry requirements for the study to those 
taking the drug required (and hence lowering sample size) or to alter 
individuals' drugs, which would prevent the ecological validity of the study. 
158 
It was originally intended to assess adherence by weighing inhalers at 
the beginning and end of the monitoring week. A proposal outlining this 
procedure was submitted to Fife Health Board Ethical Committee as an 
addition to the original study proposal. However, the proposal took almost 
four months to be considered and accepted by the committee, by which time 
the main study had commenced and it was too late to amend the study 
procedure. Hence it was not possible to take an objective measure of 
medication use for the purposes of this study. 
It was therefore decided to use three measures in the cross-sectional 
study and to compare the results and hence select the most appropriate for 
use in the intervention study. The measures chosen were: 
(1) Repeat prescriptions in the 12 months preceding the study. 
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(2) Self-report: 
(a) A response to the question "Do you actually take your medication 
as described?". The five points were labelled as follows and an 
opportunity to justify the response given: 
1 
Exactly as 
recommended 
2 
Nearly as 
recommended 
3 
Partly as 
recommended 
4 
Not at all as 
recommended 
5 
I don't take it 
at all 
An opportunity was given for individuals to justify their reasons for non-
adherence in an open-ended question, in order to encourage more honest 
responses (this data was not used in the study). 
(b) Using the Morisky, Green & Levine (1986) scale (intervention 
study only). 
(3) Written patient diaries (kept for periods of 7 days). 
Since self-report measures have been found not to differ significantly 
from inhaler weights (Tashkin et al., 1991), this change of plan was not seen 
to be a great disadvantage. 
7.6. Summary 
Possible measures for each of the components of the Self-Regulation 
Model of interest have been discussed in terms of development, psychometric 
properties and suitability for the current research. Where such measures did 
not exist, new measures were developed and hence measures of illness 
representations, coping and asthmatic control were chosen to operationalise 
the model for use in the empirical studies. Comments on the performance of 
the measures in each case will be discussed in the relevant chapters. 
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CHAPTER 8: IDENTIFICATION OF SUITABLE PARTICIPANTS FOR THE 
EMPIRICAL STUDIES: A DILEMMA 
8.1. Introduction 
The cross-sectional and intervention studies both employed rigorous 
criteria for selecting participants. In each case, it was necessary to find a 
method of identifying sufficient potential participants while biasing the 
sample as little as possible in terms of the variables of interest in the studies 
(e.g. asthmatic control, coping strategies, contact with medical services). 
Hence particularly careful consideration of the recruitment procedure was 
required. 
Estimates of the prevalence of diagnosed asthma in the general 
population vary between 3% and 5% (Alexander, 1981; Littlejohns, Ebrahim & 
Anderson, 1989; Martin, Meltzer & Elliot, 1989, p. 29; Pereira, 1993) and this 
should be borne in mind in considering the recruitment method. For 
example, if 100 participants are needed then a potential target group of 
between 2,000 and 3,333 is needed. 
This chapter begins with an discussion of the relative merits of 
recruitment methods used in previous studies, then goes on to describe the 
methods chosen to identify and recruit suitable participants for each of the 
two studies and to discuss the relative success of each method. 
8.1.1. Review Of Recruitment Methods 
A review of previous medical, epidemiological and psychological 
studies of individuals with various chronic conditions reveals several 
different approaches to recruitment, which will now be appraised in turn. It 
should be noted in reading the following review that many studies employ a 
combination of recruitment methods. 
Regardless of the method of recruitment, participation in studies is 
voluntary and the resulting sample will hence be restricted to those who (a) 
believe that they have the condition in question (regardless of medical 
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opinion), (b) consider their condition to be of a sufficient degree to warrant 
studying, (c) show a high interest in their own condition and (d) are highly 
motivated to participate. Various recruitment methods attempt to minimise 
such biases, but ultimately they are inherent in any voluntary study. 
a. Advertising 
Perhaps the simplest method of recruiting participants to medical 
studies is to advertise the study and then to screen all respondents to ensure 
that they do indeed fulfil the desired criteria before recruiting them. Such 
advertising can be done through local media, shops or medical centres, the 
main advantage being that the study is made known to a wide range of people 
with varying degrees of asthma and different degrees of contact with the 
health service. 
Placing advertisements in medical centre waiting rooms biases the 
sample towards individuals who are already in contact with the medical 
system. Furthermore, different practices will vary in the emphasis they place 
on asthma treatment and it is therefore more likely that the sample will be 
biased towards those in practices with a high concern for asthma patients, 
since they are more likely to attend for regular check-ups and monitoring and 
therefore to see the advertisement. In practice, these disadvantages mean that 
very few studies are found which recruit participants solely through 
advertising. 
b. General Practice 
Many asthma studies have identified potential participants through 
general practices before approaching them in person about the study. There 
are several methods of doing this - for example, repeat prescription records 
can be used to identify those prescribed asthma medication, GPs can be asked 
to identify suitable patients or, in practices where they are kept, disease 
registers may be consulted (e.g. Harding & Modell, 1885; Sibbald, 1989). Large 
groups of suitable potential participants can be identified using such methods. 
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Whichever method of identification is used within the practice, 
general practices or individual CPs with an existing interest in asthma care 
are more likely to co-operate in such an endeavour, meaning that the patients 
recruited are likely to have had more medical attention than may be the case 
in other practices which did not agree to aid in recruitment of participants. 
Within the participating practices, using repeat prescription records or 
CP identification will further bias recruitment towards those who 
acknowledge their asthma and seek medical help for it, those who use 
alternative coping strategies being less likely to be identified. This bias will be 
particularly likely if patients are identified by CPs, who are likely to be less 
familiar with low consulters or those with milder symptoms. Such biases 
will be reduced if suitable potential participants are identified on the basis of 
their medical notes, rather than directly through CPs. This is possibly the 
least biased method of recruiting, particularly if the medical information is 
held on computer, as has become more common in recent years (e.g. Snadden 
& Brown, 1992). 
A further important disadvantage of identifying patients through 
general practice is that ethically the patient cannot be identified to researchers 
as suffering from asthma until permission is given for such information to be 
released. In practice, this usually involves medical staff first identifying and 
approaching suitable potential participants to request permission for their 
names to be released in connection with the study. This in itself has 
disadvantages since it takes up large amounts of general practice time as well 
as adding a further stage to the study, hence requiring additional effort from 
participants and increasing the likelihood of non-agreement, non-compliance 
with the study requirements and attrition. 
c. Hospital Clinics 
Hospital clinics (both inpatient and outpatient) have often been used to 
identify suitable participants for medical studies (e.g. Mawhinney et al., 1993). 
The main advantage of these methods is that the potential for contacting a 
large number of suitable participants is great since the proportion of patients 
fulfilling the required criteria will be high. 
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These methods share many of the disadvantages mentioned in the 
discussion of recruitment through general practice; in addition, the resulting 
sample will be biased towards those with more uncontrolled asthma. 
d. Pharmacies 
Individuals taking medication for various conditions can be identified 
through pharmacies, as they collect their drugs (e.g. Rubinfeld, Dunt & 
MCClure, 1988). This method allows contact to be made with a large number 
of asthma sufferers and avoids many of the biases caused by recruiting 
through general practices or clinics but may still lead to over-representation 
of patients who cope by taking medication for their asthma and whose 
asthma is likely to be more difficult to control. 
e. NHS Drug Prescription Forms (GP10 Forms) 
Ross et al. (1993) devised a method of identifying asthma sufferers 
which is a variant on pharmacy recruitment methods yet allows a far wider 
geographical catchment area for participants. Their identified patients who 
were prescribed asthma medication using GP10 forms, which are written by 
GPs for each drug prescribed and kept at a central Pharmacy Practice Division 
(PPD). Medical information for those patients prescribed drugs in the target 
group was then obtained from their GPs in order to confirm the diagnosis. 
This procedure eliminated many of the biases inherent in other 
recruitment methods, although it was found to be very time-consuming, 
especially before computerisation at the PPD. The sample would be biased 
against those with asthma which was easily controllable with few drugs. In 
practice, such a method would be best used in large-scale studies (probably 
postal) where massive numbers of participants are required. 
f. Summer Camps 
Summer camps for children suffering from specific chronic conditions 
are held throughout the United States and researchers have often utilised 
these camps in order to recruit young participants for medical studies 
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concerning juvenile asthma (e.g. Fritz & Overholser, 1989). As in many of 
the methods mentioned previously, although a large number of people can 
be reached in this way, they are likely to have more severe or disabling 
asthma than a general population sample. In addition there is an obvious 
bias in the age of the resulting sample, which may not suit all studies. 
g. Epidemiological Screening Questionnaires 
A further option, which avoids contacting suitable participants directly 
through health services or special services for patients, is to attempt to 
approach the whole of an epidemiologically representative section of the 
general population in terms of the desired criteria, to minimise some of the 
biases mentioned above. This method requires screening a population, 
comparing it to norms with respect to the specified criteria (to check it is 
representative of the population as a whole) and asking each individual 
whether they would be prepared to take part in further studies, regardless of 
whether or not they are in the target group and without giving specific details 
of the planned study/studies. 
In practice, this is an extremely resource and time-consuming method 
of identifying potential participants for studies, since a high proportion of 
individuals will be screened who will not fulfil the study criteria. 
Furthermore, as in some of the methods mentioned above, it does require an 
extra step of input from participants in that they are asked to complete this 
preliminary questionnaire before the study is even explained to them. A 
further disadvantage is that self-report is relied on, which is more likely to 
exclude those who do not acknowledge or who minimise their asthma; 
however, careful selection of the questions can help overcome this problem. 
False positive and false negative reports would be expected, although the 
former can be allowed for by validation of the information disclosed at a later 
point in the study. 
Despite these drawbacks, this method reduces many of the other biases 
mentioned above since a large number of individuals, regardless of status on 
the required criteria, each have an equal chance of being contacted and 
agreeing to participate. Individuals with all degrees of asthma, in many 
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different general practices, are contacted, regardless of whether they are users 
of health services and this is more likely to minimise the biases in the 
resulting sample. 
8.2. The Cross-Sectional Study 
The cross-sectional study is reported fully in Chapter 9. 
Suitable participants for this study were required to be: 
(1) Aged between 18 and 45 (so that permanent airways obstruction and other 
complications were less likely). 
(2) Previously diagnosed as having asthma and aware of this diagnosis. 
(3) Suffering from no other chronic conditions. 
(4) Not taking complex asthma treatments (i.e. prescribed Reliever and 
Preventer at most), so that influences of complex treatments on coping would 
not influence the results. 
The target sample size for this study was 50. 
8.2.1. Recruitment Method Chosen 
It was decided that for this study, participants would be recruited 
through the general practice at the local health centre which was involved in 
advising on the medical aspects of all the studies for this thesis. This was to 
ensure that conditions (3) and (4), in particular, could be taken into account 
since only those fulfilling the criteria would be contacted and few false 
positive identifications would be made. The general practice was 
computerised, so biases due to GP selection or patient consultation frequency 
were eliminated. 
The practice had approximately 4,000 patients registered in total and so 
between 120 (3%) and 200 (5%) of these would be expected to suffer from 
asthma (Martin, Meltzer & Elliot, 1989; Pereira, 1993). When allowing for the 
restrictions in age and medication, as well as refusal rates, it was estimated 
that this would be sufficient to allow recruitment of at least 50 patients. 
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8.2.2. Procedure 
The practice identified those fulfilling the recruitment criteria using 
the computerised patient record system. A letter was sent to each eligible 
individual (see Appendix 2) explaining the study and containing a tear-off 
slip to be completed and returned to the general practice if the patient was 
agreeable to their name being released to the author. As the slips were 
returned, lists of names were compiled by the practice secretaries and 
forwarded to the author. 
Following the first few recruitments, this method was found to be 
rather labour-intensive for the practice staff, so the procedure was altered 
slightly. Subsequent patients were thus sent an additional letter along with 
the original letter, signed by the author, explaining the study in more detail 
and including a tear-off slip which was to be returned directly to the author in 
an SAE if the patient was interested in participating in the study (see 
Appendix 2). 
Those whose names were forwarded from the Practice or who returned 
their slip directly expressing interest in participating in the study were then 
contacted by telephone by the author. A screening questionnaire (see 
Appendix 2) was then administered to ensure that the recruitment criteria 
were indeed fulfilled. The study was then explained in more detail, any 
queries were answered and a suitable time was arranged for the study to be 
completed. Where the patient was not available by telephone, a letter was 
sent, fulfilling these same functions, and the patient was requested to reply by 
mail if they were interested in participating, specifying a time when it would 
be convenient to attend to complete the study. 
8.2.3. Results 
The general practice identified 190 patients fulfilling the recruitment 
criteria, i.e. approximately 4.75% of the registered patients. Unfortunately, 
letters were not sent to all these patients, and the practice failed to keep 
accurate records of the percentage which were sent, so acceptance and refusal 
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rates cannot be reported for this stage of recruitment. It is known however 
that at least 73 letters were sent. 
45 of the total number of patients who were sent the letter either agreed 
to their names being put forward to the author or sent their names directly to 
the author. 
When these 45 patients were contacted by the author, the screening 
questionnaire did not exclude any of them. 23 agreed to participate in the 
study and three declined. The remaining 19 patients were either contacted by 
telephone or sent a reminder letter, 11-81 days from the initial letter being 
sent (mean 25 days). This resulted in a further 12 recruitments and one 
declination; the remaining five patients never responded, despite the 
reminder. Hence 35 patients were recruited to the study, i.e. 77% of those 
who had initially expressed an interest when contacted by the general practice. 
Unfortunately, calculation of the overall recruitment rate (based on the 
number of patients initially contacted by the general practice) was not possible 
due to the lack of accurate records of the number of patients initially contacted 
by the general practice. However, taking account of al possible reasons for 
non-recruitment, 18% of eligible patients within the practice were recruited 
into the study. 
8.2.4. Discussion 
Recruiting participants through a single general practice did not lead to 
achievement of the desired sample size, perhaps because, for ethical reasons, 
so many steps were needed, each inevitably carrying with it a certain level of 
attrition. In addition, problems were encountered in that the practice failed 
keep an (a) contact all eligible patients and (b) accurate record of how many 
patients were contacted so that response rate could be calculated. 
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8.3. The Intervention Study 
A full description of the intervention study can be found in Chapter 10. 
Criteria for inc! usion in this study were: 
(1) Suffering from asthma and aware of this diagnosis. 
(2) Currently prescribed medication for asthma. 
(3) Not on complex asthma treatments. 
(4) Student status. 
Ideally, 100 participants were required for this study. 
8.3.1. Recruitment Method Chosen 
Since the method of participant recruitment in the cross-sectional 
study had not led to achievement of the target sample size and made it 
difficult to calculate recruitment rates, it was decided to take an alternative 
approach in the intervention study. An epidemiological approach was 
chosen because (a) the potential suitable sample would be larger, (b) the 
sample would be more epidemiologically sound and (c) the sample would be 
varied in terms of general practice and hence the amount of medical 
contact/ advice previously received. 
The approach taken was to identify as many as possible of the first, 
second and third year students who suffered from asthmaa. Fourth years 
were excluded because it was anticipated that they would be too preoccupied 
with final examinations to consent to participation in the study; also, some of 
them were already taking part in a separate study in conjunction with the 
health centre. This was achieved by administering a short screening 
questionnaire with six sections: 
a For clarity, the terms "first, second and third years" refer to the year the students were in 
during the academic session 1993-4, i.e. at the time of the intervention study, even though some 
of them were screened at the end of the previous year. 
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(1) Personal details (name, year of study, contact address etc). 
(2) Open-ended question about any chronic conditions suffered. The purpose 
of this question was to identify those who saw their asthma as an ongoing 
condition. 
(3) Self-report of conditions (including asthma and other breathing problems) 
suffered at any time, using a checklist of 13 conditions (taken from Marteau, 
1985, with 'breathing problems' added). This section was included in order to 
identify those who would report having had asthma at some point in the 
past, but may not perceive it as an ongoing condition (and hence report it in 
the open-ended question). It was also intended to identify those who might 
have breathing problems but not label them as asthma. 
(4) The Fife Respiratory Health Questionnaire (Pereira, 1993). This 
questionnaire measures asthma-type symptoms and was included in order to 
(a) identify those who report breathing problems but not asthma and (b) to 
compare the results with those from a larger community sample using the 
same questionnaire in the same region of Scotland (Pereira, 1993), in order to 
establish whether the student sample screened was epidemiologically sound 
with respect to asthma. A single question was added to this questionnaire -
"Have you at any time suffered from an asthma attack?". This was in order to 
identify students who may suffer from asthma but not see it as a current 
problem. 
(5) Information about medical contact for asthma or breathing problems in 
the past 12 months. 
(6) Information about current medication for asthma or breathing problems. 
At the end of the questionnaire, students were asked whether they 
would be willing to be contacted for further (non-specified) studies, regardless 
of their health status. 
The questionnaire can be seen in Appendix 2. 
8.3.2. Procedure 
Ethical approval for this study was obtained from the St Andrews 
University School of Psychology Ethical Committee. 
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Screening took place in two parts. Those in second and third years 
were sent the questionnaire by post at the end of the academic year (June, 
1993). An explanatory letter was included (see Appendix 2) and students were 
requested to return the completed questionnaire in a prepaid envelope. First 
year students completed the questionnaire during matriculationb at the start 
of the following academic year (October, 1993). 
Second and third years were identified through the university Registry 
Office, who supplied adhesive labels with the names and addresses of all 
those students who had not placed restrictions on the release of such 
information. At the time, there were 988 students in second year and 920 in 
third year (total sample size: 1908). Several non-graduating ("Junior Year 
Abroad") students studying third year courses were also included in the 
sample, since they were identified as third years by the Registry Office 
computer search and there was no way of distinguishing them from third 
year undergraduates. Hence 1,979 labels were supplied in total. There was no 
reason to believe that those who had restricted the release of their personal 
details were in any way biased with regard to the variables of interest. Letters, 
questionnaires and return envelopes were mailed to each student's term-
time address, by internal mail if they lived in university accommodation, by 
Royal Mail if not. 
First years were given the same questionnaire and a letter of 
explanation (see Appendix 2) as they entered the matriculation hall and the 
questionnaire was collected as they left the hall. Prior approval for this 
procedure was obtained from the University authorities and the Students' 
Association. In total 1,000 first year students received the questionnaire. 
This was the total number passing through the matriculation hall before 5pm 
b Matriculation is the procedure at the beginning of every academic session where students are 
required to register for their course and pay their course and residence fees. It is carried out in 
one hall in the university during three days at the start of the academic session and is a strict 
requirement for all students of the university. During matriculation all students follow the 
same route around all stages of the matriculation hall, i.e. enter by one door and leave by 
another. Hence every student of the university passes through the hall, using the same route, 
in a short period of time. 
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on the two allocated days for first year matriculation. There was no reason to 
believe that these individuals constituted a biased sample in respect to any of 
the variables of interest. 
8.3.3. Results 
a. Return Rates 
Of the 1,979 questionnaires sent to second and third years, 13 were 
returned due to being incorrectly addressed, leaving a sample size of 1,966. 
639 of these (33%) were returned. 692 (69%) of the 1,000 questionnaires given 
to first years were completed and returned. In total 2,966 questionnaires were 
distributed over the three year groups and 1429 (48%) were returned (See 
Table 8.1.). Of this final sample, 560 (39%) were male and 752 (53%) female. 
The remaining 117 (8%) did not specify their sex on the questionnaire and it 
was not determinable from any other information. 
The results will be discussed firstly in terms of verifying an 
epidemiologically sound sample and secondly in terms of the number of 
suitable participants yielded for the intervention study. 
b. Open-Ended Reports Of "Chronic (Ongoing) Conditions" And Checklist 
Reports Of Conditions Suffered. 
240 (17%) of responders reported suffering from at least one chronic 
condition in response to the open-ended question. These conditions included 
hayfever, chronic fatigue syndrome, blood conditions and conditions of the 
joints, muscles and eyes as well as epilepsy, diabetes and asthma/breathing 
problems. The number of students reporting each of the most common 
conditions in response to this question is illustrated in Figure 8.1. Of primary 
interest to this study is the fact that 89 students (6.2%) reported that they 
suffered from asthma as a chronic condition. 
When asked to indicate on a checklist of conditions (both chronic and 
acute), however, 192 (13%) reported that they had suffered from asthma at 
some time during their life. Data for each of the chronic conditions on the 
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list (including asthma), and the number of each group that also reported the 
condition as chronic (in the open-ended question), are also displayed in 
Figure 8.1. 
Figure 8.1.: Number of students reporting suffering various conditions 
(a) when asked to select from a checklist any conditions they had ever 
suffered and (b) also as "chronic (ongoing)" in an open-ended question. 
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Only 46% of the 192 students declaring asthma on the checklist also 
declared it as a chronic condition. Table 8.1. summarises the frequency of 
responses to these two questions in terms of the total sample. 
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Table 8.1.: Response rates and proportion of students reporting asthma. 
CATEGORY N(%)OF N (%) OF 2966 
PREVIOUS STUDENTS 
CATEGORY RETURNING 
QUESTIONNAIRE 
Total students in 1St, 2nd & 3rd years 3231(100%) 
Total students approached 2966 (92%) 
Total returning questionnaire 1429 (48%) 1429 (100%) 
Total reporting asthma on checklist 192 (13%) 192 (13%) 
Total reporting asthma as chronic 89 (46%) 89 (6.2%) 
c. Fife Respiratory Heath Questionnaire 
The percentage of students responding to each of the questions is 
shown in Table 8.2., alongside the results of the Fife Study of Respiratory 
Health (Pereira, 1993) - a survey of a random sample of 6,000 residents of the 
same region of Scotland as the current study - for comparison. Percentages 
shown are of the total number of respondents in each case. The table shows 
that the results obtained are comparable to those of the Fife Study of 
Respiratory Health and also to the generally accepted prevalence of asthma of 
around 5% (see Chapter 3). 
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Table 8.2.: Percentage of total number of respondents reporting each 
symptom on the Fife Respiratory Health Questionnaire: A comparison of Fife 
Study of Respiratory Health and the current study. 
% YES % YES 
FIFE STUDY OF CURRENT 
RESPIRATORY SAMPLE 
HEALTH 
1) Wheezed ever 47 47 
-Also breathless 53 31 
-without cold 57 28 
2) Wheezed in past 12 months 28 25 
3) Asthma attack everl - 12 
4) Asthma attack in past 12 months 
5 5 
Note: 1 Item not included in Fife Study Of Respiratory Health. 
d. Medical contact for asthma or breathing problems in the previous 12 
months 
The number of students reporting having visited various health 
professionals on at least one occasion in the previous 12 months in 
connection with asthma or breathing problems is shown in Figure 8.2. 130 
students (9%) had visited their GP during this time, 46 (3%) had visited an 
asthma nurse, 12 (0.8%) had seen a chest consultant, 10 (0.7%) had been to a 
hospital casualty department and 7 (0.5%) had visited another health 
professional. 
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Figure 8.2.: Number of students reporting having consulted each type 
of health professional for asthma/breathing problems at least once during the 
past 12 months. 
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Note: a.nurse = asthma nurse; ch. cons = chest consultant 
The mean number of visits to each type of health professional (based 
on those consulting that type of health professional) is shown in Figure 8.3. 
On average, those who had visited any of the health professionals had seen 
them twice during the past year, with the exception of casualty, which they 
had generally only visited once, and 'other health professionals, for whom 
the mean number of visits was approximately 4. However, it should be noted 
that this number, based on a sample of only 7, was greatly inflated due to one 
individual reporting having made 16 visits during the past 12 months. 
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Figure 8.3.: Mean number of visits to each type of health professional 
(based on number of students visiting that type of health professional during 
the past 12 months) 
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e. Current Medication For Asthma Or Breathing Problems 
The number of students currently prescribed the medications most 
commonly associated with asthma or breathing problems is shown in Figure 
8.4. 117 students (8%) reported taking Reliever medication and a further 13 
(0.9%) reported being prescribed 'inhalers' but specified no further. Since 
Reliever medication is the basic prescription for asthma sufferers (either 
alone or in conjunction with Preventer medication), these figures imply that 
130 students (9%) were currently prescribed asthma medication. 
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Figure 8.4.: Number of students currently prescribed each tvpe of 
medication for asthma/breathing problems. 
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Note: For a list of drugs included in each category, see Appendix 2. 
8.3.4. Summary 
The percentage of students identified as suffering from asthma by each 
of the different methods is summarised in Table 8.3. The number of students 
with asthma who were identified varied depending on the criteria used. 
Between 5% and 10% declared that they had asthma as an ongoing condition, 
reported having had an asthma attack in the past 12 months or reported 
having currently prescribed Reliever medication. It is likely that this number 
represents those with ongoing asthma problems. 13% reported on the 
checklist having had asthma at some time in their lives and 12% having had 
an asthma attack ever. Presumably this group also included those 
individuals who may have had infantile asthma or are in remission. 
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Table 8.3.: Percentage of students suffering from asthma using various 
criteria. 
METHOD % STUDENTS 
IDENTIFIED 
Open-ended declaration of asthma as chronic condition 6.2 
Declare asthma on checklist 13 
Report ever wheezing 47 
Report wheezing in previous 12 months 25 
Report asthma attack ever 12 
Report asthma attack in previous 12 months 5 
Visited GP for asthma/breathing problems in previous 12 
months 9 
Currently prescribed Reliever medication 9 
8.3.5. Discussion 1 
Response rates to the screening questionnaire varied depending on the 
method of administration. The group that were contacted by mail showed a 
response rate of 33% while those who were given the questionnaire during 
matriculation showed a response rate of 69%. Having a "captive audience", 
as was the case at matriculation, appeared to approximately double the 
response rate. 
The low response rate in the postal sample may have been further 
affected by the fact that the questionnaires were sent out at the end of the 
summer term, when students traditionally have either exams or the summer 
holiday on their mind and are less likely to spend time completing 
questionnaires for studies. Furthermore, subsequent to the study it was 
discovered that the internal mail system was not 100% reliable and a 
proportion of the questionnaires may have gone astray. 
Conversely, the response rate in the matriculation sample may have 
been inflated further by the fact that the first year students were on their first 
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day at university and were hence more likely to comply by completing any 
forms which looked vaguely official. 
These results indicate that the sample of students who completed the 
screening questionnaire were an epidemiologically sound sample in terms of 
asthma, although the exact prevalence varies depending on the criteria 
selected. 
8.3.6. Consent to participation in further studies 
929 (65%) of the total number of students agreed to be contacted for 
further study. Of these, 139 had reported suffering from asthma on the 
checklist. 14 students declared that they had asthma (on the checklist) but had 
omitted to complete the question asking whether they would be prepared to 
be contacted for further studies; this group were sent another questionnaire. 
Eight of these students subsequently replied and agreed to be contacted for 
further study; the remaining six did not reply. Hence 147 (77%) of the 
students declaring asthma were willing to be contacted. 
This number fell into three categories: 
(1) Currently prescribed Reliever medication and reporting asthma attack in 
the past 12 months (N=52). 
(2) Currently prescribed Reliever medication and reporting no asthma attack 
in the past 12 months (N=45). 
(3) Not currently prescribed Reliever medication (N =50). 
The first two groups fulfilled the entry criteria for recruitment into the 
intervention study and were sent a letter, a description of the study and a 
consent form for participation in the study. The letter was worded slightly 
differently for each group: group (1) were told they were being approached 
because they had "declared asthma in the past 12 months" while group (2) 
were told that they had "declared using asthma medication". 
Of the 97 students approached, 36 replied and 26 agreed to participate in 
the intervention study. This was an uptake rate of 27% of the sample 
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fulfilling the criteria for the study. Although this uptake rate was poor, it was 
not thought ethical to send another letter to those who had declined to 
participate in order to try and increase recruitments to the study. 
8.3.7. Discussion 2 
The result of screening an epidemiologically sound sample of 2966 
students was that only 26 were identified who fulfilled the criteria for 
inclusion in the intervention study and whom agreed to participate. This 
recruitment process required a high degree of resources, both in terms of time 
and money and the result was disappointing since it had been anticipated that 
around 100 students would be suitable for the study and a large proportion of 
these would agree to take part. It hence became necessary to consider further, 
perhaps less rigorous, methods of recruitment in order to attain the desired 
sample size. 
8.3.8. Further Recruitment Methods Chosen 
It was decided that advertising would be carried out, since the 
remaining participants needed to be recruited within a short time period. 
Advertisements were placed in the student newspaper, on the university 
electronic mail system, around the halls of residence and in the School of 
Psychology. In addition, "fliers" were put under the doors of each student in 
a student residence of 160 students and the author attended first and second 
year psychology classes to advertise the study. 
These efforts resulted in the recruitment of 26 more students (21 
undergraduates and five postgraduates) to the study. The sources of 
recruitment of these participants are shown in Table 8.4. 
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Table 8.4.: Sources of recruitment of participants. 
SOURCE NO. OF STUDENTS 
Student newspaper 0 
University Electronic Mail system 12 
Posters in halls of residence 2 
Poster in School of Psychology 1 
Fliers in hall of residence 4 
Psychology classes 2 
Word of mouth 5 
8.3.9. Discussion 3 
Table 8.4. demonstrates that advertising the study through the 
university electronic mail system resulted in the recruitment of the greatest 
number of participants. Fliers in halls of residence and word of mouth led to 
the recruitment of nine participants while advertising in the student 
newspaper was not useful and recruitment through posters or classes had 
minimal use. These results might be due to the fact that the advertisement in 
the student newspaper was not very conspicuous as it was reduced in size by 
the editorial team and hidden in the midst of another column, rather than 
appearing as an advertisement in its own right. Posters on student notice 
boards tend to quickly get covered by other notices; however, many of those 
put up for the purposes of this study were put on walls other than notice 
boards (namely beside the telephones). Unless they were removed, a higher 
recruitment rate from this source would have been expected. 
Hence, through use of a large epidemiological study and various other 
methods of recruitment, a sample of 50 participants was recruited for the 
study. As a final check that they did, indeed, fulfil the criteria for the study, 
the screening questionnaire which had been used in the cross-sectional study 
was administered to all participants (see Appendix 2). 
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8.4. Summary And Discussion 
Recruitment of asthma sufferers for the two empirical studies proved 
problematic and it was necessary to employ several methods in order to 
recruit sufficient numbers of participants in each case. The potential 
advantages of recruitment through general practice were lessened by the fact 
that, for ethical reasons, several stages had to be included and inevitably 
attrition resulted at each stage. In addition, the practice staff already had high 
demands on their time and were hence not able to concentrate fully on (a) 
sending letters to all the individuals identified as suitable for the studies and 
(b) providing all the information necessary to calculate recruitment rates. 
However, the sample obtained was just sufficient to allow a preliminary 
investigation of the coping process in asthma using a cross-sectional design. 
It was likely to be biased in that the general practice used had a specific interest 
in asthma care, had a practice nurse trained in asthma care and ran an asthma 
clinic which individuals were periodically invited to attend. Hence patients 
of the practice would be expected to be relatively well informed on their 
condition and its treatment. 
The epidemiological study revealed that low recruitment was not 
simply due to not enough potential participants being identified/informed of 
the study/requested to take part: even when an extremely large and 
epidemiologically sound sample were approached, only just over a quarter 
agreed to participate. Since students would be expected to show reasonably 
high rates of agreement to participation, being generally more familiar with 
the research process and used to completing questionnaires etc., this does not 
bode well for recruiting participants from the general population to studies, 
even using such sophisticated methods. 
More individuals were recruited through various other methods than 
through the epidemiological study itself. The fact that the 26 individuals who 
were recruited through such methods had previously taken part in the 
epidemiological study and yet not agreed to participate in the intervention 
study when requested to do so is puzzling. Somehow, motivation to 
participate must have been increased when the subsequent methods were 
used. It seems feasible that this might be due to the fact that the latter 
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recruitment methods appeared more personal and hence more likely to 
evoke a positive response than a large epidemiological study which all one's 
friends had also taken part in. Such a personal approach pOSSibly suggested to 
the individuals concerned that recruitment was proving problematic, 
whereas taking part in a large-scale study, one might be inclined to assume 
that everyone else would agree to take part, and hence that one's own 
participation would not be valued. The resulting sample would be expected 
to be biased in terms of interest in asthma and possibly also illness 
representations of asthma (e.g. perhaps those agreeing to take part perceived 
their asthma to be more serious, and hence of more interest, than those 
declining) and coping with asthma (e.g. maybe those agreeing to take part 
were more inclined to use approach coping and to think about their asthma a 
lot). However, it is difficult to avoid such biases. 
In summary, recruitment to studies by several different methods was 
found to be an extremely difficult procedure with difficulties inherent in each 
method. Sufficient numbers were recruited to each study, eventually, 
although biases in the sample due to recruitment methods were expected. 
See Chapter 11 for further discussion of these issues. 
184 
PART 3: 
THE EMPIRICAL STUDIES 
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CHAPTER 9: THE CROSS-SECTIONAL STUDY 
9.1. Introduction 
The model developed over Chapters 1 to 6 leads to several predictions 
about the influence of various variables on chronic disease control. 
However, the Self-Regulation Model is a general model of coping with 
chronic disease and has never been employed in the context of asthma, while 
the work of the Kinsman group on the role of emotions in asthma was 
primarily carried out using a group of asthma sufferers with poor asthmatic 
control (as indicated by their hospitalisation). The current study aimed to 
investigate factors influencing asthmatic control in a sample of asthma 
sufferers recruited through general practice, i.e. one which would include 
patients with varying degrees of asthmatic control. In particular, it was 
desired to use the framework of the Self-Regulation Model to identify 
psychological predictors of asthmatic control which were potentially 
modifiable by simple interventions, with a view to developing such an 
intervention at a later date. 
In this study, the relationships between general coping, asthma-specific 
coping (Le. carrying out actions recommended by the medical profession) and 
asthmatic control were of interest. More specifically, it was of interest to 
know whether general coping and asthma-specific coping were related, and 
which of them showed the greatest association with asthmatic control. 
A further aim of the study was to investigate the role of emotional 
reactions in the coping process. Since the Kinsman group's work had 
suggested a curvilinear relationship between emotional reactions and (a) 
coping and (b) physicians' medical recommendations, this model was tested 
in addition to a linear one. 
9.1.1. Research Questions 
See Chapter 6 for a summary of the main research questions for this 
study. In addition to addressing these questions, the data collected were used 
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to develop measures of asthmatic control and illness representations (see 
Chapter 7). 
9.2. Method 
9.2.1. Participants 
35 participants fulfilling the following criteria were recruited to the 
study: 
(1) Previously diagnosed as suffering from asthma and aware of this 
diagnosis. 
(2) Aged between 18 and 45. 
(3) Currently prescribed at least Reliever medication. 
(4) Not suffering from other chronic conditions. 
All participants were registered with a single general practice at the St 
Andrews Health Centre. The upper age limit was set so that the likelihood of 
irreversible lung damage having developed was minimised. Only 
participants without other chronic conditions were included so that the 
variables of interest (in particular, coping strategies and adherence) were not 
confounded by possible effects of other conditions or treatments. 
Participation in the study was entirely voluntary and guaranteed not to 
influence the patient's medical care in any way (Le. standard medical practices 
were continued as normal throughout the study). 
9.2.2. Measures 
See Chapter 7 for a full review and rationale for the main measures 
used; the reader is directed to other sections of this thesis where relevant. 
a. Asthmatic Control 
Asthmatic control was assessed using the measure of Amplitude 
Percent Mean derived from twice-daily Peak Flow readings taken by 
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participants for a period of seven days and recorded in a monitoring diary (see 
Chapter 7). 
b. illness representations 
Three measures were used: 
(i) The Implicit Models of Illness Questionnaire (IMIQ; Turk, Rudy & 
Salovey, 1986) was used. The internal reliabilities of the 4 scales of this 
questionnaire in the current study were 0.40 (personal responsibility), -0.77 
(controllability), 0.32 (seriousness) and 0.16 (changeability). The large, 
negative internal reliability of the controllability scale was unusual and 
deserved some investigation. It would appear to have occurred because the 
five items comprising the scale were either uncorrelated or negatively 
correlated amongst themselves (see Table 9.1.). Therefore this scale was not 
used in the subsequent analyses. Although the internal reliabilities of the 
other three scales were not satisfactory, the scales were retained as they had 
previously been found to be reliable in other samples and there was no 
existing data with asthma sufferers to compare to. The low internal 
reliabilities should be borne in mind in interpreting the results, however. 
Table 9.1.: Pearson correlations between the five items of the IMIQ 
controllability scale. 
ITEM 1 2 3 4 
2 -0.53** 
3 0.23 0.07 
4 0.06 -0.12 -0.51 ** 
5 0.29 -0.52** -0.02 0.34 
(ii) The Expectations of Quality of Life With Asthma Scale (EQOL; see 
Chapter 7) was used to assess representations of the consequences of having 
asthma. This scale had an internal reliability of 0.78 in the current sample. 
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(iii) Four scales of the Asthma Symptoms Checklist (Kinsman, 
Luparello et al., 1973; see Chapter 5) were used in order to elicit individuals' 
representations of the symptoms of their asthma. Participants were asked to 
report how often they experienced each symptom, in general, at times of 
asthma exacerbations (Le. not within a given time period). The internal 
reliabilities of these scales were 0.78 (airways obstruction), 0.75 
(hyperventilation), 0.87 (irritability) and 0.91 (fatigue). 
c. General Coping Strategies 
The COPE (Carver, Scheier & Weintraub, 1989) was used to assess 
general coping strategies, by using the instruction format " .. .indicate what 
you generally do and feel, when you experience stressful events ... ". The 
internal reliabilities of its scales in the current sample are shown in Table 9.2. 
Table 9.2.: The internal reliabilities of the 15 scales of the COPE in the 
current study. 
SCALE a 
Active coping 0.73 
Planning 0.83 
Suppression of competing activities 0.43 
Restraint coping 0.75 
Seeking social support for instrumental reasons 0.85 
Seeking social support for emotional reasons 0.90 
Focusing on & venting of emotions 0.85 
Behavioural disengagement 0.78 
Mental disengagement 0.42 
Positive reinterpretation & growth 0.89 
Denial 0.74 
Acceptance 0.64 
Turning to religion 0.98 
Alcohol! drug use 0.93 
Humour 0.94 
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d. Asthma-Specific Coping Strategies 
(i) Medication use. The number of puffs of Preventer and Reliever 
medication taken over the study week was assessed from the diaries kept by 
participants as part of the study. In addition, participants were classed as 
either "regular" Preventer medication users (Le. taking 14, 28 or 42 puffs 
during the week) or "erratic" Preventer medication users. 
(ii) Adherence to recommended treatment regimen was measured 
using three methods in this study (see Chapter 7): 
• Self-report. Participants were asked "Do you actually take your medication 
as you have described above?" and required to respond on a five-point Likert-
type scale ranging from 1 "exactly as described" to 5 "I don't take it at all" (see 
Chapter 7). Participants were then given an opportunity to justify their 
response in an open-ended question ("if you do not take your medication 
exactly as recommended, why not?"). The responses to this question do not 
form part of the analysis for this study; the question was included to attempt 
to get more honest ratings of adherence by allowing the opportunity for 
justification. They are investigated in the discussion in terms of possible 
intervention strategies aimed at improving adherence, however. 
• The number of puffs of Preventer medication which would be expected to 
be taken in one week if adherence was 100% was calculated from self-reported 
current treatment regimen. This variable was significantly correlated with 
number of puffs of Preventer expected in one week based on the GP's report 
of current treatment regimen (Pearsons r=0.63, 12.<0.01) and both were 
normally distributed. However, patients reported that they were prescribed 
significantly more Preventer medication than GPs reported (sign test 12.<0.05). 
The self-report measure was used as the basis for calculations, however, since 
GP data were missing for one participant and it was not desirable to lessen the 
sample size any further. The actual number of puffs of Preventer taken 
during the study week (as reported in the diary) was subtracted from this 
number to give an index of adherence (where zero represented complete 
adherence, negative values represent over-use and positive values represent 
under-use) . 
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• The above procedure was repeated using the number of repeat 
prescriptions for Preventer medication which would be expected in the past 
12 months (based on self-reported regimen) compared to the number of 
repeat prescriptions actually requested during that time (as reported by the 
GP). Two things should be noted about this variable. First, the number of 
repeat prescriptions expected in 12 months does not correlate 100% with the 
number of puffs of Preventer expected to be taken in one week, since it was 
necessary to take into account the number of doses in one inhaler in the 
former calculation and all individuals were not using the same brand. 
Second, this variable did not rely on the participants having completed the 
monitoring diary as the above measure did. 
(iii) Use of medical services. The number of outpatient appointments 
for asthma-related problems (including to GP, asthma nurse and hospital 
outpatient clinics) in the six months immediately prior to the study were 
assessed by the GP from medical notes. 
(iv) Peak Flow Meter use. Participants were asked whether they knew 
what a Peak Flow Meter was and whether they had ever used one. In 
addition a single yes/no question (liDo you currently use a Peak Flow Meter to 
monitor your asthma?") was used to assess current Peak Flow Meter use. 
e. Emotional Reactions To Asthma 
The Panic-Fear scale of the Asthma Symptoms Checklist (ASC; 
Kinsman, Luparello et al., 1973; see Chapter 5) was used to assess panic-fear at 
the times when symptoms were felt. The internal reliability of this scale in 
the current study was 0.91. The entire checklist was administered and the 
remaining four scales used as measure of the symptoms component of the 
illness representation. 
f. Demographic And Medical Data 
Age, sex, length of time since first prescription for asthma and length of 
time since the most recent alteration of treatment were assessed by self-report. 
The latter two variables were validated against the GP's report from medical 
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records. Information on the date of diagnosis and type of asthma 
(continuous, intermittent or triggered by allergens) were also obtained from 
the GP. 
The variables length of time since first prescription for asthma 
medication (self-report) and length of time since most recent alteration of 
treatment (self-report) were measured using the following scale: 
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<3 3-6 6 mnths-
months months 1 year 
4 
1-2 
years 
5 
2-5 
years 
6 
5-10 
years 
7 
>10 
years 
In addition, the author used this scale to code length of time since 
diagnosis for each participant, based on the GPs report of the date of diagnosis. 
g. Summary Of Measures 
The measures used for each variable of interest, along with the source 
of the information, are summarised in Table 9.3. 
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Table 9.3.: Summary of the measures used in the cross-sectional study. 
VARIABLE MEASURES USED SOURCE 
Asthmatic control Amplitude Percent Mean Diary 
Illness representations IMIQ Questionnaire 
EQOL Questionnaire 
Four ASC scales Questionnaire 
General Coping 
Strategies COPE Questionnaire 
Asthma-Specific Coping 
Strategies Medication use Diary 
Adherence to recommended Self-report/ 
medication regimen diary/GP 
Use of medical services GP 
Peak Flow Meter use Self-report 
Emotional reactions ASC panic-fear scale Questionnaire 
Medical! demographic 
data Age Self-report 
Sex Self-report 
Time since 1st prescription Self-report 
Time since most recent 
prescription Self-report 
Time since diagnosis GP 
Type of asthma GP 
9.2.3. Procedure 
Ethical approval for the study was obtained from Fife Health Board 
Area Ethical Committee ten weeks after submission of the initial proposal. 
Potential participants were identified using the method described in 
Chapter 8 and were contacted to arrange a suitable time and venue for 
completing the questionnaires. All participants were encouraged to attend 
193 
the School of Psychology, but if this was impossible then they were given the 
option of completing the questionnaires at home, in their own time. 
Participants attending in person completed the questionnaires in the presence 
of the author. Those electing to complete the questionnaires at home had 
them delivered by the researcher and it was emphasised that they should 
complete the questionnaires alone, i.e. without the assistance of anyone else 
in the household. Where possible, the author arranged to collect them 
personally approximately one week later, at the convenience of the 
participant. If this arrangement was not convenient, then stamped addressed 
envelopes were issued for their return. 
When the questionnaires were given to participants, the purposes and 
procedures of the study were once again summarised, a further opportunity 
to ask questions given, the various sections of the questionnaires outlined 
and informed consent for participation then obtained. 
Following completion of the questionnaires (or at the time of delivery, 
for those completing at home), each subject was issued with a monitoring 
diary (see Appendix 1) and requested to monitor their asthma for a period of 
seven days, recording details of their morning and evening Peak Flow 
readings, any medication taken and any asthma symptoms felt each day. The 
diary was carefully explained and an opportunity to ask questions given. In 
particular, participants were instructed to leave a blank in the diary if they 
forgot to complete it at any point during the study week, rather than to 
fabricate entries or to complete the diary retrospectively. The diary included a 
list of Reliever and Preventer medications which was drawn to the attention 
of all participants, so as to minimise confusion over drugs when completing 
the diary. 
Patients returned their diaries after a period of one week, either to the 
researcher in person or using the pre-paid envelope. Those who failed to 
return the diaries after this period were reminded by letter two to four weeks 
later. 
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As each participant completed the study, a sheet was sent to the GP, 
requesting information on the patient's asthma, based on their medical notes 
(see Appendix 3). These sheets were, again, returned in pre-paid envelopes. 
9.2.4. Data Preparation And Statistical Analysis Techniques 
Data were entered using the SPSS PC Data Entry package and then 
transferred to the SUN mainframe computer for analysis using SPSS. 
Frequency distribution charts were used to check the accuracy of data 
input and all incorrectly entered values corrected. Where data were missing 
for scale items, they were pro-rated where less than 50% of the items were 
missing, in order that as little data as possible was lost (cases where more than 
50% of the scale items were missing were not used in analyses involving the 
scale). 
All data were checked for assumptions of normality by examining 
normal and detrended boxplots and the significance values for kurtosis and 
skewness. Where these assumptions were not met, non-parametric statistical 
tests were used since it was not desired to transform variables in order to 
avoid complicating the interpretation of the results. 
Frequency data and descriptive statistics were used to describe all 
variables and these values were compared to previously reported data from 
other studies, where available. Where previous studies reported only 
summary statistics (i.e. raw data were not available), it was not possible to use 
non-parametric tests and so parametric tests were used instead. In such cases, 
corrections for non-homogeneity of variance were made by using separate 
variance estimates of t values where necessary; hence non-equal sample sizes 
were permissible and normality violations would be expected to have 
minimal effects. 
Relationships between the asthma-specific coping variables were 
investigated using Principal Components Analysis with Varimax rotation 
and retaining factors with Eigenvalues greater than one. 
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Correlations between variables were examined in order to determine 
relationships between the variables of interest. The type of correlation used 
was chosen to suit the distributions of each of the pair of variables concerned; 
the various correlations, along with the notation used for each throughout 
the results section, are shown in Table 9.4. 
Table 9.4.: Types of correlation used in the cross-sectional study. 
DISTRIBUTION OF VARIABLE A 
DISTRIBUTION Continuous: Continuous: Dichotomous 
OF VARIABLE B normal non-normal 
Continuous: Pearson's r 
normal (plain text) 
Continuous: Spearman's r Spearman's r 
non-normal (bold) (bold) 
Dichotomous Pearson's r Phi Phi 
(plain text) (italic) ~underline~ 
Howell (1989) states that when one variable is normally distributed and 
one dichotomous, Pearson's r is equivalent to point biserial correlation. 
Phi correlations were obtained from cross tabulation tables. It was 
therefore necessary to group the non-normal continuous variable into three 
at the 33rd and 66th percentiles. Three groups were chosen in order to 
preserve the distribution of the data as much as possible while still permitting 
sufficient numbers in each cell. This also meant that the problems caused by 
values lying on the median when a median split is used were avoided. 
Variables associated by correlation with asthmatic control were entered 
into Stepwise Multiple Regressions in order to investigate their relative 
relationship with this outcome variable. 
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9.3. Results 
The following section summarises the results in terms of completion 
rates, demographic/illness characteristics of the resulting sample and the 
specific research questions outlined in Chapter 6. 
9.3.1. Completion Rates 
Of the 35 participants who completed the questionnaires, 27 (77%) 
completed the study by also returning completed monitoring diaries within 
five weeks. 25 of these diaries (93%) contained a full set of 14 Peak Flow 
readings and 25 contained no missing data in other areas. Data from the 
whole group were used where possible, i.e. in analyses where data from the 
diaries were not involved. In the group which completed the whole study, 
where Peak Flow readings were missing, Amplitude Percent Mean was still 
calculated based on the remaining readings. 
9.3.2. Demographic Data 
The demographic data for the groups who did and did not complete the 
entire study are displayed in Table 9.5. The variable age was normally 
distributed. There were no significant differences between the two groups 
and hence the statistics for the group as a whole are also shown. 
Table 9.5.: Demographic data for groups who (a) did and (b) did not 
complete the whole study, and the group as a whole. 
COMPLETERS NON- STATISTIC TOTAL 
COMPLETERS SAMPLE 
N 27 8 - 35 
Sex ratio (M:F) 12:15 3:5 X21 =0.003, ns 15:20 
Mean age (s.d.) 28.3 (8.06) 27.3 (6.61) t33=0.33, ns 28.1 (7.67) 
Age range 18-43 19 - 37 - 18-43 
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Further significance tests showed that completers and non-completers 
did not differ significantly in the illness variables time since diagnosis (not 
normally distributed; Mann-Whitney U=97.5, ns), time since first prescription 
for asthma medication (not normally distributed; Mann-Whitney U=104.0, 
ns) or time since most recent alteration of treatment (normally distributed; 
t33=0.30, ns). It was not possible to test whether completers and non-
completers were significantly different in terms of being prescribed Preventer 
medication, since more than 50% of the cells had expected frequency less than 
five in X2 analysis. However, 77% of the completers and 63% of the non-
completers were prescribed Preventer medication and hence there was no 
reason to suspect a significant difference between groups. It was therefore 
considered valid to combine the questionnaire data from the two groups for 
the purposes of analysis. 
9.3.3. Medical Data 
The modal length of time since first prescription for asthma 
medication was over 10 years and this variable was not normally distributed 
(see Figure 9.1.). 
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Figure 9.1.: Time since first prescription for asthma medication. 
20 
18 
16 
14 
12 
10 
8 
6 
4 
2 
0 
:::E :::E e>:: 12 12 12 
<'"l ~ >- >- >- >-..... V <'"l . ~ U") 0 N :;;; :::E ..... 
'-C> 
LENGTH OF TIME SINCE 1 ST PRESCRIPTION 
(MONTHS/YEARS) 
12 
>-
0 
..... 
1\ 
The modal length of time since most recent alteration of medication 
was 1-2 years and this variable was normally distributed (see Figure 9.2). 
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Figure 9.2.: Time since most recent alteration of medication. 
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Note: Data unavailable for 1 participant. 
The modal length of time since diagnosiS was over 10 years, more than 
half of the participants falling into this group. This variable was not 
normally distributed; see Figure 9.3. for frequency data. 
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Figure 9.3.: Time since diagnosis. 
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The Spearman correlation between the variables time since diagnosis 
and time since first prescription for asthma medication was significant 
(r=0.52; ~<0.01). Reasons for non-perfect concordance between these two 
variables are explored in the discussion. 
The GP was only able to rate the type of asthma for 11 of the 35 
participants (69%) and hence the variable was discarded from further 
analyses. Again, reasons for this are discussed later in the chapter. 
All participants were currently prescribed Reliever medication, in line 
with the criteria for inclusion in the study. 26 participants (74%) reported 
that they were also prescribed Preventer medication. 
The distribution of Amplitude Percent Mean (APM) in the present 
sample is illustrated in Figure 9.4. Since APM was a continuous variable with 
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values to two decimal places, all APMs were rounded to the nearest 0.5 and 
then grouped into bands of 4.5 for clarity. APM was not normally distributed, 
but since interpretation of this variable following transformation would be 
very difficult, it was decided to use non-parametric statistics, where possible, 
rather than transforming the data. This also meant that transformation of 
other non-normal variables would not be necessary. It should be noted 
throughout this results section that APM is the inverse of asthmatic control, 
i.e. that a high APM indicates poor asthmatic control and v. versa. 
Figure 9.4.: Distribution of Amplitude Percent Mean scores. 
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It was of interest to see whether this sample was typical of asthma 
sufferers in general in terms of APM. Table 9.6. compares the distribution of 
APMs in this sample to that obtained by Higgins et al. in their sample of 18 to 
75 year-olds who had declared wheezing within the past year. 
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Table 9.6.: Distribution of Amplitude Percent Mean scores compared to 
those obtained by Higgins et al. (1989). 
HIGGINS ET AL. (1989) CURRENT SAMPLE 
SAMPLE 
N 221 27 
Median 13.3 12.0 
Mean (s.d.) 13.5 (0.28) 14.7 (10.92) 
The best method of comparing the data from the two studies would be 
using a non-parametric test such as the Mann-Whitney U test. However, 
such a test requires raw data, which Higgins et al. did not report. The 
parametric t-test does not require raw data, merely summary statistics; hence 
even though the assumptions of normality were not met, this test was used 
to compare the data. The current sample did not significantly differ in terms 
of APM from that of Higgins et al., even interpreting the results of the test 
liberally (Le. at the 0.1 level) (t246=-1.62, ns). Therefore there was nothing 
unusual about asthmatic control in the current sample when compared with 
a wider sample of asthma sufferers. 
9.3.4. Data Relating To Specific Research Questions 
Research question Ha): What illness representations do individuals with 
asthma hold of their condition? 
Figure 9.5. shows the mean scale score per item for each of the four 
IMIQ scales. The scores for each scale were found to be normally distributed. 
Unfortunately no data collected from asthma sufferers has been published to 
date, for comparison. However, Turk, Rudy & Salovey (1986) collected data 
from 55 diabetic patients (mean age 36.4, s.d. 1.3; mean time since diagnosis 
12.69 years, s.d. 9.5) using their questionnaire; this data is also displayed, for 
comparison. There are many similarities between diabetes and asthma in 
that they are both potentially life-threatening chronic conditions which are 
asymptomatic at low levels and controllable by a combination of drugs, self-
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monitoring and lifestyle change. Hence it is useful and interesting to 
compare the current results to this sample. 
Figure 9.5.; IMIQ scores in the current sample compared to the diabetic 
sample of Turk, Rudy & Salovey (1986). 
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Unfortunately, no raw data or variance measures are available for the 
Turk et al. study, to allow statistical comparisons, but it would appear from 
the graph that asthma sufferers' perceptions of their condition were almost 
the inverse of those of diabetes sufferers. Asthma sufferers tended to perceive 
their condition as less serious and less changeable than diabetes sufferers, but 
believed they had more personal responsibility over their condition. 
The mean (s.d.) EQOL score was 39.17 (10.48); the frequency distribution 
is shown in Figure 9.6. This variable satisfied the assumptions of normality 
but since the scale was newly developed, no previous data from clinical 
groups was available for comparison. 
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Figure 9.6.: Distribution of EQOL scores. 
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Scores for each of the four ASC symptom scales were normally 
distributed. The mean reported levels of each type of symptom are displayed 
in Table 9.7., and compared to the data reported by Brooks et al. (1989) from 
their sample of 132 adult outpatients with asthma. There were no significant 
differences between symptoms reported by the two samples. 
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Table 9.7.: ASC scores in the current sample compared to those 
obtained by Brooks et al. (1989). 
ASC SCALE MEAN (S.D.) MEAN (S.D.) T VALUE 
BROOKS ET AL. CURRENT 
SAMPLE SAMPLE 
Airways obstruction 3.69 (0.96) 3.92 (0.11) t165=-1.41 
Hyperventilation 1.92 (0.77) 1.80 (0.61) t165=0.85 
Irritability 2.61 (1.08) 2.57 (0.17) t165=0.22 
Fatiguea 3.21 (1.19) 3.11 (0.18) t165=0.49 
Research question l(b): How do the components of the illness representation 
relate to each other? 
The correlations between components of the illness representation are 
shown in Table 9.8. 
The perception of asthma as changeable was associated with high 
perceived personal responsibility for the condition and with fewer reported 
airways obstruction, irritability and fatigue symptoms. Those who associated 
few irritability or fatigue symptoms with their condition also tended to show 
higher perceived personal responsibility for their condition. The correlations 
between each of the different types of symptoms associated with asthma were 
all significant and positive. 
a Brooks et al. slightly adapted the original scale and therefore two items included in 
their fatigue scale were not administered in the current study. However, since (a) this was the 
only outpatient data collected by the Kinsman group it was the most suitable available for 
comparison and (b) average symptom scores were reported in both cases, the comparison remains 
valid. 
Table 9.8.: Correlations between components of the illness representation. 
ILLNESS REPRESENTATION 1 2 3 4 5 
COMPONENT 
1. Seriousness 0.06 
2. Personal responsibility 
3. Changeability 0.04 0.54** 
4. Consequences 0.10 -0.22 -0.16 
PERCEIVED SYMPTOMS: 
5. Airways obstruction 0.10 0.22 -0.34* 0.43** 
6. Hyperventilation 0.14 -0.19 -0.02 0.38* 0.33 
7. Irritability -0.18 -0.39** -0.39** 0.39* 0.35* 
8. Fatigue -0.21 -0.43** -0.36* 0.38* 0.44** 
Note: *I2<O.05 ** 12<0.01 
6 
0.59** 
0.35** 
7 
0.67** 
.10.1, "' .... L.;..:J..~ 
N 
o 
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Research question He); Which demographic/medical variables might 
influence illness representations? 
Table 9.9. shows the correlations between illness and demographic 
variables and the components of the illness representation. 
Table 9.9.: Correlations between illness representation components 
and demographic/medical variables. 
ILLNESS REPRESENTATION AGE SEX TIME SINCE TIME SINCE TIME SINCE 
COMPONENT DIAGNOSIS 1ST CURRENT 
PRESCR. PRESCR. 
Seriousness 0.28a -0.04 -0.31 .... -0.27a 0.18 
Personal responsibility 0.07 0.21 -0.07 -0.20 0.20 
Changeabili ty 0.14 0.12 -0.17 -0.31" 0.14 
Consequences 0.03 -0.28 0.13 -0.30" -0.01 
PERCEIVED SYMPTOMS: 
Airways obstruction 0.27 -0.38* -0.05 0.16 0.14 
Hyperventilation -0.02 -0.40* -0.02 0.09 0.10 
Irri tabili ty 0.03 -0.18 0.38* 0.47 .... -0.03 
Fatigue 0.19 -0.39* -0.03 0.12 -0.01 
** 12.<0.01 
There was a tendency for older individuals to perceive their asthma as 
more serious than younger ones and for those who had first received asthma 
medication longer ago to perceive their condition as less serious. Males 
associated less airways obstruction, hyperventilation and irritability 
symptoms with their asthma than females did. The longer the time since 
diagnosis, the lower was the perception of seriousness and the higher was the 
association of irritability symptoms with asthma. Time since first 
prescription was significantly associated with perception of low changeability 
and few consequences of asthma and high levels of irritability symptoms. 
208 
Research question 2(a): How do individuals with asthma cope in terms of 
behaviours which are recommended by the medical profession? 
£Incorporating Research question 2(b): How might adherence to 
recommended Preventer medication regimens as a coping response to 
asthma be assessed?] 
Of the complete sample of 35 participants, 27 were prescribed Preventer 
medication and eight were not. The modal number of prescribed puffs of 
Preventer medication per week was 28, i.e. two puffs twice daily, the mean 
(based on the 27 participants prescribed Preventer medication) was 26.19 puffs 
(s.d. 11.03) and the distribution of this variable is shown in Figure 9.7. It is 
important to bear this data in mind when in assessing medication use and 
adherence (below). 
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The distributions of Reliever and Preventer medication use over the 
study week for the 27 participants who completed the study are shown in 
Figure 9.S. Preventer medication use was normally distributed but Reliever 
medication use was not. 
Figure 9.S.: Distributions of Reliever and Preventer medication use 
over the study week (N=27 completers only). 
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The mean number of puffs of Reliever medication used during the 
study week was 7.3 (s.d. 12.2); this is below the recommended limit of two 
puffs per day, although there was large variation. Three individuals (11 %) 
took more than 14 puffs of Reliever medication during the study week (i.e. an 
average of more than two puffs per day) and seven participants (26%) 
reported using no Reliever medication at all during the study week. One 
individual reported taking 64 puffs of Reliever medication during the study 
week. 
Of the 27 participants completing the study, 21 were prescribed 
Preventer medication (six were not), but four of these reported using none 
during the study week. One of the participants who was not currently 
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prescribed Preventer medication did report having taken one puff during the 
study week, however. The mean number of puffs of Preventer medication 
used during the study week was 17.0 (s.d. 11.7; based on the 21 participants 
who were prescribed Preventer medication), which represents an average of 
slightly more than two puffs per day. 
Fifteen participants were classified as "regular" Preventer medication 
users (coded 'I') and the remaining six (including the four who were 
prescribed Preventer medication but took none) as "erratic" Preventer 
medication users (coded '0'). 
Using the self-report measure of adherence, 21 participants described 
themselves as taking their medication "exactly as prescribed", 13 "partly as 
described" and one "not at all". Hence this variable was recoded 
dichotomously, participants being either "self-reported adherers" (n=21; coded 
'I') or "self-reported non-adherers" (n=14; coded '0'). 
The distribution of Adherence as assessed by expected number of puffs 
of Preventer compared to actual number of puffs of Preventer medication 
taken during the study week is shown in Figure 9.9. Sixteen participants took 
their Preventer medication as prescribed during the study week. Two took 
more than prescribed (by up to 2 puffs) and nine less than prescribed (by up to 
56 puffs). This variable was normally distributed with a mean of 6.70 (s.d. 
12.8), indicating overall under-use of Preventer medication by approximately 
one puff per day but, again, large variability. For the purposes of further 
analysis, participants were classified as either fully adherent (n=16; coded 'I') 
or not fully adherent (n=l1; coded '0') to recommended Preventer medication 
regimen. This classification was used for simplicity of correlations, since all 
other data were either continuous or dichotomous. 
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Figure 9.9.: Distribution of adherence to recommended Preventer 
medication regimen as assessed by actual Preventer medication use compared 
to expected Preventer medication use over the study week. 
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Figure 9.10. shows adherence to recommended Pre venter medication 
regimen as assessed from repeat prescription data. 
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Figure 9.10.: Adherence to recommended Preventer medication 
regimen as assessed from repeat prescription data. 
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Note: Data missing for 7 participants. 
Four participants showed complete adherence by this measure. Three 
had used more Preventer medication than prescribed (by up to two 
prescriptions) and 21 had used less (by up to 21 prescriptions). The variable 
was not normally distributed. 
However, illness data (see above) had revealed that 12 participants had 
had their treatment regimen altered during the previous 12 months, so using 
current regimen to calculate expected number of repeat prescriptions over 
this period was not valid and hence this variable was not used in further 
analyses. 
Use of medical services for asthma-related problems. The number of 
outpatient visits made during the 12 months prior to the study are shown in 
Figure 9.11. 
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Figure 9.11.: Number of outpatient visits during the 12 months prior 
to the study. 
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19 participants (54%) had not made any outpatient visits during the 
previous 12 months. The mean number of visits was 1.9 (s.d. 2.64) and this 
variable was not normally distributed. For the purposes of analysis, 
participants were classified as either having used outpatient services in the 
previous 12 months (n=16; coded '1') or not having used them (n=19; coded 
'a') and the variable re-named "use of outpatient services". 
All the participants knew what a Peak Flow Meter was, all but one had 
used one at some time and 33 owned their own meter (or one on loan from 
the Health Centre). 16 participants (46%) reported that they currently used a 
Peak Flow Meter to monitor their asthma (coded '1') and 19 (54%) that they 
did not (coded 'a'). 
Table 9.10.: Correlations between asthma-specific coping strategies. 
COPING STRATEGY 1 2 3 
1. Reliever use 
2. Preventer use 0.66** 
3. Regular Preventer use 0.13 0.59** 
4. Self-reported adherence 0.25 0.19 0.29 
5. Adherence (from diary) 0.11 0.41 * 0.67** 
6. Use of outpatient services 0.33 0.18 0.49* 
7. PFM use 0.24 -0.04 -0.03 
Note: *12<0.05 ** 12<0.01 a 12 = 0.051 
4 5 
0.62** 
0.40* 0.49** 
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Research question 2(c): Are there relationships between different asthma-
specific coping strategies? 
The correlations between the seven asthma-specific coping strategies 
are shown in Table 9.10. There were several significant relationships and 
every variable correlated significantly with at least one other. Reliever and 
Preventer medication use were significantly correlated. In addition, 
Preventer medication use was significantly positively correlated with both 
regular Preventer medication use and adherence to recommended Preventer 
medication regimen (as assessed from the diary). Regular Preventer 
medication use was further associated with adherence (as assessed from the 
diary) and having used outpatient services during the previous 12 months, as 
was self-reported adherence. Finally, adherence (as assessed from the diary) 
was significantly correlated with having used outpatient services in the 
previous 12 months. 
Principal Components Analysis with Varimax rotation was carried out 
in order to investigate whether the seven coping strategies were independent, 
or grouped together into factors. The variables:participants ratio was 1:3.9, 
which is slightly below the recommended minimum of 1:5 (Tabachnick & 
Fidell, 1989) so the results of this analysis should be interpreted liberally, but it 
was still considered useful to investigate the relationships between the 
variables using this method. Two factors were found with eigenvalues of 3.36 
and 1.34 respectively. Following rotation, four variables were found to load 
onto Factor 1 and three onto Factor 2 (see Table 9.11.). However, three of the 
variables loaded >0.3 onto both factors. 
Three of the variables in Factor 1 (Preventer medication use, regular 
Preventer medication use and adherence to recommended Preventer 
treatment regimen) were derived from Preventer medication use reported in 
the diary. The final variable loading onto this factor was use of outpatient 
services. Hence the factor was concerned with "Pre venter medication use and 
use of outpatient services". 
The second factor included the coping strategies Peak Flow Meter use, 
Reliever medication use and self-reported adherence. Two of these variables 
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were derived from self-report and one from diary information, and Peak 
Flow Meter use loaded negatively onto the factor. This variable was more 
difficult to summarise than the first factor as it was concerned with high use 
of Reliever medication, high self-reported adherence and non-use of Peak 
Flow Meters. 
Table 9.11.: Results of Principal Components Analysis of the seven 
asthma-specific coping variables. 
SUBSCALE LOADING ONTO LOADING ONTO 
FACTOR 1 FACTOR 2 
Regular Preventer med. use 0.86 0.04 
Use of outpatient services 0.76 0.01 
Adherence (from diary) 0.74 0.46 
Preventer medication use 0.73 0.48 
Peak Flow Meter use 0.14 -0.88 
Self-reported adherence 0.27 0.80 
Reliever medication use 0.32 0.49 
Interpretation of the factors was facilitated by correlating factor scores 
with (a) general coping strategies, (b) illness representations and (c) panic-fear, 
in order to assess whether the coping strategies might fulfil approach or 
avoidance functions (see the relevant sections below and the discussion 
section of this chapter). Scores for both factors were normally distributed. 
Despite the emergence of these two factors, individual asthma-specific 
coping strategies were retained in the analyses, for the following reasons: 
(1) It was only possible to calculate factor scores for 18 participants since the 
remainder had missing data on at least one variable. 
(2) Interpretation of results would be more simple. 
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(3) It was more desirable in terms of intervention to identify specific coping 
strategies which were associated with asthmatic control, so that interventions 
could target such specific behaviours, rather than combinations of 
behaviours. 
(4) Factor 2 was difficult to interpret. 
Research question 3(a); Are illness representations associated with asthma-
specific coping? 
Table 9.12. displays correlations between illness representation 
components and asthma-specific copings strategies. It can be seen that 
Reliever medication use was associated with low perceived seriousness and 
high perceived changeability. Regular Preventer medication use was 
associated with low perceived levels of hyperventilation symptoms and PFM 
use with low perceived airways obstruction symptoms. Perceived 
changeability was significantly and negatively correlated with adherence to 
recommended Preventer regimen (as assessed from diaries) and Factor 1 
scores were significantly negatively correlated with perceived airways 
obstruction. 
Research question 3(b): Is panic-fear associated with asthma-specific coping 
and if so, is the relationship linear or curvilinear? Also: Is the relationship 
between panic-fear and prescribed Preventer medication regimen 
curvilinear? 
First, the levels of panic-fear in the group were assessed. The mean 
score for the ASC Panic-Fear scales was 1.96 (s.d. 0.14) and this variable did not 
follow a normal distribution. However it was necessary to perform a t-test to 
examine whether this mean was significantly different from previously 
reported data (non-parametric statistics were impossible since only summary 
statistics were provided). The mean (s.d.) level of panic-fear reported by 
Brooks et al. (1989) was 2.28 (1.06) in a sample of adult outpatients. A liberal 
Significance level was used and the participants in the current sample 
reported significantly fewer panic-fear symptoms than this group (t16S=-1.78, 
12<0.10). 
Table 9.12.: Correlations between illness representation components and asthma-specific coping strategies. 
ILLNESS REPRESENTATION RELIEVER PREVo USE REGULAR S-REPORT ADH. USE OF PFM USE FACTOR 1 FACTOR 2 
COMPONENT USE PREV.USE ADH. (DIARY) OUT. SERV 
Seriousness -0.29a -0.16 0.12 -0.08 0.13 -0.03 -0.27 0.15 -0.06 
Personal responsibility 0.15 0.07 -0.10 0.03 -0.26 -0.09 -0.17 -0.02 0.08 
Changeability 0.50"" 0.13 -0.17 -0.25 -0040* -0.19 0.13 -0.08 -0.10 
Consequences -0.05 -0.05 -0.33 0.02 -0.24 -0.15 -0.06 -0.36 -0.05 
PERCEIVED SYMPTOMS: 
Airways obstruction -0.23 -0.04 -0.38 0.18 -0.05 -0.22 -0.34* -0.54 * 0.10 
Hyperventilation 0.02 0.08 -0.48* 0.07 0.002 0.28 -0.02 -0.34 0.14 
Irritability 0.02 0.14 -0.20 0.04 0.04 0.13 -0.06 -0.04 0.16 
Fatigue -0.09 0.09 -0.23 0.06 -0.06 -0.11 -0.07 -0.29 0.18 
----- ---
-- ---_ .. _----_ .. _-------------- ---- -- ----
Note: *~<0.05 ** 12<0.01 
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In order to investigate whether the relationship between panic-fear and 
coping was best represented by a linear model or a curvilinear model, two 
correlations were carried out (MCNemar, 1962; DuBois, 1965). Pearsons 
correlations were carried out and Eta (with coping strategy as the dependent 
variable), as calculated from crosstabulation tables. 
In order for the latter statistic to be calculated, and the comparison to be 
made, it was necessary to group the variables for both analyses. Ideally, such 
grouping would have been carried out to be consistent with the original 
Kinsman group work. However, Kinsman and his colleagues have shown 
some inconsistency in grouping, sometimes choosing 0.5 standard deviations 
above and below the mean as cut-off points (e.g. Dahlem, Kinsman & Horton, 
1977; Jones et al., 1979; Staudenmayer et al., 1979) and sometimes various 
unspecified t- or z-scores (e.g. Kinsman et al., 1977). It was therefore decided 
to choose a single consistent grouping method and the 33rd and 66th 
percentiles were chosen, in line with the previous analysis. There were 
hence low (n=10), moderate (n=10) and high (n=8) groups based on panic-fear 
scores. All the coping variables were grouped thus also, in order for the cross 
tabulations to be carried out. 
The statistic 
F= (eta2~~)/(n-2) 
(1 - eta2) I (N-n) 
where n is the number of groups of the dependent variable and N the 
number of cases was compared to Fn-2, N-n in order to test the departure from 
linearity (DuBois, 1965). Since curvilinearity was predicted, one-tailed 
significance levels were employed. Table 9.13. shows the results of this 
analysis. 
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Table 9.13.: Correlations (eta and Pearson's r) between panic-fear and 
asthma-specific coping strategies. 
CORRELATION WITH 
PANIC-FEAR 
COPING MEASURE ETA r F VALUE 
Reliever medication use 0.33 -0.27 F124=0.97 , 
Preventer medication use 0.47 0.05 Fl,24 = 6.73* 
Regular Preventer med. use 0.27 -0.03 Fl16= 1.24 , 
Self-reported adherence 0.30 -0.16 Fl,32= 2.11 
Adherence (diary) 0.03 -0.02 F124 = 0.01 , 
Use of outpatient services 0.08 -0.04 Fl,32 = 0.15 
PFM use 0.13 -0.12 Fl,32 = 0.08 
Factor 1 0.09 0.08 Fl,15 = 0.03 
Factor 2 0.32 0.23 Fl,15 = 0.83 
The only coping strategy/factor which showed a Significant curvilinear 
relationship with panic-fear was Preventer medication use. No Significant 
linear correlations were found. 
In order to investigate further the nature of this curvilinear 
relationship, the mean number of puffs of Preventer medication use were 
compared for the low, moderate and high panic-fear groups (see Figure 9.12.). 
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Figure 9.12.: A comparison of Preventer medication use of individuals 
showing different levels of panic-fear. 
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It can be seen that the relationship between panic-fear and Preventer 
medication use was V-shaped, those showing moderate levels of panic-fear 
using less Preventer medication than those showing extreme panic-fear in 
either direction. However, a one-way Analysis of Variance with Preventer 
medication use as the dependent variable yielded a non-significant result 
(F2,2S=2.46, R.=O.ll). Hence, despite the significant correlation between the two 
variables, there were no statistically significant differences between the 
overall Preventer medication use of individuals reporting different levels of 
panic-fear. 
The relationship between amount of Preventer medication prescribed 
(rather than taken) and panic-fear was not found to be curvilinear (Eta=O.18, 
Pearson's r=O.03; Fl,31=0.50, ns). 
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Research question 3(d: Is asthma-specific coping related to asthmatic control? 
Table 9.14. shows the correlations between asthmatic control and each 
of the asthma-specific coping strategies. 
Table 9.14.: Correlations between asthma-specific coping strategies and 
asthmatic control. 
COPING MEASURE CORRELATION WITH APM 
Reliever medication use 0.0000 
Preventer medication use 0.27a 
Regular Preventer medication use 0.16 
Self-reported adherence -0.38 
Adherence (diary) -0.20 
Use of outpatient services -0.55* 
PPM use 0.11 
Factor 1 -0.32a 
Factor 2 -0.13 
al2.<O.10 
Individuals who had made use of outpatient services during the 
previous 12 months were more likely to show good asthmatic control. 
Furthermore, there was a tendency for individuals who used more Preventer 
medication to show poorer asthmatic control. None of the other individual 
coping strategies showed significant relationships with asthmatic control, but 
Factor 1 scores showed a trend towards association with good asthmatic 
control. 
Research question Ma): Do illness representations show a direct relationship 
to asthmatic control? 
Table 9.15. shows the correlations between components of the illness 
representation and asthmatic control. 
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Table 9.15.: Correlations between illness representation components 
and asthmatic control. 
ILLNESS REPRESENTATION CORRELATION WITH APM 
COMPONENT 
Seriousness -0.06 
Personal responsibility -OAoa 
Changeability 0.07 
Consequences 0.33* 
PERCEIVED SYMPTOMS: 
Airways obstruction 0.10 
Hyperventilation 0.008 
Irritability 0.32a 
Fatigue 0.37a 
Poor asthmatic control was associated with the belief that asthma has 
high consequences for the sufferer. Beliefs about personal responsibility for 
asthma showed a trend towards association with asthmatic control, those 
with a greater belief showing better asthmatic control. There were also 
tendencies for high perceived irritability or fatigue symptoms to be related to 
poor asthmatic control. 
Research question 4(b): Does panic-fear show a direct relationship to 
asthmatic control? 
Panic-fear was not significantly correlated with APM using a linear 
model (Spearman's r=0.09, ns). However, when both variables were grouped 
into three (as described above), eta was 0.19 and Pearson's r 0.0000 (Fl,24=8.99, 
12.<0.05). Hence there was a significant curvilinear relationship between the 
two variables. Figure 9.13. shows the mean levels of APM between 
individuals reporting different levels of panic-fear. 
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Figure 9.13.: A comparison of Amplitude Percent Mean between 
individuals showing different levels of panic-fear. 
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Once again, this relationship appeared to be V-shaped, with those 
reporting moderate levels of panic-fear showing better asthmatic control than 
those with either high or low levels. However, the mean level of asthmatic 
control was not significantly different between the three groups (F2,24=O.62, 
ns). 
Research question Me): Is the relationship between illness 
representations/panic-fear and asthmatic control stronger than the one 
between asthma-specific coping and asthmatic control? 
Since the relationship between panic-fear and asthmatic control had 
been demonstrated to be non-linear, this variable was not included in the 
analysis. However, the relationship between illness representations, asthma-
specific coping and asthmatic control was investigated. A summary of the 
significant correlations between illness representations, coping (general and 
asthma-specific) and asthmatic control is shown in Figure 9.16. 
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Based on the results of the correlational analyses, stepwise multiple 
regression was carried out in order to investigate the relative relationships of 
illness representation components and coping strategies to asthmatic controL 
It was required to enter no more than six independent variables to allow for a 
minimum ratio of independent variables to cases of 1:4 (Tabachnick & Fidell, 
1989). 
The two variables from each category with the highest direct 
correlation with asthmatic control were chosen. These variables were the 
illness representation components personal responsibility and consequences 
and the coping strategies use of outpatient services and Preventer medication 
use. A two-tailed significance level of 0.10 was selected to allow for the use of 
variables which had displayed only a trend in association with asthmatic 
controL The results of the regression are shown in Table 9.16, which displays 
the unstandardised regression coefficients (B) and intercept, the semipartial 
correlations (sr2) and R2, adjusted R2 and F for the resulting equation. 
Table 9.16.: Multiple regression of illness representation components 
and asthma-specific coping strategies onto asthmatic controL 
INDEPENDENT VARIABLE B BETA sr2 
Use of outpatient services -11.92 -0.54** 0.29 
Preventer medication use 0.26 0.29a 0.08 
Personal responsibility ns -
Consequences ns -
Constant=16.9990 
R2=0.35051b Adjusted R2=0.29403 
F2 23=6.21 ** , 
bUnique variability = 0.29+0.08=0.37; Shared variability = 0.35051-0.37=-0.02 
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R for the regression was significantly different from zero (F2,23=6.21, 
I2-<O.Ol). Two of the independent variables contributed significantly to 
asthmatic control: use of outpatient service in the previous 12 months alone 
accounted for 29% of the variance and Preventer medication use accounted 
for 8% of the variance. No shared variability between these two variables was 
seen (in fact a slightly negative number was obtained due to the rounding of 
figures). 
Research question 4(d); Does panic-fear moderate the relationship between 
asthmatic control and medication use? 
In order to investigate whether panic-fear might moderate any 
association between asthmatic control and medication use, MANOV A 
analysis was carried out with medication use as the dependent variable. The 
analysis was carried out separately for Reliever medication use (following the 
results of Dahlem, Kinsman & Horton, 1977) and Preventer medication use 
(since this had been the only asthma-specific coping strategy significantly 
related to panic-fear). APM was used in this analysis where the Kinsman 
group used "days on which lung function was low/moderate/high"; 
although both were seen to be indices of asthmatic control, the current 
measure takes account of asthmatic control over a seven-day period and is 
hence slightly different. Although both Reliever medication use and 
asthmatic control were non-normally distributed, no non-parametric 
equivalent of the MANOV A procedure was available. Since the cell sizes in 
this analysis were small (N=2 to N=6), the results (shown in Figures 9.13 and 
9.14) should be interpreted with caution. There was no significant main effect 
on Reliever medication use of either asthmatic control (F2,18=0.85, ns) or 
panic-fear (F2,18=0.23, ns) and the interaction term was also non-significant 
(F4 18=0.47, ns). , 
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Figure 9.14.: Results of MANOV A with Reliever medication use as the 
dependent variable and Amplitude Percent Mean and panic-fear as 
independent variables. 
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Figure 9.15.: Results of MANa V A with Preventer medication use as 
the dependent variable and Amplitude Percent Mean and panic-fear as 
independent variables. 
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There was no significant main effect on Preventer medication use of 
either asthmatic control (F2,lS=0.21, ns) or panic-fear (F2,lS=1.46, ns) and the 
interaction term was also non-Significant (F4,lS=0.64, ns). 
Research question S(a): Are general coping strategies related to asthma-
specific coping strategies? 
Table 9.17. shows the mean level of reported use of each of the 15 
general coping strategies measured by the COPE and compares them to those 
obtained by Carver, Scheier and Weintraub (1989) in their original sample of 
1,030 college students in order to investigate whether the current sample were 
unusual in terms of their general coping. All the scales apart from five 
(active coping, denial, behavioural disengagement, religion and drug use) 
were normally distributed but since only summary statistics were available 
from the Carver paper, it was necessary to use parametric t-tests. Note that at 
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the time of the report, the humour and alcohol/drug use scales were not 
properly developed and therefore analyses were not possible for these 
variables. 
Table 9.17.: Mean reported use of each coping strategy compared to data 
from Carver, Scheier & Weintraub (1989). 
SCALE .MEAN (S.D.) MEAN (S.D.) TVALUE 
CARVER ET AL. CURRENT 
SAMPLE SAMPLE 
Active coping 11.89 (2.26) 11.09 (2.69) t1063=0.77 
Planning 12.58 (2.66) 11.02 (3.32) t1063=3.38** 
Suppression of competing 
activities 9.92 (2.42) 8.80 (2.18) t1063=2.70** 
Restraint coping 10.28 (2.53) 8.51 (2.61) t1063=4.06** 
Seeking social support for 
instrumental reasons 11.50 (2.28) 9.74 (3.53) t1063=4.39** 
Seeking social support for 
emotional reasons 11.01 (3.46) 9.43 (3.67) t1063=2.64 ** 
Focusing on and venting of 
emotions 10.17 (3.08) 8.23 (3.50) t1063=3 .64** 
Behavioural disengagement 6.11 (2.07) 7.02 (2.37) t1063=-2.54 * 
Mental disengagement 9.66 (2.46) 9.20 (2.37) t1063=1.09 
Positive reinterpretation & 
growth 12.40 (2.42) 10.89 (3.50) t1063=3.56** 
Denial 6.07 (2.37) 7.22 (2.87) t1063=-2.8 0** 
Acceptance 11.84 (2.56) 11.87 (2.42) t1063=- 0.03 
Turning to religion 8.82 (4.10) 6.31 (4.19) t1063=1.34 
Alcohol! drug use - 6.31 (3.34) -
Humour - 9.69 (3.63) -
** 12.<0.01 
The current sample reported using seven of the coping strategies significantly 
less often in their everyday life than the sample studied by 
Table 9.18.: Correlations between general coping strategies and asthma-specific coping strategies. 
COPE SCALE RELIEVER PREV.USE REGULAR S-REPORT ADH. USE OF PFMUSE FACTOR 1 
USE PREV.USE ADH. (DIARY) OUT. SERV 
Active coping -0.13 -0.14 -0.38 0.22 0.17 -0.07 -0.31 -0.07 
Planning -0.02 -0.12 -0.03 -0.12 0.06 -0.15 -0.03 -0.04 
Suppression ... -0.08 -0.02 -0.02 -0.27 0.03 -0.02 -0.18 -0.04 
Restraint coping -0.008 -0.11 -0.22 -0.18 -0.15 -0.23 0.15 -0.26 
Soc. supp. inst. -0.06 -0.20 -0.18 -0.19 -0.18 -0.28 -0.20 -0.32 
Soc. supp. em. -0.06 -0.16 -0.27 -0.18 -0.08 -0.16 0.0002 -0.24 
Focusing/venting -0.16 -0.06 -0.28 -0.20 -0.13 -0.21 0.07 -0.33 
Beh. diseng. 0.11 0.38* -0.22 -0.27 0.25 -0.31 0.34 -0.15 
Mental diseng. -0.06 0.19 -0.02 0.02 0.10 -0.13 0.07 0.05 
Positive reint. 0.03 -0.19 -0.09 -0.23 0.02 -0.14 0.11 -0.14 
Denial -0.20 0.14 -0.37 -0.37n -0.24 0.15 0.44* 0.18 
Acceptance 0.14 0.02 0.25 -0.29 0.04 -0.09 0.20 0.23 
Religion 0.06 0.19 X X X X X 0.24 
Alcohol! drug use -0.14 -0.002 0.21 -0.18 0.22 -0.10 0.43* 0.28 
Humour -0.02 0.32 0.45 -0.02 0.12 0.03 0.0005 0.54* 
Note: *12<0.05 X Could not be calculated due to poor distribution of the categorised variable. 
FACTOR 2 
0.01 
-0.04 
0.08 
-0.14 
0.05 
-0.23 
-0.23 
0.08 
0.11 
-0.25 
-0.36* 
-0.26 
-0.08 
-0.18 
-0.01 
I 
I 
N 
VJ 
a 
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Carver, Scheier and Weintraub and significantly higher use of denial and 
behavioural disengagement as coping strategies. 
The correlations between general coping strategies and asthma-specific 
coping strategies are shown in Table 9.18. Only three significant associations 
were found between individual asthma-specific coping strategies and general 
coping strategies. Preventer medication use was significantly associated with 
behavioural disengagement, those reporting using this coping strategy more 
in everyday life using more Preventer medication. Peak Flow Meter use was 
associated with both denial and use of alcohol/ drugs, individuals using either 
of these coping strategies more being more likely to use a Peak Flow Meter. In 
addition there was a tendency for individuals who reported high denial in 
everyday life to self-report greater adherence to recommended Preventer 
treatment. Factor 1 was significantly correlated with general coping by use of 
humour and Factor 2 showed a tendency towards a negative association with 
denial. However, since only three out of 130 correlations were found to be 
significant, there is a strong possibility that the results were due to chance and 
hence should be interpreted with caution. 
Research question S(b): Are general coping strategies related to asthmatic 
control? 
The correlations between asthmatic control and each of the general 
coping strategies are displayed in Table 9.19. APM was significantly positively 
correlated with mental disengagement, restraint coping and denial, Le. 
individuals reporting high use of anyone of these coping strategies in 
everyday life showed poorer asthmatic control. In addition, there was a 
tendency for those reporting coping by either suppression of competing 
activities or venting of emotions to show poorer asthmatic control. None of 
the other 11 coping strategies showed an association with asthmatic control. 
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Table 9.19.: Correlations between general coping strategies and 
asthmatic control. 
COPE SCALE CORRELATION 
WITH APM 
Active coping 0.13 
Planning -0.01 
Suppression of competing activities 0.26a 
Restraint coping 0.37* 
Seeking social support for instrumental reasons 0.002 
Seeking social support for emotional reasons 0.09 
Focusing on and venting of emotions 0.27a 
Behavioural disengagement 0.08 
Mental disengagement 0.56** 
Positive reinterpretation & growth 0.09 
Denial 0.39* 
Acceptance 0.25 
Religion 0.16 
Alcohol/ drug use 0.10 
Humour 0.22 
Research question 5(c): Do general or asthma-specific coping strategies show 
the greatest association with asthmatic control? 
Next, the possible contribution of general coping strategies to asthmatic 
control was investigated (see Figure 9.16 for a summary of significant 
correlations). Each illness representation, asthma-specific coping or general 
coping variable which had been found to be significantly correlated with 
asthmatic control was employed as an independent variable (i.e. perceived 
consequences, Preventer medication use, mental disengagement, suppression 
of competing activities and denial). Hence a two-tailed significance level of 
0.05 was chosen. The results are shown in Table 9.20. 
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Table 9.20.: Multiple regression of illness representation components 
and coping (asthma-specific and general) onto asthmatic control. 
INDEPENDENT VARIABLE 
Denial 
Consequences 
Preventer medication use 
Mental disengagement 
Suppression of competing 
activities 
Note: * l2.<0.05 
Constant=-3.92 
R2=0.1923Sa 
F125=5.97* , 
B BETA sr2 
2.00 0.44* 0.19 
ns -
ns -
ns -
ns -
Adjusted R2=0.16045 
The general coping strategy denial was the only variable entered into 
the equation. R for the regression was significantly different from zero 
(Fl,25=5.97, 12.<0.05) and this variable alone explained 19% of the variance in 
asthmatic control. 
Research question 6: Are illness representations and emotional reactions to 
asthma independent or intercorrelated? 
The correlations between panic-fear and the components of the illness 
representation are shown in Table 9.21. Panic-fear was significantly correlated 
with all components of the illness representation with the exception of 
seriousness. It was positively associated with perceived consequences and 
each of the four symptom groups and negatively associated with perceived 
personal responsibility and changeability. 
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Table 9.21.: Correlations between illness representation components 
and panic-fear. 
ILLNESS REPRESENTATION CORRELATION WITH 
COMPONENT PANIC-FEAR 
Seriousness 0.08 
Personal responsibility -0.53** 
Changeability -0.41 ** 
Consequences 0.62** 
PERCEIVED SYMPTOMS: 
Airways obstruction 0.34* 
Hyperventilation 0.37* 
Irritability 0.43** 
Fatigue 0.45** 
.... }2.<0.01 
9.4. Discussion 
This section first summarises the results of the study and discusses 
them in terms of previous research findings. Methodological considerations 
are discussed and then the implications for both theory and research are 
considered. 
9.4.1. Summary And Discussion Of Results 
This study was carried out in order to investigate the coping process in 
a sample of 35 adult asthma sufferers currently prescribed medication and, in 
general, first diagnosed at least 10 years ago. The disease outcome of interest 
was asthmatic control and the sample were within the previously identified 
normal range on this variable and therefore assumed to be representative of 
the general population of adult asthma sufferers. Illness representations, 
coping and emotional reactions were of interest, both in their own right and 
in terms of their relationship with the outcome variable. 
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a. Illness Representations 
The illness representations which individuals held of their condition 
were quite different from those of a previous study of diabetes sufferers: 
asthma sufferers believed their condition to be less serious and less 
changeable, yet they perceived more personal responsibility over their 
condition. Such differences may be the result of differences in the course and 
treatment of the two conditions, although diabetes and asthma are often 
viewed as similar in such respects. In addition it is possible that the 
differences found might have been caused by differences in demographic or 
illness variables between the two clinical groups. The only such data 
available for the diabetic sample were mean age and length of time since 
diagnosis. The former was approximately equal between the samples, but the 
mean age was some eight years higher in the diabetes sufferers. Since the 
only illness representation component associated with age in the current 
study was seriousness and this did not appear to differ significantly between 
the diabetes and asthma groups, it is unlikely that this demographic variable 
accounts for differences in illness representations found. 
The representations which individuals held of the actual symptoms of 
their asthma were typical when compared to previous studies (e.g. Brooks et 
al., 1989), airways obstruction symptoms being the most commonly associated 
with the condition. This finding is not surprising since airways obstruction is 
the defining feature of asthma, but certain levels of other symptoms (fatigue, 
irritability and hyperventilation) were also perceived. 
The symptoms associated with asthma showed relationships to other 
aspects of the illness representation. Those with high perceptions of personal 
responsibility were less likely to associate irritability and fatigue with their 
asthma - perhaps because the belief that things can be done to control the 
asthma causes less irritability when symptoms are felt and leads to efficient 
coping which might reduce fatigue. Individuals reporting high levels of 
airways obstruction believed their asthma to be more changeable and higher 
consequences were perceived by individuals associating high levels of any of 
the four symptoms with their condition. 
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Illness representations also co-varied with various 
demographic/medical factors, as had been expected from previous studies. Of 
particular interest was the finding that high perceived seriousness was 
associated with increasing age, but also with more recent diagnosis. This 
seeming anomaly can be better understood when it is noted that age and time 
since diagnosis were not significantly correlated (r=O.05), i.e. older individuals 
had not necessarily suffered from asthma for a different time period than 
younger ones. It is possible that those who have been recently diagnosed may 
not have had time to come to terms with their condition and therefore 
consider it more serious, while illness may be generally seen as more serious 
when experienced in later life (whatever stage the condition is at). It would 
therefore be predicted that older individuals who have only recently received 
a diagnosis of asthma would show the highest perceptions of seriousness; 
however, the sample size was not sufficient to test this hypothesis in the 
current study. 
If experience of a condition does modify the illness representation held 
of that condition, then future research is necessary in order to determine 
whether individuals with different levels of experience with asthma hold 
different illness representations. A preliminary analysis would be possible 
using the EQOL data from Chapter 7 in order to investigate whether 
individuals with different levels of personal experience with asthma hold 
different beliefs about its consequences for the sufferer. For example, it might 
be predicted that an individual who has several friends and family members 
with asthma may perceive the consequences of the condition very differently 
from one who has never come into contact with a sufferer. In this respect, 
Marteau (1985) found that parents rated a condition with which they were 
familiar (i.e. one which their own child suffered from) as less serious than 
other childhood conditions, regardless of the actual condition suffered 
(diabetes, asthma or epilepsy). 
Unexpectedly, time since diagnosis and time since first prescription for 
asthma were not significantly correlated. There are two reasons why this 
might be so. Firstly, it is possible that medication is not prescribed 
immediately upon diagnosiS, but rather that an individual is first 
recommended to use non-medical coping strategies (such as avoidance of 
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triggers) for a time before medication is prescribed in an attempt to control the 
asthma. Perhaps a more likely explanation, however, is that the data for 
these two variables was obtained from different sources (data on time since 
diagnosis from the GP and data on time since first prescription from the 
patient). Memory factors are likely to influence patient reports, while GP data 
ought to be more objective, being obtained from the medical notes. Despite 
this, it is noteworthy that subjective time since diagnosis (Le. the 
individual's perception of when their asthma began) showed a closer 
association with illness representation than did objective time since 
diagnosis, but that the associations with illness representations were 
congruent, where found. This finding suggests that it is the individual's 
perception of the situation which is important in shaping other cognitions, 
rather than objective reality. 
b. Coping With Asthma 
With regard to asthma-specific coping strategies, i.e. the carrying out of 
behaviours which are recommended by the medical profession in order to 
control asthma, interesting, but not entirely unforeseen results were found. 
The mean number of puffs of Reliever medication taken was less than two 
per day, and this number was greatly inflated by the one individual who 
reported having taken 64 puffs of Reliever medication during the study week. 
It is possible that this individual inadvertently reported Reliever and 
Preventer medication use in the wrong columns in the diary, although the 
medication reported to have been taken was not used regularly throughout 
the week, as would be expected of Preventer medication. Such high levels of 
Reliever medication use are certainly undesirable and warrant further 
investigation. It would perhaps be useful to examine this case as an outlier 
and perhaps repeat the analysis once it has been omitted in order to see 
whether it has biased the results in any way. 11 % of the sample used, on 
average, more than the two puffs of Reliever medication per day 
recommended as maximum. 
The mean number of puffs of Preventer medication taken during the 
study week was 17, representing an average of between 2 and 3 puffs per day. 
Since the modal level of prescribed Preventer medication was four puffs per 
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day (mean for the whole group of N=27 prescribed Preventer medication 
approximately 26), this suggests general under-use in the group as a whole. 
This finding is reflected in the fact that over 80% of non-adherence to 
recommended Preventer medication was due to under-use and is consistent 
with the findings of Kleiger and Dirks (1979), who found that 52% of non-
adherence was due to under-use of asthma medication and 20% due to over-
use in a sample of 100 adult inpatients. Only 60% of participants took the 
recommended number of doses of Preventer medication during the study 
week and it should be borne in mind that this variable still took no account of 
the timing of the doses. Approximately 70% of those prescribed Preventer 
medication took it regularly. Considering the treatment regimen as a whole, 
60% of participants regarded themselves as completely adherent .. This figure 
is very high compared to the more objective methods of assessment of 
adherence, but is likely to be inflated by the fact that eight individuals were 
only prescribed PRN Reliever medication. 
More than half of the sample had had no contact with outpatient 
services in connection with their asthma during the previous 12 months and 
less than half used a Peak Flow Meter at the time of the study, despite 
possessing one and knowing how to use it. 
These health-care behaviours were not all related to one another, i.e. 
people were not all either "copers" or "non-copers". In fact, two factors of 
asthma-specific coping were found: one concerning Preventer medication use 
and recent use of outpatient services, the other including Reliever 
medication use, non-use of PFMs and self-reported adherence. It is 
interesting to note that in this analysis, Reliever and Preventer medication 
use fell into two separate factors, whereas in the factor analysis reported in 
Chapter 7 (development of the measure of asthmatic controD, they fell into 
the same factor. This result can only be attributed to the fact that a different 
combination of variables was entered into the analysis in each case. It was 
hypothesised that the two current factors might represent approach coping 
and avoidance coping respectively, but as the reasons for use of each strategy 
were not known (e.g. outpatient visits might be a response to poorly 
controlled asthma or, alternatively, might fulfil a preventive function) it was 
not possible to label the factors as such without further investigation. A 
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factor associated with high panic-fear (Hyland et aI., 1993b), general approach 
coping or low levels of perceived airways obstruction might be hypothesised 
to be of the approach type. Conversely, a factor which was significantly 
correlated with low panic-fear, general avoidance coping or high perception 
of airways obstruction would appear to fulfil an avoidant role. 
High scores on Factor 1 were indeed found to be associated with low 
perceived airways obstruction symptoms and so it was unlikely that the 
coping strategies included in the factor were carried out as responses to high 
perceived symptoms, i.e. Factor 1 may, indeed, be seen as representing 
approach coping. This factor was un correlated with panic-fear and general 
avoidance coping strategies such as denial and mental disengagement, but 
showed a positive correlation with the use of humour as a general coping 
strategy. 
Factor 2 was uncorrelated with perceived airways obstruction, but 
showed a tendency towards negative association with the general coping 
strategy of denial. Once more, this factor was uncorrelated with panic-fear. 
Such results are a little difficult to interpret due to the nature of the loadings 
of the three asthma-specific coping strategies onto the factor and the direction 
of the correlation with denial. However, the factor as it stands would also 
appear to represent a form of approach coping, i.e. high self-reported 
adherence, high use of Reliever medication and not using a PFM appear, by 
this method, to serve approach functions. The relationship between self-
reported adherence and Reliever medication use may be due to the fact that 
the adherence measure referred to the medication regimen as a whole and 
hence those prescribed Reliever medication only were more likely to report 
high adherence (since Reliever medication is generally prescribed to be taken 
PRN and hence non-adherence is impossible, as discussed above). It is 
possible that this group were also likely to take more Reliever medication. 
Since both factors of asthma-specific coping appeared to serve approach 
functions (although Factor 2 was more difficult to interpret) it is difficult to 
state exactly what the factors represent and to incorporate them into the wider 
framework of coping theory. 
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The use of Factor 1 coping was found to be associated with good 
asthmatic control (although this relationship was not strong), whereas Factor 
2 scores were not correlated with asthmatic control. Hence it appears that use 
of Preventer medication and outpatient services have more influence on 
asthmatic control than do use of Peak Flow Meters and Reliever medication. 
c. Emotional Reactions To Asthma 
The sample reported low levels of panic-fear compared to a previous 
sample of asthma sufferers (Brooks et al., 1989). It is possible that this 
difference could be due to cultural differences between the samples, the latter 
being from the U.S. 
Curvilinear, as well as linear relationships between panic-fear and 
other variables were examined since previous research findings had 
suggested that this emotional reaction showed a non-linear relationship with 
coping variables. Individuals reporting moderate levels of panic-fear showed 
better asthmatic control than those with extreme levels in either direction. 
This result is seemingly contradictory to the results of Kinsman et al. (1977), 
who found panic-fear and pulmonary function measures to be uncorrelated. 
However, there are two important differences between the two studies. 
Firstly, Kinsman only assessed lung function at a single time point (using 
FEV 1 and PVC measurements - see Chapter 7). In this context, Kinsman was 
not assessing asthmatic control, but rather absolute lung function at a single 
point in time. When the present results are considered in terms of outcomes 
of coping, it seems reasonable that asthmatic control shows a similar 
relationship to panic-fear as the Kinsman group found with several coping 
strategies (Kinsman et al., 1977; Dahlem, Kinsman & Horton, 1977). 
Secondly, only Pearson product-moment correlations were used between 
panic-fear and pulmonary function in the Kinsman studies and the 
possibility of a curvilinear relationship was never investigated. 
The relationships between panic-fear and coping were even more 
surprising when compared to previous results. Coping by Preventer 
medication use was the only method associated with panic-fear, but the 
results were in the opposite direction to that predicted, individuals with 
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moderate panic-fear levels tending to use less Preventer medication than 
others. This result can be compared to that of Hyland et al. (1993b), who 
found a linear relationship between panic-fear and levels of steroid Preventer 
medication prescribed (rather than taken). In the current study no linear 
relationship was found between panic-fear and Preventer medication use. It 
hence appears that panic-fear may influence practitioner decisions (i.e. 
prescribing of Preventer medication) and individual coping strategies (i.e. use 
of Preventer medication) in different ways. Practitioners appear to react in a 
uniform way to panic-fear expressed by patients while within the individual, 
a moderate level of panic-fear is detrimental compared to extreme low or 
high levels. 
Reflecting the finding that asthmatic control and Preventer medication 
use showed exactly inverse relationships with asthmatic control, but contrary 
to medical predictions, the amount of Preventer medication taken was found 
to be negatively associated with asthmatic control, those with poorer control 
(and extreme levels of panic-fear) taking more Preventer medication during 
the study week. These findings together suggest that Pre venter medication 
use may be started as a response to poorly controlled asthma, rather than 
being used in a prophylactic role. Frenzel et al. (1988) found similar results 
(increased coping being related to poor diabetic control) and made the same 
proposal: that coping was the result, rather than the cause, of poor disease 
control. However, this finding is contradictory to the finding that the first 
factor of asthma-specific coping was related to good asthmatic control; it 
would appear that the effects of the other variable included in this factor (use 
of outpatient services) masks the effect of Preventer medication use when 
examined in combination. 
Panic-fear did not moderate the relationship between asthmatic control 
and Reliever medication use as had been predicted from previous studies: in 
fact, there was no relationship between Reliever medication use and 
asthmatic control at all. However, the measures used here were different 
from previous studies in that asthmatic control and Reliever medication use 
were assessed over a full seven-day period, rather than day-to-day. The 
relationship between panic-fear, asthmatic control and Preventer medication 
use was examined in a similar fashion, since Preventer medication use had 
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been the only asthma-specific coping strategy to show a significant 
relationship with panic-fear in the earlier analysis. However, once more 
panic-fear and asthmatic control did not interact in determining the amount 
of Preventer medication used during the study week. 
Panic-fear was also significantly associated with several aspects of the 
illness representation. Alongside the above results concerning coping, this 
finding supports the hypothesis that the two pathways of the Self-Regulation 
Model are not independent, but are inter correlated (Leventhal, Diefenbach & 
Leventhal, 1992). High levels of perceived symptoms, low perceived personal 
responsibility and changeability of asthma and high perceived consequences 
of asthma were associated with high levels of panic-fear. Once more, it is 
interesting to speculate on the exact nature of this relationship. It could be 
that an individual with high levels of panic-fear is more vigilant to 
symptoms (e.g. Leventhal, Diefenbach & Leventhal, 1992) but it is equally 
possible that high levels of perceived symptoms precede the emotional 
reactions. It might be hypothesised that individuals who perceive high levels 
of symptoms with severe consequences, yet feel they have low personal 
responsibility for their condition (i.e. that there are few things which they can 
do to control it) would show the highest levels of panic-fear. However, the 
sample size in this study was not large enough to permit such analysis and 
further research would be required in order to investigate this possibility. 
d. General Coping 
The sample showed differences in general coping from previous 
samples. Particularly noteworthy is that, although generally reporting less 
coping, higher levels of the avoidance coping strategies denial and 
behavioural disengagement were found in this group. Such differences could 
occur for several possible reasons. The original study was carried out in the 
U.S. and it could simply be that coping differs between cultures. Perhaps 
more interesting is the possibility that the result might be due to the use of a 
clinical sample, but unfortunately no other COPE data is available for asthma 
sufferers to allow the investigation of this hypothesis. The higher levels of 
denial seen might be a general coping strategy employed by those suffering 
from chronic illness, or alternatively the data could support a psychosomatic 
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view - namely that individuals with certain personalities are more prone to 
developing chronic conditions (e.g. Alexander, 1981). Unless longitudinal 
data are available, it is not possible to speculate on which of these 
explanations is more likely. 
e. Influences On Asthmatic Control 
High levels of the general coping strategies mental disengagement, 
restraint coping and denial were associated with poor asthmatic control. In 
fact, in combination with illness representations and asthma-specific coping, 
low denial was the best predictor of good asthmatic control. These are all 
examples of avoidance coping and since asthma is a condition which requires 
continuous assessment and coping in the "here and now" rather than 
avoidance, if one assumes that general coping style generalises to coping with 
asthma, this result is not surprising. Since the levels of denial were higher 
than average in this sample, this finding gives cause for concern. 
Leventhal, Diefenbach and Leventhal (1992) propose three possible 
mechanisms by which general coping may influence the coping process. 
Firstly, it might influence the formation of illness representations, by shaping 
the information which is (a) obtained and (b) retained. Secondly, it can affect 
the amount of attention diverted towards physical symptoms, as well as 
influencing the interpretations of such states. Finally, it may influence 
coping strategies and appraisal criteria, as proposed by the Self-Regulation 
Model. Although there is no evidence of denial exerting any of these effects, 
there is some evidence to support the latter possibility in the current study, 
where low use of the general coping strategy behavioural disengagement was 
associated with Preventer medication use which was, in turn, associated with 
asthmatic control. The study did not address the relationship between 
general coping strategies and illness representations, but the data would 
permit a future investigation of the hypothesis that general coping is 
associated with various aspects of the illness representation. 
Sherbourne et al. (1992) had found that individuals with hypertension, 
diabetes and heart disease who generally used avoidant coping strategies were 
less likely to adhere to the recommended treatment regimen. Although not 
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strongly, this result was supported in the current study, where high levels of 
denial were associated with low self-reported adherence (but not adherence as 
assessed by any other means). The current results are also in line with the 
finding of Carver, Scheier and Weintraub (1989) that denial is one coping 
strategy in a cluster of 'less adaptive coping strategies'. 
Recently having come into contact with outpatient services in 
connection with asthma was associated with good asthmatic control. This 
finding is consistent with the finding that, in a sample of 210 adult asthma 
sufferers recruited through GPs and hospital clinics, delay in consulting a 
health professional was significantly associated with poor asthmatic control 
(as indexed by frequency of attacks, increased breathlessness while walking 
and interference with everyday activities) (Sibbald, 1989). Reasons for 
consultations were not recorded in the current study and hence it is not 
known whether visits were routine or were made because asthma was poorly 
controlled, but the fact that the first factor of asthma-specific coping was 
associated with good asthmatic control suggests that the visits were 
preventive, rather than reactive in nature. It appears that such contact was 
particularly helpful in improving/maintaining asthmatic control, perhaps 
because it encouraged patients to adhere to regular Preventer medication use. 
It is also possible that visits to outpatient services performed some kind of 
monitoring function for the patient or reduce denial of the problems 
associated with suffering from asthma, encouraging the patient to consider 
the stressor and its implications for coping. However, in generalising this 
result to other samples of adult asthma sufferers it should be borne in mind 
that the current sample were all under the care of the same general practice, 
which had a specific interest in asthma care, and that many of their outpatient 
visits would have been within the practice. Contact with general practices 
with less interest in asthma care may not prove so beneficial. 
There was evidence for some associations between illness 
representations and asthmatic control. Individuals who perceived asthma to 
have high consequences for sufferers' lives were more likely to show poor 
asthmatic control themselves. It could be hypothesised that they were basing 
their expectations of the effects of asthma on other sufferers' lives on their 
own experience, since their lives would be expected to be more highly 
245 
restricted due to their uncontrolled asthma. Alternatively, however, it could 
be that individuals who believe asthma has, in general, severe consequences 
for the sufferer, do not take appropriate action when their asthma causes 
them restrictions since they believe such restrictions are inevitable. The 
testing of the hypothesis that personal experience has a modifying effect upon 
illness representations has been discussed above. 
There was also a tendency for those reporting high perceived personal 
responsibility to have good asthmatic control. Once more, there are two 
possible explanations for this finding. It could be that individuals who 
believe there are many things they can do to control their asthma cope more 
effectively, using these strategies, and hence control their asthma more 
effectively. Alternatively, this finding may reflect a form of self-serving bias 
(e.g. Abramson & Alloy, 1980; Langer, 1975; Miller & Ross, 1975), those having 
good asthmatic control attributing it to behaviours within their own control 
while those whose asthmatic control is poor attribute this to other influences. 
With this point in mind, it would be useful and interesting to investigate the 
role of Locus of Control (LOC) over asthmatic control in order to see whether 
those with internal attributions for good asthmatic control show better 
asthmatic control than those with external attributions. 
Previous evidence addressing the relationship between LOC and 
disease outcomes in chronic conditions has revealed conflicting results. For 
example, Burns, Green and Chase (1986) found that internal LOC beliefs were 
associated with diabetic control in a sample of 72 children (aged 8-16) suffering 
from diabetes mellitus. In this study, however, those with high internal LOC 
beliefs showed poorer diabetic control. It is possible that the relationship 
between LOC and disease outcome is different for different age groups, 
however, as even within this study the relationship did not hold for 
subgroups of all ages. Marks et al. (1986) found that internal LOC or 
"powerful others" LOC were associated with better adjustment and recovery 
in individuals suffering from chronic disease, especially where the condition 
was perceived as severe. Hence there is evidence that it may not be the belief 
in oneself having control over the situation, as such, which is adaptive, but 
rather the belief that someone (be it oneself or powerful others) can control 
the situation which might be adaptive. In summary, although there is some 
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evidence that internal LOC may playa role in determining health outcomes 
in chronic conditions, research to date has not unequivocally demonstrated 
the nature of this relationship and further investigation is required. 
f. Influences On Coping With Asthma 
Coping with asthma was associated with some aspects of the illness 
representation. Perceived symptoms, perhaps surprisingly, were not 
associated with individual asthma-specific coping strategies, although there 
was a negative correlation between perceived airways obstruction and 
approach coping (see above). High perceived changeability was associated 
wi th both high use of Reliever medica tion and low adherence to 
recommended Pre venter regimen (assessed from monitoring diaries), 
suggesting that individuals who believe their asthma to be highly changeable 
do not take preventive action, but rather react to the symptoms once they are 
felt by using Reliever medication. Alternatively, since Reliever medication 
does not prevent symptoms, but merely relieves them for a period of time, 
those who cope reactively by using Reliever medication are likely to have 
changeable symptoms which appear, are masked by medication, re-appear, are 
masked again etc. ad. nauseam. 
Regular use of Preventer medication was associated with low perceived 
hyperventilation symptoms at times of exacerbation. Since hyperventilation 
is associated with the clinical syndrome of panic, this result suggests that 
individuals who tend to panic when they feel asthma symptoms are less 
likely to decide to take Preventer medication on a regular basis. 
Peak Flow Meter use was found to be significantly correlated with low 
perceived airways obstruction, which suggests that those using meters for self-
monitoring tend to do so as a preventive (approach) measure, rather than as a 
reaction to perceived symptoms. 
9.4.2. Methodological Considerations 
The most important consideration in interpreting the results of this 
study is that the relationships found are only correlational, so no direct causal 
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explanations can be made. It is already clear, from the above discussion, that 
in many cases there are several possible interpretations of the associations 
found between variables and each is merely a hypotheses for further 
investigation. There are two possible methods of investigation which could 
provide further insight into the nature of the relationships found. Firstly, 
longitudinal studies could be carried out which assess illness representations, 
coping and asthmatic control at several consecutive time points and look at 
whether certain variables at one point in time are predictive of other 
variables at later time points. A second possibility is to carry out 
interventions aimed at altering specific variables and investigate the effects 
brought about on other, related variables, which is the aim of the 
intervention study (see Chapter 10). 
In addition, many of the relationships found between variables in this 
study were somewhat tentative. Liberal interpretations of correlations has 
been made in some cases in an attempt to identify possible intervention 
points. In this respect, the small sample size must be borne in mind. Ideally, 
a similar study with a larger sample size (e.g. 100 participants) needs to be 
carried out; the difficulties in recruiting participants to this study have been 
discussed in Chapter 8 and possible methods to overcome them suggested. In 
addition, the sample used were all patients registered with a single general 
practice with a high interest in asthma and its treatment. It is therefore likely 
that a restricted range of outcomes was obtained compared to those expected 
in a larger, more heterogeneous sample. However, the poor coping (in terms 
of high Reliever medication use, low adherence and use of Preventer 
medication as a response to poorly controlled asthma, rather than a 
preventive measure) identified suggests that a wider problem might be 
identified should a more heterogeneous sample be studied. 
The results concerning variables obtained from the diaries are possibly 
further limited due to the fact that the 77% of participants returning the 
diaries, although not found to differ significantly from those who did not 
complete the study in terms of medical and demographic variables, were 
likely to be a biased sample in terms of adherence to requests. This possibility 
is strengthened by the fact that completion rated in the diaries were high 
(around 93%). it is even possible that those who had not completed the 
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diaries properly were the ones who did not return them. However, it is 
encouraging that participants did respond to the specific request to leave 
blanks if they forgot to complete their diary at any time during the study 
week, rather than fabricating information retrospectively, suggesting that the 
data which were returned were valid. Completion rates might be increased by 
(a) stressing even more strongly to participants that leaving blank spaces was 
not only permissible, but it was expected and (b) offering incentives (perhaps 
financial) for successful completion of the entire study. 
One of the strengths of this study was that data were obtained from 
several sources: self-report, GP report (from medical notes) and self-
monitoring diaries. Where data were obtained from more than one source, 
reasonable reliabilities were found. The data also covered various time 
periods: for example, much of the self-report was concerned with general 
experience of asthma, information from the monitoring diaries was collected 
over a period of one week and GP data assessed coping retrospectively over 
longer periods. The latter method has been successfully employed by other 
researchers in the area; for example, Schlosser (1992) found hospital 
admissions in the previous year to be associated with current illness 
representations and days absent from work due to asthma in the previous 
year to be associated with coping. 
Some of the variables it was originally intended to include in the 
analysis proved impossible to use. In particular, the GPs were unable to give 
reports of the type of asthma suffered by each individual 
(continuous/intermittent/triggered) in the majority of cases, despite agreeing 
to do so at the outset of the study and despite these terms being used 
frequently in the medical literature. It would appear that despite providing 
some loose guidelines, the technical use of such terms is limited, perhaps due 
to the variable nature of asthma. In many cases, a combination of factors 
might be involved - for example, asthma could be continuously triggered by 
allergens. In addition it was not possible to assess adherence from the 
number of repeat prescriptions requested during the previous months from 
the data available because several participants had had their treatment 
regimen altered during that time period. In order to use such a measure, 
accurate data concerning the dates and details of changes in the prescribed 
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treatment regimen would be required in order to calculate the number of 
repeat prescriptions which would be required if adherence was 100%. Since 
the demands on GPs for the study were already high, this was not possible in 
the current study. 
The pre-existing measures used appeared to operationalise the model 
varied in terms of their reliabilities in the current sample. The four IMIQ 
scales showed low reliabilities (including one which was negative because its 
items were, in fact, strongly negatively correlated), while the ASC and the 
COPE fared rather better and showed satisfactory reliability. It could be that 
the IMIQ simply is not suitable for use with asthma sufferers; its reliability in 
a larger sample therefore requires investigation. The EQOL appeared 
satisfactory as a measure of illness representations, showing significant 
relationships with both other aspects of the illness representation and some 
of the coping variables, as predicted. 
The measures of adherence showed different results in this study. Self-
reported adherence (to the complete recommended medication regimen, i.e. 
including Reliever medication and, where prescribed, Preventer medication 
too) was significantly correlated with adherence to recommended Preventer 
medication regimen as assessed from the diaries. However, the two were 
included in different factors of coping when factor analYSis was carried out. 
Neither variable was associated with asthmatic control. The study was hence 
unsuccessful in identifying a reliable and valid measure of adherence to 
recommended medication regimen. 
Throughout the study, where possible, the underlying assumptions of 
statistical analyses were checked and adhered to. Particular attention was paid 
to employing the correct correlational statistics. However, since there was no 
non-parametric equivalent of multiple regression available, and the variables 
of interest varied in distributional qualities, it was necessary to use parametric 
regression even where some of the variables of interest violated the 
assumptions of normality. Since such variables were chosen for entry into 
the regression on the basis of non-parametric correlations, the results of 
regressions are not always in complete correspondence with the preceding 
correlations. 
250 
Emotional reactions were operationalised as panic-fear responses at the 
times when symptoms were felt, since these had been previously found to be 
associated with coping. They were, indeed, found to relate to asthmatic 
control in this study and as such this choice was correct. However, Leventhal 
(1991) suggests that it might also be useful to examine emotional reactions at 
other times: for example, 
(1) Emotional reactions to being given a diagnosis of asthma. 
(2) Emotional reactions to requiring ongoing treatment. 
(3) Emotional reactions to the social consequences of suffering from asthma. 
(4) Emotional reactions to suffering from a chronic condition. 
Such possibilities require exploration in future research. 
9.4.3. Theoretical Implications 
The only complete pathway between illness representations, asthma-
specific coping and asthmatic control was that between perceptions of low 
airways obstruction, high levels of Factor 1 coping and asthmatic control (see 
Figure 9.16.). This relationship possibly occurs because individuals who 
employed approach methods of coping showed better asthmatic control and 
perceived less airways obstruction as a result. However, the exact causal 
pathway is unclear from the current study. When individual coping 
strategies were considered, there were no direct links between illness 
representations, coping and asthmatic control, although there were plenty of 
associations between the individual components of the Self-Regulation 
Model. 
This finding supports the previous research on approach and 
avoidance coping which has found approach coping to be associated with 
favourable outcomes and avoidance coping to be less adaptive when dealing 
with chronic stressors (e.g. Felton & Revenson, 1984; Frenzel et al., 1988; Suls 
& Fletcher, 1985). However, because of the uncertain nature of the second 
factor of coping, this result is unclear. 
Figure 9.16.: Summary of significant correlations between illness representations. coping (general and asthma-
specific) and asthmatic control. 
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Panic-fear was found to be associated with illness representations and 
coping by Preventer medication use and hence there was evidence that the 
two pathways of the Self-Regulation Model (the so-called "objective" and 
"emotional" pathways) were intercorrelated, as latterly suggested by 
Leventhal, Diefenbach & Leventhal (1992). 
Asthmatic control demonstrated a stronger relationship with coping 
than it did with illness representations, in line with the model's predictions 
but contradictory to various recent research findings (e.g. Earll & Johnston, 
1994; Earll, Johnston & Mitchell, 1993; Moss-Morris, Petrie & Weinman, 1995). 
9.4.4. Clinical Implications 
The results obtained in the cross-sectional study may be used to form 
the basis for interventions aimed at improving (a) coping and (b) asthmatic 
control in asthma sufferers. In this respect the following results are relevant: 
a. Improving coping with asthma 
It would be desirable to increase the coping strategies which were found 
to be associated with good asthmatic control in this study. The data suggest 
that it would be desirable to increase coping using the strategies included in 
Factor I, i.e. taking Preventer medication prophylactically, attending for 
regular check-ups and adhering to recommended treatment regimens. Low 
levels of hyperventilation symptoms were associated with regular use of 
Preventer medication, suggesting that teaching strategies to decrease 
hyperventilation may have favourable outcomes. No specific methods of 
increasing Preventer medication use were suggested by the data, however. To 
some extent, the beneficial process of attending for regular check-ups is under 
the influence of organisational factors within the general practice, but it is 
possible to encourage individuals to share the responsibility for controlling 
their asthma with physicians and hence to make appointments at regular 
intervals. 
Although the data suggest that lowering the perceived changeability of 
asthma may lead to increased adherence (as well as decreased Reliever 
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medication use and increased approach coping), further investigation is 
required in order to understand the behavioural process of adherence and 
hence to identify possible methods of intervention in order to improve the 
low levels of adherence seen. In an attempt to obtain more reliable self-
reports of adherence, participants had been given the opportunity to state 
reasons for not taking their medication as prescribed. It is enlightening to 
note the reasons given at this point. Fourteen participants gave up to three 
reasons each for low adherence and there were nineteen possible reasons 
given altogether. These reasons were classified into six intuitive categories by 
the researcher (when a second, non-expert, rater placed each reason into one 
of the six categories, percentage agreement on classification was 89%). These 
categories are summarised, in descending order of frequency of report by 
participants, in Table 9.22. 
Table 9.22.: Reasons given for non-optimal adherence. 
REASON EXAMPLES 
(NO. OF TIMES MENTIONED) 
Negative beliefs about My medication has side-effects 
medication (6) I feel bad about needing it/don't like taking it 
It only cures symptoms, not the underlying problem 
Forgetting/not bothering (5) I forget 
I cannot be bothered 
Belief that symptoms do not I have no symptoms 
require medication (3) 
Practical reasons (2) I was away from home 
I lose/run out of inhalers 
Alter own doses (3) I take lower doses than I am meant to 
I currently do not take any medication 
I take higher doses when my symptoms are worse 
Only the final one of these reasons for non-optimal adherence would 
appear to be reasonable in some instances, in that (a) some participants were 
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only prescribed Reliever medication and taking none of this cannot be 
classified as non-adherent and (b) patients are often encouraged to step-up 
and step-down their Preventer medication themselves, depending on the 
current status of their asthmatic control. None of the participants mentioned 
adjusting their Preventer medication in accordance with Peak Flow readings, 
all instead using symptoms alone as an indication of when to alter 
medication. Since Peak Flow monitoring appeared to be being used as a 
response to asthma symptoms, so it might also be beneficial to encourage 
ongoing monitoring, regardless of the symptomatic state of the asthma. 
The other four reasons for not taking medication as recommended also 
offer possibilities for intervention. For example, beliefs about medication and 
the importance of taking it prophylactically can be altered by giving accurate 
information/recommendations and advice on how to overcome practicalities 
(including forgetting) provided. 
b. Improving asthmatic control. 
The above results suggest that several methods might be employed in 
order to improve asthmatic control. Firstly, although denial as a general 
coping strategy would be extremely difficult to modify, it could be feasible to 
attempt to modify denial in connection with asthma and its treatment by 
providing alternative coping strategies. Such a method has been employed in 
previous research with surgery patients. For example, Ridgeway and 
Matthews (1982) administered a manual teaching cognitive coping strategies 
to patients who were about to undergo hysterectomy. They found that such 
patients showed better outcomes in that they used less analgesics whilst in 
hospital and reported fewer symptoms post-discharge than individuals who 
had received a (a) similar length workbook containing information about the 
surgical procedure, (b) a workbook containing a description of the 
ward/hospital (placebo group) and (c) regular care (control group). 
In attempting to reduce denial, however, it would be desirable to 
moderate panic-fear levels, i.e. to increase awareness and acceptance of 
asthma so that a moderate level of panic-fear was present, without raising the 
levels so far that they interfere with effective coping. In order to do this, the 
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results suggest that perceived personal responsibility and changeability of 
asthma be increased while perceived consequences should be decreased. 
However it was necessary to bear in mind the effect that this might have on 
Preventer medication use (although the exact role of Preventer medication 
was unclear from this study). 
9.5. Conclusion 
This study has demonstrated the value of coping theory and, in 
particular, the Self-Regulation Model, in identifying relationships between 
illness representations, coping, emotional reactions to asthma and asthmatic 
control. Methodologically, some important considerations for carrying out 
such research have been identified and there are clinical implications in that 
the results suggest various possible methods of improving asthmatic control. 
The results can hence form the basis for the intervention study reported in 
Chapter 10. 
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CHAPTER 10: THE INTERVENTION STUDY 
10.1. Overview 
The purpose of this study was to use the Self-Regulation Model and the 
results of the cross-sectional study as the basis for an intervention aimed at 
improving asthmatic control in a specific clinical group, and to evaluate the 
effects of the intervention. 
A brief review and critique of the history of psychological 
interventions with asthma sufferers follows, culminating in the recent 
interest in self-management interventions. The Self-Regulation Model and 
the results of the cross-sectional study are introduced as compatible with this 
self-management approach. There follows a discussion of the importance of 
the transitional period immediately after leaving the parental horne for the 
young adult asthma sufferer, drawing on three lines of evidence: 
epidemiology, clinical observation and the developmental perspective. For 
this group, who may be developing self-management skills which will last a 
lifetime, epidemiological data suggest that asthmatic outcomes are poor, and 
clinicians have regularly found poor asthmatic control to be a particular 
problem. A self-management workbook, "Controlling your Asthma", was 
hence developed to encourage good asthmatic control in student asthma 
sufferers. A randomised controlled study evaluating the effects of this 
intervention is then reported and the results discussed. 
10.2. Introduction 
10.2.1. The Target Population: Student Asthma Sufferers 
Student asthma sufferers were chosen as the target population for 
intervention, for three reasons: 
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a. Epidemiological evidence for poor self-management in young adult 
asthma sufferers 
The general epidemiology of asthma is discussed fully in Chapter 3. 
The data presented suggest that deaths from asthma begin to increase steadily 
after age 15-19 and that deaths in the age group 15-34 have increased over 
recent years. It is possible that such differences arise from poor coping with 
asthma, commencing in early adulthood. Hospital admissions due to asthma 
are low in this group, suggesting that coping at times of severe exacerbation 
may also be inappropriate. Hence it seems feasible to investigate the coping 
process and its relationship to asthmatic control in this group in particular. 
b. Clinical observations suggesting sub-optimal self-management in student 
asthma sufferers: the problem in the University of St Andrews 
St Andrews is a small city with a population of around 20,000. In 
addition, the university has approximately 5,600 full-time students registered 
at anyone time (including both undergraduates and postgraduates), all of 
whom are required to register with a local GP (Davidson, 1995). Hence 
approximately 28% of the patients registered at the St Andrews Health Centre 
are students, shared equally among the three general practices. 
Approximately 280 of these students (5%) would be expected to be 
diagnosed asthma sufferers, most of them being within the first seven years 
of living away from the parental home. The epidemiological study of the 
University of St Andrews students presented in Chapter 8 suggests that this 
estimate of prevalence was conservative, since 13% reported having had 
asthma at some time in their lives, 5% reporting symptoms during the 
previous 12 months. 
One particular general practice, with a strong interest in asthma, made 
several important observations suggesting that the student asthma sufferers 
under its care were not optimally self-managing their asthma, despite input 
and guidance from health professionals in many cases. Firstly, when the 
notes of all the recently arrived students were searched for audit purposes, it 
became apparent that several individuals who had been diagnosed as 
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suffering from asthma had not declared this to the general practice when 
asked to declare any conditions they suffered from on a questionnaire 
administered to all new students at the start of the academic year. This 
suggests not only that these students may not have been coping with their 
asthma adequately, but also that, within a practice with less interest in 
asthma, their asthma may go unnoticed and largely untreated. Secondly, 
within the student patients were also a number who, despite relatively high 
guidance and monitoring of their asthma self-management by the practice, 
repeatedly presented with uncontrolled asthma, sometimes in emergency 
situations, but more often during routine check-ups. Again, this finding 
suggested that the self-management of these individuals was less than 
optimal. 
These findings are consistent with the results of a study carried out by 
Martin, Landau and Phelan (1982). 326 21-year olds who had suffered from 
asthma since before the age of seven were studied and found to have poor 
knowledge of their condition, as well as inadequate coping. 
c. The importance of adolescence in shaping future self-management 
behaviours 
From the moment an initial diagnosis of a chronic condition is made, 
the sufferer becomes involved in self-management of the condition. This 
self-management is not an instantaneous process, but involves much 
learning, experience and practice and thus evolves over time. Where 
diagnosis is at a young age, generally the parents take on almost total 
responsibility for controlling the young child's asthma: administering drugs 
at the correct times, encouraging the child to exercise, removing potential 
allergens from the home, ensuring as far as possible that the child avoids 
exposure to further allergens outside the home and being vigilant in 
identifying times when the child's lung function may be deteriorating and 
hence require action. In addition, the parent will generally be the one to take 
charge of consulting a doctor, ensuring regular check-ups, making sure 
medication prescriptions are ordered and collected etc. Hence the parents 
may significantly influence the course of the child's asthma (Everaerd, 
Vromans & van der Elst, 1990). 
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Once the child reaches school age, it is typical for the teacher to also 
become involved in treatment, by safeguarding the prescribed drugs, 
administering them at the correct time and again, observing the child's 
breathing during exercise and other activities. During this early stage, since 
the parents and teacher are primarily responsible for controlling the child's 
asthma, it is their illness representations and coping which are likely to be the 
main influence on the child's asthmatic control. Such effects are outwith the 
scope of this thesis, but are extremely important and research in this area 
would be valuable and important. 
It has previously been demonstrated that increasingly sophisticated 
illness representations develop naturally in healthy children (Bibace & 
Walsh, 1980; Schmidt & Weishaupt, 1990) and there is no reason to believe 
that this process is fundamentally different in sick children, although it may 
be accelerated or follow a slightly different course. According to the Self-
Regulation Model, such changes in illness representations would be expected 
to lead to changes in coping (self-management). For example, the child might 
increasingly request medication from the parents or teacher, rather than 
waiting for it to be given, and will learn to identify and avoid triggers without 
being told to do so. Between the ages of five and seven it is also 
recommended that children commence the use of Peak Flow monitoring 
(National Asthma Campaign, 1994). However, throughout the childhood 
years the parent will generally oversee the self-management process and 
ensure that the child is learning to cope in a way they consider suitable, based 
on their own illness representations. 
As adolescence approaches, however, the child will generally strive to 
achieve complete autonomy in self-management, as in other areas of life 
(Hauser & Bowlds, 1990), and will gradually be granted this. However, it is 
important to note that although the young adult may become completely 
responsible for actions such as administering his or her own drugs and 
avoiding triggers, generally as long as he or she remains living in the parental 
home, the parents will continue to play at least a small role in decisions such 
as, for example, consulting a GP, re-ordering medications as they run out and 
ensuring the home is kept free of allergens. 
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It is only when the young adult finally leaves the parental home that 
full autonomy in all aspects of asthma self-management is attained. In 
addition to all the other responsibilities which are suddenly thrust upon the 
individual, there is also nobody constantly watching over them and 
encouraging them to control their asthma. At this point, according to the 
Self-Regulation Model, the illness representation and coping behaviour of 
the young adult becomes, the primary determinant of asthmatic control -
although this is likely to be based on the parents' illness representation and 
coping, to some degree, through exposure and learning. 
Since the young adult has, by degrees, been taking responsibility for the 
asthma for years, the importance of this final stage may not be recognised. In 
addition, other aspects of adjustment to adult life may take priority over 
healthcare, or peer pressure or desire to be "normal" may strongly influence 
the coping process. Research has shown that health status level (indexed by 
disability) in a group of 106 children (aged 6-14 years) remained the same in 
25% of cases, improved in 62% of cases and deteriorated in 16% of cases when 
assessed eight years later (i.e. during young adulthood; Orr et al., 1984). 
Although only a relatively small proportion of the total sample, the 17% 
whose health status might be at risk of deteriorating during young adulthood 
need to be identified in order that such deterioration may be prevented and 
satisfactory coping strategies established. 
Not all asthma sufferers are diagnosed at such an early age as the 
previous discussion assumes, however. Some may not be diagnosed until 
much later in life, in which case the transition to self-managing may come 
before coping has been properly established with the assistance of family 
members. Depending on the ages at (a) diagnosis and (b) leaving the parental 
home, different stages of coping may have been attained when autonomy in 
self-management becomes necessary. A whole new learning experience then 
begins as the asthma sufferer starts to incorporate self-management into a 
new way of life. The next few years form an important stage of development, 
since the illness representations and coping methods developed now may 
influence asthmatic control for a lifetime. 
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Nowhere else is a group at this stage so well-defined as in students in 
the course of further education. Approximately 5% of every intake of 
university students will be asthma sufferers attempting to self-manage their 
condition completely alone for the first time, and 5% of those in higher years 
will be in the early years of such adaptation. It is therefore crucial that these 
students receive as much guidance as possible to enable them to cope 
adequately with their asthma, alone, for the first time. An additional 
problem in this respect is that students tend to register with a new GP who is 
not so familiar with their medical history and, in addition, mayor may not be 
specifically interested in asthma treatment. Hence they have, in addition, the 
problems of forging a relationship with their new GP and perhaps with 
receiving less support and advice than they may have formerly received from 
their family GP. 
d. Summary 
The years immediately after leaving the parental home are crucial for 
the individual who is learning to cope with asthma autonomously for the 
first time, since the self-management behaviours adopted at this stage will 
largely be carried on throughout adult life. Large numbers of students suffer 
from asthma, and it has been noted that in a significant number of them, self-
management appears to be sub-optimal, even in a general practice where 
asthma care is a priority. Hence it is useful to study this group in order to 
understand the coping process and important to intervene in an attempt to 
encourage students to adopt better self-management during these years, and 
particularly to reach those registered in practices which may not offer so 
much input into their condition. 
10.2.2. Review Of Previous Interventions With Asthma Sufferers 
In order to set the current work into context and introduce the Self-
Regulation Model as a potential framework for intervention, a brief historical 
review of studies evaluating various intervention methods with asthma 
sufferers - both adults and children - follows. There are many more studies 
assessing interventions aimed at children than there are aimed at adult 
asthma sufferers (Bailey et al., 1987; Worth, 1990), but since the current study 
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was aimed at young adult asthma sufferers, successful intervention with 
adult patients is particularly noted throughout. Where possible, review 
papers are discussed and the reader is referred to the original paper for further 
details. Individual papers are incorporated into the review where 
appropriate. See Alexander (1981) for a further review. 
a. Psychoanalytic Approaches 
Psychoanalytic therapy for asthma was popular between 1920 and 1950. 
It aimed to alter individuals' psychological make-up but there was no 
substantial evidence for its success and this approach is no longer used or 
documented, in line with the theory behind it (Kaptein et al., 1988). 
b. Behavioural Approaches 
Behavioural interventions such as relaxation training, biofeedback, 
systematic desensitisation, assertiveness training and operant conditioning 
became popular between 1950 and 1980 (Kaptein et al., 1988). Cluss (1986) 
reviews 26 such studies published between 1965 and 1982 and a summary of 
this review is given below. Individual papers are not referred to; instead, the 
interested reader is referred back to the source paper. Since some studies 
compared more than one intervention method, 37 different groups are 
included in the report. In general, the principal outcome measure was Peak 
Flow, and many of the interventions were aimed at reducing anxiety. 
(i) 12 relaxation training (anxiety reduction) groups are reviewed. 
Such interventions are based on the assumptions that high levels of anxiety 
are likely to exacerbate and sustain asthma symptoms. Five studies (42%) 
resulted in a statistically significant improvement in Peak Flow, one of which 
employed adult participants and the other four children. Only five of the 
studies employed adequate control groups and used suitable statistical 
procedures for the sample sizes. The use of relaxation training as an 
intervention in asthma has, more recently, declined because of rather poor 
results such as these (Kaptein et al., 1988). 
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(ii) Biofeedback was the technique employed in 15 of the groups. 
Either muscle tension (using electromyographic feedback: EMG) or respiratory 
functioning can be monitored in an attempt to improve relaxation. A slightly 
higher rate of success was attained, 11 groups (73%) showing a statistically 
significant improvement in lung function following intervention and three 
of these involving adults. This research demonstrated more attention to 
methodological considerations, including sample size and use of control 
groups, than relaxation interventions. Erskine-Milliss and Schonell (1981), in 
their review, state that muscular relaxation alone has no effect on the course 
of asthma, but that including biofeedback can lead to Significant effects. 
Conflicting results on the effects of relaxation training on asthma have been 
found and Kinsman et al. (1980) suggest two reasons why this might be the 
case. Firstly, not all asthma sufferers show exacerbated symptoms following 
emotional distress, and sufferers may differ in the levels of emotional distress 
brought about by the same stressor. Hence the same stressor may have very 
different effects on two individuals. In addition, a certain level of anxiety 
which is focused on breathing difficulties may be adaptive (see Chapter 5) and 
hence it would not be desirable to eliminate such anxiety. 
(iii) Systematic desensitisation has not been as widely investigated as 
other behavioural techniques, but was the method of intervention in four 
groups. This involves encouraging individuals to think about asthma and its 
precipitants progressively without causing anxiety or precipitating symptoms, 
with the aim of discouraging anxiety at the times when symptoms are felt, so 
that the symptoms are less likely to deteriorate. Relaxation techniques are 
often employed to attain this result. Once more, Peak Flow has been the 
main outcome variable. Three of the studies (75%) showed significantly 
increased Peak Flow and three studies used adult participants. However, the 
lack of appropriate controls and poor statistical analysis in these studies has 
been criticised (Cluss, 1986; Kaptein et aI., 1988). 
(iv) Another technique aimed at improving lung function was 
assertiveness training, also designed to reduce anxiety. This method was 
employed in just two groups of children and led to no significant 
improvements in outcome. 
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(v) Operant techniques were the final intervention method reviewed, 
used in three studies. In addition to Peak Flow measurements, these studies 
also included symptoms and behavioural outcomes (hospital visits). Again, 
only children were studied and two of the groups (66%) showed statistically 
significant improvements in outcomes. 
Apart from the low proportion of positive findings (especially when 
one takes into account likely publication biases towards positive results), 
Cluss also notes several shortcomings in the research she reviews. A great 
many of the studies did not utilise control groups, for example, and only six 
of the 26 studies reviewed (23%) were carried out with adult samples, the 
majority being restricted by only including children and even, in one case, 
male children. The results demonstrate a distinct lack of success of purely 
behavioural techniques in improving disease outcomes in adult asthma 
sufferers. 
c. Self-Management Approaches 
Since around 1980, the trend has been towards self-management 
programmes, based on cognitive-behavioural principles (Kaptein et al., 1988). 
These interventions, rather than simply offering information regarding 
asthma and its treatment, aim to teach skills (such as preventive behaviours 
and acute attack management) and change attitudes and coping styles. The 
outcomes of interest are generally not restricted to medical ones, but also 
include behavioural outcomes (e.g. adherence) and psychological outcomes 
(e.g. cognitive and attitudinal measures). 
Bauman (1993) reports a meta-analysis of 24 such studies carried out 
between 1980 and 1991 and employing randomised or quasi-experimental 
designs. Self-management was assessed in nine studies, adherence in 13 and 
psychological outcomes in 10. The analysis revealed overall significant effects 
on psychological measures (e.g. LOC; self-efficacy), adherence and self-
management following such interventions, even when statistical precautions 
were taken to allow for potential publication biases. Again, however, most 
studies were interested only in facilitating self-management in children. 
Bauman criticises the studies on several counts. First, only 63% of the total 
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number of self-management studies identified (N =38) contained 
psychological or self-management measures of interest in this study and were 
hence included. Secondly, follow-ups were not included in many cases in 
order to see whether the positive effects were maintained. 
Clark (1989) reviews a further 14 self-management studies (four of 
which overlap with those reviewed by Bauman), only three of which target 
adult asthma sufferers. All of the programmes resulted in some significant 
effects, ranging from improved self-management behaviour (including use of 
Peak Flow Meters and healthcare) to improved illness outcomes (such as self-
reported wheezing episodes). 
Schlosser (1992), in her review of 12 controlled studies with adults, 
distinguishes and compares non-contact self-management interventions 
(such as videos and booklets), individual (didactic) interventions and group 
interventions. Eight studies showed significant short-term effects and six 
long-term effects (either with or without short-term effects). Schlosser 
concludes that, in general, non-contact interventions tend to alter knowledge 
and satisfaction but not illness outcomes, didactic interventions show good 
short-term effects and group interventions provide the best long-term effects. 
This review covers more fully studies with adult asthma sufferers and 
stresses the importance of rigorous methodologies, such as appropriate 
control groups. Evidence from a study by Hilton et al. (1982) found that there 
was no association between knowledge and morbidity due to asthma in a 
sample of 50 asthma patients (aged 5-65) recruited through a single general 
practice. Hence interventions which provide information alone are not 
suitable when disease outcome is the target for improvement. This suggests 
that non-contact interventions may be improved if they are designed to 
include elements other than purely information, e.g. coping skills training. 
Maes and Schlosser (1988a; 1988b) carried out a pre-test, post-test study 
based loosely on coping theory, in order to investigate the effect of a psycho-
educational self-management programme on asthma-related coping 
behaviours (both day-to-day and in attack situations), emotional distress 
(measured Dutch versions of Spielberger's State-Trait Anxiety Inventory and 
State-Trait Anger Scale), LOC, adherence to medical advice, use of medical 
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resources (hospital admissions, consultations with lung specialist and GP 
consultations) and daily and social functioning (days absent from 
work/housekeeping due to asthma). A sample of 19 asthma patients were 
recruited through two lung specialists. The eight two-hour sessions offered to 
participants in the study did not lead to significant changes in attack-related 
coping or LOC, but did lead to less focusing on asthma in everyday life. The 
author hypothesised that this effect may have been due to the anxiety felt at 
times when symptoms are experienced preventing alterations in coping. It is 
hence apparent that emotional reactions must also be considered in designing 
such interventions. 
Vazquez and Buceta (1993) carried out a controlled study comparing 
self-management intervention with and without relaxation training. They 
found that self-management training led to a reduction in self-assessment of 
symptoms but that including relaxation training only added positive benefit 
to those individuals who showed high levels of emotional influence on 
symptoms. Once again, this result indicates that it is important to consider 
emotional reactions to illness in planning interventions. 
d. Using the Self-Regulation Model as the basis for a self-management 
intervention 
The above discussion suggests that self-management interventions are 
more effective than behavioural interventions for asthma sufferers. Most 
previous self-management interventions, however, have not stemmed from 
a firm theoretical base, but rather were developed on an ad hoc. basis, 
including many distinct components. Vinck (1994) warns against designing 
interventions in such a 'top-down' fashion, where experts decide that they 
have identified a problem and attempt to intervene with no sound scientific 
evidence. Instead, he argues, interventions should be grounded in theory. In 
addition, very few self-management studies have addressed the issue of the 
influences of emotions in the progression of asthma, although previous 
research strongly suggests that this is important. 
The Self-Regulation Model provides an ideal theoretical framework for 
self-management interventions with asthma sufferers since it hypothesises 
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links between cognitions, behaviour (coping), emotional reactions and 
asthmatic control. However, with only one exception (Pimm et al., 1994), 
the Self-Regulation Model has not, to date, been used as the basis for self-
management interventions. The current study hence aimed to use a self-
management approach based on the theoretical principles of the Self-
Regulation Model and the results of the cross-sectional study. Hence, in 
addition to providing illness and treatment information, and encouraging 
appropriate coping strategies, it was required to address emotional reactions 
evoked by asthma and possible ways of coping with them. 
10.2.3. Format Chosen For The Intervention 
It was required to determine the most suitable method of intervention 
with this population, both in terms of form and content. An intervention 
was required which could reach the largest number of student asthma 
sufferers possible, regardless of which general practice they were registered 
with, and which was tailored to the particular level of development of these 
individuals. Although students are young adults, they are still in a learning 
environment and may therefore be taught in ways which would not 
necessarily be appropriate for members of the general adult population. It 
was therefore decided to present the intervention in the form of an 
interactive workbook. This form was chosen because (a) it would be possible 
to reach individuals who may receive only a minimal amount of input from 
their general practice, using minimal resources and (b) in a survey, 20% of 
responding GPs in Fife had indicated that they would welcome patient 
education material in addition to that already available (St Andrews Health 
Centre, 1992b). Despite the results of Schlosser (1992) concerning the relative 
efficacy of contact and non-contact interventions, since this non-contact 
intervention contained more than simply information this was considered a 
valid approach. The workbook contained 49 pages with sections to read, 
multiple-choice questions at the end of each section and spaces for the 
participants to complete with details of various aspects of their own asthma. 
The aim of this format was to present ideas to the students in an interesting 
way and to make them think about how they could apply them to their own 
situation. 
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Three separate sections of the workbook were chosen at random and 
assessed for reading ease using the FLESCH reading ease formula (see Ley, 
1990). The results of this assessment are displayed in Table 10.1. 
Table 10.1.: Analysis of reading ease of the workbook intervention. 
SECTION OF NO. OF FLESCH EDUCATION LEVEL 
WORKBOOK WORDS READING REQUIRED TO 
EASE SCORE UNDERSTAND 
Introduction (p.3) 160 51.4 Some High School 
Section 2 (p.29) 120 63.3 Grades 7-8 
Section 4 (p.48) 199 49.0 Some college 
This assessment suggests that the workbook was, in general, written in 
suitable style for the University students taking part in the study (in parts it 
may even have been a little simplistic in its style). 
10.2.4. Content Of The Intervention: Results Of The Cross-Sectional Study 
The content of the workbook was based on the Self-Regulation Model, 
i.e. it aimed to improve asthmatic control by altering illness representations 
and coping with both the objective features of asthma and the emotional 
reactions it might evoke. Specific ways of doing this were derived from the 
cross-sectional study and are summarised below: 
a. Altering illness representations 
(1) Reduce perceived changeability of asthma. This would be expected to 
increase adherence and decrease Reliever medication use. 
(2) Increase perceived personal responsibility for asthma. This would be 
expected to moderate panic-fear levels. 
(3) Decrease perceived consequences of asthma for sufferers. This would be 
expected to moderate panic-fear levels. 
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b. Altering coping with asthma 
(1) Encourage prophylactic use of Preventer medication, rather than use only 
as a response to poorly controlled asthma. This would also involve reducing 
hyperventilation at times when asthma symptoms are felt, by suggesting ways 
of coping with panic. 
(2) Encourage attendance at regular check-ups by stressing the importance of 
co-management with medical professionals. 
(3) Increase adherence to recommended treatment regimens by 
(a) Changing perceptions regarding medication use and its relation to 
perceived symptoms. 
(b) Providing practical advice on how to remember to take medication. 
(c) Reducing perceived changeability of asthma. 
(4) Encourage individuals to monitor their asthma using Peak Flow Meters 
as an ongoing practice, rather than simply as a response to poor asthmatic 
control, and to use monitoring results as the basis for altering their coping. 
(5) Reduce denial of asthma by providing alternative, approach methods of 
coping. 
c. Keeping panic-fear to an optimal level 
By altering illness representations - see above. 
d. Topics addressed 
The workbook can be seen in Appendix 4. A summary of the topics 
addressed, and the effects they were intended to bring about will be given 
here: 
(1) An introduction to asthma, asthma treatment, asthmatic control and how 
to assess that control. This section was intended to ensure that participants 
had the relevant background knowledge required as a prerequisite to 
behaviour change. It also aimed to alter illness representations in the ways 
described above. Coping by using co-management was also encouraged. 
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(2) Using Preventer medication regularly. This section aimed to encourage 
coping by prophylactic Preventer medication use by explaining why it is 
important and how to remember to do it. 
(3) Monitoring asthma using a Peak Flow Meter and diary. This section 
aimed to encourage coping by Peak Flow monitoring even at times when 
symptoms were not felt, and included a diary and information on how to 
interpret the results. 
(4) Avoiding panic. This section aimed to (a) reduce denial and (b) reduce the 
likelihood of hyperventilation at times when symptoms were felt by offering 
various other methods for coping with asthma. 
(5) Dealing with panic if it does occur. This section offered advice on how to 
cope should hyperventilation occur when symptoms were felt. 
In addition there was a hypothetical "case study" of a patient who 
successfully controlled her asthma, and the difference it made to her life, in 
order to emphasise what can be achieved, and a "summary card" which 
participants could keep in a prominent place to remind them of the central 
points of the workbook. 
10.2.5. Research Questions 
See Chapter 6 for a full list of the research questions. 
10.2.6. Specific Hypotheses 
The data in the results section is organised so as to address the 
following hypotheses in turn: 
(1) The experimental and control groups will be equivalent on all 
demographic/medical variables at baseline. 
(2) The experimental group will show a Significant improvement in 
asthmatic control compared to the control group following intervention. 
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(3) The experimental group will also show changes in illness representations, 
coping and emotional reactions compared to the control group following 
intervention. More specifically, following intervention: 
Illness representations 
(a) Perceived personal responsibility for controlling asthma will 
increase. 
(b) Perceived changeability of asthma will decrease. 
(c) Individuals will see their asthma as more ongoing, rather than 
acute. 
(d) The perceived consequences of suffering from asthma will 
decrease. 
(e) Individuals will perceive their asthma as less distressing and 
puzzling. 
Coping 
Coping with asthma will become more rational and conform more to 
current medical recommendations, including: 
(a) Higher adherence to recommended medication regimen. 
(b) More regular (prophylactic) Preventer medication use and less 
Reliever medication use. 
(c) More contact with medical services. 
(d) More self-monitoring of asthma using Peak Flow Meters. 
Emotional reactions to asthma 
(a) Hyperventilation at times when symptoms are felt will decrease. 
(b) Panic-fear at times when symptoms are felt will be moderated. 
(4) These benefits will remain at three-month follow-up. 
(5) The changes in illness representations, coping, emotional reactions and 
asthmatic control will be correlated, as suggested by the Self-Regulation 
Model. 
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10.3. Method 
10.3.1. Participants 
Participants were required to meet the following criteria: 
(1) Self-reporting asthma. 
(2) Previously diagnosed as suffering from asthma. 
(3) Currently prescribed medication for asthma. 
(4) Student status at the University of St Andrews. 
For two reasons it was anticipated at the planning stage of the study 
that the student sample would not show equal baseline levels of asthmatic 
control as the sample used for the cross-sectional study. Firstly, a student 
sample was selected precisely because it was anticipated that this group would 
show poor asthmatic control. Secondly, unlike the sample used for the cross-
sectional study, who were all recruited through one general practice with a 
particular interest in asthma care, this sample was drawn from more than 
one practice, and would therefore be expected to be more varied in terms of 
asthmatic controL It was hence not possible at the outset of the study to 
perform power analysis (in order to determine the sample sizes required to 
demonstrate the desired improvement in asthmatic control) based on the 
cross-sectional study results. However, see the discussion section of this 
chapter for a post-hoc assessment of the power of this study. 
It was therefore attempted to recruit up to 100 students into the study. 
However, as described in Chapter 8, recruitment proved problematic and was 
stopped at N =50. 
Following initial consent and being issued with the baseline 
questionnaires and monitoring forms, one participant decided that the study 
would take too much time and so returned her baseline questionnaires 
uncompleted. She had already been allocated to the experimental group on 
the basis of the author's initial visit, and this randomisation was left 
unaltered so as not to complicate the rest of the procedure. Hence the final 
sample consisted of 49 participants. 
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Only three other participants dropped out before the end of the study. 
One withdrew from the control group after the one-week follow-up, due to 
(non asthma-related) ill health. A second, from the experimental group, 
went to study abroad after the six-week follow-up. The third completed the 
baseline questionnaires but declined to complete the one-week follow-up and 
simply failed to have completed the two subsequent questionnaires, despite 
several reminders each time. A number of other participants failed to 
complete various individual parts of the study, for several reasons. At all 
time points the data from every participant completing that stage were used 
for analysis, apart from in the repeated measures ANOV A, which can only 
take utilise data from participants completing the entire study. 
10.3.2. Design 
A pre-test post-test randomised controlled design was used in order to 
investigate the effects of the workbook. Data were collected at four time 
points, as shown in Table 10.2. 
It is important to note that not all measures were taken at each time 
point, for both theoretical and practical reasons. For example, it was 
anticipated that while illness representations might be expected to change 
immediately following intervention, any changes in asthmatic control would 
not occur so soon. Hence, all measures were taken at baseline and three-
month follow-up, but not at the one-week and 6-week follow-ups. This 
methodology also reduced the possibility of boredom and/ or repetition effects 
on responses to the questionnaires. See Table 10.2. for a summary of the 
measures taken at each stage of the study. 
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Table 10.2.: Self-Regulation Model components assessed at each stage 
of the study. 
STAGE OF RANGE MEAN MODE MEASURES TAKEN 
STUDY (DAYS) (DAYS) (DAYS) 
1 week pre- 8-13 8.3 7 Illness representations 
intervention Coping 
Asthmatic control 
Emotional reactions 
RANDOMISATION: INTERVENTION GIVEN TO EXPERIMENTAL GRP 
1 week post- 5-14 
intervention 
6 weeks (42 34-49 
days) post-
intervention 
12 weeks (84 78-89 
days) post-
in terven tion 
Note. ExceptlOns. 
7.7 7 Illness representations1 
Workbook assessment 
(expt'l grp only) 
41.8 42 Coping2 
Asthmatic control 
Emotional reactions 
84.4 85 Coping 
Asthmatic control 
Emotional reactions 
1 RepresentatIons of symptoms assessed 6 weeks post 
intervention instead. 
-
2Coping by use of outpatient services not assessed. 
Participants were randomly allocated to an experimental condition 
(n=25) and a control condition (n=25), based on the order in which the initial 
visits were carried out. 
The experimental group received the workbook in addition to their 
standard medical care; the control group received only their standard medical 
care and simply completed the questionnaires and monitoring diaries for the 
study. Aside from the intervention itself, participants in the experimental 
and control groups both underwent exactly the same procedure, with the 
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exception that at the one-week follow-up the experimental group received, in 
addition to the main questionnaires and monitoring diaries, a short 
questionnaire specifically concerning the workbook. 
For the control group, the timings of the follow-ups were calculated 
from the point at which the investigator collected the baseline questionnaire. 
Because of the significant problems encountered in recruiting 
participants to the study (see Chapter 8), it was decided that, although labour-
intensive, the data collection procedure would be modified so that the author 
personally visited participants in order to deliver and collect questionnaires, 
to minimise demands on participants and minimise attrition. At each visit 
the questionnaires/monitoring forms were left with participants for one 
week. This time period was chosen because (a) when monitoring was carried 
out, a week was required to complete the diary, (b) the whole study was based 
on periods of one week and (c) many participants preferred to keep the same 
appointment time each week, for convenience. In practice, it was not always 
possible to deliver and collect the questionnaires at exactly the scheduled 
times, however. The mean number of days for which the questionnaires 
were kept by participants at the one-week follow-up (when no monitoring 
was required) was 7.5 days (range 1-9 days; mode 7 days). The mean length of 
time for which the questionnaires were kept by participants at the two follow-
ups which involved monitoring was 8.7 days (range 7-14 days; mode 8 days). 
10.3.3. Measures 
See Chapter 7 for a comprehensive discussion of the measures used. 
Several amendments were made to the measures used following the cross-
sectional study. The COPE was not used since, although denial had been 
found to be associated with asthmatic control in the cross-sectional study, the 
other 15 scales of the COPE had not shown any significant results and it was 
felt it would simply be too long to include them. Hence the Asthma Coping 
Questionnaire was added as an additional measure of asthma-specific coping. 
This questionnaire included the trait scales focusing on asthma and hiding 
asthma which, together, were thought to encompass the concept of denial in 
a more asthma-specific way. An extra measure of illness representations - the 
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Illness Perceptions Questionnaire - was added and the EQOL was not used to 
assess illness representations as the IPQ contained a scale to assess perceived 
consequences of asthma and the questionnaire was required to be as short as 
possible, since the demands of participation in the study were already high. 
In the following summary, where internal reliabilities of scales in the 
current study are reported, they are taken from baseline data. 
a. Asthmatic Control 
Asthmatic control was assessed using the measure of Amplitude 
Percent Mean, derived from twice-daily Peak Flow readings taken by 
participants for a period of seven days and recorded in a monitoring diary (see 
Chapter 7 and Appendix 1). 
b. Illness Representations 
Three measures were used: 
(i) The Implicit Models of Illness Questionnaire (IMIQ; Turk, Rudy & 
Salovey, 1986) was used. The internal reliabilities of the four scales of this 
questionnaire in the current study were 0.48 (seriousness), 0.71 (personal 
responsibility), 0.12 (controllability) and 0.53 (changeability). Since the 
controllability scale showed particularly poor reliability and had been 
excluded from the cross-sectional study due to a negative reliability, it was 
excluded from the analyses below. 
(ii) The Illness Perceptions Questionnaire (IPQ; Weinman et al., 1995) 
was also administered. The symptoms subscale of this questionnaire was not 
used, but was replaced by four symptoms subscales of the Asthma Symptoms 
Checklist (see below), as recommended by the author. 
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The internal reliabilities of the four IPQ subscales in the current study 
were 0.74 (timeline), 0.37 (control/ cure), 0.44a (consequences), 0.12 (symptom 
quality) and 0.38 (emotional attributions). 
(iii) Four scales of the Asthma Symptoms Checklist (Kinsman, 
Luparello et al., 1973; see Chapter 5) were used in order to elicit individuals' 
representations of the symptoms of their asthma. Participants were asked to 
report how often they had experienced each symptom since the previous 
stage of the study (with the exception of baseline, where general experiences 
were asked about). The internal reliabilities of these scales in the current 
study were 0.85 (airways obstruction), 0.71 (hyperventilation), 0.88 (irritability) 
and 0.91 (fatigue). 
c. Coping 
Coping was assessed using the Asthma Coping Questionnaire (ACQ; 
Schlosser, 1992). The internal reliabilities of the three trait coping scales in 
the current study were 0.35 (maintaining a healthy lifestyle), 0.56 (focusing on 
asthma) and 0.76 (hiding asthma) and for the three state coping scales the 
figures were 0.88 (minimising the seriousness of the attack), 0.78 (rational 
action) and 0.65 (reacting emotionally). 
Two measures of medication use were employed: Reliever and 
Preventer medication use. The total number of puffs of each type of 
medication taken by each participant during the study week was assessed 
from the diaries kept by participants as part of the study. Where a participant 
was prescribed two Preventer medications and used them both during the 
study week, only the first one entered on the form was analysed, for 
simplicity and ease of comparisons between all participants. In addition, 
participants were classified as either "regular" Preventer medication users (i.e. 
taking 14, 28 or 42 puffs during the study week) or "erratic" Preventer 
medication users. 
a Based on N=26 since one item was inadvertently omitted from the questionnaire in the other 
23 cases. Pro-rated values were used for the other analyses in those cases but this analysis is 
based on the original data. 
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Adherence to recommended treatment regimen was assessed using 
three methods: 
(D Self-report. Participants were asked to rate on a five-point Likert-
type scale whether they took their medication as they were recommended to 
by their GP and given the opportunity to justify their answer. This 
methodology followed that used in the cross-sectional study. 
(ii) Those who reported that they did not take their medication 
"exactly as recommended" were then asked to indicate the reasons behind 
this non-adherence using a scale designed by Morisky, Green and Levine 
(1986). The reliability of this scale in the current study was 0.26. Since this 
reliability was not acceptable, it was decided to consider each of the four items 
of the scale as a separate variable; hence there were variables concerning poor 
adherence due to forgetting, carelessness, feeling better and feeling worse after 
medication. 
(iii) The number of puffs of Preventer medication which would be 
expected to be taken in one week if adherence was 100% was calculated from 
self-reported current treatment regimen (this was assessed at baseline, six 
week and 12 weeks post-intervention; where no response was given, it was 
assumed that the regimen had not been altered from that reported in the 
previous part of the study). The actual number of puffs of Preventer 
medication taken during the study week (as reported in the diary) was 
subtracted from this to give an index of adherence (where zero represented 
complete adherence, negative values over-use and positive values under-
use). 
The number of visits to the GP for asthma-related problems was 
chosen as the index of outpatient visits. This was measured retrospectively 
for the previous 12 months at baseline. Since the cross-sectional study had 
revealed significant problems in obtaining retrospective information from 
GPs, this information was obtained from participants' self-reports on the 
General Questionnaire for Asthmatic Patients (GQA; see beloW). Follow-up 
data was obtained from participants at both the six-week and 12-week follow-
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ups (at each time point the number of visits since the previous follow-up was 
reported; the number of visits at each time were combined). 
Use of Peak Flow Meters was assessed by self-report using a yes/no 
question: "Did you monitor your asthma using a Peak Flow Meter and diary 
since the last time I saw you?" (at baseline the question was "do you currently 
use a Peak Flow Meter to monitor your asthma?"). 
d. Emotional Reactions To Asthma 
The panic-fear scale of the Asthma Symptoms Checklist (ASe; 
Kinsman, Luparello et aI., 1973; see Chapter 5) was used to assess panic-fear 
at times when symptoms were felt. The internal reliability of this scale in the 
current study was 0.91. As in the cross-sectional study, the entire checklist 
was administered and the remaining four scales used as measures of the 
symptoms components of the illness representation. 
e. Demographic And Medical Data 
Participants completed the General Questionnaire for Asthmatic 
Patients (GQA; Maes, Schlosser & Vromans, 1984). In addition they were 
asked to state their age, sex, year of study and which general practice they were 
registered with. 
f. Questionnaire concerning workbook (intervention group only) 
One week post-intervention, the experimental group were requested to 
complete an additional short questionnaire, written by the author, concerning 
various aspects of the workbook (see Appendix 4). 
g. Summary Of Measures 
The measures for each variable of interest, along with the source of the 
information, are summarised in Table 10.3. 
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Table 10.3.: Summary of the measures used in the intervention study. 
VARIABLE MEASURES USED SOURCE 
Asthmatic Amplitude Percent Mean Diary 
control 
Illness Implicit Models of Illness 
Representation Questionnaire Questionnaire 
Illness Perceptions 
Questionnaire Questionnaire 
4 Asthma Symptoms 
Checklist scales Questionnaire 
Coping Asthma Coping 
Questionnaire Questionnaire 
Medication use Diary 
Adherence to recommended self-report / questionnaire/ 
medication regimen diary 
Use of medical services self-report 
Peak Flow Meter use self-report 
Emotional Asthma Symptoms Checklist 
reactions panic-fear scale Questionnaire 
Demographic! Age self-report 
medical data Sex self-report 
Year of study self-report 
General practice registered 
with self-report 
Age at 1st sh. of br. self-report 
Previous PFM use self-report 
10.3.4. Procedure 
Ethical approval for the study was obtained from Fife Regional Health 
Board Ethical Committee. 
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A randomisation schedule was prepared, tables of random numbers 
being used to allocate study numbers 1 to 100 to either experimental or 
control group, based on odd or even numbers. Randomisation was carried 
out in blocks of ten as it was not certain at the outset exactly how many 
participants would be recruited to the study. Once this schedule had been 
prepared, it was not referred to by the author until the baseline measures had 
been collected. 
Once potential participants had identified themselves to the author, 
and indicated either verbally or in writing that they were interested in taking 
part in the study and wished further details (see Chapter 8), an initial 
appointment with the author was set up, usually at the participant's horne, 
but occasionally elsewhere (such as the students' union, the library, the 
participant's department or the author's office) if the participant preferred. 
This appointment was arranged by telephone where possible; alternatively, a 
letter was sent with an a suggested appointment time and participants could 
telephone the author to rearrange inconvenient appointments. 
At the initial meeting, a standard procedure was followed. The study 
was explained, with particular emphasis on the voluntary nature of 
participation, the randomisation procedure, exact requirements of the study 
and the fact that each participant's GP would be informed of their 
participation in the study. The initial questionnaire was explained in some 
detail to give participants a good idea of what was expected of them. Each 
participant who did not already possess a Mini-Wright Peak Flow Meter 
identical to the study meters was issued with one for use during the studyb. 
Use of the Peak Flow Meter was demonstrated and attention drawn to the 
manufacturer's instruction booklet included in the box. Participants were 
required to demonstrate their technique and it was corrected and re-
demonstrated where necessary until satisfactory technique was achieved. The 
monitoring diary was explained in some detail, with particular emphasis on 
the importance of taking Peak Flow readings before using Reliever 
medication and recording the best of three readings. In addition, it was 
b The Mini-Wright Peak Flow Meters were kindly donated by Clement Clarke International, to 
whom special thanks must go. The meters were donated to participants following the study, as 
a token of thanks for their participation. 
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stressed that blank spaces should be left in the event of forgetting to complete 
the diary at any time during the week, rather than false or retrospective data 
being reported. 
Arrangements were made for the author to pay a return visit one week 
later. Hence each potential participant was left with the following documents 
for one week: 
(1) Consent form. 
(2) Questionnaire. 
(3) Monitoring form. 
Each patient's GP was sent a letter informing them of their 
participation in the study. 
Participants were allocated a study number based on the order in which 
the initial visits had been carried out. One week later, immediately prior to 
visiting each participant, the author referred to the randomisation schedule 
to determine which group the participant was to join. 
The first part of this visit was standardised and involved the collection 
of the completed forms and an opportunity to ask any questions arising. In 
addition, the monitoring forms were inspected to ensure they had been 
completed correctly and the monitoring instructions clarified if this was not 
the case. Only after this had been carried out were participants informed 
which group they had been allocated to. Those who had been allocated to the 
experimental group were issued with a workbook and requested to study and 
complete it during the following week. Those allocated to the control group 
were told that they would not be receiving a workbook at that time, but 
would receive one on completion of the study. The one-week follow-up visit 
was then arranged with all participants. 
At this visit a second questionnaire was delivered to all participants. 
The experimental group were also offered the opportunity to ask any 
questions about the contents of the workbook, and received the questionnaire 
about the workbook (at no other time during the study were participants in 
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the experimental group offered the opportunity to discuss the workbook). An 
appointment was arranged for the following week to collect the 
questionnaires. 
To avoid arranging meetings too far in advance, participants were 
either sent a letter or telephoned approximately three weeks later, to arrange 
the six-week follow-up. At this meeting a third questionnaire, and a second 
monitoring form were issued and a time arranged the following week for 
their collection. Again, the experimental group received an additional short 
questionnaire concerning their use of the workbook since the last one. 
The procedure for the final follow-up began a further four weeks later 
and was identical to that for the six-week follow-up. Once the questionnaires 
had been collected, participants who had been issued with Peak Flow meters 
were allowed to keep them and those in the control group were issued with a 
workbook. All participants were thanked for their co-operation with the 
study. Once all data were collected, a final thank-you letter was sent to each 
participant. 
Throughout the study, if a participant failed to keep an appointment 
then a message was left informing them that the author had visited and 
suggesting another time within the next day or two. Participants were asked 
to telephone and re-schedule the appointment if it was not suitable. This 
methodology resulted in the majority of the visits being carried out within a 
reasonable period of the intended schedule. However, in some cases, where 
the purpose of the visit was only to collect completed questionnaires, they 
were left with flatmates for collection or mailed back if it proved impossible 
to arrange a meeting within 10 days of the scheduled time. 
10.3.8. Data Preparation and Statistical Analysis Techniques 
Data were entered using the Data Entry programme on SPSS PC, and 
analysed using SPSS on mainframe. All data were initially checked using 
frequency distribution charts and incorrectly entered values were corrected. 
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Items with negative loading onto a particular scale were reverse-coded 
and scale scores calculated. Where less than 50% of the items from a scale 
were missing for an individual participant, they were substituted using pro-
rating based on the completed items for that scale. (In cases where more than 
50% of the items for a scale were missing, they were not pro-rated and the 
scale score was considered missing). 
All dependent variables were examined for normality (within 
experimental groups, where appropriate), initially by visual inspection of 
normal and detrended box plots and then by examination of kurtosis and 
skewness values. The transformation >J-;Z + >J x+ 1 was applied to variables 
where skewness and/or kurtosis were significant, and normality re-checked. 
Where the transformation was found not to improve the distribution of the 
variable towards normality or to alter the results of the analysis, the raw data 
were reverted to. This decision was taken because the ANOVA techniques 
planned are reasonably robust to violations of normality (Maxwell & Delaney, 
1990, p.109) and untransformed results are easier to interpret. Where the 
transformed data were used, untransformed statistics are also reported where 
they are of clinical importance. 
Baseline data for the complete sample were assessed and compared to 
data from the cross-sectional study (or other studies for the variables not used 
in the cross-sectional study) using t-tests, Mann-Whitney V-tests or X2 
analysis, depending on the nature and distribution of the variables involved. 
Where separate variance estimates were used for t-tests, to account for non-
homogeneity of variance between groups, the corrected degrees of freedom 
are reported. Yates' continuity correction was used in cases where the X2 
analysis had only one degree of freedom. 
Differences between the experimental and control groups at baseline 
were also assessed using X2 analyses and t-tests (t-tests were used for all 
continuous variables, regardless of distribution, since MANOVA analyses 
were to be employed and the t-test is robust to violations of such 
assumptions). Where significant differences were found between the two 
groups, baseline levels of the variables were used as covariates in the 
subsequent MANOVA analysis. The underlying assumptions of such 
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analyses were checked: it was assumed that (a) a linear relationship existed 
between the dependent variable and the covariate (since the two variables 
comprised repeated measures of the same construct) and (b) the covariate was 
measured without error. In addition, the slopes of the regression lines in 
each cell were checked for equality using the interaction term of MANOVA 
(Bryman & Cramer, 1990). The adjusted means were calculated by hand (it 
was therefore impossible to calculate variances, but the means are presented 
as an illustration of the effects found). 
The effects of the intervention on the continuous interval variables 
were evaluated using the univariate repeated measures MANOVA 
procedures. Each of the scales of the two illness representation questionnaires 
(IMIQ and IPQ), the coping measures (ACS scales, Reliever and Preventer 
medication use, adherence to Preventer medication regimen as assessed from 
diary), asthmatic control (Amplitude Percent Mean) and emotional reactions 
(ASC panic-fear) were used as dependent variables and the two groups 
(experimental, control) and three times (baseline, one weeki six weeks post-
intervention, 12 weeks post-intervention) as independent variables. Where 
the assumption of sphericity was violated in any analysis, the Greenhouse-
Geisser correction was used in assessing the main time and interaction effects 
and this is reflected in the adjusted degrees of freedom in the reporting of 
statistics. 
Lack of homogeneity of variances, where it existed, was not corrected 
for, since the sample sizes were approximately equal between experimental 
and control groups, and both groups contained more than 5 participants. In 
such cases, violation of homogeneity of variance assumptions has been found 
to have minimal effects (Maxwell & Delaney, 1990, p.IIO). 
Although it is customary to examine and remove outliers and to 
correct for non-homogeneity of variance for MANOVA analyses, this was not 
considered essential in the present study. In the case of medical variables, 
such as Amplitude Percent Mean, outliers are of clinical importance, and 
many of the other variables were scale scores, where a spread of scores is 
desirable. Furthermore, removal of outliers is more important in 
correlational analyses than ANOVA, where it affects results more minimally. 
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Significant main group effects were investigated simply by 
examination of the overall means for the experimental and control groups. 
Any main time or interaction effects emerging were further examined using 
two planned comparisons: 
(1) Baseline vs one weeki six weeks post-intervention. 
(2) One weeki six weeks post-intervention vs 12 weeks post-intervention. 
This made it possible to identify whether any changes observed had 
occurred immediately following the intervention, between follow-ups or 
during both time periods. Since two comparisons were planned, Bonferroni 
adjustments were made to the significance levels, i.e. probabilities of less than 
0.025 were considered significant (Maxwell & Delaney, 1990, p.177). 
No specific statistical methods are available for investigating 
intervention effects on dichotomous variables; in such cases, exploratory 
techniques were used. Time effects were examined within experimental and 
control groups separately using repeated measures Cochran's Q statistics 
(MCNemar tests were used as an alternative for the variable visits to CP, 
where only two time points were available). Repeated measures Friedman's 
X2 analysis was used for the variable panic-fear when it was grouped into 
three categories. In all cases, differences between the two groups were 
examined separately for each time point using X2 statistics. 
For the variable panic-fear, where three groups were used, Friedman's 
X2 test was used to investigate time effects and X2 statistics to examine 
differences between the groups at each time point. 
In order to investigate whether changes in each variable were 
associated in the ways predicted by the Self-Regulation Model, overall change 
scores (from baseline to 12-week follow-up) were calculated. The 
distributions of the resulting variables were checked and the appropriate 
correlations between pairs of variables performed. 
287 
10.4. Results 
1004.1. Baseline Data For The Total Sample 
a. Demographic Characteristics Of Participants 
The final sample comprised 26 males and 23 females aged 
between 18 and 25 (mean age 20.24). 44 were undergraduates and five were 
postgraduates (see Figure 10.1.) and there was a mix of participants from each 
of the three general practices at the St Andrews Health Centre (see Figure 
10.2.). 
Figure 10.1.: Year of study of participants. 
20 
18 
16 
en [-0 
14 Z 
< ~ 12 
-u 
-[-0 10 ~ 
< 8 ~ 
... 
0 6 d 
z 4 
2 
0 
UG 1 UG2 UG3 UG4 PG 1 PG2 PG3 
YEAR OF STUDY 
Note: UC = undergraduate; PC = postgraduate. 
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Figure 10.2.: Number of participants registered with each general 
practice. 
b. Medical Characteristics of Participants 
Figures 10.3. and 10.4. show the distributions of self-reported age at first 
shortness of breath and length of time since first shortness of breath 
(calculated by subtracting length of time since first shortness of breath from 
current age) respectively. 
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Figure 10.3.: Age at first shortness of breath (self-report). 
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The majority of participants reported having suffered from shortness 
of breath since childhood. Only 12 (28% of those for whom data were 
available) had experienced their first shortness of breath during adolescence, 
the maximum age of onset being 19 years. 
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Figure lOA.: Length of time since first shortness of breath. 
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Note: Data unavailable for 6 participants. 
Only 16% of the sample had suffered their first shortness of breath 
within the previous five years, and 7% reported first suffering more than 20 
years ago. The majority (77%) reported first experiencing shortness of breath 
between 6 and 20 years previously. 
In addition to being prescribed Reliever medication, 32 participants 
(65%) were prescribed Preventer medication, three of these (9%) being 
prescribed two such medications. 
c. Baseline Data for Study Variables 
Figures 10.5. to 10.11. summarise the baseline data in the group as a 
whole for asthmatic control, illness representations, coping and emotional 
reactions to asthma. Where possible, data were compared to the results 
obtained in the general population sample of asthma sufferers in the cross-
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sectional study (Chapter 9), but where such data were not available, 
comparisons were made with existing published data. 
Asthmatic control. Figure 10.5. shows the distribution of Amplitude 
Percent Mean (APM) scores found in this sample. It should be noted 
throughout this results section that APM is the inverse of asthmatic control, 
i.e. that a high APM indicates poor asthmatic control and v. versa. 
Figure 10.5.: Distribution of Amplitude Percent Mean scores (baseline). 
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A Mann-Whitney U-test showed that APMs were significantly higher 
in the current sample (mean=21.26; s.d. 14.31) than in the sample used in the 
cross-sectional study (mean=14.70; s.d. 0.28) (U=463, I2.<0.05; variable not 
normally distributed in either sample). A desirable effect would be for the 
mean APM to reduce to the mean levels shown in the cross-sectional study 
sample and the sample studied by Higgins et al. (1989), Le. approximately 13-
15, following intervention. 
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Illness representations. Table 10.4. shows the mean scale scores per 
item for each of the four IMIQ scales and compares them to the data from the 
sample in the cross-sectional study. All variables were normally distributed. 
Table 10.4.: !MIO data compared to cross-sectional study results. 
IMIQSCALE MEAN (S.D.) MEAN (S.D.) T VALUE 
CROSS- CURRENT 
SECTIONAL SAMPLE 
SAMPLE 
Seriousness 4.06 (0.97) 4.32 (0.99) tS2=-1.18 
Personal responsibility 5.50 (1.23) 5.88 (1.37) tS2=-1.29 
Changeabili ty 4.22 (0.78) 6.40 (1.11)1 9 ** tS1=- .77 
Notes: 1 Data missing for one participant. 
*12.<0.05 **12.<0.01 
The student sample believed their asthma to be significantly more 
changeable than the general population sample. No significant differences in 
perceived seriousness or personal responsibility were found between the two 
samples. 
Since no data from asthma sufferers was available for comparison, the 
baseline IPQ scores were compared to data reported by Weinman et al. (1995) 
from a sample of 88 diabetes sufferers (mean age 45.6; 48% female). All four 
variables were normally distributed in the current study and it was assumed 
that since parametric statistics were used in the Weinman et al. study, those 
variables were, too. The results of the analysis are shown in Table 10.5. 
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Table 10.5.: Mean !PO scale scores per item compared to those found in 
a sample of diabetes sufferers (Weinman et al., 1995). 
!PQSCALE MEAN (S.D.) MEAN (S.D.) T VALUE 
WEINMAN ET CURRENT 
AL. SAMPLE SAMPLE 
Timeline 4.24 (0.66) 3.46 (0.68)1 t134=6.47** 
Control! cure 3.55 (0.51) 3.40 (0.54) t135=1.60 
Consequences 3.15 (1.00) 2.40 (0.72) t135=4.59** 
Symptom quality - 2.65 (0.67) -
Emotional attributions - 1.86 (0.80) -
Notes: 1 Data missing for one participant. 
*12.<0.05 **12.<0.01 
The Weinman et aI. paper reported a slightly updated version of the 
IPQ (since it was still under development at the time of planning of this 
study); hence no data for the emotional attributions or symptom quality scales 
were available for comparison. The student asthma sufferers perceived their 
asthma to have less serious consequences and to have a less chronic timeline 
than did the diabetes sufferers. No differences in perceived control/ cure were 
found between the two samples. 
The mean perceived levels of each of the four ASC symptoms at 
baseline are displayed in Table 10.6. and compared to the data from the cross-
sectional study. Only perceived airways obstruction was normally distributed 
in both studies; for the other variables, Mann-Whitney U-tests were used. 
The current sample associated significantly less of each type of 
symptom with their asthma, although in the case of hyperventilation this 
was only a trend. 
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Table 10.6.: Mean scale scores per item for four ASC scales compared to 
data from the cross-sectional study. 
ASC SCALE MEAN (S.D.) MEAN (S.D.) STATISTIC 
CROSS- CURRENT VALUE 
SECTIONAL SAMPLEI 
SAMPLE 
Airways obstruction 3.92 (0.11) 3.57 (0.77) t85=2.67 ** 
Hyperventilation 1.S0 (0.61) 1.63 (0.54) U=6SSa 
Irritability 2.57 (0.17) 2.10 (0.93) U=572.5* 
Fatigue 3.11 (O.lS) 2.32 (1.0S) U=490** 
Notes: 1 Data missing for one participant. 
*}2.<0.05 **}2.<0.01 al2.<0.10 
Coping. Only one previous study (Schlosser, 1992) reports ACQ data: 
baseline data from a pilot study with a sample of 19 non-hospitalised patients 
with confirmed diagnosis of bronchial asthma, FEV1 at least SO% of predicted 
(either with or without using Reliever medication) and high medication 
consumption. This sample comprised nine females and 10 males; the 
experimental group contained 10 participants and the control group nine. 
However, Schlosser only reports baseline data separately for experimental and 
control groups, as part of an Analysis of Covariance results summary. Since 
there was no simple way to combine the results for these two groups, it was 
decided to use the data from the experimental group for comparison, since it 
was the larger group (Schlosser does not report data comparing the means of 
the two groups, but from inspection of the data they do not appear to differ 
greatly). T-tests were performed in order to investigate whether the two 
samples differed on any of the scale scores (non-parametric statistics were not 
suitable since only summary statistics were available for the Schlosser 
sample). The results are summarised in Table 10.7. 
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Table 10.7.: Mean scale scores per item for the six ACQ scales compared 
to data from Schlosser (1992). 
SCALE/SUBSCALE MEAN (S.D.) MEAN (S.D.) T VALUE 
SCHLOSSER CURRENT 
SAMPLE 
ACT 
Maintaining a healthy lifestyle 18.60 (2.88) 24.73 (3.75) tS7=-4.79 ** 
Focusing on asthma 16.50 (3.17) 21.28 (3.99) tS7=-3.50 ** 
Hiding asthma 10.10 (1.73) 22.06 (5.27) tS7=-6.98 ** 
ACS1 
Minimising seriousness of attack 41.56 (7.63) 36.47 (9.65) tS6=1.54 
Reacting emotionally 13.10 (1.97) 14.65 (3.25) tS6=-1.57 
Rational action 22.60 (6.47) 32.36 (5.94) tS6=-4.58 ** 
Note: lData missing for one participant. 
** ~ < 0.01 
The current sample showed significantly higher levels of all three trait 
coping strategies and of the state coping strategy rational action, but there 
were no differences between the two groups in coping by reacting emotionally 
or maintaining a healthy lifestyle. 
Figure 10.6. shows the distribution of the number of puffs of Reliever 
and Preventer medication taken during the study week. 
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Figure 10.6.: Distribution of coping by Reliever and Preventer 
medication use over a seven-day period (baseline). 
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Note: Data on Preventer medication use missing for three participants. 
The mean number of reported puffs of Reliever medication over the 
course of the study week was nine (s.d. 11.4). This was not significantly 
different from the number of puffs of Reliever medication taken by the 
sample in the cross-sectional study (Mann-Whitney U=513.5, ns) and 
represented an average of less than the recommended upper limit of two 
puffs per participant per day. Eight participants did not report using Reliever 
medication at all during the study week. The maximum number of puffs 
reported was 48, i.e. an average of almost nine puffs per day. 
The mean (s.d.) number of puffs of Preventer medication used during 
the seven day period was 11 (13.8). This did not differ significantly from the 
number of puffs of Preventer medication taken by the sample in the cross-
sectional study (Mann-Whitney U=641, ns). 20 participants reported using no 
Preventer medication at all during the baseline study week. However, it 
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should be borne in mind that 17 participants were not prescribed Preventer 
medication at the start of the study; hence only 3 participants did not use any 
Preventer medication when it had been recommended to by their GP. The 
majority of participants reported having taken 8-14 puffs or 22-28 puffs of 
Preventer medication during the study week. Much smaller numbers had 
taken between 1 and 7 puffs or 15-21 puffs. Two patients reported having 
used 50-55 puffs of Preventer medication over the course of the week. 
Of the participants who were prescribed Preventer medication and for 
whom data were available, six were classed as 'regular' and 27 as 'erratic' 
Preventer medication users. Regular Preventer medication use was 
significantly lower in the current sample than in the cross-sectional study 
sample (18% compared to 71 %; X21=13.15, 12<0.01). 
Adherence data are displayed in Figures 10.7. and 10.8. 
Figure 10.7.: Coping by self-reported adherence (baseline). 
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Note: Exactly/nearly/partly = 'exactly/nearly/partly as recommended'; Not = 'not 
at all as recommended'; Don't = '1 don't take it at all'. 
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13 participants (27%) reported following their GP's recommendations 
regarding medication exactly. One reported not taking the medication at all as 
recommended and two stated that they did not take it at all. The majority 
(43%) reported taking their medication "nearly as prescribed". When the data 
were collapsed into two categories ("exactly" vs the other four responses), X2 
analysis revealed that the current sample reported significantly less complete 
adherence than did the sample in the cross-sectional study (27% compared to 
60%; X21=8.15, 12.<0.01). 
Participants completed the Morisky, Green and Levine scale only if 
they had self-reported that they did not always follow their treatment exactly 
as recommended; it was therefore assumed that the 13 participants who did 
not complete the scale would have scored zero (complete adherence) for each 
item. Morisky et al. do not provide data for each item individually so it was 
not possible to compare the two samples. The total number of participants 
reporting non-adherence for each of the four reasons is shown in Figure 10.8. 
Figure 10.8.: Reasons for non-adherence at baseline (Morisky, Green & 
Levine scale). 
FORGETIING 
CARELFSSNFSS 
FEELING BETIER 
FEELING WORSE 
o 5 10 15 20 25 30 35 40 45 50 
NO. OF PARTICIPANTS 
fiYEsl 
~ 
299 
The most common reason given for non-adherence was forgetting 
(59% of participants reporting non-adherence for this reason), followed 
closely by feeling better (55%) and carelessness (51 %). Feeling worse following 
medication was reported as a reason for non-adherence in only a small 
proportion of cases (16%). 
Assessment of adherence to recommended Preventer treatment 
regimen required information on how much Preventer medication was 
prescribed for each participant. The number of puffs prescribed per week at 
baseline (from self-report) are shown in Figure 10.9. (note that where more 
than one Preventer medication was prescribed, the first one listed was used 
for the purposes of this calculation). 
Figure 10.9.: Distribution of the number of puffs of Preventer 
medication prescribed per week at baseline. 
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300 
The number of puffs of Preventer medication prescribed in the current 
sample did not differ significantly from that found in the cross-sectional study 
sample (Mann-Whitney U=748, ns). 
Figure 10.10. shows adherence to recommended Preventer medication 
regimen as assessed by subtracting the number of puffs taken during the study 
week from the number prescribed. 
Figure 10.10.: Coping by adherence to recommended Preventer 
medication regimen as assessed by actual Preventer medication use compared 
to expected Preventer medication use over a seven-day period (baseline). 
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17 participants took their Preventer medication exactly as prescribed 
during the study week, and it is interesting to note that these were not simply 
the ones who were prescribed no Preventer medication, and hence took none. 
Five took more than prescribed (by up to 55 puffs) and 23 less than prescribed 
(by up to 54 puffs). This variable was not normally distributed and levels of 
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adherence did not differ significantly from those found in the cross-sectional 
study sample (Mann-Whitney U=523, ns). Although in the cross-sectional 
study participants were coded as either 'fully adherent' or 'not fully adherent' 
by this measure, since MANOV A analysis was to be performed, such recoding 
was not carried out for the purposes of the current study. 
The distribution of number of visits to GP in the 12 months previous 
to the baseline assessment is shown in Figure 10.11. 
Figure 10.11.: Number of visits to GP in previous 12 months (baseline). 
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At baseline, 36 individuals reported having visited their GP at least 
once during the previous 12 months and 11 reported no visits. This figure 
could not be compared to data from the cross-sectional study since the 
variable was operationalised by GP visits only (not including other outpatient 
visits as it did in the cross-sectional study). 
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48 participants (98%) knew what a Peak Flow Meter was, 38 (78%) had 
used one at some time and 23 (47%) owned their own meter (or one on loan 
from the health centre). Nine participants (18%) reported that they currently 
used a Peak Flow Meter to monitor their asthma and 40 (82%) that they did 
not. X2 analysis showed that the proportion of current PFM users was 
significantly lower than that in the cross-sectional study sample (18% 
compared to 46%; X21=6.05, J;!<0.05). 
Emotional reactions to asthma. The mean panic-fear score in the 
current sample was 1.96 (s.d. 0.14). A Mann-Whitney V-test revealed no 
difference between levels of panic-fear in this sample and the sample in the 
cross-sectional study (V=714.5, ns). Participants were classified into low, 
moderate and high panic-fear categories using the same numerical cut-offs as 
had been used in the cross-sectional sample (since panic-fear, when grouped 
in this way, had been found to be associated with APM and coping). A 
significantly higher proportion of the current sample were found to show 
moderate levels of panic-fear than the cross-sectional study sample (X22=8.3l, 
~<0.05; see Table 10.8.). 
Table 10.8.: Number of participants falling into low, moderate and 
high panic-fear categories compared to the cross-sectional study sample. 
PANIC-FEAR % CROSS-SECTIONAL % CURRENT SAMPLE 
CATEGORY STUDY SAMPLE 
Low 36 21 
Moderate 36 69 
High 29 10 
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10.4.2. Comparison Of Baseline Status Of Experimental And Control Groups: 
Randomisation Checks 
a. Demographic and medical variables 
See Table 10.9. for a comparison of these variables between 
experimental and control groups. Year of study was categorised into those 
recently having arrived at university (1st and 2nd year undergraduates) and 
others. Individuals were classified as either being prescribed Preventer 
medication or not. Standard deviations are in parentheses. 
Table 10.9.: Demographic and medical variables (baseline). 
VARIABLE EXPT'L 
GRP 
DEMOGRAPHIC VARIABLES: 
Mean age 20.0 (1.47) 
Sex (m:f) 13:11 
GP practicel 7:5:8 
Year of study (1/2:other) 12:12 
MEDICAL VARIABLES: 
Mean age at 1st s.o.b. 8.52 (6.32) 
Mean time since 1 st s.o.b. 11.48 (6.72) 
Previous PFM use (yes:no) 19:5 
Prescribed Preventer? (yes:no) 13:11 
Notes: 1 Data missing for six participants. 
s.o.b.=shortness of breath. 
*~<O.05 
CONTROL STATISTIC 
GRP 
20.5 (2.02) 47=-0.95 
13:12 X21=0.08 
8:5:10 X22=1.46 
15:10 X21=3.1 
7.60 (5.09) 41=0.52 
13.20 (4.97) 41=-0.94 
19:6 X2 l =0.006 
19:6 X21=6.06* 
The only significant difference found was that the experimental group 
contained a significantly lower proportion of individuals who were 
prescribed Preventer medication. 
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b. Study variables 
The results of tests for differences in baseline levels of continuous 
study variables are summarised in Table 10.10. and of dichotomous variables 
in Table 10.11. The illness representation component symptom quality (IPQ) 
and the coping variable maintaining a healthy lifestyle (ACQ) - were found to 
differ significantly between the two groups at baseline. Therefore baseline 
levels of these two variables were used as covariates in the subsequent 
MANOV A analyses. In addition, a lower proportion of the experimental 
group reported current use of a PFM to monitor their asthma (12% compared 
to 25%). When participants were classified into low, moderate and high 
groups, based on panic-fear scores, no significant differences were found 
between the experimental and control groups (4:17:2 versus 6:16:3; X22=0.55, 
ns). 
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Table 10.10.: Results of t-tests between experimental and control groups 
for continuous variables (baseline). 
VARIABLE MEAN (S.D.) MEAN (S.D.) T VALUE 
EXPT'L GRP CONT. GRP 
APM 19.90 (13.00) 22.69 (15.72) 47=-0.68 
IMIQ 
Seriousness 4.52 (1.03) 4.12 (0.94) 47=1.45 
Personal responsibility 5.66 (1.38) 6.11 (1.34) 47=-1.15 
Changeability 3.13 (1.65) 3.14 (1.78) 46=-0.02 
ll'Q 
Timeline 3.34 (0.75) 3.58 (0.59) 46=-1.21 
Control! cure 3.35 (0.48) 3.43 (0.60) 47=-0.51 
Consequences 2.25 (0.68) 2.54 (0.74) 47=-1.44 
Symptom quality 2.89 (0.55) 2.41 (0.70) 47=2.63* 
Emotional attributions 1.96 (0.74) 1.76 (0.86) 47=0.87 
ASC 
Airways obstruction 3.64 (0.78) 3.50 (0.76) 46=0.64 
Hyperventilation 1.63 (0.48) 1.64 (0.60) 46=-0.08 
Irritability 2.10 (0.68) 2.08 (1.13) t39.94=0.11 
Fatigue 2.46 (0.94) 2.20 (1.20) 46=0.82 
ACQ 
Maintaining a healthy lifestyle 2.60 (0.38) 2.35 (0.34) 46=2.44* 
Focusing on asthma 2.09 (0.42) 2.16 (0.39) 46=-0.59 
Hiding asthma 2.25 (0.45) 2.16 (0.60) 46=0.59 
Minimising seriousness of attack 2.24 (0.51) 2.06 (0.62) 45=1.10 
Reacting emotionally 1.45 (0.21) 1.48 (0.41) t34.49=-0.30 
Rational action 2.76 (0.51) 2.64 (0.48) 45=0.86 
Preventer medication use 13.39 (13.74) 8.87 (13.72) 44=1.12 
Reliever medication use 11.28 (13.56) 7.33 (8.31) 40.06=1.23 
Adherence (diary) 5.73 (17.35) 9.23 (17.68) 43=-0.67 
ASC 
Panic-fear 1.85 (0.68) 1.62 (0.66) 46=1.15 
... Notes: Pers. resp.=Personal responsIbIhty; Em. attnbutlOns=Emotional attnbutIons; 
Airw. obstruction=Airways obstruction; Reacting em.=Reacting emotionally. 
"12.<0.05 
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Table 10.11: Results of Xknalyses between experimental and control 
groups for dichotomous variables (baseline). 
VARIABLE % YES % YES X2 
EXPT'L GRP CONTROL 
GRP 
Regular Preventer med. use 21 21 X21=0.00 
Adherence (self-report) 29 24 X21=0.01 
Morisky, Green & Levine scale 
Forgetting 54 64 X21=0.17 
Carelessness 42 60 X21 =1.00 
Feeling better 46 64 X21=0.98 
Feeling worse 17 16 X21=0.OO 
Visited GP 30 46 X21=0.61 
Current PPM use 12 25 X21=6.58* 
10.4.4. Use of the workbook by the experimental group 
22 participants from the experimental group returned a questionnaire 
concerning their use of and opinions of the workbook at the one-week 
follow-up. Of these, eight had read the workbook completely and 14 partly 
(the workbook was designed so that the sections considered most relevant 
could be selected by the individual). It took between 30 minutes and three 
hours to complete (mode: 90 minutes). 
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10.4.3. Intervention Effects 
Exact summary statistics for all MANOV A analyses (including those 
which showed no significant effects) are displayed in Appendix 4; only the 
significant results are presented in detail below. 
a. Asthmatic Control 
Figure 10.12. shows the mean levels of APM in each group at each of 
the three time points. 
Figure 10.12.: Changes in Amplitude Percent Mean over the course of 
the study. 
30 
Z 28 --0- EXPERIMENT L GROUP CN=19) < w 
-ts:- CONTROLG UPCN=22) :::E 26 
E-o 
Z 24 w 
U 
~ 22 w 
c.. 
w 20 
0 
;:J 18 E-o 
-...J 16 c.. 
:::E 
< 14 
Z 
< 12 w 
:::E 10 
BASELINE INT.+6 WKS INT.+12 WKS 
TIME 
The data violated assumptions of normality and so were transformed. 
The transformation did not improve the distribution or alter the results, 
however, so the raw data were used. A significant time effect was found 
(F1.61,78=12.51, 12.<0.01) with APM decreasing over the course of the study. 
This effect occurred between baseline and six week follow-up (t4o=3.30, 
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12.<0.025) and not between follow-ups (t40=-1.41, ns). No significant effects of 
group (F1.39=1.04, ns) or interaction (F1.61,78=3.03, ns) were found. 
c. Illness representations 
No significant effects were found for the IMIQ variables perceived 
seriousness and perceived changeability. Figure 10.13. shows the results for 
perceived personal responsibility. 
Figure 10.13.: Changes in perceived personal responsibility (IMIQ) over 
the course of the study. 
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A significant group effect was found (Fl,41 =4.24, 12.<0.05), the control 
group reporting higher levels of perceived personal responsibility for their 
asthma (mean=5.95) than the experimental group (mean=5.31). A significant 
time effect was also found (F2,82=6.22, 12.<0.01) with perceived personal 
responsibility decreasing between baseline and one week follow-up (t42=3.06, 
12.<0.025) but not between follow-ups (t42=-0.74, ns). No significant interaction 
was found (F2 82=1.40, ns). , 
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No significant effects were seen for the IPQ variables timeline, 
control! cure, consequences or emotional attributions. Figure 10.14. shows the 
results for perceived symptom quality. 
Figure 10.14.: Changes in perceived symptom quality (IPQ) over the 
course of the study. 
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There was a significant group/time interaction (F2,82=3.78, p'<O.05). 
This effect was seen between baseline and one-week follow-up (t41 =-3.25, 
p'<0.025), where the experimental group scores decreased while the control 
group scores increased, but not between follow-ups (t41 =-1.22, ns). No 
significant main effects were observed for either group (Fl,41 =0.59, ns) or time 
(F2 82=0.39, ns). , 
Since the experimental group had shown significantly higher levels of 
perceived symptom quality at baseline, Analysis of Covariance was performed 
with baseline scores entered as covariates. The slopes were equal between 
cells (Fl,39=0.71, ns) and hence the assumptions for this analysis were met. 
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See Figure 10.15. for the adjusted means. A significant group effect was found 
(Fl,40=31.18, 12-<0.01) with the control group scoring higher than the 
experimental group. There were no significant effects of either time 
(Fl,41 =0.02, ns) or interaction (Fl,41 =1.49, ns). 
Figure 10.15.: Adjusted means for the Analysis of Covariance on IPQ 
symptom quality scores. 
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No significant effects were seen for the ASC variables hyperventilation, 
irritability or fatigue. The results for perceived airways obstruction are shown 
in Figure 10.16. 
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Figure 10.16.: Changes in perceived airways obstruction CASC) over the 
course of the study. 
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There were no significant group (Fl,3S==0.20, ns) or interaction 
(F2,76==2.54, ns) effects. However the time effect was significant (F2,76==6.59, 
12.<0.01), perceived airways obstruction decreasing between baseline and six-
week follow-up (t39==3.57, p'<0.025) but not between follow-ups (t39==-0.45, ns). 
e. Coping 
All three ACQ 'trait' coping scales showed significant results; these are 
displayed in Figures 10.17. to 10.20. 
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Figure 10.17.: Changes in coping by maintaining a healthy lifestyle 
(ACQ 'trait' scale) over the course of the study. 
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There was a significant difference between the two groups (Fl,39=11.38, 
ll.<O.Ol), the experimental group scoring higher overall (mean=2.61) than the 
control group (mean=2.31). There were no significant effects of time 
(Fl.53,78=0.20, ns) or interaction (F1.53,78=0.55, ns). 
Since the experimental group had shown significantly higher levels of 
perceived symptom quality at baseline, Analysis of Covariance was performed 
with baseline scores entered as covariates. The slopes were equal between 
cells (Fl,37=0.22, ns) and hence the assumptions for this analysis were met. 
See Figure 10.18. for adjusted means. The group effect was no longer 
significant (Fl,38=3.64, ns) and the interaction was non-significant (Fl,39=0.00, 
ns). A significant main effect for time was found, however (Fl,39=6.84, 
ll.<0.05), coping by maintaining a healthy lifestyle increasing between six and 
12-weeks post-intervention. 
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Figure 10.lS.: Adjusted means for the Analysis of Covariance on the 
ACQ 'trait' scale maintaining a healthy lifestyle. 
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Figure 10.19.: Changes in coping by focusing on asthma (ACQ 'trait' 
scale) over the course of the study. 
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No significant group effect was found (Fl,39=1.05, ns) and the 
interaction was also non-significant (F1.71,7S=2.40, ns). The main time effect 
was, however, significant (Fl.71,7S=7.96, 12.<0.01), coping by focusing on asthma 
decreasing between baseline and six-week follow-up (t40=4.35, 12.<0.025) and 
also between follow-ups (40=4.38,12.<0.025). 
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Figure 10.20.: Changes in coping by hiding asthma (ACQ 'trait' scale) 
over the course of the study. 
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This variable was not normally distributed, but transformation did not 
improve the distribution or alter the results, so the raw data were analysed. 
No significant group effect (Fl,37=0.00, ns) or interaction (F2,74=1.07, ns) were 
found. There was a significant time effect, however (F2,74=4.03, ~<0.05), 
coping by hiding asthma decreasing between baseline and six-week follow-up 
(t38=2.54, ~<0.025) and also between follow-ups (t38=2.60, p'<0.025). 
No significant effects were found for the ACQ 'state' scale minimising 
the seriousness of the attack. The results for coping by rational action and 
reacting emotionally are shown in Figure 10.21. and 10.22. respectively. 
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Figure 10.21.: Changes in coping by rational action (ACQ 'state' scale) 
over the course of the study. 
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This variable was not normally distributed, but raw data were used as 
transformation did not improve the distribution or alter the results. A main 
group effect was found (Fl,37=11.28, 12.<0.01), the overall mean being higher for 
the experimental group (mean=2.45) than for the control group (mean=2.38). 
No significant effects were found for either time (F1.66,74=2.59, ns) or 
interaction (F1.66,74=1.38, ns). 
317 
Figure 10.22.: Changes in coping by reacting emotionally (ACQ 'state' 
scale) over the course of the study. 
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This variable was not normally distributed. Transformation did not 
improve its distribution or alter the results, however, so the original data 
were employed in the analysis. There were no significant effects for either 
group (Fl,37=0.22, ns) or interaction (F2,74=2.46, ns). However a significant 
time effect was observed (F2,74=7.51, }2.<0.01), coping by reacting emotionally 
decreasing between baseline and six-week follow-up (t38=2.97, }2.<0.025) and 
also between follow-ups (t3S=3.90, }2.<0.025). 
Significant effects were found for coping by both Reliever and 
Preventer medication use. For both variables, transformation corrected the 
initial violations of normality assumptions and therefore the transformed 
data were analysed. The results are shown in Figures 10.23. and 10.24. 
respectively. 
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Figure 10.23.: Changes in coping by Reliever medication use 
(transformed) over the course of the study. 
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No significant effects were seen for either group (F1,38=0.36, ns) or 
interaction (F2,76=0.12, ns). However, the time effect was significant 
(F2,76=8.18, J2.<0.01), coping by Reliever medication use decreasing between 
baseline and six-week follow-up (t39=2.86, J2.<0.025) but remaining constant 
between follow-ups (t39=-0.80, ns). The untransformed mean (s.d.) number of 
puffs of Reliever medication taken in one week at the 12-week follow-up 
were 6.32 (8.69) for the experimental group, 4.00 (4.52) for the control group 
and 5.28 (7.14) for the sample as a whole. 
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Figure 10.24.: Changes in coping by Preventer medication use 
(transformed) over the course of the study. 
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There was no significant difference between groups (Fl,37=0.68, ns). A 
significant time effect was found, however (F2,74=7.96, 12.<0.01), coping by 
Preventer medication use remaining constant between baseline and six-week 
follow-up (t3S=-1.29, ns) but increasing between follow-ups (t3S=2.60, p'<0.025). 
Furthermore, there was a significant group/time interaction (F2,74=3.61, 
12-<0.05) which showed the same pattern as the time effect, no change 
occurring between baseline and six-week follow-up (t3S=-0.14, ns), but the 
experimental group showing a trend towards a greater increase in Preventer 
medication use than the control group between follow-ups (t3S=-0.32, 
12.=0.026). The untransformed data are presented in Figure 10.25., since they 
are of clinical importance. 
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Figure 10.25.: Changes in coping by Preventer medication use 
(untransformed) over the course of the study. 
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Regular Preventer medication use was found not to change 
significantly over the course of the study in either the experimental group 
(Q2=3.20, ns) or the control group (Q2=0.60, ns). The proportion of 
participants using Preventer medication regularly did not differ between 
groups at either the six-week follow-up (23% vs 26%; X21 =0.00, ns) or the 12-
week follow-up (50% vs 32%; X21 =0.71, ns). 
Self-reported adherence did not change significantly over the course of 
the study in either the experimental group (Q2=1.40, ns) or the control group 
(Q2=0.33, ns). The proportion of participants reporting total adherence using 
this measure did not differ between groups at either the six-week follow-up 
(48% vs 25%; X21 =1.61, ns) or the 12-week follow-up (33% vs 22%; X21 =0.27, 
ns). 
Non-adherence reported on the Morisky, Green and Levine scale item 
forgetting did not change significantly over the course of the study in either 
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the experimental group (Q2=3.71, ns) or the control group (Q2=2.33, ns). The 
proportion of participants reporting non-adherence for this reason did not 
differ between groups at either the six-week follow-up (29% vs 56%; X21=2.59, 
ns) or the 12-week follow-up (50% vs 64%; X21 =0.49, ns). Non-adherence due 
to carelessness did not change significantly over the course of the study in 
either the experimental group (Q2=0.86, ns) or the control group (Q2=0.25, ns). 
The proportion of participants reporting non-adherence for this reason did 
not differ between groups at the six-week follow-up (29% vs 48%; X21=1.12, 
ns) but there was a trend for the experimental group to report less non-
adherence due to carelessness at the 12-week follow-up (25% vs 56%; 
X21 =3.67, 12-=0.055). Non-adherence due to feeling better did not change 
significantly over the course of the study in either the experimental group 
(Q2=1.75, ns) or the control group (Q2=2.80, ns). There was a trend for the 
experimental group to report less non-adherence due to feeling better at the 
six-week follow-up (21% vs 48%; X21 =2.88, 12.<0.10) but the proportion of 
participants reporting non-adherence due to feeling better did not differ 
between groups at the 12-week follow-up (42% vs 40%; X21 =0.00, ns). Non-
adherence due to feeling worse following medication decreased significantly 
over the course of the study in the experimental group (Q2=9.57, 12.<0.01) but 
not in the control group (Q2=1.60, ns). Due to an empty cell, it was not 
possible to test for differences in the groups at the six-week follow-up (no 
participants in the experimental group reported non-adherence for this 
reason). However, the proportion of participants reporting non-adherence 
due to feeling worse following medication did not differ significantly between 
the two groups at the 12-week follow-up (8% vs 4%; X21=0.001, ns). 
Three participants reported having changed the type of Preventer 
medication they used during the course of the study, but not the number of 
puffs prescribed. A further eight (four from the experimental group and four 
from the control group) reported having changed the number of puffs of 
Preventer in their prescribed Preventer regimen; this was taken into account 
when assessing adherence from Preventer medication use recorded in the 
diaries. Although the variable was not normally distributed in the sample as 
a whole, it was normally distributed within the groups. No significant effects 
on this variable were seen, using MANOVA analysis. 
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The number of visits to the GP was assessed at baseline, six-week 
follow-up and 12-week follow-up. At each follow-up the number of visits 
since the previous follow-up were reported; hence the number of visits made 
in the 12 weeks following intervention were calculated by adding these two 
figures. A crude assessment of how many individuals would have visited 
their GP in the 12 months following intervention was derived by 
multiplying this figure by four. However this method meant that repeated 
measures analysis was not suitable and so X 2 analysis was used for this 
variable. The proportion of participants who had visited their GP did not 
differ between the two groups at follow-up (53% vs 48%; X21 =0.01, ns). 
The proportion of participants reporting using a Peak Flow Meter to 
monitor their asthma at each stage of the study are shown in Table 10.12. 
Table 10.12.: Changes in coping by Peak Flow Meter use over the course 
of the study. 
TIME % OF P ARTICIP ANTS USING PFM 
EXPT'L GROUP CONTROL GROUP 
Baseline 12 25 
6-week follow-up 23 30 
12-week follow-up 36 26 
Peak Flow Meter use did not change significantly over the course of the 
study in the control group (Q2=0.15, ns) but there was a trend towards an 
increase in use in the experimental group CQ2=5.60, 12.=0.06). The proportion 
of participants using a Peak Flow Meter to monitor their asthma did not differ 
between groups at either the six-week follow-up (X21 =0.06, ns) or the 12-week 
follow-up (X21 =0.18, ns). It should be noted that significantly fewer of the 
experimental group had reported using a Peak Flow Meter at baseline. 
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e. Emotional reactions to asthma 
Figure 10.26. shows the levels of panic-fear in each study group over 
the course of the study. 
Figure 10.26.: Changes in panic-fear over the course of the study. 
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The assumptions of normality were not met and the data were 
transformed. This did not improve the distribution or alter the results and 
therefore the analysis was performed on the raw data. No significant group 
effect (Fl,39=3.35, ns) or interaction (F1.60,7S=1.15, ns) was found. The time 
effect was significant, however (F1.60,78=4.69, 12.<0.05), panic-fear decreasing 
between baseline and six-week follow-up (t=3.99, 12.<0.025) but not between 
follow-ups (t=1.97, ns). 
When panic-fear was categorised as either low, moderate or high, no 
significant change was seen over the course of the study for the experimental 
group (Friedman's X22=1.58, ns) or the control group (Friedman's X22=4.98, 
ns). There were no significant differences in the proportion of participants 
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falling into each category at either the six-week follow-up (X22=0.43, ns) or 12-
week follow-up (X22=3.85, ns). See Table 10.13. for a summary of panic-fear 
levels throughout the study. 
Table 10.13.: Percentage of participants showing low, moderate and 
high levels of panic-fear over the course of the study. 
TIME PANIC- % EXPT'L % CONTROL 
FEAR GROUP GROUP 
GROUP 
Low 14 6 
Baseline Moderate 7 16 
High 2 3 
Low 9 14 
Six-week follow-up Moderate 12 10 
High 0 0 
Low 6 12 
12-week follow-up Moderate 12 11 
High 2 0 
10.4.4. Associations between changes in illness representations, coping, 
emotional reactions and asthmatic control 
Change scores between baseline and 12-week follow-up were calculated 
for each variable which had shown any significant effects (this time period 
was valid since all changes occurring remained at 12 weeks). For the 
dichotomous variable Peak Flow Meter, participants were classed as either 
having begun to use a Peak Flow Meter over the course of the study, having 
not used one at baseline, (coded 1) or not (coded 0) and Pearson's r was used as 
the equivalent to point biserial correlation between this variable and the 
other, continuous variables (see Howell, 1989). The results are displayed in 
Table 10.14.: Correlations between changes in illness representations, coping, emotional reactions and asthmatic 
control over the course of the study. 
VARIABLE PERS. SYMP. AIRW. MAINT. FOCUS. HIDING RAT. REACT. REL. PREVo PPM PANIC-
RESP. QUAL. OBSTR. ACT. EM. USE USE USE FEAR 
APM 0.24a -0.08 -0.10 0.21 -0.06 0.31* 0.23a -0.21 0.19 0.17 0.31 0.12 
PERSONAL RESP. 0.02 -0.21 0.08 -0.08 0.06 -0.34** -0.03 0.16 0.20 -0.12 -0.29* 
SYMPTOM QUALITY 0.20 -0.06 0.01 0.42** -0.04 0.18 0.004 0.09 0.06 0.14 
AIRWAYS OBSTR. -0.11 -0.06 0.19 0.14 0.21 0.05 -0.14 -0.03 0.21a 
MAINTAINING ... 0.23 -0.09 0.16 0.18 0.13 0.02 0.24 0.07 (;J 
FOCUSING ... 0.08 0.65** 0.34** -0.16 0.12 0.33* 0.34* ~ 
HIDING ASTHMA 0.34* 0.07 -0.27a 0.03 0.02 0.24a 
RATIONAL ACTION 0.04 -0.36* 0.24a 0.13 0.21a 
REACTING EM. 0.21 0.18 0.59** 0.38** 
RELIEVER USE 0.05 0.11 0.05 
PRE VENTER USE 0.21 0.12 
PFMUSE 0.3Sa 
Notes: plain text=Pearson's r bold=Spearman's r italic=Phi 
*12<0.05 **12<0.01 a12<O.lO 
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Table 10.14. (variables are grouped into illness representations, coping and 
emotional reactions for clarity). 
There were two significant relationships between changes in coping 
and the change in asthmatic control: coping by hiding asthma and rational 
action both decreased as APM decreased, although the latter relationship was 
only a trend. In addition perceived personal responsibility decreased as APM 
decreased. There were also two significant relationships between changes in 
illness representations and changes in coping: perceived symptom quality 
decreased as coping by hiding asthma decreased, while perceived personal 
responsibility decreased as coping by rational action increased. Reduction in 
panic-fear occurred in conjunction with changes in the illness representation 
components perceived personal responsibility (increase) and airways 
obstruction (decrease) and decreased coping by focusing on asthma, hiding 
asthma and rational action. Illness representation components changed 
independently of each other, while there were significant correlations 
between changes in different coping strategies (each one being significantly 
correlated with at least one other). 
A summary of the significant correlations between changes in illness 
representations, coping, emotional reactions and asthmatic control can be 
seen in Figure 10.27. 
10.5. Discussion 
10.5.1. Summary Of Results 
a. The student sample 
A mixture of student asthma sufferers from each of the three general 
practices was included in the study, as desired. Compared to the sample used 
in the cross-sectional study (who showed acceptable levels of asthmatic 
control compared to a previously published study), this sample of students 
showed poor initial levels of asthmatic control, as had been predicted. 
Despite this, they perceived less airways obstruction and used similar levels of 
both Reliever and Preventer medication to the previous sample. In addition, 
Figure 10.27: Summary of significant correlations between changes in variables. 
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the student sample were less likely to use Pre venter medication regularly and 
reported lower adherence (by both self-report and from diary information) 
and less Peak Flow monitoring. These findings confirmed the hypothesis 
that students were, in general, not perceiving their asthmatic control 
accurately, not coping optimally and hence failing to control their asthma 
satisfactorily. The attempt to intervene in this sample was therefore justified. 
b. Study results 
The randomisation procedure was, on the whole, effective, leaving 
significant differences between the experimental and control groups on only 
four variables. 
Any effects brought about by the workbook would be expected to be 
reflected in significant interactions in the MANOVA analyses, with the 
experimental group showing more beneficial changes following intervention 
than the control group. A summary of the significant MANOV A results 
(with covariates where relevant) is shown in Table 10.15. 
In addition, non-parametric analyses showed that although the 
experimental group were initially less likely to use Peak Flow Meters to 
monitor their asthma, by the six-week follow-up their use had increased in 
this group and remained constant in the control group. There was no ceiling 
effect in the control group which prevented an increase: only 25% of this 
group reported carrying out Peak Flow monitoring at baseline. Even at 12 
weeks, less than 40% of the sample monitored their asthma for themselves. 
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Table 10.15.: Summary of the significant MANOVA results. 
MEASURE SIGNIFICANT COMMENTS 
EFFECTS 
GRP TIME GxT 
Asthmatic control 
APM ** Decrease bI6 weeks post-int. 
Illness representations 
IMIQ personal responsibility * ** Control grp >expt'l grp 
Decrease by 1 week post-into 
IPQ symptom quality (1) * Between baseline and 1 week 
post-int: 
Expt'l grp decrease 
(2) ** Control grp increase Control grp>expt'l grp 
ASC airways obstruction ** Decrease ~ 6 weeks post-int. 
Coping 
ACQ maintaining a healthy ** 
lifestyle (1) * Expt'l grp>control grp 
(2) Increase 6-12 wks post-into 
ACQ focusing on asthma ** Decrease by 6 weeks post-int. 
ACQ hiding asthma * Decrease by 6 weeks post-into 
ACQ reacting emotionally ** Decrease by 6 weeks post-int. 
ACQ rational action ** Expt'l grp>control grp 
Reliever medication use ** Decrease by 6 weeks 
Preventer medication use ** * Increase 6-12 weeks post-into 
Between 6&12 weeks post-int: 
Expt'l grp increase 
Control~ decrease 
Emotional reactions 
ASC panic-fear * Decrease by 6 weeks 
(1) Original analysis (2) Baseline scores used as covariates. 
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The specific effects of the workbook were hence to decrease perceived 
symptom quality (puzzling/distress over asthma), to increase Preventer 
medication use up to 12 weeks following intervention and to increase 
monitoring of asthma using Peak Flow Meters. The former result was the 
only one predicted in the hypotheses, and is supported by the fact that the 
majority of the participants in the experimental group reported on the 
questionnaire concerning the workbook that it had made them feel more 
optimistic and confident about their asthma, but not more knowledgeable 
(see Figure 10.28). This result is not surprising since the workbook did not 
aim to alter knowledge, as such, but rather cognitions and coping in 
connection with asthma. 
Figure 10.28.: The experimental group's reported feelings about their 
asthma following the workbook intervention. 
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This result is interesting when compared with the results of Pimm et 
al. (1994), who found that individuals with low illness representations of 
symptom quality (assessed using the IPQ), i.e. those who were less 
puzzled/ distressed, were more likely to benefit from self-management 
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interventions. However, there are two problems with the current result. 
Firstly, the reduction in symptom quality produced by the workbook was not 
associated with changes in coping and asthmatic control. In addition, it 
appears that the effect occurred only because baseline levels on this variable 
were high in the experimental group (when these were corrected for, the 
result disappeared). Similarly, the increase in Peak Flow Meter use in the 
experimental group may be simply due to the fact that use was low in this 
group at baseline. It would appear that the workbook might be useful for 
those who are either particularly puzzled and distressed about their asthma, 
or who do not already use Peak Flow Meters to monitor their condition. Only 
the relative increase in Preventer medication use in the experimental group 
compared to the control group between six and 12 weeks post-intervention 
appears to be a direct result of the intervention, but this increase was not 
accompanied by an increase in adherence when the amount of Preventer 
medication prescribed and the timing of the doses were taken into account, 
despite the fact that adherence was generally poor at baseline (only 27% of 
participants reporting taking their medication exactly as recommended, 
despite the fact that 35% were only prescribed Reliever medication). 
However, there were slight, if temporary, reductions in non-adherence due to 
carelessness, feeling better and feeling worse following medication. Methods 
of increasing and sustaining these effects need to be identified. 
Some main group effects were found for certain variables. Perceived 
personal responsibility was higher in the control group than in the 
experimental group throughout the study, but decreased in the whole sample 
over the course of the study. The difference in the coping strategy 
maintaining a healthy lifestyle was an artefact of randomisation and 
disappeared when baseline scores were taken into account. Rational action 
was found to be a more common coping strategy in the experimental group 
than in the control group over the whole study period. 
The majority of the Significant results, however, occurred when 
variables showed a Significant change over the course of the study, but not 
differentially between experimental and control groups. Hence the mean 
level of asthmatic control improved in the entire sample within seven weeks 
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of recruitment to the study, to within the range of 13-15 initially targeted as a 
reasonable improvement. In addition the following effects were seen: 
(1) A decrease in belief in the illness representation components perceived 
personal responsibility two weeks after recruitment to the study and in 
perceived airways obstruction seven weeks after recruitment. (Note that the 
former result was the opposite to that hypothesised). 
(2) Decreases in the coping strategies maintaining a healthy lifestyle, focusing 
on asthma, hiding asthma, reacting emotionally and Reliever medication 
use seven weeks after recruitment. All the ACQ coping variables continued 
to change between seven and 13 weeks following recruitment. 
(3) An increase in coping by Preventer medication use between seven and 13 
weeks following recruitment. 
(4) An overall decrease in the emotional reaction panic-fear in the seven 
weeks following recruitment (but no change in terms of those categorised as 
low, moderate and high on this variable). 
Only one variable (perceived personal responsibility) showed a 
significant time effect in combination with a significant group effect. An 
initial difference between experimental and control groups (control group 
participants perceiving greater personal responsibility) remained throughout 
the study, but both groups simultaneously decreased their belief in personal 
responsibility over the course of the study. Coping by Preventer medication 
use showed significant time and interaction effects, the experimental group 
increasing between 6 and 12 weeks post-intervention and hence showing a 
higher overall mean than the control group. 
The changes in variables over the course of the study were correlated 
in several cases. 
10.5.2. Discussion Of Results 
Despite the initially low levels of asthmatic control, the workbook 
intervention did not improve this outcome significantly. There could be 
several possible explanations for this lack of effect. 
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It is possible that the contents of the workbook were simply unsuitable 
for the students in some respect. This possibility was explored by examining 
the responses to the questionnaire on which the experimental group rated 
several aspects of the workbook on a six-point Likert-type scale (l=very poor; 
6=excellent). For ease of display, responses were categorised into either 'yes' 
(1-3) or 'no' (4-6) and are displayed in Figure 10.29. 
Figure 10.29.: The experimental group's assessment of the workbook. 
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It can be seen that the workbook was considered to have good content, 
to be useful and interesting and to make practical, sensible suggestions. 
However, most individuals saw it as being of low relevance to themselves. 
Interestingly, despite this, 15 participants said they would recommend the 
workbook to other students suffering from asthma (and five of the remaining 
seven said they might). This result may represent a form of downward 
comparison (Taylor & Aspinwall, 1990; Wills, 1981) whereby individuals who 
are stressed show a tendency to compare themselves to individuals who are 
relatively worse off than themselves, with the result that their subjective 
well-being increases. Such processes tend to occur particularly when the 
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stressor is chronic and not easily controllable (Wills, 1991). Alternatively, a 
form of Precaution Adoption Process (Weinstein, 1988) might be occurring, 
individuals being at the stage of believing in the relevance of coping well 
with asthma and improving asthmatic control for others, but not for 
themselves. Viewed within this theoretical framework, ongoing coping 
behaviours such as prophylactic Preventer medication use and Peak Flow 
Monitoring might be viewed as a preventive behaviours carried out to 
prevent symptoms in an "at risk' population of asthma sufferers. Figure 
10.30. gives one example of how the model might be applied to asthma self-
management. 
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Figure 10.30.: The Precaution Adoption Process (Weinstein, 1988) as it 
might be applied to asthma self-management. 
( HAS HEARD OF HAZARD J 
"I have heard that poor asthmatic control can be bad for you" 
1 
BELIEVES IN SIGNIFICANT LIKELIHOOD FOR OTHERS 
"Poor asthmatic control is a problem for some asthma sufferers" 
1 
ACKNOWLEDGES PERSONAL SUSCEPTIBILITY J 
"There is a real chance that my asthma could be poorly controlled" 
( DECIDES TO TAKE PRECAUTION J 
"I plan to self - manage my asthma properly in order to improve 
my asthmatic control" 
1 
( TAKES PRECAUTION J 
"I have started avoiding triggers / taking my medication properly 
etc" 
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It would be of use to investigate the power of social cognition models 
such as the Precaution Adoption Process to explain the adoption and 
maintenance of the preventive behaviours required of asthma sufferers (e.g. 
Peak Flow monitoring, avoidance of triggers and Preventer medication use). 
However, asthmatic control did show a significant improvement in 
the sample as a whole over the course of the study and the other Self-
Regulation Model variables did change in some respects. There are several 
reasons why this might be the case. 
Because there was no one-year follow-up, as is ideal in asthma studies 
to allow for the fact that in many cases asthma is seasonally influenced, it is 
possible that seasonal variation might account for the improvement in 
asthmatic control, and that the changes in illness representations and coping 
might follow on from this change, via the feedback loops of the model. 
However, this is unlikely because recruitment took place over a four-month 
period, beginning in mid-winter and ending in spring. Hence the first 
participants recruited had almost completed the study when the last were 
beginning. However, no significant differences in asthmatic control were 
found between the first 50% of the participants to begin the study and the last 
50% at either baseline or 12-week follow-up so it is unlikely that the results 
were caused by seasonal changes in asthma. 
It therefore appears that something in the study procedure itself caused 
the results found. Perhaps a Hawthorne effect, whereby simply knowing one 
is being studied causes changes in behaviour (either actual or reported), 
occurred. Alternatively, simply repeating the same questionnaires three 
times may influence the responses given, although this is unlikely because 
several different assessment methods were used. In addition, neither of these 
possibilities explain the fact that other elements of the coping process (e.g. 
illness representations) changed in a coherent way, consistent with the Self-
Regulation Model. 
Something in the study procedure would appear to have prompted a 
change in the whole coping process. Vazquez and Buceta (1993) found similar 
results in their study of self-management programmes and relaxation 
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training, where the control group showed an improvement in outcomes 
(attack frequency/duration, emergency medical consultations and school 
absences) as well as the intervention group. In this study monitoring of lung 
function and medication use had been used to form outcome measures and 
the authors attributed the improvements to such monitoring in combination 
with contact with the therapist carrying out the study. It seems possible that 
participants' coping was altered incidentally, by requiring them to monitor 
their asthma as part of the study procedure, and that this change in coping 
influenced other aspects of the coping process proposed by the Self-Regulation 
Model, via the proposed feedback loops. Indeed, not only was the monitoring 
a change in coping, but it can be seen to provide concrete evidence on which 
to appraise one's coping, as proposed by the Self-Regulation Model. In this 
way, the results found are entirely consistent with the Self-Regulation Model 
and were brought about because the operationalisation of the model and the 
actual process of interest had inadvertently become confounded. 
Since at baseline participants were found to be poor at assessing 
asthmatic control, perceived airways obstruction being low but asthmatic 
control (as assessed by APM) poor, this result makes clinical sense. The 
illness representation held of the symptoms of asthma may previously have 
been guiding the coping process, but now a new way of appraising asthmatic 
control had been created and may have been used, resulting in changes in the 
rest of the coping process. 
The results hence point to the central importance of self-monitoring in 
influencing the coping process in asthma. The benefits of Peak Flow 
monitoring are clinically acknowledged (e.g. Bellia et al., 1985; Williams & 
Church, 1985) but the current results cannot be attributed solely to this 
monitoring because other medical and behavioural variables (e.g. perceived 
symptoms, medication use) were also self-monitored. In fact, recent evidence 
has shown that Peak Flow monitoring leads to no improvement in outcome 
(assessed by prescribed bronchodilators, courses of oral steroids, visits to GP 
for asthma or hospital admissions) above simple monitoring of symptoms in 
a large sample of 801 asthma sufferers in Scotland (Drummond et al., 1994). 
Similarly conflicting results have been found regarding blood pressure 
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monitoring in hypertension sufferers and blood glucose monitoring in 
diabetes sufferers (Southam & Dunbar, 1986). 
Behavioural self-monitoring effects have long been demonstrated in 
many other situations which require self-regulation, e.g. weight loss, stopping 
smoking, studying, reducing antisocial behaviours in individuals with 
learning disabilities and agoraphobia (Kirschenbaum, 1987; Kanfer & Gaelick-
Buys, 1991), These effects are now so well-established in clinical psychology 
(Karoly, 1991) that they are included in most general texts and are one of the 
principles of many therapies. Hence most of the original literature was 
published in the 1970s. For example, Romanczyck (1974) found that self-
monitoring of daily calorie intake was more effective in reducing weight than 
self-monitoring of weight (which had no effect at all) or behaviour 
management in a randomised controlled study of 70 obese individuals. Baker 
and Kirschenbaum (1993) replicated these results. In this study, individuals 
who were more consistent at monitoring lost more weight, demonstrating 
the importance of regular self-monitoring. In addition, within the same 
individual, more weight was lost in weeks when monitoring was regular 
than in weeks when it was erratic. More recently, Haddock et al. (1994) have 
found similar results in obese children and adolescents. At least three 
randomised controlled studies have shown that students who monitor their 
studying attain better grades than those who do not (Johnson & White, 1971; 
Richards, 1975; Lan, Bradley & Parr, 1993). A study by Nelson, Lipinski and 
Black (1976) found that self-monitoring increased the frequency of social 
behaviour (talking) and was more effective at reducing the frequency of 
antisocial behaviours than traditional behavioural methods (e.g. token 
economies) in adults with learning disabilities. Emmelkamp (1974) found 
that self-monitoring was equally as effective as flooding treatment in treating 
agoraphobia in a randomised controlled study of 20 patients. If the two 
treatments were used together, then success rates improved further. 
However, it should be noted that the sample size in this study was small. 
Further research is required in order to determine whether 
physiological or behavioural aspects of self-monitoring are responsible for 
changing the coping process and outcome. 
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Self-monitoring effects can only be obtained if the individual (a) can 
interpret the results of the monitoring, (b) holds standards to compare these 
results to and (c) possesses suitable coping strategies (Kanfer & Gaelick-Buys, 
1991; Southam & Dunbar, 1986). It is likely that the workbook was, indeed, of 
little relevance to participants in the study because they already knew how to 
interpret the results of their monitoring and to adapt their coping, but simply 
were not carrying self-monitoring on a regular basis in order to begin this 
process. The problem hence becomes one of persuading individuals to 
monitor their asthma for themselves, and not only as a reactive measure to 
poorly controlled asthma, but prophylactically. Such monitoring may then 
prompt appropriate coping. 
Again, social cognition models might be useful in understanding the 
processes involved in encouraging individuals to cope prophylactically by 
monitoring their Peak Flow measurements. One particular model, 
developed by Prochaska and DiClemente (1982), could be especially useful in 
this respect since well-documented methods of intervention have been based 
on it. The model states that an individual passes through several stages of 
change in order to adopt a new, health behaviour (or, indeed, to abolish an 
existing, unhealthy behaviour). These stages are outlined in Figure 10.31. 
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Figure 10.31.: The stages of behaviour change (Prochaska & 
DiClemente, 1982). 
PERSON IS UNAWARE OF THE IMPORTANCE OF 
BEHA VIOUR CHANGE 
PERSON IS AWARE OF THE IMPORTANCE OF 
BEHAVIOUR CHANGE 
PERSON PLANS HOW TO CHANGE 
BEHAVIOUR 
PERSON CHANGES BEHAVIOUR 
PERSON CONTINUES TO CARRY OUT NEW 
BEHAVIOUR 
PERSON CEASES CARRYING OUT NEW 
BEHA VIOUR AND REVERTS TO OLD 
BEHAVIOUR 
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The model suggests that an individual may be at any of six stages of 
behaviour change. An individual who has never considered the 
implications of a particular behaviour is in the precontemplation stage. In 
order to actually change the behaviour, this individual must first understand 
the importance of the behaviour and wish to change it (contemplation stage). 
Next, the individual prepares to change the behaviour, thinking of ways in 
which to do so (preparation stage) and then these plans are carried out in 
theaction stage. From here, the behaviour may either be maintained, or 
relapse may occur. If relapse occurs then the individual may return to any of 
the previous stages apart from precontemplation. Miller and Rollnick (1991) 
suggest that this process forms a "wheel", which an individual may go 
through several times before successfully maintaining behaviour change. In 
addition he proposes that relapse may lead to the individual leaving to 
process altogether, Le. deciding not to change behaviour after all. 
Although the model has recently been criticised (e.g. Davidson, 1992) 
because of lack of scientific evidence supporting its proposals, it is compatible 
with other social cognition models of behaviour change (e.g. the Precaution 
Adoption Process), has been used to investigate addictive behaviours such as 
smoking (Prochaska & DiClemente, 1983) and has been widely cited as the 
most influential paper of the 1980s (Davidson, 1992). In addition, an 
intervention technique aimed at encouraging behaviour change in 
individuals by determining which stage of the model they are currently at has 
been developed (see Miller & Rollnick, 1991). This technique involves 
motivational interviewing, and was originally developed as a technique for 
encouraging individuals to give up addictive behaviours such as drinking 
(Miller, 1983). Motivational interviewing is defined as 
"A particular way to help people recognise and do something about their 
present or potential problems. It is particularly useful with people who are 
reluctant to change and ambivalent about changing." 
(Miller & Rollnick, 1991, p.52). 
Since the current study has identified reluctance on the part of student 
asthma sufferers to adopt preventive behaviours such as Peak Flow 
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monitoring and adherence to preventive medication regimens, despite the 
encouragement to do so from the workbook intervention, it appears feasible 
to extend the technique to such behaviours. 
For a full description of the technique and application of motivational 
interviewing, the reader is referred to Miller and Rollnick (1991). Briefly, the 
process involves identifying the current state of the individual's beliefs about 
the behaviour of concern (using the Prochaska and DiClemente model) and 
tailoring intervention to that stage. For example, an individual who has not 
contemplated Peak Flow monitoring requires information and subtle 
persuasion that this is an important component of coping with asthma, while 
someone who is contemplating beginning monitoring may require assistance 
with learning to monitor correctly, interpreting the results and responding 
appropriately as well as motivation to actually commence the behaviour. 
Those who have previously monitored in this way, but relapsed, may instead 
require techniques to help them remember to monitor regularly, regardless of 
their symptoms. An important component of the method is that the 
individual must be encouraged to reach a decisional balance, i.e. perceive that 
the costs of continuing a behaviour (or, in this case, of not carrying out a 
behaviour) outweigh the perceived benefits, before changing their behaviour. 
In this sense, the model is similar to other social cognition models such as the 
Health Belief Model (Becker & Rosenstock, 1984). Similar strategies could be 
employed for other coping behaviours, such as prophylactic Preventer 
medication use and avoidance of triggers. 
Encouraging individuals to progress from the contemplation stage 
through to the action stage, and to maintain appropriate coping behaviours is 
the primary challenge for health psychologists. Further research is required 
in order to investigate whether the Prochaska and DiClemente model is 
indeed suitable for use with preventive behaviours in asthma self-
management. This would require assessing the beliefs and coping of large 
groups of individuals with asthma in order to see whether the adoption of 
preventive coping behaviours involves similar stages to the abolition of 
unhealthy behaviours. This could open up possibilities for designing 
personalised interventions targeted at individuals at different stages of 
change with respect to each desired behaviour. Indeed, one of the weaknesses 
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of the workbook intervention in the current study may have been that, 
because it was designed to apply to a wide range of asthma sufferers, it lost 
personal relevance which may be attained with one-to-one interventions, 
although the latter are more expensive. 
The initial status of the sample may have influenced the results seen 
for variables where time effects were seen, as well as for the interaction effects 
discussed above. For example, the initially high level of perceived personal 
responsibility could account for the fact that this variable decreased, rather 
than increasing as had been hypothesised. Similarly, the lack of change in 
perceived hyperventilation and panic-fear (when categorised), when changes 
had been predicted, may have been due to the fact that initial levels were 
already found to be normal compared to previous samples. The reductions 
seen in the ACQ coping variables were possible due to the initially high levels 
on many of these variables. 
Despite initially high levels, however, perceived changeability did not 
decrease over the course of the study as predicted. The other variables which 
did not change which might have been expected to, based on the initial 
hypotheses and baseline levels of each variable, were the illness 
representations perceived consequences and timeline and coping by regular 
Preventer medication use, adherence and use of medical services. However, 
it is unfortunate that previous data using the IPQ with asthma sufferers were 
not available for comparison; it could be that perceived consequences and 
timeline were, in fact, unremarkable compared with other sufferers of the 
same condition, rather than diabetes sufferers. It could be that genuine 
differences in the nature of the two conditions cause the variations in 
perceived consequences, although since both are chronic and asymptomatic if 
controlled adequately it is not clear why asthma sufferers should perceive 
their condition as less chronic than diabetes sufferers do. 
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10.5.2. Methodological Considerations 
The strengths and weaknesses of the study were assessed using the 
guidelines provided by Creer et al. (1990). This paper suggests that 12 
important methodological considerations for empirical studies evaluating 
self-management interventions are: 
(1) Confirmation of the diagnosis of asthma. In this study, formal 
confirmation was not sought for the diagnosis, but all participants were 
prescribed Reliever medication. It was also assumed that if the self-reported 
diagnosis was not medically correct, GPs would have stated this upon 
receiving the letter informing them that their patient was taking part in the 
study. 
(2) Application of unbiased subject recruitment and random assignment. 
The recruitment procedure, although aiming to be as unbiased as possible, 
may have been somewhat biased towards individuals holding an illness 
representation containing the label "asthma" (see Chapter 8). It was 
attempted to recruit individuals who reported wheezing but did not label it 
such through the epidemiological study, but this proved impossible. 
Randomisation was completely unbiased. 
(3) Selection of participants from similar populations with respect to severity, 
classification and treatment of asthma. For the purposes of this study, it was 
in fact required to recruit as heterogeneous a sample as possible and this was 
achieved, the sample being drawn from three different general practices and 
being prescribed different medication regimens. However, perhaps further 
studies could study the coping process with respect to specific groups of 
individuals (e.g. those who have only recently received a diagnosis of asthma 
or those who are prescribed both Reliever and Preventer medications). 
(4) Use of appropriate experimental designs, including appropriate control 
procedures. The randomised controlled design allowed appropriate statistical 
comparisons to be made and the control group was essential; without it the 
possible monitoring effects found would not have been identified and false 
conclusions may possibly have been drawn. 
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(5) Application of standardised treatment and assessment procedures. The 
study procedure was purposefully standardised in terms of the background 
information given about the study, opportunities for discussion etc. The 
assessment procedures were all standardised by their questionnaire/diary 
nature. 
(6) Controlling of concurrent independent variables: 
(a) Assessment of adherence 
(b) Controlling potential adherence. 
Since adherence was actually a study variable, (a) was taken account of 
and (b) was unnecessary. 
(7) Add a broad spectrum of dependent variables to investigations. Ensure 
reliability and validity of each measure. Several of the wide range of 
variables used in this study did not demonstrate good internal reliability. If a 
liberal estimate of satisfactory reliability is used, i.e. 0.70, then three of the four 
IMIQ scales, four of the five IPQ scales, three of the six ACQ scales and the 
Morisky, Green and Levine adherence scale were unreliable. In two cases 
where reliability was particularly low (less than 0.30), the scales were either 
dropped from the analysis or their constituent items considered separately. In 
the other cases, since the questionnaires were pre-selected, analysis was 
carried out but should be interpreted with caution: the main example being 
the IPQ variable symptom quality, which showed an interesting effect (but 
note the other supporting evidence for a reduction in emotional 
representations of asthma following intervention, as described above). In this 
respect, it should be noted that in later versions of the IPQ, its authors have 
dropped the symptom quality scale altogether (Weinman et al., 1995), partly 
because of its low internal reliability. There would hence appear to be 
significant problems in reliably assessing illness representations in asthma 
sufferers using pre-existing questionnaires. In the case of the IPQ, low 
reliabilities might be expected because the scales are designed to be content 
valid (theory-driven) rather than construct valid (statistically derived). The 
IMIQ, however, is a statistically derived questionnaire so better reliabilities 
would have been expected. It could simply be that the content of illness 
representations differs widely between medical conditions, and hence it is not 
possible to develop psychometrically sound general measures of illness 
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representations (note that this does not invalidate the concept of components 
of the illness representation proposed by the Self-Regulation Model; the 
domains could be the same for all medical conditions, but the content of each 
domain might differ). 
(8) Collect sufficient follow-up data to rule out normal fluctuations of 
asthmatic symptoms or medication effects. Possible seasonal influences have 
been discussed above and it appears they did not influence the results of the 
study. The randomised, controlled nature of the study should allow the 
identification of such effects. Ideally a one-year follow-up would have been 
carried out, but the time constraints imposed upon the study did not allow 
this. It is hence not possible to generalise the results further than three 
months; further study would be needed in order to assess the long-term 
benefits of self-monitoring. 
(9) Recruit large enough samples to permit appropriate statistical procedures 
to be applied. As explained in the introduction to this chapter, power analysis 
was not possible prior to the commencement of the study. However, post-hoc 
power analysis, based on the baseline scores of the sample, was possible in 
order to determine that the study had indeed been of sufficient power to 
detect an emerging difference in asthmatic control between experimental and 
control groups. This analysis was based on the guidelines of Edwards (1968), 
who presents a simple method of carrying out what is often viewed as a 
particularly complex analysis. 
The effect desired in the intervention was to improve asthmatic 
control by reducing APM as far as possible towards that found in a normal 
random population. Higgins et al. (1989) report data from such a sample 
(mean 8.7, N=121) which can be used to calculate effect size. Based on the 
baseline data from this study (mean 21.26, s.d. 14.32), the effect size required to 
decrease APM to this level was: 
E.s. = 21.26 - 8.7 = 0.87 
14.32 
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Looking up this value in the tables supplied by Edwards (1968, p.94) 
reveals that with a sample size of 25 per group the study did, indeed, have 
just over an 84% chance of detecting a reduction in APM to that found in a 
random population of non-asthma sufferers, had it occurred. Should a 
smaller improvement in asthmatic control have been found, this power 
would have decreased, however. 
(10) Apply acceptable criteria for the evaluation of treatment effects. In this 
study, data were evaluated by comparison with existing published data where 
possible. 
(11) Interpret data in a reasonable and appropriate manner. Where necessary, 
additional statistics were carried out in order to clarify the results found; for 
example, when transformed data were analysed, raw data were also reported 
as they were of clinical importance. 
(12) Determine the clinical significance of findings. It was not possible to 
determine the clinical significance of the improvement in asthmatic control 
since the variable used to assess this construct was developed especially for 
the study. However, previous data were referred to where possible. 
Some further points concerning the measures and procedures 
employed in the study are worth noting. 
The measure of illness representations of the consequences of having 
asthma was different from that used in the cross-sectional study. This was 
because it formed part of the IPQ questionnaire and the study demands were 
required to be minimised as much as possible, so it was not desirable to 
include two measures. In retrospect, it would have been better to use the 
EQOL measure as well, since (a) this was the one which had been found to be 
important in the cross-sectional study and (b) the IPQ consequences scale did 
not demonstrate good reliability. The measure of use of outpatient visits was 
problematic in two ways. Firstly, because participants were recruited from 
more than one general practice, GP report (as used in the cross-sectional 
study) was not ideal because reliability between different GPs' reports is not 
necessarily high. Second, the GQA was used and this questionnaire assessed 
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GP visits only (not total number of outpatient visits). It was not ideal that the 
time periods over which the measure was taken were different and hence 
multiplication had to be carried out in order to compare the two and repeated 
measures analysis was not possible. Because of all these problems, the results 
concerning this variable should be interpreted cautiously. 
The assessment of adherence proved difficult and, by some measures, 
perhaps insensitive. The Morisky, Green and Levine scale was unreliable, 
perhaps because two of its items assessed opposite reasons for non-adherence: 
namely, feeling better/feeling worse following medication. It is unlikely that 
an individual who has had the experience of one of these situations has also 
had the experience of the other, although in other samples reliability has 
proved satisfactory, despite this seeming anomaly. In addition, the reasons 
for non-adherence included in this scale were not the same as those which 
had been identified in the open-ended question in the cross-sectional study 
(see Chapter 9). The only overlap between the two was forgetting, the 
Morisky, Green and Levine scale taking no account of negative beliefs about 
medication, practical difficulties etc. It may therefore be fruitful to develop 
and evaluate a measure based on the results of the cross-sectional study. 
Although the absolute level of Preventer medication use increased, none of 
the adherence measures showed any change. However, the reasons for non-
adherence did appear to change somewhat in the experimental group, non-
adherence due to carelessness and feeling worse following medication 
decreasing slightly (if temporarily) in the control group. 
The degrees of freedom for the analyses varied between variables, but 
in general the goal of retaining as many participants as possible for the 
analyses was reached satisfactorily. One participant failed to complete the 
'state' scales of the Asthma Coping Questionnaire, because the instructions 
referred to "times when attacks are experienced". The participant persistently 
claimed not to suffer "attacks", despite being requested at the start of the study 
to think about "times when symptoms are experienced" if "attacks", as such, 
were not experienced. Hence the wording of the questionnaire was contrary 
to the participant's illness representation; it is important to consider this 
when carrying out research or clinical work. It might be desirable to update 
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the instructions to the questionnaire so that it is suitable for all asthma 
sufferers, regardless of their illness representation of their condition. 
The author was blind as to which study group each participant was in 
until after the baseline assessment. Ideally, complete blindness would have 
been employed, but due to lack of resources this was not possible. Even if it 
were, the procedure would have been problematic since participants in the 
experimental group tended to have their workbooks and summary cards in 
view in the students' rooms, where most meetings between the author and 
participants took place. The only way to avoid this would be for all contact 
between participants and author to occur outwith participants' homes, but 
this would be expected to significantly reduce return rates and increase 
attrition from the study. In addition, the questionnaire concerning the 
workbook would have to be administered to all participants, regardless of 
whether they had received the workbook or not. Even with these 
precautions, the possibility that participants might somehow identify their 
study group to the researcher could not be fully eliminated. In this study, the 
effects of the author not being completely blind to the randomisation were 
minimised by adherence to a strict procedure with all participants (e.g. 
refusing to answer questions etc). 
When the study was planned, because it was anticipated that illness 
representations would change quite rapidly, whereas coping and asthmatic 
control may take somewhat longer to change, the assessment of all 
components of the Self-Regulation Model were not carried out 
simultaneously. However, this methodology made it difficult to assess 
changes in different elements of the coping process temporally, since there 
was no way to test whether this initial premise was in fact correct. The only 
data which it was possible to compare validly were the baseline and 12-week 
follow-up data, where all variables were assessed. The fact that only coping 
variables showed significant changes between follow-ups suggests that 
changes in illness representations are rather rapid while coping changes occur 
over long time periods; however it is still not possible to comment on the 
relative onset of change in each variable. It might have been more desirable 
to assess all variables at the same time points - perhaps replacing the one-
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week and six-week follow-ups by a single follow-up, four weeks post-
intervention. This possibility could be incorporated into future studies. 
In order to investigate the relative effects of (a) the workbook and (b) 
self-monitoring as part of the study procedure, it would have been useful to 
follow up the control group after they had been given a copy of the workbook 
at the end of the study, in order to assess whether the intervention would 
influence the coping process above the changes already seen. However, due 
to time constraints on the study this was not possible. 
10.5.3. Theoretical Implications 
This study had a strong theoretical base in the Self-Regulation Model 
in three ways. Firstly, the methodology was designed around the predictions 
of the model (as discussed above). Secondly, the workbook was designed in 
order to address the variables proposed by the model to influence asthmatic 
control. Finally, the power of the model in explaining the results found was 
under investigation. 
Although the results seen were not those initially hypothesised, they 
were indeed compatible with the Self-Regulation Model, as demonstrated by 
the fact that significant correlations were found between changes in illness 
representations, coping, emotional reactions and asthmatic control over the 
course of the study. 
The finding that changes in perceived personal responsibility were 
directly associated with changes in asthmatic control was consistent with the 
results of the cross-sectional study; however, in this case the relationship was 
the opposite way round, reductions in perceived personal responsibility being 
associated with improvements in asthmatic control and vice versa. This 
finding is also contrary to the other findings of this study: namely that (a) 
increased perceived personal responsibility was associated with decreased 
coping by rational action which was, in turn, associated with improvements 
in asthmatic control and (b) there was a significant association between 
reductions in each combination of the variables perceived personal 
responsibility, panic-fear and rational action. Because of these results, and the 
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fact that the direct association between changes in perceived personal 
responsibility and asthmatic control was only a trend, the significance of this 
result is doubtful. 
Panic-fear appeared to influence coping in more ways (if not as 
strongly) than illness representations did, and not only for the coping 
strategies with an 'emotional' component (see below). This finding supports 
the findings of the cross-sectional study: that the two pathways of the Self-
Regulation Model are not independent, as initially proposed, but instead 
mutually influence each other as latterly suggested (Leventhal, Diefenbach & 
Leventhal 1992). 
In line with this suggestion, the measures used to assess both illness 
representations and asthma-specific coping both incorporated emotional 
components. From the labels of these constructs, it appears possible that they 
may have become confounded with emotional reactions to asthma and this 
possibility was investigated. For example, the symptom quality scale of the 
IPQ is concerned with puzzlement and distress concerning asthma - concepts 
which would, perhaps, be better defined as 'emotional reactions to asthma'. 
The role of the ACQ 'state' coping variable reacting emotionally is easier to 
assess. This variable correlated significantly with panic-fear (Pearson's r=0.51, 
t00.01) and the changes in this variable correlated significantly with changes 
in panic-fear (Spearman's r=0.38, I2.<0.01). In addition, the behaviours 
included in the scale (such as becoming frightened, worrying and becoming 
angry) do not appear to fulfil the function of reducing either (a) the stress 
caused by the objective features of the illness or (b) the emotional distress 
caused by the illness, as in the definition of coping. Hence it seems that, 
within the framework of the Self-Regulation Model, the ACQ variable 
reacting emotionally operationalises the emotional pathway rather than the 
objective, and is, as suggested by its name, a reaction rather than a coping 
behaviour aimed at reducing distress. 
Perhaps the main methodological challenge for asthma research is to 
identify methods of measuring outcome which do not provide information 
to the patient on which appraisals of coping can be made and the coping 
process hence modified (see below). 
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10.5.4. Clinical Implications 
This study clearly indicates the potential of self-monitoring of asthma 
to change the whole coping process and hence improve asthmatic control. 
However, the results, like those found in the cross-sectional study, suggest 
that although individuals are willing to carry out such monitoring for 
someone else (in this case the author), they are far less likely to monitor their 
asthma for themselves, especially in a prophylactic fashion. Two possible 
strategies for encouraging self-monitoring are therefore recommended: 
(1) That patients are required to monitor their asthma regularly and that this 
monitoring is prompted and assessed by another individual. 
(2) That the benefits of monitoring are clearly demonstrated to patients in 
ways which they can understand so they are more likely to carry out 
monitoring of their own accord. 
Previous findings in health promotion (Becker & Rosenstock, 1984) 
suggest that implementing a cue to action might increase the likelihood of 
asthma sufferers monitoring their asthma if they already believe in the 
benefits of such monitoring. It would be useful to assess the effects of a 
simple letter from the GP, prepared and sent to all the names on the asthma 
register, on individuals' self-monitoring behaviour. Monitoring was carried 
out every six weeks for the study and the effects appeared to be sustained until 
the next monitoring session. It would hence be recommended that 
monitoring be carried out for a period of one week every six weeks in order to 
optimise asthmatic control and therefore that reminders be sent at these 
intervals. Although this procedure would be expensive, it may prove 
economical if it successfully improved asthmatic control, as the resulting 
costs of emergency care would be expected to be reduced. 
Other prophylactic coping strategies should also be encouraged. In 
particular, GPs might attempt to identify reasons for non-adherence and 
make efforts to correct them. For example, if an individual simply forgets to 
take Preventer medication then memory aids might be suggested, if non-
adherence is due to a lack of understanding of the asymptomatic nature of 
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asthma then further information on this could be given and if side-effects of 
medication reduce its use then alternative drugs might be prescribed. 
Although all the data presented in this study are mean group data, it is 
important to note that there was great variability in almost all of the 
measures used, i.e. individuals hold very different illness representations and 
cope in a range of ways. Health professionals might be advised to attempt to 
identify these variables in individuals patients and to create one-to-one 
interventions appropriate on this basis. For example, misguided illness 
representations might be corrected, or an individual's perceived 
controllability over his/her asthma increased. Hence discrete sections of the 
workbook might be selected as interventions for individual participants. 
It might also be advisable for health professionals to identify those 
individuals who react emotionally to their condition and to intervene in 
order to reduce this. The potential benefits of the workbook in this respect are 
suggested by the study. The workbook also encouraged individuals to 
increase their Preventer medication use; such effects were beginning to be 
seen by 12 weeks post-intervention and may persevere even longer than that. 
10.5.5. Recommendations for future research 
The results of this study indicate several possibilities for future 
research. Firstly, it would be desirable to assess whether the intervention 
might have been effective if self-monitoring had not been required in order 
to assess asthmatic control, i.e. whether its possible benefits were hidden by 
the effects of monitoring on the coping process. This is unfortunate given 
that a considerable amount of work had been put into developing a reliable 
and clinically-based method of assessing asthmatic control, based on the 
clinical concept of self-monitoring. One possibility would be to only collect 
Peak Flow Meter readings and to code them so that participants were unable 
to interpret the results of the monitoring (e.g. Higgs et al., 1986; Steiner et al., 
1987). However, special equipment would be required for each participant in 
order to do this and the costs would be high. Alternatively, the results 
presented in Chapter 7 suggest that, after APM, total self-reported shortness of 
breath in a seven day period (as recorded daily in a diary on a scale of 0 to 3) 
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was the index used most often in clinicians' judgements of asthmatic control 
that also loaded onto the same factor of asthmatic control as APM did. Hence 
this variable might be employed as a substitute measure of asthmatic control 
in order to eliminate the possible monitoring effects. However, since rating 
symptoms on a daily basis also comprises a form of self-monitoring, it is 
doubtful whether such effects could ever be totally eliminated. 
The particular aspects of self-monitoring which are responsible for the 
change in the coping process need to be identified (since, in addition to Peak 
Flow readings, information on symptoms etc was also collected, although 
these data were not used for the current study). This could be done by 
carrying out a randomised controlled study including the following groups: 
(1) Peak Flow monitoring and symptoms monitoring (as in this study). 
(2) Coded Peak Flow monitoring and symptoms monitoring. 
(3) Peak flow monitoring. 
(4) Coded Peak Flow monitoring 
(5) Symptoms monitoring. 
(6) No monitoring. 
However, once more a measure of asthmatic control which was not 
confounded with the monitoring method would be required and it is difficult 
to identify one. Higgs et al. (1986) compared monitoring using a coded Peak 
Flow Meter to monitoring with a regular Peak Flow Meter in a cross-over 
study, i.e. each participant monitored using a coded Peak Flow Meter for two 
weeks followed by a regular Peak Flow Meter for two weeks. Although the 
study only contained 12 participants, the results suggested that knowledge of 
Peak Flow readings led individuals to perceive their lung function more 
accurately (as indicated by a self-report visual analogue scale). Hence it seems 
possible that this might be the mechanism by which the coping process is 
changed by self-monitoring. However, other forms of self-monitoring (e.g. 
monitoring of symptoms or medication use) were not examined in this study 
so it was not possible to compare the relative merits of different methods of 
self-monitoring. 
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In addition, an investigation needs to be carried out into the process of 
self-monitoring. In particular, factors which might encourage ongoing self-
monitoring need to be identified and suitable interventions aimed at 
encouraging self-monitoring designed and evaluated. Similarly, barriers to 
other prophylactic coping methods, including regular Preventer medication 
use, adherence and use of outpatient services, need to be identified. In this 
capacity, as has been recommended above, it may be useful to investigate the 
potential use of existing models of preventive health behaviour, such as the 
Health Belief Model (Becker & Rosenstock, 1984), the Precaution Adoption 
Process (Weinstein, 1988) or the Prochaska and DiClemente model of 
behaviour change (Prochaska & DiClemente, 1983), as discussed earlier. One 
previous study (Jones, Jones & Katz, 1987) has used the Health Belief Model to 
develop an intervention aimed at increasing adherence to a recommended 
prophylactic coping strategy (making/keeping a follow-up appointment) in a 
sample of 74 asthma sufferers recruited through and emergency department. 
The intervention involved assessing and modifying patients' perceived 
susceptibility, seriousness, benefits and risks associated with further 
exacerbations. Individuals who received the intervention were more likely 
to (a) make and (b) keep the follow-up appointment than individuals in the 
control group. There is hence some evidence that such an approach to 
intervention may be effective in increasing prophylactic coping in asthma 
sufferers, but investigation of other prophylactic coping behaviours is still 
necessary. 
The role of individuals' appraisal of their coping requires further 
investigation. It would be useful to determine which components of the Self-
Regulation Model form the basis for appraisals of coping. For example, do 
individuals believe they have coped well if they have (a) reduced the 
perceived symptoms, (b) coped in a certain way, (c) reduced their emotional 
reactions to the condition or (d) improved the outcome of their illness? Such 
an investigation could be carried out either using hypothetical examples or, 
for higher validity, in a cross-sectional study assessing individuals' ratings of 
the success of the coping process they have carried out in addition to the 
variables assessed in this study. 
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The comparison of one's own self-regulation to perceived standards is 
a further issue worthy of investigation and has been little studied although it 
is a central assumption of the Self-Regulation Model (Pyszczynski et aI, 
1991). For example, if an individual believes that all asthma sufferers wheeze 
constantly (either as a result of downward comparison or because of the 
relative visibility of individuals with poorly controlled asthma compared to 
those with well controlled asthma), then it is likely that coping will not be 
altered even when symptoms are experienced regularly. Such 
representations of standards may form part of the illness representation, form 
the basis for appraisal and hence influence the whole coping process. It 
should be possible to (a) identify perceived standards for self-regulation and 
(b) to intervene in order to create more realistic goals for self-management. 
10.6. Conclusion 
This methodologically sound study, although not obtaining the 
predicted results, gives valuable insight into the process of coping with 
asthma which are consistent with the Self-Regulation Model, which have 
clinical implications and which suggest numerous possibilities for future 
research. 
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PART 4: 
GENERAL DISCUSSION 
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CHAPTER 11: GENERAL DISCUSSION AND CONCLUSION 
11.10 Summary And Discussion Of The Main Results 
This thesis aimed to use the Self-Regulation Model in order to 
investigate the coping process in individuals suffering from asthma and to 
design an intervention which would (a) change illness representations, (b) 
encourage adaptive coping, (c) moderate emotional reactions to asthma and 
hence improve asthmatic control. To some extent, these goals were reached: 
the cross-sectional study successfully identified possible methods of 
intervention, but the resulting cognitive-behavioural workbook intervention 
showed limited effects on illness representations and coping and did not, in 
itself, lead to improved asthmatic control. A more significant, but 
unpredicted effect was seen whereby simply participating in the study 
appeared to modify the coping process and improve asthmatic control. It was, 
however, possible to interpret this result within the framework of the Self-
Regulation Model if the self-monitoring required of participants as part of the 
study procedure was conceptualised as an enforced change of coping strategy. 
Such self-monitoring may modify the information on which appraisals of 
coping are made and hence influence the whole coping process. This result is 
compatible with the results of previous research concerning self-monitoring 
of various self-regulatory procedures, as discussed in Chapter 10. 
Both studies highlighted the importance of prophylactic coping 
(including visits to the GP and self-monitoring) in attaining and maintaining 
good asthmatic controL It was disappointing that an intervention specifically 
designed to encourage such coping failed to have an effect, while enforcement 
of this coping strategy (as part of the study procedure) proved highly 
beneficial. It appears to be of paramount importance to identify strategies for 
motivating individuals to carry out such behaviours for themselves, as part 
of an ongoing self-regulation process. Alternative theoretical models may be 
employed as a basis for investigation into such processes (see below). 
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11.2. Methodological Considerations 
One of the strengths of this thesis is that it employed a wide variety of 
recruitment procedures, designs, methodologies and statistical analysis 
techniques. Much was learned from the problems encountered in running 
the cross-sectional study which allowed the intervention study to be 
particularly rigorous in these respects. This discussion focuses on (a) the 
recruitment of participants (b) the design and methodologies employed and 
(c) the performance of the measures used throughout the thesis. 
Great attention was paid to reducing potential biases in the recruitment 
of participants for the empirical studies. Recruitment for the cross-sectional 
study, carried out through a single general practice with computerised 
medical records, was disappointing, leading to recruitment of only 18% of 
individuals fulfilling the study criteria. Low recruitment rates appeared to be 
caused by (a) reliance on busy health centre staff to identify and contact 
eligible patients, (b) the ethical requirements of several stages of recruitment 
and (c) biases due to the patients themselves (see below). A more labour-
intensive method was thus chosen for the intervention study but still only 
14% of eligible individuals volunteered to participate and alternative 
methods of recruitment had to be implemented in order to attain the target 
sample size. In this study, since individuals were contacted directly by the 
author and only two stages of recruitment were necessary, it appears that 
different variables may have influenced recruitment rates, e.g. the 
impersonal and extensive nature of the recruitment procedure. Both 
recruitment methods failed to eliminate biases due to patient characteristics 
inherent in studies where when one is reliant upon voluntary participation. 
Individuals with a low interest in their own condition, or who perceive their 
own condition as trivial (either accurately, or due to perceptual biases) will 
always be less likely to agree to participate in studies. The only potential 
methods of motivating individuals with low interest to participate in studies 
are (a) to stress heavily during the recruitment procedure that all individuals 
are of interest, whatever the perceived nature of their condition or (b) to offer 
incentives for participation in, and completion of, the study. 
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These possible sample biases must be considered in interpreting the 
results of the empirical studies. It does not appear that participants formed a 
biased sample towards those who were particularly interested in their asthma 
and were coping reasonably well anyway, since poor coping was identified in 
both studies, high levels of general denial (associated with poor asthmatic 
control) were apparent in the cross-sectional study sample and asthmatic 
control in the intervention study sample was poor. Conversely, a bias 
towards initially low levels of asthmatic control/ perceived symptoms was 
unlikely, since perceived airways obstruction symptoms were found to be 
similar in both cases, and in line with previous studies, and few individuals 
were involved in ongoing Peak Flow monitoring and would hence have had 
alternative methods of identifying poor asthmatic control. 
Because individuals in the cross-sectional study sample were all drawn 
from the same general practice, which had a particular interest in asthma care 
(as reflected by its involvement in the study), the finding that recent contact 
with medical services was associated with good asthmatic control must not be 
over-generalised. While it is desirable that the medical profession as a whole 
be well-versed and up-to-date in asthma care, unfortunately this is not always 
the case when so many aspects of medical care are competing for priority. At 
the very least, the results suggest that GPs should be educated in the benefits 
of requesting patients to self-monitor their asthma at regular intervals after 
providing initial guidance on (a) interpretation of the results of monitoring, 
(b) the standards of asthmatic control attainable and (c) the coping strategies 
necessary to attain these standards. 
The results of the cross-sectional and intervention studies were 
coherent and complemented each other in providing insight into the coping 
process in chronic disease. However, the small sample size in the cross-
sectional study, in combination with the correlational methods used and the 
fact that some of the relationships identified were relatively weak, indicate 
that care must be taken in generalising its results. The methodology of the 
intervention study was rigorous and allowed for valid statistical tests of the 
hypotheses under investigation. The unforeseen confounding of process and 
outcome in this study, due to the use of self-monitoring as the basis for the 
outcome variable, was unfortunate but actually led to some insightful 
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theoretical and clinical results. It was unfortunate that the timings of the 
follow-ups did not permit an investigation of the dynamic nature of the 
complete coping process over several time points, since all measures were not 
taken at all time points. The methodology of future studies should take these 
implications into account in order to obtain a clearer picture of the constantly 
evolving self-regulation process. 
A wide variety of measures were carefully selected to operationalise the 
Self-Regulation Model, including self-report measures, published 
questionnaires, monitoring data and data obtained from GPs. These 
measures were used with varying success. Several existing measures which 
were employed did not show satisfactory reliability - in particular, the IMIQ 
and IPQ measures of illness representations. Where reliabilities were 
exceptionally low, the relevant scale was excluded from the analysis, but it 
was necessary to retain some measures showing non-optimal reliability in 
order to test the hypotheses made. Problems of low reliability have been 
discussed extensively in the empirical chapters; in summary, at present it 
appears questionable whether it is indeed possible to develop reliable illness 
representation measures which are applicable to a wide variety of conditions 
since, although the components of the illness representation appear to be 
consistent (based on previous research), the exact content of each component 
may differ between conditions. However, illness representation measures are 
constantly being developed (e.g. Weinman et al., 1995) and it appears possible 
that, as research continues, the barriers to reliability, general applicability etc 
will be overcome. 
The research of Leventhal and his colleagues into illness 
representations was, almost without exception, based on qualitative 
methodologies and this method is valuable in clinical research, e.g. for 
identifying particular problemslrelationships between varaibles in specific 
clinical groups. Because their methodology was never fully reported, 
however, it is difficult to replicate such methodology exactly and hence the 
model is very much a framework for research, as discussed in Chapter 2 
(Leventhal, 1990). Until such time as specific measures are identified to 
operationalise the model, it will not attain the level of a theory and it is 
doubtful whether this will ever be possible. In the meantime, however, the 
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framework has proved to be of considerable use in modelling the 
relationships between cognitions, behaviour, emotional reactions and illness 
outcomes in a wide variety of chronic diseases. 
In the cross-sectional study, some of the data was obtained from GPs 
(based on medical notes) while in the intervention study, questionnaires, 
monitoring diaries and self-reports were the sole sources of data because 
participants were registered with a variety of different GPs and the reliability 
of the resulting data was anticipated to be questionable. However, this 
omission turned out not to be a disadvantage for additional reasons: (a) it was 
discovered that GPs were unable to supply some of the information requested 
(e.g. concerning type of asthma) anyway, (b) it sometimes proved difficult to 
obtain the information from GPs, (c) there is evidence that information- other 
than diagnosis (e.g. history of an illness) is not reliably recorded in GP notes 
anyway (e.g. Romm & Putnam, 1981) and (d) there is evidence that self-report 
is equally, if not more, reliable than GP notes (e.g. Harlow & Linet, 1989). 
The assessment of adherence to recommended prescribed medication 
use, although a central objective of this thesis, proved problematic. The more 
reliable and valid methods, such as inhaler weighing, were unsuitable 
because of (a) restrictions on resources and (b) the ethical approval required. 
A previously reported reliable self-report measure (Morisky, Green & Levine, 
1986) proved to be of poor reliability while number of repeat prescriptions 
requested was invalid since some individuals had their treatment regimen 
altered during the course of the study and it was hence impossible to calculate 
the number of repeat prescriptions expected if adherence was 100%. 
Comparing expected medication use to actual medication use, as reported in 
the monitoring diary, was a useful index of adherence, but unfortunately took 
account of Preventer medication only. Ultimately, the simplest measure - a 
self-report scale - appeared to be as valid as any, and simpler to collect. It 
should be noted that participants were offered the opportunity to justify their 
self-reported adherence in an effort to increase the reliability of this self-
report. Whether this result was obtained or not is indeterminable but it 
would be possible to carry out a simple study to investigate whether self-
reported adherence was lower when individuals were permitted to justify 
their response than when they were not. 
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The two measures which were developed for use in the empirical 
studies were used with reasonable success. The measure of asthmatic control 
was selected because of its validity, based on clinicians' ratings, and was 
assumed to be reliable due to the fact that the Peak Flow Meter readings on 
which the measure was based have been demonstrated to show reasonable 
reliability (see Chapter 3). It produced interesting results in the empirical 
studies (correlating with illness representations, coping and panic-fear, as 
predicted by the Self-Regulation Model) and was found to be amenable to 
intervention using self-monitoring. Similarly, the EQOL appeared to 
successfully assess illness representations of the consequences of asthma for 
the sufferer, again correlating significantly with other variables as predicted by 
the Self-Regulation Model. Basing this measure on items from 11 domains of 
an existing Quality of Life questionnaire ensured that it had adequate content 
validity and it was designed to have good internal reliability. Assessment of 
the test-retest reliability of this scale would be desirable, however. 
11.3. Theoretical Implications 
The results of the intervention study, although unexpected, emphasise 
the value of the Self-Regulation Model in understanding the coping process 
in chronic disease. In order to obtain such results, however, it was necessary 
to modify the model by incorporating illness outcomes. The results do 
support the hypothesis that illness outcomes result from coping efforts and 
may form the basis for the appraisal of coping, hence having the potential to 
modify the entire coping process. Although results compatible with this 
hypothesis have been found in previous research (as discussed in Chapter 2), 
they become more theoretically clear when interpreted within this 
framework. 
This research focused on a physiological illness outcome, since this was 
identified as the most valid measure of the pre-existing clinical concept of 
asthmatic control. However, it would also be possible to incorporate other 
illness outcomes, such as disability, handicap and Quality of Life into the 
model in a similar fashion. Indeed, Johnston (1994) has hypothesised that the 
World Health Organisation model of impairment, disability and handicap 
(World Health Organisation, 1980) may be fully incorporated into the Self-
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Regulation Model as outcomes. Since there is evidence that such outcomes 
are poor in asthma (e.g. Nocon, 1991) and Kaptein et al. (1988) have found 
that these outcomes to be uncorrelated, it would be valuable to identify 
variables influencing each one. Although variables external to the Self-
Regulation Model (e.g. social support) may be expected to influence these 
outcomes, the empirical results cited in support of the Self-Regulation Model 
in Chapter 2 demonstrate that such outcomes are additionally related to the 
other variables proposed by the model. Such outcomes may potentially form 
alternative bases for the appraisal of the coping process and it is possible that 
they would do so, at least in some cases, being more 'visible' than 
physiological outcomes. Research including these alternative illness 
outcomes would hence be valuable. 
The results of the intervention study suggested that changing coping 
with asthma may lead to changes in the rest of the coping process, including 
illness representations, coping and emotional reactions. The research 
methodologies and statistical analyses employed in this thesis do not permit 
the identification of causal pathways between these components, however. 
The model does not necessarily require that this is done, since it includes 
feedback loops which enable any variable to influence any other variable and 
it is, by design, a dynamic model of coping. Insight into the nature of these 
processes might be obtained by (a) smaller, experimental studies which 
manipulate one variable contained in the model and investigate the effects 
on other variables or (b) longitudinal studies. Researchers such as Croyle and 
Barger (1993) have begun to carry out such experimental studies, but the 
paradigms employed to date, although showing interesting results, are 
extremely complex and their ethical status is dubious because they involve 
supplying individuals with false diagnoses of possessing risk factors for 
fictional conditions. 
The incorporation of adherence as a coping response and panic-fear as 
an emotional reaction to asthma into the model appeared to be successful and 
yielded some interesting results. Although there were problems with 
assessing adherence (as discussed above), the results had some interesting and 
important implications, suggesting that Preventer medication use, where 
implemented, was a response to, rather than a precursor of, asthmatic 
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control. Although the average level of adherence overall was within the 
recommended limits, it was noted that several individuals in each study 
showed very poor adherence, i.e. that there was large variation between 
individuals which was not taken into account. Such variation suggests the 
need to assess adherence in individual asthma sufferers and to design suitable 
interventions for the particular type of non-adherence identified. It does 
appear that in many cases non-adherence was due to forgetting - a factor 
which is easily reduced by simple interventions. If individuals who forget to 
take their Preventer medication could be identified then a large increase in 
prophylactic medication use could be made at relatively low cost. Panic-fear 
at times when symptoms were felt was found to be associated with all three 
components of the model (illness representations, coping and asthmatic 
control), in several cases showing the curvilinear relationship suggested by 
previous studies (e.g. Dahlem, Kinsman & Horton, 1977; Kinsman et al., 
1977). That the two pathways of the model were found to be non-
independent in this way supports the view of Leventhal, Diefenbach and 
Leventhal (1992), rather than Leventhal (1990). However, once more, due to 
the design of the studies, it was not possible to determine causality in the 
relationships identified. It could be that individuals who hold a pessimistic 
view of their asthma and do not cope well are more likely to panic when 
symptoms are felt. Alternatively, high levels of panic-fear may lead an 
individual to interpret the condition in certain ways and may influence the 
coping strategies available. 
Although this thesis aimed to utilise the complete Self-Regulation 
Model, the appraisal component was neglected throughout. Even though the 
results suggest that self-monitoring may form the basis of an appraisal of 
coping, there is no evidence from the studies that this was the case, or if it was 
then in what way. Further studies are required in order to investigate which 
aspects of the self-regulatory process individuals use as the basis for 
appraising the coping process. It is possible that the techniques described in 
Chapter 7 for investigating the indices which health professionals use to 
assess asthmatic control (Le. regression of outcome variables onto ratings of 
asthmatic control) could also be applied to patients' ratings of their own 
asthmatic control. However, since individual differences would be expected, 
analysis on a more individual basis may be required. Marteau (1985) assessed 
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goals for coping in the parents of 85 children with diabetes mellitus by 
presenting hypothetical blood and urine test results. The results showed that 
parents and GPs based their appraisal of coping on different outcomes 
(avoidance of hypoglycaemia was used by the former group, avoidance of 
hyperglycaemia by the latter). A similar paradigm may be used to identify 
which aspects of asthma are used by individuals with asthma in order to 
appraise the coping process. Whatever information initially formed the basis 
for appraisal of coping in the sample in the intervention study, the results 
suggest that using self-monitoring outcomes was a more appropriate method 
of appraisal in terms of optimising asthmatic control (methods of identifying 
the specific aspects of self-monitoring which are beneficial was discussed in 
Chapter 10). 
Alternative models of self-regulation do exist in the literature. For 
example, Kanfer and Gaelick-Buys (1991) describe a model which has been 
applied to a wide variety of conditions, e.g. depression, study skills and 
diabetes. This model stresses the roles of self-monitoring, self-evaluation 
(based on the results of monitoring and perceived standards) and feedback 
(information and self-reinforcement) in self-regulation. The role of 
perceived control in this process is also emphasised, being hypothesised to 
influence both self-observation and feedback and behavioural principles of 
reinforcement are also incorporated. The model is dynamic, and can account 
for the results described in this thesis concerning self-monitoring. However, 
since it takes no account of the emotional reactions which have been shown 
by the current studies and previous research to be important in the self-
regulation process, it is lacking in its explanatory power. Wing et al. (1986) 
have developed a self-regulation model of diabetes. This model once more 
stresses the roles of self-monitoring and comparison to standards in self-
regulation, but takes no account of the influences of cognitive or emotional 
factors on this process and is hence incomplete. In addition, the model is 
specific to diabetes and has not been extended for use in the context of other 
chronic diseases. In common to all these models, however, is the emphasis 
on the role of self-monitoring in the self-regulation process which has been 
identified as so important in this thesis. 
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11.4. Clinical Implications 
The results presented in this thesis have several clinical implications. 
Firstly, they clearly show that young adult asthma sufferers do not cope 
adequately with their asthma and do not maintain their asthma under 
control optimally. Thus health professionals would be advised to pay 
particular attention to this group and to carry out appropriate interventions 
where necessary in order to optimise asthmatic controL 
Secondly, self-monitoring on a regular basic (regardless of the 
symptomatic state of the asthma) appears to be a key to good asthma self-
management. Providing an accurate basis for the appraisal of the results of 
self-monitoring is important. Patients need to know (a) how to interpret the 
self-monitoring results, (b) what the standards are for comparison (i.e. an 
aspect of the illness representation) and (c) how to alter coping appropriately. 
Hence it would be advisable to provide newly diagnosed asthma sufferers 
with such information, along with instructions on self-monitoring, at an 
early stage. 
Regular contact between the asthma sufferer and health professionals 
is potentially beneficial, and it would be possible to incorporate requests for 
self-monitoring (with the results being returned to the clinician) into this 
process. This might be achieved by the use of three-monthly letters 
requesting individuals to monitor their asthma for a period of one week. The 
results would preferable be returned to the health professional in person, but 
returning them by mail may also be beneficial if the important factor is 
simply that somebody else oversees the process. 
Finally, health professionals would be advised to make an objective 
assessment of the individual's perceptions of their asthma and their coping 
strategies, since the results of the empirical studies suggest that illness 
representations are often incongruent with current medical opinion (see also, 
for example, Marteau, 1985) and that coping is poor compared to medical 
recommendations. Where efforts are made to alter coping, it would be useful 
to identify the stage of change which the individual is already at (e.g. has the 
patient heard of the behaviour before; have they tried and failed to change the 
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behaviour already?). Altering illness representations by stressing facts such as 
the controllability of asthma, the dangers of poor asthmatic control and the 
possibility of an unrestricted lifestyle might be useful with individuals who 
have not contemplated controlling their asthma before, while suggesting 
memory aids for remembering to self-monitor and take Preventer medication 
may be more appropriate for individuals who have tried and failed to change 
their coping. 
Although such personalised interventions are recommended, non-
contact interventions such as the workbook designed for the intervention 
study may also have a role to play in patient education. In particular, the 
workbook might be used when (a) individuals who do not already do so are 
being encouraged to self-monitor their asthma, (b) individuals are identified 
to be particularly puzzled or distressed over their asthma and (c) individuals 
would not otherwise receive substantial input into the management of their 
asthma. 
11.5. Recommendations For Future Research 
The results of this thesis suggest several interesting and valuable 
possibilities for future research. The discussion below is simply a summary, 
since most possibilities have already been discussed in the relevant empirical 
chapters. 
Firstly, it would be useful to gain insight into the roles of (a) contact 
with outpatient services and (b) self-monitoring in the coping process. The 
former could be investigated by studying illness representations and coping 
before and after GP visits, for example. Possibilities for investigating self-
monitoring have been discussed in Chapter 10 and include identifying the 
precise aspects of self-monitoring which are responsible for modifying the 
coping process, using randomised controlled studies and employing different 
forms of self-monitoring and alternative indices of asthmatic control. 
Research aimed at identifying the aspects of the self-regulation process on 
which appraisals of coping are made is also necessary (see above). 
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Secondly, the influence of personal experience of chronic disease on (a) 
illness representations and (b) general coping requires investigating. This 
would be a challenging, long-term study since it would involve assessing well 
individuals and following them up in order to identify those who go on to 
develop chronic conditions. In order to narrow the study, only individuals 
who are at risk for a certain condition (e.g. those with a family history of the 
condition) might be studied, although it should then be borne in mind that 
this sample would be biased in terms of previous contact with the condition 
of interest and hence illness representations would not be expected to be 
typical of a general population sample. In this connection, further 
investigation into the influence of previous experience of others with asthma 
on illness representations would be valuable, as discussed in Chapter 9. 
One particularly interesting direction for future research is the utility of 
social cognition models in understanding the implementation and 
maintenance of prophylactic coping behaviours in chronic disease. In this 
context, such behaviours must be viewed as preventive behaviours aimed at 
lessening the risk of poor disease control. The relevance of the Health Belief 
:WIodel and Prochaska and DiClementes' model of behaviour change, in 
particular, have been emphasised in Chapter 10. 1£ the process of behaviour 
change in such cases is found to be similar to that found regarding other 
preventive behaviours (e.g. dieting, exercise), suitable methods of 
intervention might be identified on the basis of previous research. 
Finally, the extension of the current research to include other illness 
outcomes such as disability, handicap and Quality of Life would be valuable. 
11.6. Condusion 
The Self-Regulation :WIodel has been demonstrated to form a valuable 
framework within which to investigate the coping process in asthma. It has 
permitted the identification of cognitive, behavioural and emotional 
processes influencing asthmatic control and has highlighted possible 
strategies for intervention into the process of coping with chronic disease. In 
addition, the results of the empirical studies have led to the generation of 
numerous suggestions for possible research, both clinical and theoretical. 
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APPENDIX 1: CHAPTER 7 
(a) Self-monitoring diary (also used in cross-sectional and 
intervention studies). 
(b) The adapted version of the 72-item Living With Asthma 
Questionnaire administered to students. 
(c) The EQOL questionnaire. 
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NAME: ____________________ _ 
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ASTHMA STUDY: MONITORING STAGE 
I would like you to monitor and record your asthma for a week. 
You will have been issued with a peak flow meter (assuming you don't already have 
one), and shown how_to use this device. I would then like you to carryon managing 
your asthma as nonnal, but monitoring your Peak Expiratory Row Rate (PEFR) twice 
daily, using the peak flow meter. Beginning on the morning following my initial visit, 
please record your PEFR readings, along with the infonnation requested, on the 
attached sheet, for a period of seven CONSECUfIVE days, using the following plan: 
EACH MORNING: 
1) BEFORE USING YOUR RELIEVER INHALER*, take yourPEFR reading and- -- -. 
record it both on the chart (line 2) and by placing a cross at the appropriate place on the 
graph. You should take THREE PEFR readings, and record only the highest one. 
2) Record (on lines 1 and 4) the number of doses you have taken from your reliever 
and preventer* inhalers since the previous evening (NB 1 dose=1puff=1suck on 
inhaler). 
3) Record whether your sleep was disturbed the previous night (line 3). 
EACH EVENING: 
1) BEFORE USING YOUR RELIEVER INHALER, take your PEFR reading (as 
above) and record in the chart (line 9) and on the graph. 
2) Record the number of doses you have taken from your reliever and preventer 
inhalers since the morning (lines 5 and 10). 
3) Grade the severity of your asthma symptoms for that day, as directed on the chart 
(lines 6-8). 
We realise that this looks like a lot of work, but it should take no more than 5 minutes 
of your time each morning and evening, especially once you get into the routine of 
filling in the chart and graph. 
If you have any problem at all in understanding or carrying out any part of these 
instructions, please do not hesitate to contact me immediately on 62092 
(day and answering machine) or 76396 (eve). Should you forget to complete 
your diary at any point. simply leave it blank for that time - d~ NOT guess at your 
measurements as this will spoil the data. 
It is important that you monitor for 7 consecutive days. I will arrange a return visit (see 
the time written on your questionnaire booklet) and you should have a complete diary to 
hand to me by then. 
;: For definitions of RELEIVER ::md PREVENTER inhalers. see list overleaf. 
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*RELIEVER AND PREVENTER INHALERS 
Before beginning to monitor your asthma, please make certain that you are clear about 
which of your inhalers is the RELIEVER and which is the PREVENTER. 
In general, RELIEVER inhalers are prescribed to be taken as needed, and come in blue 
canisters. PREVENTER medications are usually prescribed to be taken regularly and 
tend to come in brown inhalers. 
Look up the names of your inhalers an the following lists, circle them and make sure 
you are not confused about which is which. 
RELIEVERS 
. Ventolin 
Salbutamol 
Bricanyl 
Atrovent 
Aerolin autohal er 
Berotec 
Exirol 
Pulmadil 
Serevent 
PREVENTERS 
Tilade 
In tal 
Becotide 
Becloforte 
Becodisc 
Pulmicort 
Even if you have only been prescribed one of these types of inhalers, please complete 
the diary as fully as possible 
1700 
650 
600 
, 
1
550 
1
500 
450 
400 
350 
300 
--
250 
200 
150 
100 
50 
--
-MORNING ( wa'k7ng ) DAYC>1 
How manv doses have you taken from your I 
REL.J EVE~ since yesterday evening? I 
PEFR (best of 3). Do not use your ~E1.)eVER i I before measuring this. 
Was your sleep disturbed by asthma 
I (Yes/No)? 
How many doses have you taken from your I p~eVENTQt< . this morning? t 
EVENING (bed~tme) DAYC> 
How many doses have you taken from your 
f2El..le.Ve~ since this morning? 
Grade the Cough 
I severity (0-3) of your asthma Wheeze symptoms Shortness today. of Breath 
PEFR (best of 3). Do not use your ~E~ 
before measuring this. 
How many doses have you taken from your 
P~EVE.NlOr!4 this evening? 
------- --------------
0= none 
1 = mild = aware of symptom but easily tolerated 
2 '" moderate = symptom caused occasional 
interference with normal activities 
3 = severe = symptoms caused constant 
interference with normal activities 
398 
AM I P~1 
1 
1 
AMIPM AM PM AM~PM AMIPM AMIPM 
2 3 4 5 6 
2 3 4 5 6 
WEEKLY 
Has your asthma disturbed the sleep of 
anyone living with you in the last week? 
(Yes/No/Not applicable) 
How many work/school/college days 
(including half days) have you missed 
because of your asthma over the last week? 
AM I P~( 
7 
I 
I 
I 
7 
I 
I 
t 
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YOUR EXPECTATIONS OF LIFE WITH ASTHMA. 
We would like to ask you about how you think life is, in general, 
for people who suffer from asthma. Below are 72 statements 
concerning everyday activities which mayor may not be affected by 
asthma. We would--nke you to imagine that each statement is given to 
1 00 people, chosen at random from the total population of people who 
suffer from asthma, and to indicate beside each statement the number 
of these people (out of 100) who you think would say that the 
statement was TRUE of them, because of their asthma. 
So, for example, if an item reads If I cannot go to the cinema 
because of my asthma If and you think that 10 out of 100 people with 
asthma would say that this is true- they cannot go to the cinema 
because of their asthma- then write '10' beside that item. Please do 
this for all 72 of the items. 
You should write a single number (from 1 to 100) beside each 
item. 
1) I can take part in any sport I want. 
2) When invited to a friend's house, I worry that there may be something 
there which sets off an attack. 
3) Having asthma restricts the sort of holiday I can take. 
4) I am a sound sleeper. 
S) I take good care to avoid doing things which make my asthma worse. 
6) I find it easy to carry shopping. 
7) I think that those who live with me find it stressful because of my asthma. 
8) I check all the time that I have my inhaler with me. 
9) I feel angry with my body. 
10) I hardly ever think about my asthma. 
11 ) I sometimes let people down because my asthma prevents me from 
doing something I have previously agreed to do. 
1 2) I can run like other people. 
1 3) I never worry that going on holiday can make my asthma worse. 
14) Most nights I wake up needing to use my inhaler. 
TRUE 
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15) I have trouble doing physically demanding tasks like gardening. 
16) I tend to be more conscious than other people of the early symptoms of a cold. 
1 7) There are times wh~,! I have difficulty getting around the house. 
18) I think that my asthma does not affect the lives of my relatives. 
19) If I forgot my inhaler it would probably make no difference. 
20) I never feel fed up because I have asthma. 
21) I feel that there are many worse things than asthma. 
22) Eating out can be ruined if the restaurant is smoky. 
23) I feel that I miss out because there are some sporting activities I cannot 
join in with. 
24) I feel frustrated at being unable to engage in sports. 
25) I can go on the same kind of holiday as everyone else. 
26) I find housework easy. 
27) Because of my asthma I feel drained after a cold. 
28) I need to take regular stops when I walk up a hill. 
29) I don't feel in control of my body. 
30) I feel anxious about not knowing when my next asthma attack is coming. 
31) I sometimes go into a toilet just to take a puff of my inhaler. 
32) I get emotionally upset when wheezy. 
33) I don't have to make excuses to my friends because of my asthma. 
34) I sleep badly because of my asthma. 
35) I find it difficult to do some DIY activities like decorating. 
36) Colds don't bother me much. 
37) I can walk up a hill as fast as anyone else of my age. 
38) I can visit a pub without any problems. 
39) I tend to cough a lot at night. 
40) I can't do some jobs I would like to do because of my asthma. 
41 ) I tend to avoid other people who have colds. 
42) I can walk up a flight of stairs without stopping. 
TRUE 
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43) I try to avoid getting emotionally upset because it makes my asthma worse. 
44) My asthma makes me feel so helpless. 
45) Having asthma means I sometimes have to go home after a night out 
sooner than other peopl€.-
46) Having asthma makes no difference to the way I work. 
47) My colds last longer than other peoples'. 
48) I can only walk up a flight of stairs if I have one or more stops on the way. 
49) I feel inadequate because of my asthma. 
50) I have a good future ahead of me. 
51) I work badly when my asthma is bad. 
52) There are places I would like to go, but can't because of my asthma. 
53) I find it a real nuisance having to use my inhaler. 
54) I find it a real nuisance having to take my tablets for asthma 
55) I am in charge of my own life. 
56) I sometimes feel sexually frustrated because of my asthma. 
57) I worry about what my condition will be like in 10 years' time. 
58) I have panicky feelings when I think about the future. 
59) I am embarrassed by having asthma. 
60) I often feel depressed because of my asthma. 
61) I find it easy to relax. 
62) Except when I have an attack, I am never really affected by asthma. 
63) I don't bother much about my asthma. 
64) My asthma does not amount to a serious health problem. 
65) I have confidence in my ability to cope with an asthma attack. 
66) I worry about the long-term effects of asthma drugs on my health. 
67) I find that stress brings about an asthma attack. 
68) Having an asthma attack makes me angry. 
69) Asthma does not reduce my enjoyment of sex. 
70) My colds are no worse than other peoples'. 
TRUE 
402 
TRUE 
71) I am never embarrassed at having to use an inhaler. 
72) I find it easy to use my inhaler. 
Many thanks for your help. It is greatly appreciated. Please 
remember to put your questionnaire into the box below the honours 
pigeonholes! 
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THE EQOL QUESTIONNAIRE 
We would like to ask you about how you think life is for people who 
suffer from asthma. Below are 22 statements concerning everyday activities 
which mayor may11.ot be affected by asthma. We would like you to imagine 
that each statement is given to each of 100 people, chosen at random from 
the total population of people who suffer from asthma, and to indicate for 
each item the number of those people (out of 100) who you think would say 
that the statement was TRUE of them, because of their asthma. 
So, for example, if an item reads "I cannot go to the cinema because of 
my asthma" and you think that 10 out of 100 people with asthma would say 
that this is true - they cannot go to the cinema because of their asthma - then 
write '10' beside that item. Please do this for all 22 items. 
(1) 
(2) 
(3) 
(4) 
(5) 
You should write a single number (from 1 to 100) beside each item. 
Having asthma restricts the sort of holiday I can take. 
I am a sound sleeper. 
I think that those I live with find it stressful because of my asthma. 
I never worry that going on holiday can make my asthma worse. 
I have trouble doing physically demanding tasks like gardening. 
(6) I tend to be more conscious than other people of the early symptoms of a 
cold. 
(7) There are times when I have difficulty getting around the house. 
(8) I think that my asthma does not affect the lives of my relatives. 
(9) I feel that I miss out because there are some sporting activities I cannot 
join in with. 
(10) I feel frustrated at being unable to engage in sports. 
(11) I find housework easy. 
(12) I sleep badly because of my asthma. 
(13) I can visit a pub without any problems. 
(14) I can walk up a flight of stairs without stopping. 
(15) My asthma makes me feel so helpless. 
(16) There are places I would like to go, but can't because of my asthma. 
(17) I find it a real nuisance having to use my inhaler. 
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(18) I find it a real nuisance having to take tablets for my asthma. 
(19) I sometimes feel sexually frustrated because of my asthma. 
(20) I have panicky feelings when I think about the future. 
(21) Asthma does not reduce my enjoyment of sex. 
(22) My colds arellO worse than other peoples'. 
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APPENDIX 2: CHAPTER 8 
CROSS-SECTIONAL STUDY: 
(a) Letter from health centre to potential participants. 406 
(b) Letter from author to potential participants. 407 
(c) Patient screening questionnaire (also used in intervention 
study). 408 
INTERVENTION STUDY: 
(a) Epidemiological screening study: letters. 409 
(b) Epidemiological screening study: questionnaire. 411 
(c) Classification of drugs taken for asthma/breathing problems. 413 
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THE HEALTH CENTRE. 
68 PIPE LAND ROAD. 
ST ANDREWS. KY16 8JZ 
TEL: 
AF1" 
"F2'" 
"F ~" 
"F4" 
0334 73441 
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Th~ Psvcholonv D~onrtmf'>nt ~t. St Anrll"'f>WS nn;vp.rsit,v ic; inte~st~rl in 
how oeonlp m;::\n;:H1P thpir <'Ic;thma. Onp. of t.hp. sturlents is wantinn tn rlo 
a PhD which will involve sturlp.nt<: who h~vp. had chp.st prohlems. Thev 
will hp as k",rl to r.nmolp.te fllJPst;onn<'lirps. Tn the fir<;t inst",nr.f'! shp. 
woulrl like to pilot these o I.lp.stionn<'lil"'f'S. 
I wonrlp.r if VOl) would hp. 'lol"'f'p.i'lble to IJour name he;na a;ven to thp. 
(j"'O<'lrtmp.nt. Could VOIl plp.asp. comolete the oermission i'lt the bottom 
i'lnri rpturn it to thp. He<'llth Centre <'IS <:non RS possible. 
A V OAVIDSON 
To~-
Or A V Davidson 
Hp.alth Centre 
68 Pioeland Road 
st Andrews. KY16 8.17 
r i'loree to mv ni'lmp. bp.ino nivpn to the Psvcholoav Deoartmp.nt. 
L1n;versitv of St Anrirp.ws. i'l<: c;omp.onf' who h<'ls had chest oroblems. 
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A u turon, 1992 
Dear Sir or Madam, ~ 
I am currently running a research project, with the Health 
Centre, looking at how those diagnosed as suffering from asthma or other chest 
complaints cope with their illness and its treatment. The health centre has forwarded 
this letter to you because you have at some time been given such a diagnosis; I am 
writing to ask whether you would be prepared to give up a little of your time to 
participate in my study? 
If you do agree to take part, I will contact you to arrange for you to complete 
some questionnaires, which will take up about an hour of your time and can either be 
done by you coming into the department or by me delivering the forms to you - in 
either case this will be arranged at a time convenient to yourself. In addition, you will 
be asked to monitor your symptoms and treatment for a period of one week. Your 
medication will not be changed at all for the study, and no -physiological or medical 
tests will be carried out. 
If you feel you could spare the time to take part, please fill in the form below 
and return it to me in the envelope provided. I will then contact you to make 
arrangements for the completion of the questionnaires. If, however, you feel that you 
cannot participate, please still return the slip to indicate that this is so. 
Although your doctor has been involved in recruiting you for this study, he or 
she will never know any of your personal answers and results; only the data for the 
group of participants as a whole. Nobody outside the research team will ever see your 
personal data. 
If you have any queries about the study before deciding, please do not hesitate 
to call me on St Andrews 72965. 
Thank you very much for your help, and I look forward very much to hearing 
from you. 
Yours faithfully, 
Julie Williams 
NAME:. ____________ D.O.B. ___________ _ 
(Please delete as appropriate) 
1) I will NOT be able to participate in your study. 
2) I WILL be able to participate in your study; you can contact me 
at ____________________________________________________________ ___ 
TELEPHONE: DAY __________ _ EVE~G _______________ _ 
.. IF YOU ARE A STUDENT, WHAT YEAR ARE YOU CURRENTLY IN? ____ ___ 
• ___ :.;l;f· 
-------
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INITIAL PATIENT SCREENING QUESTIONNAIRE 
(Can be carried out either by letter or by phone) 
NAME: D.O.B. 
We are currently ~carrying out a study which involves people who have 
asthma or other chest problems completing questionnaires. 
1) Have you ever been diagnosed as having asthma? YES NO 
(go to Q4) 
2) Do you currently have medication for your asthma? YES NO 
3) We are asking people who have asthma to complete questionnaires about 
their asthma. Would you be able and prepared to complete questions 
concerning your asthma? YES NO 
4) Have you ever been diagnosed as having chest 
problems? 
5) Do you currently possess medication for your chest 
problems? 
(end) (go to Q4) 
YES NO 
YES NO 
6) We are asking people with chest problems to complete questionnaires 
about these problems. Would you be able and prepared to complete 
questionnaires about your condition? YES NO 
From: 
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UNIVERSITY OF ST. ANDREWS 
ST. ANDREWS, FIFE, SCOTLAND, KY169JU 
Dear student, 
PSYCHOLOGICAL LABORATORY 
Tel.: St. Andrews 76161 
(S.T.D. 0334) Ext. 
Fax No. 033477441 
May 24th, 1993. 
. I am a second year PhD student carrying out health 
research in the Psychology department. My work mainly involves 
looking athow people think about certain illnesses, and how people who 
have those illnesses cope with them, and I am particularly interested in 
asthma ,and other breathing problems. Since it is not always easy to 
locate people who are suitable and willing to participate in my studies 
through the health. centre, I am currently writing to all first and second 
year students in the student directory to try and find out 
(a) How many have various different experiences of health, and in 
particular breathing problems, and 
(b) How many are willing to be contacted for future suitable research 
projects. 
I would therefore be extremely grateful if you could spare a few 
moments to complete the short form I enclose, and return it to me in the 
. envelope provided, via internal mail (you will find internal mail boxes in 
. ,each hall of residence, in the foyer of the main library or in departmental 
offices / mailrooms). 
All the information you give to me will be treated with the strictest 
confidence. Only myself and my immediate supervisor will ever see 
your details;. they will not be revealed to anyone else. Your responses 
will not be revealed to your doctor and your health care will not be 
affected in any way. Names will not be used in any publications which 
may arise from this survey. 
It is very important that I have as many of these questionnaires as 
possible returned, so please try to complete and return the form - even if 
your responses to all the questions are negative, this is still useful 
information for me to have. Since this term is a short one, and we hope 
to complete this survey before the summer, I would appreciate it if you 
could return your questionnaire as soon as possible. 
Thank you very much for your help, and I look forward to 
hearing from you. 
Best wishes, 
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BREATHING PROBLEMS SURVEY 
I am a third year PhD student carrying out health research in 
the Psychology department. 
My work mainly involves looking at how people think about 
certain illnesses, and how people who have those illnesses 
cope with them, and I am particularly interested in asthma and 
other breathing problems. 
I am currently screening all first, second and third year 
students to find out: 
(a) How many have various different experiences of health, 
and in particular breathing problems, and 
(b) How many are willing to be contacted for future suitable 
research projects. 
I would therefore be extremely grateful if you could spare a 
few moments to complete this short questionnaire while you 
pass through the matriculation hall. 
All the information you give to me will be treated with the 
strictest confidence. Only myself and my immediate 
supervisor will ever see your details; they will not be revealed 
to anyone else. Your responses will not be revealed to your 
doctor and your health care will not be affected in any way. 
Names will not be used in any publications which may arise 
from this survey. 
It is very important that I have as many of these questionnaires 
as possible returned, so please try to complete and return the 
form - even if your responses to all the questions are 
negative. 
THANK YOU VERY MUCH FOR YOUR TIME. 
JULIE WILLIAMS 
SCHOOL OF PSYCHOLOGY 
UNIVERSITY OF ST ANDREWS 
A. PERSONAL DETAILS 
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QUESTIONNAIRE 
NAME: ________________________ _ SEX: MALE I FEMALE (circle one) 
DA TE OF BIRTH:, _________ _ YEAR OF STUDY: _____ _ 
TERM ADDRESS: ____________________ _ 
TEL. No.: ___________ _ 
SUMMER ADDRESS: ___________________ _ 
TEL. No: ____________________ --'-
NEXT YEAR'S TERM ADDRESS (IF KNOWN):, ___________ _ 
TEL. No.:, ___________ _ 
B. YOURHEALTH 
00 YOU SUFFER FROM ANY CHRONIC (ONGOING) CONDITIONS (INCLUDING 
ANY MENTIONED ELSEWHERE ON THIS FORM)? YES INO 
IF YES, WHICH CONDITION(S) 00 YOU SUFFER FROM? _______ _ 
PLEASE ORCLE ANY OF THE FOLLOWING YOU HAVE SUFFERED FROM AT ANY 
TIME: APPENDIOTIS 
ASTHMA 
OTHER BREATHING PROBLEMS 
BROKEN ARM 
DIABETES 
EPILEPSY 
FOOD POISONING 
HEARING PROBLEMS 
INFLUENZA ('FLU) 
INGROWING TOENAIL 
MUMPS 
SMALLPOX 
TUMOUR 
C. YOUR BREATHING 
1. Have you, at any time in your life, heard a wheezing noise coming from your chest? 
('wheezing" means a whistling sound, whether high or low pitched, and however 
fu~ Y5/~ 
IF "YES": Have you ever been at all breathless when the wheezing noise 
was present? 
Have you at anv time of your life had this wheezing noise 
when you did not have a cold? 
YES I NO 
YES I NO 
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2. Have you had a wheezing or whistling in your chest at any time in the last 12 
months? YES / NO 
3. Have you at anv time of your life had an attack of asthma? YES / NO 
4. Have you had an attack of asthma at any time in the past 12 months? YES / NO 
D. TREATMENT FOR ASTHMA AND BREATHING PROBLEMS 
How many times in the past 12 months have you seen the following medical experts 
about asthma or breathing problems (this includes both times when you have made an 
appointment and times when you have been caIled in to see someone)? 
GP ______________________ _ PRACTICE NURSE ______________ _ 
CHEST CONSULT ANT ____ _ CASUALTY NURSE/OOCTOR, __ _ 
OTHER (SPECIFY) ______ _ 
What medications are you currently taking for asthma or breathing 
problems? ___ _ 
D. WILLINGNESS TO PARTICIPATE IN FUTURE STUDIES 
*****REGARDLESS OF YOUR ANSWERS TO THE ABOVE QUESTIONS, PLEASE 
COMPLETE THIS SECTION. IT IS VERY IMPORTANT TO OUR RESEARCH. ***** 
I plan to run several research studies in the near future, and will need a large 
number of willing participants - both with and without ongoing conditions or breathing 
problems - to ensure their success. These projects, although in medical areas, are 
mainly questionnaire-based, and involve no drugs of any type. If you agree you name 
will be placed on a list of people willing to be contacted for research, and when a 
suitable project comes up, you will be given full details and asked to sign a further 
consent form if you are interested in taking part. Replying "yes" to the question belo'w does 
not place you under any obligation to actuaIly take part in any future projects; it simply 
means that we may contact you to give you more details on projects you would be 
suitable to take part in. YOUR AGREEMENT AT THIS STAGE WOULD BE MOST 
USEFUL TO US. 
Are you willing to be contacted about future research projects 
which you might be suitable to take part in? YES / NO 
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CLASSIFICATION OF DRUGS TAKEN FOR ASTHMA OR BREATHING 
PROBLEMS 
CATEGORY 
~ 
(1) Relievers 
(2) Pre venters 
(3) 'Inhalers' 
(4) Nasal sprays 
(5) 'Other' 
DRUGS INCLUDED 
Aerolin autohaler 
Atrovent 
Berotec 
Bricanyl 
Exirol 
Pulmadil 
Unspecified 'salbutamol' 
Sere vent 
Venti de 
Ventodisc 
Ventolin 
I Becodisc 
Becloforte 
Becotide 
unspecified 'beclomethasone , 
Flixotide 
Intal 
Pulmicort 
Tilade 
I An f "nh I ' , I y response 0 1 a er wnere no 
further specification is made 
Beconase 
Flixonase 
, t'b' f 'C I ' 'W I an~l 10 ICS, Inc, penlcl.u.ln, 
I predmsolone) 
'antihistamines' (incl. Triludan) 
T Lomudal 
'pills' 
Rhinocort 
'steroids' 
I Teldanex 
Zvtec 
.I 
I 
I 
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APPENDIX 3: CHAPTER 9 
(a) GP report form. 415 
415 
GP REPORT FORM 
• NAME OF PATIENT: 
• D.O.B.: 
• DATE OF DIAGNOSIS: 
• TYPE OF ASTHMA (PLEASE GRCLE ONE): Intermittent / Continuous / Triggered 
• PRESCRIBED MEDICATION REGIMEN AT _--<-1_--<-1 __ 
DRUG DOSE TIMING 
• TIME SINCE (a) FIRST and (b) START OF CURRENT ASnn-.1A TREATMENT (PLEASE 
TrCK ONE IN EACH CASE): 
I FIRST REGIMEN CURRENT REGIMEN 
1) <=3 months 
2) 3 months 1 day - 6 months 
3) 6 months 1 day - 1 year 
4) 1 year 1 day - 2 years 
5) 2 years 1 day - 5 years 
6) 5 years 1 day - 10 years 
7) >10years 
I 
I 
I I 
• NO. OF REPEAT PRESCRIPTIONS IN 12 MONTHS TO _--<-1_--<-1 __ 
DRUG 
I 
I 
NO. OF REPEAT PRESCRIPTIONS 
• NO. OF OUTPATIENT VISITS (GP/ ASTHMA NURSE/HOSPITAL OUTPATIENT 
CLINIC) IN 6 MONTHS TO / I 
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APPENDIX 4: CHAPTER 10 
(a) The workbook intervention. 417 
(b) Workbook assessment questionnaire (experimental group only). 418 
(c) Summary of MANOVA results. 421 
417 
A COpy OF THE WORKBOOK INTERVENTION MAYBE FOUND 
INSIDE THE BACK COVER OF THIS THESIS 
418 
YOUR ASSESSMENT OF THE ASTHMA WORKBOOK 
Thank you very much for taking the time to complete the 
questionnaires, monitor your asthma and read the workbook so far. I'd now 
like you to complete the following questions regarding the workbook and 
how you used it, followed by another set. of questions about your asthma. 
In answering these questions about the workbook, please be honest. I'd 
rather hear that you didn't even read the workbook than have you return a 
complete set of questionnaires with made-up answers just to spare my 
feelings! 
Please make sure you answer all the questions below and then move 
on to the next section. 
I will collect them at: 
on: 
NAME : _______________________________________________ _ 
1) Did you read the workbook? (Please circle) 
COMPLETEL Y / PARTLY / NOT AT ALL 
2) If you did not read the workbook completely, why not? (Please circle) 
IT'S TOO LONG 
I DIDNT HAVE TllvIE 
ITS TOO BORING 
I FORGOT TO READ IT 
I LOST IT 
IT'S NOT RELEV ANT TO :tvIE 
PARTS WERE IRRELEV ANT TO ME 
OTHER (SPECIFY) : ___________ _ 
3) If you did read the workbook completely: 
a) Did you read it ALL IN ONE GO I fN SEVERAL SESSIONS 
b) Did you complete the parts you were asked to? 
COMPLETELY / PARTLY / NOT AT ALL 
c) About how long did it take you to read and complete what you did 
do, in total? ______________ _ 
4) Please rate the following aspects of the workbook, overall, using the scales. 
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a) CONTENT 1 2 3 4 5 6 
very poor excellent 
b) LAYOUT 1 2 ., 4 5 6 :J 
very poor excellent 
c) PRESENTATION 1 2 3 4 5 6 
very poor excellent 
d) FORNIAT 1 2 ., 4 5 6 :J 
very poor excellent 
e) LENGTH 1 2 3 4 5,;- 6 
too short too long 
f) USEFULNESS 1 2 3 4 5 6 
very poor excellent 
g) INTEREST 1 2 3 4 5 6 
very boring v. interesting 
h) RELEV ANCE TO YOU 
1 2 ., 4 5 6 :J 
completely completely 
irrelevant relevant 
i) SENSIBILITY OF SUGGESTIONS 
1 2 3 4 5 6 
v. insensible v. sensible 
j) PRACTICALITY OF SUGGESTIONS 
1 2 3 4 5 6 
v. impractical v. practice I 
k) DIFFERENCE FRONI EXISTING BOOKLETS FOR ASTHNIA SUFFERERS 
1 2 3 4 5 6 
very similar v. different 
1) ENJOYNIENT 2 ., 4 5 6 :J 
very low very high 
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5) Now, please rate the following aspects of each section on a scale from 1 (v. 
poor) to 10 (excellent). 
USEFULNESS INTE REST RELEVANCE TO YOU ENJOYMENT 
SECTION 1 
SECTION 2 
SECTION 3 
SECTION 4 
6) What new things did you learn from the workbook? ______ _ 
7) VVhat was the best part of the workbook? _________ _ 
8) What was the worst part of the workbook? _________ _ 
9) How has the workbook made you feel about your asthma, compared to 
before? 
a) BETTER I WORSE I SAME 
b) MORE CONFIDENT / LESS CONFIDENt / SAME 
c) MORE WORRIED / LESS WORRIED / SAME 
d) MORE KNOWLEDGEABLE / LESS 
KNOWLEDGEABLE / SA.tvIE 
e) OPTIMISTIC / PESSIMISTIC / SAME 
10) Will you refer to the workbook in future? YES / NO / :NIAYBE 
11) Would you recommend the workbook to other students suffering from 
asthma? YES rNO / :NIAYBE 
12) Please write overleaf any further comments and suggestions on 
(a) particular sections (b) the workbook as a whole 
survIIvIARY OF MANOVA RESULTS FOR ASTHMATIC CONTROL AND ILLNESS REPRESENTATION VARIABLES 
ty'lEASURE 
APMu 
IMIQ 
Seriousness 
Personal responsibility 
Changeability 
IPQ 
Timeline 
Control/ cure 
Consequences 
Symptom quality 
Emotional Attributions 
ASC 
Airways obstruction 
Hyperventilationb 
lrritabilityb 
Fatigueb 
MEAN (S.D.) 
BASELINE 
------ ------ -
EXPT'L CONTROL E 
-- ------
-, 
25.62 (16.3) 19.42 (13.4) 15 
4.52 (1.10) 4.15 (0.80) 4.' 
5.74 (1.36) 6.10 (1.40) 5: 
3.32 (1.45) 3.09 (1.86) 3.: 
3.31 (0.75) 3.55 (0.59) 3.: 
3.31 (0.49) 3.40 (0.64) 3.: 
2.20 (0.69) 2.59 (0.72) 2. 
2.84 (0.55) 2.38 (0.74) 2.' 
2.02 (0.77) 1.80 (0.90) l,C 
3.73 (0.74) 3.46 (0.76) 3.: 
1.65 (0.46) 1.60 (0.58) 1., 
2.14 (0.60) 2.00 (1.08) U 
2.53 (1.02) 2.04 (1.08) 2.1 
~AN (S.D.) ty EAN (S.D.) 
JLOW-UP 1 FC LLOW-UP 2 
--
'L CONTROL 
--
L I CONTROL I EXPT 
.3) 1 17.16 (5.7) 116.66 ( 
)6) 4.11 (0.84) 4.36 (1 
33) 5.92 (0.94) 5.03 (0 
54) 3.02 (1.47) 2.92 (1 
51) 3.54 (0.50) 
36) 3.36 (0.55) 
56) 2.46 (0.62) 
58) 2.62 (0.91) 
93) 1.75 (0.55) 
3.24 (0 
3.62 (0 
2.12 (0 
2.59 (0 
2.02 (0 
82) 3.12 (0.94) 3.07 (0 
38) 1.45 (0.47) 1.75 (0 
65) 1. 90 (1.13) 2.29 (0 
95) 1.88 (0.90) 2.40 (0 
1.0) 12.58 (7.2) 
.12) 4.07 (0.79) 
.87) 5.84 (0.99) 
.33) 3.05 (1.35) 
.72) 3.48 (0.56) 
.38) 3.44 (0.61) 
.43) 2.31 (0.50) 
.86) 2.44 (0.83) 
.75) 1.80 (0.72) 
.76) 3.29 (0.82) 
.61 ) 1.58 (0.80) 
.85) 1.72(1.11) 
.86) 2.00 (1.03) 
------------, -
GROUP TIME EFFECT 
EFFECt 
1--._----
--
FI39=1.04 d ** F 1.61 78=12.51 
Fl,41=1.06 1'1.70,82=0.87 
cFl,41=4.24* d ** F2 S2=6.22 , 
Fl,39=0.14 F2,7B=0.58 
F),40=2.28 F=I.5B,400.37 
Fl,41=1.77 F 1.63,82=2.66 
Fl,41=0.67 F1.71,82=2.07 
Fl,41=O.59 FZ,82=0.39 
Fl,41=1.32 FZ,82=0.11 
F1,38=O.20 dF2,76=6.59'* 
Fl,38=O.28 FZ,76=2.33 
Fl,38=O.84 F1.18,76=0.76 
Fl,38=1.90 FZ,76=2.23 
--
Notes: a Variable not normally distributed; transformation not used as it did not improve distribution or alter results. 
b Variable not normally distributed; transformation used. 
C Control group> experimental group. 
d Effect found between baseline and one-weeki six·-week follow-up. 
e Effect found between follow-ups. 
* *',k 12<0.05 12<0.01. 
GxT 
INTERACTION 
I F1.61 78=3.03 
F1.70,82=0.57 
F2,S2=1.40 
F2,7S=0.56 
F1.58,40=0.00 
Fl,63,82=3.07 
F1.71,82=0.61 
dF2,82=3.78* 
F2,82=0.00 
F2,76=2.54 
F2,76=0.30 
F1.18,76=2.10 
F2,76=0.49 
~ 
I--' 
SUIvIMARY OF IvlANOV A RESULTS FOR COPING AND EMOTIONAL REACTION VARIABLES 
MEASURE MEAN (S.D.) MEAN (S.D.) MEAN (S.D.) GROUP TIME EFFECT 
BASELINE FOLLOW-UP 1 flOLLOW-UP 2 EFFECT 
--------
EXPT'L CONTROL EXPT'L CONTROL EXPT'L CONTROL 
-- --r-'--- f------- f.--- --1----------
, 
ACQ 
Maintaining ... 2.60 (0.35) 2.34 (0.35) 2.63 (0.31) 2.25 (0.33) 2.61 (0.42) 2.34 (0.43) cFl,39=11.38 ** F1.53,78=0.20 
Focusing on asthma 2.06 (0.34) 2.13 (0.37) 1.93 (0.37) 1.79 (0.44) 1.96 (0.57) 1.73 (0.40) Fl,39=1.05 d ** eF1.71,78=7.96 
Hiding asthma il 2.26 (0.64) 2.13 (0.64) 1.98 (0.53) 2.00 (0.63) 1.96 (0.57) 2.06 (0.71) Fl,37=0.00 dF2,7'1=4.03* 
tvlinimising ... il 2.24 (0.45) 2.02 (0.63) 2.07 (0.48) 1.90 (0.58) 2.14 (0.67) 1.72 (0.55) Fl,37=3.32 F1.71,74=2.51 
Rational action" 2.82 (0.38) 2.60 (0.49) 2.77 (0.55) 2.27 (0.47) 2.76 (0.55) 2.27 (0.61) cFl,37=11.28** F2,7'1=2.59 
Rei\cting emolionallya 1.45 (0.20) 1.46 (0.41) 1.25 (0.26) 1.41 (0.51) 1.30 (0.23) 1.27 (0.35) Fl,37=0.22 F2,74=7.51 
Reliever med. llseb 5.36 (2.95) 5.67 (3.95) 3.73 (2.37) 4.49 (3.38) 3.54 (2.32) 4.01 (3.36) Fl,38=0.36 dF2,76=8.18** 
Preventer med. llseb 4.54 (3.86) 6.20 (4.24) 5.16 (4.29) 6.98 (4.27) 8.05 (2.58) 7.14 (3.47) Fl,37=0.68 d ** eF2,74=7.96 
Adherence (diary) 9.61 (12.1) 10.00 (18.4) 7.28 (13.7) 8.00 (22.0) 5.28 (13.8) 9.30 (21.0) F136=0.12 F271=0.72 1------------r·-----1-.-----t-------- ------1----------
ASC 
Panic-fear il 1.93 (0.62) 1.57 (0.62) 1.44 (0.47) 1.36 (0.52) 1.83 (0.90) 1.43 (0.59) Fl,39=3.35 dF1.60,78=4.69* 
"-'---Notes: a Variable not normally distributed; transformation not used as it did not improve distribution or alter results. 
b Variable not normally distributed; transformation used. 
c Experimental group> control group. 
d Effect found between baseline and one-weeki six·-week follow-up. 
e Effect found between follow-ups. 
Maintaining ... =Maintaining a healthy lifestyle; Minimising ... =Minimising the seriousness of the attack. 
*12<0.05 **12<0.01. 
GxT 
INTERACTION 
I F1.53,78=0.55 
F1.71,78=2.40 
F2,74=1.07 
F1.71,74,=0.95 
dF2,74=2.46** 
F2,74= 1.38 
F2,76=O.12 ~ 
deF274=3.61* , 
F271=O.39 
F 1.60,78= 1.15 
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INIROIlIIC'IION 
WIIAT THIS WORKBOOK IS INTENDED TO 00 
This workbook is intended to help you to manage your own asthma more 
effectively. This should mean that: 
1) You experience less symptoms from your asthma. 
2) Your asthma intrudes less in your day-to--day life. 
3) You are more confident in dealing with your asthma. 
4) You are aware of a variety of things which might help in dealing with 
your asthma. 
5) Your asthma will be less likely to lead to complications in later life. 
WHAT TIllS \VORKBOOK IS NOT INTENDED TO 00 
This workbook is not intended to provide extensive medical information 
about asthma or its treatment - plenty of existing booklets do just this. If 
you don't have them already, and would like to see them, you may obtain 
them from your CP or practice nurse. (At the 5t Andrews Health Centre 
there are three practices and you will be registered with one of them. Each 
practice has its own practice nurse who is trained Specifically to deal with 
asthma problems and will be happy to see you or give you further 
information). 
This workbook is not intended to be a hlue-print for dealing with asthma. 
Everybody is different and different parts of the workbook will be more 
relevant to different people. It is up to you to decide for yourself which 
parts will be most useful to you after reading the whole workbook, and to 
go on and make use of them. 
2 
HOW TO USE TIllS WORKBOOK 
Work through the entire workbook.. carefully. Think carefully about each 
section as you do, and try to get an idea of which sections are particularly 
relevant to you. As you go along, complete the sections which you are 
asked to. This will help to make the contents more relevant to you by 
making you think about how certain points relate to your own experience. 
For example, we have just mentioned CPs and practice nurses.. Write in 
the space below the name of your own GP in St Andrews, and the name of 
the practice nurse associated with your CPs practice. They are both 
important people in helping you to deal with your asthma, so also make 
sure you keep a note of the telephone number you can contact them on. If 
you don't know this informatiol\. then make an effort to find out, now -
make sure you complete this part of the workbook before moving on. 
.. .. 
* 
.. 
* NAME OFCP: .. 
* 
.. 
.. NAME OF PRACI1CE NURSE: .. 
.. .. 
.. PRAcnCE PHONE NUMBER: .. 
.. .. 
* • 
As well as completing parts of the workbook as you go along, at the end of 
each section you will find one or two multi-choice questions relating to 
what you have just read. Answer the questions, check the answers on the 
following page and make sure you understand which is correct, and why. 
This will give you a fuller understanding of the ideas contained in the 
workbook, and help you to remember them more easily, which is 
important if you are going to apply them in your everyday life. 
To make the best use of the workbook, we suggest that once you have 
completed it, you do not simply toss it into a cupboard and forget all about 
it. Read over it again, perhaps a day or two later, then keep it in a safe, 
handy place, for reference. U you refer to it periodically you will be able to 
see just how much your asthma seU·management has improved, which 
will be very encouraging for you. 
QUESTION 
This workbook will: 
a) Make my asthma better. 
b) Make no difference to my asthma. 
c) Help me to manage my asthma better. 
d) Help me understand what my asthma is. 
1 
ANSWER 
This workbook will: 
a) Make my asthma better. 
This workbook will not cure your asthma. What it can do is help you to 
learn how to lessen the effects of your asthma, by using good self~ 
management to control it. 
b) Make no difference to my asfhma. 
If you use the workbook correctly, and incorporate some of the ideas in it 
into your own life, then it really can make a difference to your astJuna. 
c) Help me to manage my asthma better. 
Correct. U you use the workbook correctly then the ideas in it really can 
help you to manage your asthma better. 
d) Help me to understand whot my Qsthma is. 
This is not one of the aims of this workbook. You can find this out 
elsewhere, in other booklets available from your GP or practice nurse -
whose names you should have noted on Page 3. What this workbook 
does intend to do is to help you to understand how to manage your 
asthma. 
SE[IION 1: . 
ASIHMA, ASIHMA 
'JREA'JMENI ANI) 
ASTHMATIC CONTROL 
5 
6 
ASTHMA AND ITS EFFECTS 
Asthma is a medical condition of the lungs which varies in nature but 
generally results in wheezing and shortness of breath at certain times. Put 
very simply, the lining of the lungs becomes inflamed and at times the 
airways in the lungs are likely to constrict, causing asthma symptoms. 
Although there will be some times when few symptoms are experienced, 
and other times when they are bad, asthma sufferers must always take 
account of their condition. Even when you feel no symptoms, you must 
~Iways t~ke appropriate action to keep things that way. The important 
thing about asthma is that the longer it is kept under control, the less 
problems it is likely to cause, and the less likely it is to recur. Properly 
controlled asthma can have very little, or no, adverse effects on the 
sufferer's life. 
With the right combination of drugs and ~ppropriate behaviour, even the 
worst and the most unpredictable asthma (an be brought under control 
and need not be a major problem. Then it is just a matter of lcnowing how 
you can do this, which is exactly what this workbook intends to help you 
to do. 
QUESTION 
The effects of asthma are: 
a) Constant 
b) Affected by drugs 
c) Affected by my behaviour 
d) Uncontrollable 
7 
ANSWER 
The effects of asthma are: 
a) Constant .. No .. the effects of asthma are variable in themselves and 
can also be affected by the actions you take to control them. 
b) Affected by drugs. Yes, drugs can help to control the effects of your 
asthma - if, of course, you take them correctly and also adapt your 
behaviour appropriately. 
c) Affected by my behaviour. This is also correct - your behaviour (which 
includes taking your drugs correctly) can alter the effects of your a~tluna. 
d) Uncontrollable. This is incorrect - with the correct combination of 
drugs and behaviour change, the effects of asthma can be minimised. 
8 
DRUGS YOU MAY TAKE TO HELP CONTROL YOUR ASTHMA 
Br,?adly speaking, there are two types of treatment for astruna: . 
1) Preventer medication. 
2) Reliever medication. 
1. PREVENTERMEDICATION 
This type of medication decreases the inflammation in the lungs and must 
be taken regularly, and long-term to keep its effect constant and prevent 
the airways constricting and leading to symptoms. There are many 
different types of Preventer medications, but they generally rome in brown 
inhalers. 
Not every asthma sufferer is prescribed Preventer medication - if asthma 
is well-controlled then it might not be necessary. In this case, some. of the 
following sections will not be applicable to you, but it is still a good idea to 
at least glance at them, for future reference. If you have not been 
prescribed Preventer medication and your asthma turns out to be poorly 
controlled then your doctor might consider prescribing Preventer 
medication for you, to help you get it under control. 
If you have been prescribed Preventer medication already, please circle the 
medication which your doctor has prescribed for you in the list below. 
Next, write in the space provided how much you are supposed to take, and 
when. If you are not sure how your doctor has recommended you to take 
your Preventer medication, find out - either from the medication label or 
from your doctor. Make sure you have completed the space below before 
continuing through this workbook. 
• • 
• HOW MUCH? WHEN? * 
• Becotide * 
• Becodisk • 
• Intal * 
• Tilade * 
• Becloforte • 
• Pulmicort • 
• Other (specify) * 
• • 
--
9 
2. REUEVER MEDICATION. 
At times, especially if inflammation is not kept down by the use of 
Pre venter medication, the airways in the lungs constrict and symptoms 
are experienced. Reliever medication may then be used to provide rapid 
relief by getting rid of the constriction. It is therefore generally prescribed 
to be used lias needed", rather than on a regular basis. Generally, Reliever 
medications come in blue inhalers, although again, there are many 
different types. Circle below the Reliever medication your doctor has 
prescribed for you. 
* * 
* Ventolin Bricanyl Atrovent * 
* * 
* Exirol Salbutamol Aerolin autohaler * 
* * 
* Berotec Pulmodil Other: * 
* * 
3. OTIIER DRUGS 
There are, in addition, other, more powerful medications which are 
prescribed for acute asthma episodes, including steroid preparations and 
drugs for intensive inhalation. This workbook is not concerned with 
thesei rather, it concentrates on day-to-day seU-management of asthma. If, 
despite your best efforts, your condition does deteriorate seriously, then 
your doctor will become involved and will help you by prescribing such 
treatments. 
10 
QUESTION 
If you have no asthma symptoms: 
a) You can ignore the asthma. 
b) You can give up taking Preventer medication. 
c) You do not need to use Reliever medication. 
d) You no longer need to control your astluna. 
II 
ANSWER 
If you have no asthma symptoms: 
a) You am ignore the Ilsthma. 
No - you must never ignore your condition, although it need not disrupt 
your life, or be apparent to other people. You should strive to keep it 
under control. as we will go on to describe next, and to do this you must be 
aware of it even when you feel no symptoms. 
b) You can give up taking Preventer medication. 
Preventer medication is the key to good sell-management of asthma and 
you should take it as prescribed, on a day-to-day basis, until your asthma is 
well-controlled and your doctor recommends that you stop taking it. If, 
with Preventer medication, you feel no symptoms for a long period of 
time, then you should consult your doctor or practice nurse. They may 
then recommend you to reduce the amount of Preventer medication you 
take, but you should never do this without consulting them first. 
c) You do not need to use Reliever medication. 
Correct. Reliever medication is used to lessen symptoms when they are 
experienced. Ii Preventer medication is used correctly then few symptoms 
should be experienced and it may not be necessary to take Reliever 
medication. Doctors generally advise that if asthma is properly controlled, 
Reliever medication should be used no more than once a day. 
d) You no longer need to control your asthma. 
This is incorrect. Asthma must be kept under control at all times. 
11 
WHAT IS ASTHMATIC CONTROL? 
Put simply, keeping your asthma under control means keeping your lungs 
functioning at or near to the best level possible for you, so that symptoms 
are less likely to occur. This is done using a combination of the drugs we 
have just mentioned and other appropriate behaviour changes. 
WHY IS ASTHMATIC CONTROL IMPORTANT? 
The aim of successful asthma self-management is to have good asthmatic 
control. Why? There are two reasons for this: 
1) The medical consequences of poor asthmatic control. 
2) The social consequences of poor asthmatic control. 
1. TIlE MEDICAL CONSEQUENCES OF ASIHMATIC CONTROL 
Poor asthmatic control means that there is more chance that severe 
symptoms will be experienced, which in the worst cases can be life-
threatening, even where asthma has so far been only mild or moderate. 
Good asthmatic control means that this is far less likely to happen. 
Furthermore, asthma which is not kept under control is far more likely to 
have serious consequences in the future. Permanent lung damage can 
occur in cases where asthmatic control is poor over long periods of time, 
resulting in an irreversible problem. 
QUESTION 
Asthmatic control refers to: 
a) Keeping yourself under control when you are wheezing. 
b) Keeping your lung function stable, within certain limits. 
c) Avoiding long-term consequences due to asthma. 
d) Making your asthma go away. 
13 
ANSWER 
Asthmatic control refers to: 
a) Keeping yourself under control when you are wheezing. 
This is not what asthmatic control means, although as we will see later, it 
can be an important factor in improving asthmatic control 
b) Keeping your lung function stable, within certlJin limits. 
Correct. Asthmatic control means miling sure that your lung function 
does not vary too much from a certain level. . 
c) Avoiding long-term consequences due to Qsthma. 
This is not what we mean by asthmatic control, although it is a 
consequence of good asthmatic control, and an important reason for 
having good asthmatic control. 
d) Making your asthma go away. . 
Cood asthmatic control does not mean making your asthma go away, 
although if it is maintained for a long period of time, it may mean that 
your asthma could go into "remission" i.e. that you could have few 
problems even without the use of drugs. 
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2. 1HE SOCIAL CONSEQUENCES OF ASllIMATIC CONTROL. 
As well as being potentially dangerous, asthma symptoms can lead to 
severe restrictions in the lives of many sufferers. Many people with 
asthma become accustomed to the restrictions it places on their lives, and 
expect never to be able to do all they'd like. What they do not realise is 
that with correct self-management, there is no reason why they cannot 
lead completely unrestricted lives, as do many asthma sufferers who 
control their asthma successfully - including several successful sportsmen 
such as Duncan Goodhew, Ian Botham and Sebastian Coe. This is because 
they have paid careful attention to managing their asthma and keeping it 
under good control. 
If they can do it, then so can you, with a little effort! First, think about all 
the things which your asthma prevents you from doing, which you either 
used to do or would like to do otherwise. In the space below, write down 
everything you can think of, however unimportant it might seem - from 
running a marathon to canying your shopping. 
*--------------------------------------------------------* 
* 
* 
* 
• 
• 
• 
• 
• 
• 
* 
* 
• 
• 
• 
• 
• 
* 
* 
*,--------------------------------------------------------------* 
This workbook aims to help you to plan how to gain control over your 
asthma so that, in time, you will be more able to do these things when 
you want to. Use the things you have written above as motivation lor 
putting effort into gaining control over your asthma. If it feels like hard 
work, at times, try to think about the benefits you might have, such as 
being able to do the things you have mentioned above. In addition, when 
your asthma is under O)ntro~ you will be able to look back at this list and 
be encouraged by the things you have become better able to do. 
QUESTION 
Restrictions due to asthma: 
a) Are inevitable. 
b) Can be overcome by good astlunatic control. 
c) Can be overcome by willpower. 
d) Can reduce Quality of We. 
IS 
ANSWER 
, ; ~ ,- • L 
Restrictions in activity due to asthma: 
a) Are inevitable. This is incorrect - restrictions in activity due to asthma 
can be minimised by improving asthmatic control. r 
b) Can be overcome by good asthmatic control. This is correct - if 
asthmatic control is good, then restrictions in activity due to asthma 
should be minimised. 
c) Can be overcome by willpower. Restrictions can only be overcome by 
taking appropriate action in order to keep your aslluna under control. Of 
course, this might require willpower, but willpower on its own is not 
enough· you must 00 something, too! 
d) Can reduce Quality of Life. Correct - restrictions due to asthma can 
mean that your life is not as full as it might be. Only when asthma is 
properly controlled can restrictions be minimised and Quality of Life 
improved. 
HOW CAN I TELL IF MY ASTHMATIC CONfROL IS GOOD OR lWR? 
Most people with asthma use their symptoms to decide what to do about 
their condition. However, symptoms are not always an accurate reflection 
of the state of their lungs, since lung function can often be significantly 
reduced before any symptoms are felt. Since it is the lung function level 
which is important in determining the long-term outcome of asthma, it 
follows that merely relying on symptoms as an indicator is not always 
sufficient, and that it is often important to be able to measure underlying 
lung function before it reaches a stage where symptoms will be 
experienced. 
A portable device called a Peak Flow Meter is now available to enable 
asthma sufferers to measure their lung function. Standing upright and 
holding the meter to the mouth horizontally, with the lips tightly sealed 
around the mouthpiece, the patient takes the deepest breath poSSible then 
blows out as sharply as possible into the meter. The meter then gives a 
reading of the lung's capacity. 
The goal of asthmatic control is to keep these readings as constant as 
possible (although there will always be small natural fluctuations, 
especially between morning and night-time readings) and as close to the 
best attainable for the individual as possible. We will look soon at how 
you can do this. 
Most doctors now recommend that asthma sufferers use a combination of 
a) Symptoms 
b) Peak flow measurements 
c) Reliever medication used 
and d) Disruption to everyday life 
(these should be few) 
(these should not vary 
too much) 
(this should be < once a day) 
(this should be minimal) , 
in order to assess their asthmatic control. They supply patients with Peak 
flow meters and special diaries for keeping a record of this information so 
that they can assess their own asthmatic control. 
QUESTION 
A way to tell if your asthmatic ,control is good or poor is: 
a) Whether you have symptoms or not. 
h) Whether you feel in control of your asthma or not. 
c) By using a Peak Flow Meter to monitor your lung function. 
d) All of the above. 
17 
ANSWER 
A way to tell if your asthmatic control is good or poor is: 
a) Whether you have symptoms or not. ; 
Although this can give you an indication of how good your asthmatic 
control is, it is not a good idea to rely solely on symptoms as you may not 
experience any symptoms until your lung function has deteriorated to 
well below its ideal level. 
b) Whether you feel in control 0/ your Qsthma or not. 
Asthmatic control is not merely a feeling; it is the actual state of the lungs. 
Therefore this answer is incorrect. 
c) By using Q Peak Flow Altier to monitor your lung junction. 
This is perhaps the best way to tell how well your lungs are functioning so 
that you can take appropriate action when they start to deteriorate. It is 
much more reliable than waiting until you feel symptoms, by which time 
your asthma could be more seriously out of control. 
d) All of the above. 
Incorrect. Only (a) and (e) are correct answers. 
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WUO IS RESPONSmLE FOR ASlliMATIC CQN[ROL? 
As with any ongoing condition, those who suffer from asthma must take 
responsibility for keeping it under control on a day·to-day basis. 
Your doctor will be involved in diagnosing your condition and will, 
alongside your practice nurse, supervise you closely at first and help you to 
learn about your asthma. They will also deal with any asthmd problems 
that might arise. However, they cannot constantly supervise you, and 
ultimately the responsibility for your own health is yours. This means 
that you need to: 
a) Take any Preventer medication you have been prescribed properly and 
continuously. 
b) Monitor your lung function properly and take appropriate action if it 
begins to deteriorate. 
c) Know what to do in certain situations that might trigger your asthma. 
In the next section, we will look at these in turn. 
QUESTION 
Who is responsible for keeping your asthma under control on a day-to-day 
basis? 
a) Myself. 
b) My doctor. 
c) Nobody can keep my asthma under control. 
d) Two of the above. 
J' 
ANSWER 
• -1 
Who is responsible for keeping your asUuna under control on a day-to-<tay 
basis? 
a) Myself. 
This is correct .. only you can be responsible for looking after an ongoing 
condition like asthma on a day-to-day basis. Of course, your doctor and 
practice nurse are there to help you, should you need the~ but it is your 
responsibility to approach them at the appropriate times. 
b) My doctor. 
Although your doctor can help you to manage your astluna, and can make 
medical recommendations, ultimately it is your own responsibility to take 
appropriate action to keep your asthma under control (of course, this 
could mean consulting your doctor, in certain situations). 
c) Nobody can keep my llsthma under control. 
This is untrue. By doing the right things, under the advice of your doctor 
and nurse, you can keep your asthma under good control. 
d) Two 0/ the above. 
Only you can be ultimately responsible for your own health, including 
asthmatic control. Of course, this may involve consulting your doctor or 
nurse when you feel it appropriate, and they will help you by offering 
advice and prescribing treatment. 
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SECTION a: 
<' .I. \ ~. . or ~ 
"WHAT CAN IUD IO 
IMPRDv-E MY 
ASIHMAIIC 
[ONTROL ?" . 
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INTRODUCTION 
This section aims to look at the things you might do in order to keep your 
asthma under control. We will discuss, in tum: 
1) Using Preventer medication regularly and continuously, as prescribed. 
2) Monitoring your asthma regularly using a diary. 
3) Planning ahead to avoid panic. 
4) Dealing appropriately with panic if and when it does occur. 
1) USE YOUR PREVENfER MEDICATION REGULARLY AND 
CONTINUOUSLY, AS PRESCRIBEp. 
As we have seen, it is very important that, if recommended to by their 
doctor, asthma sufferers take Preventer medication regularly, whether 
they feel symptoms or not. U they do not then their asthmatic control can 
decrease, leading to problems. However, it is known that many asthma 
sufferers do not follow their doctor's advice on Preventive treatment, and 
there are many reasons why this might be so. 
lf you have not been prescribe Preventer medication by your doctor, then 
you may miss this section for· now, and go straight to the section on 
"Monitoring your asthma regularly using a diary" on Page 29. 
If you have been prescribed Pre venter medication, answer the questions 
below (honestly!) about the Preventer medication you take, but before you 
do so, go back to Page 9 and make sure you are clear about which is your 
Preventer medication. 
*----------------------------------------------------* 
* .,' * 
* Do you ALWAYS take your Preventer medication as * 
* recommended by your doctor, and reported on Page 91 YES I NO • 
• * 
*If yes, then proCeed to the next section.: 
• 
* If no, then think of all the reasons why you do not take it, 
• and circle them in the list below: 
• 
* I DON'T BELIEVE I SHOULD BECAUSE 
* 
* a) I don't see how it can help. 
* 
* b) I don't think my doctor was correct to prescribe it for me. 
• 
• c) I worry about becoming 'addicted- to it 
* 
* d) I don't believe it does my asthma any good. 
* 
(CONID) 
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• 
• 
* 
* 
* 
* 
* 
* 
• 
* 
* 
• 
* 
* 
* 
• e) I believe it sym~1ises that something is wrong with me. 
.. 
• 0 I feel wen for long periods of time. 
.. 
.. g) I am worried about taking steroid preparations for my asthma. 
• 
• h) There are other reasons. 
.. 
.. I BELIEVE 1 SHOULD, BUT I OONT BECAUSE: 
.. 
• i) It is inconvenient. 
• 
.. j) It has side-effects. 
.. 
.. k) People important to me discourage me from taking it. 
.. 
- . 
.. I) I intend to, but I forget. 
.. 
.. m) There are other reasons. 
.. 
• 
• 
.. 
• 
.. 
• 
• 
• 
• 
• 
.. 
• 
.. 
.. 
.. 
.. 
• 
.. 
.. 
.. 
. ----------------------------------------------------. 
Now you have thought about the reasons - to do with both beliefs, barriers 
to action and forgetting - why you don't take your Preventer medication, 
even though it is so important to good asthmatic controL let's look at each 
of these possible reasons in turn,. and see what might be done about them: 
BELIEFS 
a) 1 don't see the point of it. Correct use of Preventer medication really is 
the key to good asthmatic control - any doctor will tell you this. By 
reducing inflammation in the lungs, it makes symptoms less likely. If 
you doubt this, or don't understand how this is so, you might want to 
try finding out some more information, either through your doctor or 
nurse or through a library. . 
b) I don't think my doctor was correct to prescribe it for me. WHY do you 
think this? Is it because the doctor simply hasn't explained clearly 
enough why the drugs are prescribed? Maybe you have never had the 
time to ask about these things? Have you misunderstood or been 
unclear about something you have been told? Are there other 
reasons? 
Whatever your reasons, you could try and find out more; from 
information booklets, from your doctor or from another medical 
expert, before deciding whether this really is the case. 
c) I am scartd of becoming 'addicted' to my drugs. Although you will 
need to take Preventer drugs for some time, you will not become 
physicaUy addicted to them. Also, once your asthma is under control, 
2) 
your doctor will reduce the dosage of your Preventer med~cation - you 
will not have to take it forever if you tak.e it correctly now. In actual 
fact, it is more likely that people who do not take their Pre venter 
medication properly will be in danger because their asthma is poorly 
controlled, or will become dependent on their Reliever medication, 
which is far more dangerous in the long-tenn. 
d) I don't believe it does me Imy good. If other evidence does not 
convince you that Preventer medication really does help, then the best 
way to find out is to try it, and see! Have you ever really tried taking 
your medication properly, on a long-tenn basis, and recording either 
the symptoms you experience or your Peak Flow measurements both 
before and after doing this? We suggest you try it - the improvement 
you see in your own asthmatic control over a period of a few weeks 
should be all the evidence you need! 
e) 1 believe it symbolises that somtthing is wrong with me. Lers face it • 
something IS wrong with yo~ medically - your doctor has diagnosed 
you as having asthma. However, try to see your Preventer medication 
not as something which constantly reminds you of this, but as 
something which can help you to reduce the effects of the asthma as 
much as possible and to lead a less restricted life. Surely taking an 
inhaler each day is much less inconvenient and less obvious to the 
outside world than coughing and wheezing and being unable to do 
many things you would like to do? 
f) I feel well for long periods of time. As we have already explained, 
having no asthma symptoms does not necessarily mean that the lungs 
are functiOning normally and that the asthma is under control 
(although this may be the case). Only Peak Flow measurements can tell 
you that. U good control is achieved and maintained for a long period 
. of time, then you should consult your doctor, who might consider 
lowering or stopping the dosage of Preventer medication prescribed. 
However you should never stop taking your Preventer medication 
without consulting your doctor first 
g) I am worried about taking steroid preparations for my asthma. You 
should not worry about this. The steroids which are prescribed for 
asthma treatment are not the same as anabolic steroids, which have 
had so much publicity over recent years. The doses prescribed are very 
low, and are inhaled so that they only act locally, in the lungs, and 
never enter the bloodstream. There is no danger in using them, and 
they can be of huge benefit in preventing long-term destruction of your 
lungs. Again. you should see your doctor or Practice nurse if you need 
more information, or consult a library. 
h) Other reasons. Are these reasons based on a lack of information about 
your condition or its treatment? Perhaps it would be useful to discuss 
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~ . 
these reasons' ~ith your CP, Pract'ice 'Nurse or other medical 
, practitioners, if this is the case . 
. --------------.-------------------------------------. 
• 
• • 
• I las this section dealt with any of your reasons for not always .. 
• taking your preventer medication as recommended? YES I NO .. 
• .. 
.. If yes, do you now believe you should take your Preventer .. 
.. medication regularly and constantly? YES I NO .. 
.. .. 
.. If no, it could be useful for you to discuss your reasons in more 
.. detail with your GP or asthma nurse. Also, read on ..... 
.. 
.. 
.. .. 
.------------------------------------------------------* 
BARRIERS TO ACI10N 
i) It is inconvenient. This might be so, but so is brushing your teeth in the 
morning, and most people manage to build this into their daily 
routine, somehow! Hopefully what you have read so far will have 
convinced you that the health benefits of taking your Preventer 
medication regularly can far outweigh the inconvenience of doing so, 
and that it would be worth making an effort to take it regularly. 
j, It has side-effocts. By far the most common side-effects of asthma drugs 
are irritations in the throat caused by certain types of inhaled Preventer 
medication. 
If these are experienced then you should NOT stop taking your 
Preventer medication,. but should consult a doctor as soon as possible. 
The sore throat is a direct effect of the drug hitting the back of the 
throat as it is inhaled, and several simple things can be done in order to 
prevent it, for example: 
-rinsing the mouth out after using the inhaler 
. -using a "'spacer" device - a plastic "'tube" which spreads out the inhaled 
medication so it doesn't all come into contact with the back of the 
throat at once. 
-if the above don't work, then your doctor will generally be willing to 
prescribe an alternative, equally effective drug which will not cause 
these probJems. Of course, you have to Jet him or her know about the 
problems, rather than simply stopping taking your medication! 
k) People important to me discourage me from taking it. First of all, are 
you SURE that people close to you really believe you shouldn't take 
your Preventer medication? Discuss this with them and make sure 
you are clear about whether this is the case, and if so, why. 
Always remember, it is YOUR health which needs special attention 
because of your asthma, not other peoples' - however important those 
other people are to you. Their reasons for believing you should not 
2S 
r take your rreventer medication could be some of those you have just 
thought about (above) for yourself. Think about the reasons people 
discourage you and show them the relevant pieces of information 
from the section above - get more information from your doctor and 
show it to them, if necessary. And remember, even if this information 
doesn't change their beliefs about Preventer medication, it is YOUR 
asthma which needs controlling, and it is ultimately your 
responsibility to do that. What other people think should not 
influence your efforts - it is you who might end up having to cope with 
asthma symptoms, in the end, not them! 
*-------------------------------------------------------------* 
* * 
* Has this section dealt with any of your reasons for not always * 
* taking your Preventer medication as recommended? YES I NO * 
* 
* U yes, do you now believe that, with the right action, you could take * , 
* your Preventer medication regularly and constantly? * 
• YFS/ IF I REMEMBERED I NO • 
* 
* If you don't think you could take your medication as prescribed, • 
* . perhaps it would be worth talking about this with a friend, flatmate, • 
* GP or asthma nurse to look at the reasons why. * 
* • 
• If you now believe that you should take your Preventer regularly, 
* as prescribed, but think that you might forget, read on..... . • 
* * 
* ft 
FORGETIING 
1) I intend to, but 1 forget. As with all medications, forgetting to take 
Preventer medication can be a considerable problem. Write down in 
the first two columns in the table on the next page when and why you 
forget to !ake your ~edication (for example, maybe you always 
remember In the morrungs, but tend to forget at night). Next we will 
look at methods you might use to remind yourself, then you can come 
back and complete the third column. . 
*----------------------------------_____________________ ft 
• WHEN? 
* 
* 
· . 
* . 
ft, 
• 
• 
WHY? possIBLE SOLlIDONS? . * 
ft 
• 
ft 
* 
* 
* 
* *--------------------------------------________ , ______ ft 
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'" 1- ..... ~ 
Since Preventer medication is only effective in controlling asthma if 
.. taken on a regular basis, there are, several things you might try to help 
you remember at these difficult times. A few ideas are: 
• Leave yourself a Mnote", or perhaps just a brightly coloured marker, 
somewhere where you can't miss it, to remind yourself - maybe on the 
mirror, or,the front door so you will see it at a regular time every day. 
• Try to associate taking your medication either with a certain time of 
day, or with an activity which you do regularly. For example, many 
people find it useful to take it immediately on waking and on going to 
bed. Others keep their medication by their toothbrush, hairbrush or 
makeup bag and use it regularly before they use these other things. Of 
course, you must find a way of reminding yourseU which fits in with 
both your doctor's recommendations and your lifestyle. 
• If you tend to forget most at a certain time of day, try placing your 
medication, or a note, somewhere you are bound to see it at that time. 
For example, if you tend to forget mostly at night, you may try placing 
your medication on your pillow after you have used it in the morning, 
so you see it when you get into bed at night and remember to take it. If 
you tend to forget more in the morning, a possibility is to put a note on 
your door so you will be reminded as you leave in the morning 
• U you have trouble even remembering to take your medication with 
you so you can use it at the correct times - for example, when on 
holiday - try keeping some extra medication with something you 
a1 ways take away from 'home, such as your suitcase or your toilet bag. 
Think about how these strategies, or similar ones, more suited to your 
lifestyle, could help at the times you have written down, then go back 
and add your ideas in the final column in the table. Over the next few 
days, try to incorporate them into your day. You will find that very 
soon you take your medication almost without thinking about it - and 
your asthma will improve. 
m) There art other reasons. Are these reasons connected with how your 
lifestyle is organised? Could discussing them with a flatmate or friend 
help to get around whatever other barriers you might find stopping 
you taking your Preventor medication regularly, as prescribed? 
QUESTION 
Under what circumstances should you not take your Preventer 
medication as prescribed by your doctor? 
a) When taking the medication has wtpleasant side-effects. 
b) When I feel perfectly well. 
c) If I am scared of becoming 'addicted' to the medication. 
d) If I don't believe my doctor has advised me correctly. 
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ANSWER 
Under what circumstances should you not take your Preventer 
medication as prescribed by your doctor? 
a) Men talci11g the medicine has unpleasant side-effects. 
No, you should not stop your medication for this reason. You should try 
rinsing your mouth out thoroughly with tap water after using your 
inhaler, and if this does not work, consult your doctor or nurse as soon as 
possible so that they can give you a spacer or arrange alternative 
medjcation to keep your asthma under control. 
b) When I feel perfectly well. 
You can feel perfectly well when your lung function is poor - lung 
function can deteriorate before any symptoms are felt, or some asthma 
sufferers might become so used to having poor lung function that they 
"feel well" despite it. It is important to keep your asthma under control 
before symptoms are felt. Asthma is an ongoing condition and you 
should treat it constantly with Preventer medication. 
c) 1/ 1 am scared of becoming 'addicted' to my PrtVtnter medication. 
Physical addiction to asthma drugs is not possible. Far more dangerous to 
your health are the possible results of poor asthmatic control, so you 
shouJd not stop taking your medication for this reason. Discuss your 
wonies with your doctor or Practice nurse if you need more reassurance. 
d) If 1 don't believe my doctor has advised me correctly. 
This is important, and you should discuss your worries with your doctor 
or nurse, or another doctor if you prefer. However, it is important that 
you do take your Preventer medication to keep your asthma under 
control. 
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2) MONITOR YOUR Am IMA REGULARLY USING A DIARY 
As noted~ good asthmatic control is indicated by low vari~tion in Peak 
Flow measurements, few symptoms, low Reliever medication use and 
little life disruption. 
Asthma sufferers often underestimate the amount of symptoms they have 
and how much their life is disrupted because they are used to coughing, 
wheezing and being unable to do things they want to. Perhaps the best 
'way of gaining an accurate picture of how well your asthma is controlled is 
to keep a diary with this infonnation in it. This does not have to be done 
every day for the rest of your life, however! It is most useful to do it 
- when you are first trying to get your asthma under control 
- every time your doctor changes your medication 
- when you have a cold 
- When you know you will be in a trigger situation 
- for a week or so every few months~ regardless of any of the above, 
just to check that your asthma really is still under control. 
On Page 34, you will find an example page of a Peak Flow diary. Starting 
tomorrow mornin~ we would like you to complete this~ using the Peak 
Flow meter we have supplied you with for the purposes of the study. 
(You should have been shown how to use this correctly and should refer 
to the instructions to make sure you are doing so). Take Peak Flow 
measurements every morning and night (record the best of three' blows 
each time) and record your symptoms in the spaces provided. 
Before you begin the diary, read on to find out how to assess what it 
means. If, after doing this, you still do not understand how to assess your 
asthmatic control from the information, then you should take the 
completed diary page along to your doctor or Practice nurse, who will 
explain to you what it means and how it relates to your asthmatic control. 
If your diary does show you that your asthmatic control is poor, please .. 
00 NOT PANIC! There is plenty you can do to improve it and we will be 
looking at how in the rest of the workbook. As you monitor your asthma 
in coming days~ you will see how your asthmatic control can improve. 
QUESfIQN 
Keeping a diary of my Peak Flow measurements and symptoms: 
a) Will help me to control my asthma. 
b) Will give me infonnalion which I cannot understand. 
c) Might show that I need to change the ways I am managing my asthma. 
d) Is unnecessary if I feel well. 
e) Can be done when I have the time. 
t) Might be frightening as it could show that my asthma is out of control. 
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ANSWER 
Keeping a diary of my Peak Flow measurements and symptoms: 
a) Will htlp me to control m.v asthma. This is indeed true .. keeping a 
careful track of your asthma will mean that you can assess how wen it is 
controlled and decide, on the basis of this, what you should do about it to 
maximise asthmatic control. 
b) Will give me information which I cannot understand. This should not 
be the case. The infonnation recorded in a Peak Flow diary is simple and 
should be easy to understand. You should be looking for relatively 
constant Peak Flow measurements, low Reliever medication use, few 
symptoms, and little life disruption. If any of these are not seen, then 
additional action is needed to improve your asthmatic control. If you do 
not understand what you should be looking for in your diary, then you 
should consult your doctor or asthma nurse, who will explain in more 
detail. 
c) Might show that 1 need 10 change how I am managing my asthma. If 
the diary suggests that your ashmatic control is not good, then you should 
immediately be doing something to try and improve it, and keeping a 
diary as you take this action to see if it does improve your asthmatic 
control. See the section "What to do if your diary shows you have poor 
asthmatic control" (below). 
d) Is unnecessary if 1 feel well. Even when you feel well, it is a good idea 
to check your asthmatic control by keeping a diary, once every few weeks. 
In this way, should your control start to deteriorate for any reason, you 
will be able to detect this early and take appropriate acti!Jn before things get 
out of hand. 
e) Can be done when 1 have the time. Make the time! Completing the 
diary should take you less than five minutes of your time, and should be 
done at roughly the same time each day. The potential benefits should 
mean that time should not be an obstacle to looking after your health in 
this valuable way! 
o Might be frighte,,;ng as it could show that my asthma is out of control. 
_) If you have completed this workbook correctly then you should realise 
that you should not be frightened if your asthma is out of control, as you 
should be able to detect this in time and act appropriately to get it back 
under control again. 
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DOES MY DIARY SHOWS COOp OR pooR ASTHMATIC CONTROL? 
If your diary shows any of the following then your asthma is not well 
controlled and you should take action to bring it under better control: 
- Large variation in Peak Flow measurements from day to day. 
- Use of reliever medication more than once on anyone day. 
- Symptoms (even mild) more than once in a week. 
- Interference in any daily activity even once in the week. 
WHAT SHOULD I po IF MY ASTHMATIC CONTROL IS lOOR? 
If your diary shows that your asthmatic control is not good then do not 
paniel There are plenty of things you can do to improve it. 
First of all, you should ask yourself why your asthma is out of control. 
Perhaps you are exposing yourself to too many allergens which trigger it? 
In this case, you should by to identify these triggers and avoid them. 
If you have not been prescribed Preventer medication, it might be useful 
in helping to get your astluna under control. See your doctor or Practice 
nurse to discuss this possibility .. take your diary along and they will decide 
whether to prescribe Preventer medication. Then read "Using your 
Preventer medication regularly and continuously, as prescribed" (p. 22). 
If you have been prescribed Preventer medication, have you lapsed into 
not taking it as prescribed? U so, you should also read "Using your 
Preventer medication regularly and continuously, as prescribed" (p. 22). 
If this workbook does not provide possible solutions, or if using them does 
not improve your asthmatic control (remember - keep diaries as you try to 
control your asthma, to check this) consult your doctor or Practice nurse to 
see if increasing your Preventer medication could help control your 
asthma (if it does, the doses can be reduced again by your doctor or nurse). 
QUESTION 
If my diary shows my asthmatic control is poor, then I should: 
a) Stop monitoring my asthma. 
b) Contact my CP or asthma nurse. 
c) Ignore it if I feel well. 
d) Use my Reliever medication regularly." 
e) Increase my Preventer medication. 
f) Avoid things which trigger my asthma. 
g) Go to bed. 
h) Tell my friends. 
i) Continue monitoring my asthma. 
j) Call an ambulance. 
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ANSWER 
If my diary shows my asthmatic control is poor, then) should: 
a) Stop monitoring my asthma. No! You should monitor your asthma 
more when your control is poor, to assess how well anything you do 
works, and also to detect early whether your control is decreasing further. 
b) Contact In.V GP or asthma nurse. This is probably a good idea if you are 
sure you avoid triggers, take your Preventer medication correctly and 
monitor your asthma using a diary. They will probably increase your 
Preventer medication to try to help bring your asthma under control 
(when this is done they might decrease it again). 
c) Ignore it if I feel well. If your asthma is out of control, you will 
generany feel at least some symptoms. However, even if you do not, or if 
you feel they are tolerable, if your diary suggests your asthma is out of 
control, you should take care to do something to improve it, before you 
really do start to feel unwell. 
d) Use my Reliever medication regularly. No - this is incorrect. One 
indication of good asthmatic control is low usage of Reliever medication, 
and over·use masks the effects of asthma, but does not treat them. What 
you should do is make sure you are using your Preventer medication 
regularly, as prescribed by your doctor. 
e) Increase Iny Preventer medication. You should never do this without 
first (a) making sure you have done everything else possible to improve 
your asthmatic control (avoiding triggers, taking Preventer medication 
regularly etc) and (b) consulting your GP or asthma nurse. 
£) Avoid things which trigger my asthma. Correct - this should be one of 
the first things you make sure you do when your asthma is not well 
controlled (the other is to take your Preventer medication regularly, as 
prescribed). 
g) Go to bed. If you are really feeling bad, then yes, this might be the thing 
to do. However, you should not expect this in itself to improve your 
asthmatic control. Poor asthmatic control requires active coping and you 
should not expect the problem to have gone away once you get up again if 
you do nothing else about it. 
h) Tell my friends. You mayor may not wish to do this. If you feel that 
they can help you then it is a good idea to let them know, and use their 
practical help and support. Also, you might wish to let them know what 
you would like them to do in the event that you experience severe 
symptoms (see Section c, Page 39). 
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i) Continue monitoring. Yes - it is particularly important that you 
-monitor your asthma' whenever it is not well controlled, as well as at 
regular periods when you feel it is. In this way you can tell if your actions 
to deal with it have worked or not. 
j) Call an ambulance. This is only necessary if your symptoms are very 
serious, despite trying all the other things you can think of. This is 
extremely unlikely, if you act properly to keep your asthma under control 
and detect poor control early. 
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PEAK FLOw DIARY 
700 AM PM AM PM AM PM AM PM AM PM AM PM AM PM 
650 
600 
550 
500 
450 
.. 00 
lSO 
lOO 
250 
200 
150 
100 
50 
MORNING (W8~I~ J DAV[> 1 2 3 4 5 6 7 
How roanv doses haw WOO taken from your 
'IUIYIIII: IInce yeslerday evening? 
PEFA (best of 3~ Do no! use your Il.W,," 
before measuring this. 
Was yotM' IIeep dislurbed b)' aSlhma 
(Yes/No)? 
How many doses have WOO taken from your 
H""~ . this morning? 
-= V -- .. _ ... - (bediime) DAV[> 1 2 3 4 5 6 7 
How many doses haw you laken rrom your 
1t(L~v'lt IIncethis moming? 
Grade the Cough 
f severity (0-3) of your asthma Wheeze symptoms Shortness today. of Breath PEFR (besl 01 3). Do no! use your I Al""~ 
I before measuring Ihls. 
How many do.s have WOO laken rrom your 
~~ ""'v£N'"lt.q !his evening? t WEEKLY 
Has your asthma dlslurbed the sleep of 
O· none anyone living wilh you In !he 'ast week? 
1 • mild • aware of symptom bUI easily tolerated (¥aslNo/Not applicable) 
2 • moderale • symptom caused occasional How many work/school/college days 
Interference with normal Bellvilles (Including half days) haw you missed 
3 • severe • symploms caused conslant because of your aSlhma over the last week? 
Interference With normal activllies 
3) AVOID PANIC BY PLANNING AHEAP 
If you control your asthma well, and monitor it regularly so you can detect 
any problems early and correct them, then you should be able to mostly 
avoid asthma symptoms. However, there will still be times when you 
will feel symptoms, and you should make sure you know how to deal 
with them effectively when you do. 
Many people, when they feel their asthma symptoms beginning, panic 
because they don't know what to do, or are anxious about how the attack 
will tum out. This panic has two results: 
a) It tightens the airways in the lungs and makes it even harder to breathe 
out. 
b) It prevents the person from thinking clearly about what they can do 
about their asthma which can really have a positive effect. 
These factors together mean that there is more chance of the symptoms 
getting out of control and perhaps putting the person in danger. 
It is necessaI)' to be vigilant when you have asthma, and to know what is 
going on within your body and how well your asthma is controlled. In 
this way you will be able to detect problems early, while there is still plenty 
of time to take action before things get out of control. 
Forward planning can help to lessen the likelihood that you will panic, 
and there are many positive things you can do in advance to make you 
less likely to panic. We will look at some of these next. 
OUESTION 
Panicking when I feel asthma symptoms coming on is bad because: 
a) It makes my lung function worse and can increase the symptoms. 
b) It stops me from doing other, more useful things to relieve the 
symptoms. 
c) Neither a nor b. 
d) Both a and b. 
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ANSWER 
Panicking when I feel asthma symptoms coming on is bad because: 
a) It makes my lung function worst and can increase the symptoms. 
Correct. Panicking increases the load you put on your lungs and can make 
asthma symptoms worse. It also prevents you from thinking of other, 
better things you could be doing to deal with your symptoms. 
b) It stops me from doing other, more useful things to relieve the 
symptoms. 
It is true that panicking makes you less able to be constructive in dealing 
with your asthma. It also makes it even more difficult to breathe out, thus 
making the asthma symptoms worse. 
c) Neither a nor b. 
Untrue .. both of the above are correct. 
d) Both a and b. 
True. Panicking can have both of these effects and in combination this 
means that the sufferer may be in danger from their asthma. It is 
definitely not a good thing! 
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HOW CAN] PLAN AHEAD TO AVOID PANIC? 
", ' 
As we have seen, it is best to avoid panic on the occasions you do 
experience asthma symptoms, and one of the best ways to do this it to 
plan ahead, i.e. to prepare yourself for what you will do if you do feel 
asthma symptoms beginning. In the following pages, we will look at 
strategies you might like to keep in mind which may help you to deal with 
your asthma better if it does cause you problems. 
First of all, think about the reasons wily you might panic, if your 
symptoms begin. Write them in the first column in the space below: 
*------------------------------------------------------* 
* REASONS FOR PANIC POSSIDLE SOLUTIONS * 
* * 
* * 
* • 
* • 
* * 
• * 
* • 
* • 
*--------------------------------------------------- • 
Everyone will have different reasons for panicking, but by far the 
commonest are: 
- fear that the symptoms will get worse, and you won't be able to breathe. 
- fear that there are triggers present which might make the symptoms 
worse. 
- fear that you will panic. ' 
The only way to deal with these fears is by advance planning to make sure 
you are prepared for controlling your symptoms when they do occur. 
The main strategies for avoiding panic include: 
(a) Having Reliever medication at hand 
(b) Preparing for your reaction to known. unavoidable triggers" 
(c) Making sure your friends know what you want them to do 
(d) Avoiding or escaping from triggers " 
(e) Knowing how to contact your doctor or nurse, should that become 
necessary 
(f) Knowing how to handle panic if it does happen. 
As you read more about these, below, think about whether any of them 
could help you tackle the causes of panic you have written above. Write 
the letter of any useful strategies in the second column in the table above. 
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PLANS FOR AVOIDING PANIC 
af Make sure you always have your Reliever medication at hand. It is not 
recommended that as soon as you feel the slightest symptom, you reach 
for your inhaler. By doing this, many people manage to "ignore" the fact 
that their asthma is out of control, and can use as much as several inhalers 
per week just to suppress the symptoms they feel as a result. Remember, 
this is very bad for you as it only gets rid of the symptoms of asthma, and 
doesn't tackle the underlying cause - only regular use of Preventer 
medication can do that. 
However, - there will be times when, even if your asthma is well 
controlled, you might feel some symptoms, and they might become severe 
enough to justify the use of Reliever medication. At these times you 
should not reach for your Reliever medication right away, but do keep in 
mind that it might be necessary to use it. 
Therefore, you should always make sure that you (1) have Reliever 
medication, and (2) know where it is and can get to it should you need it. 
1) Be sure that you don't run out of your medication, or let it run out-
of -date. U your asthma is well-controlled and you don't use Reliever 
medication very often, then this could be a problem. However, 
modem medications tend to last for a reasonably long time - you could 
try each time you collect a new prescription for Reliever medication to 
write yourself a reminder in your diary or on your calendar of when it 
will run out-of-date, and remember to get a new prescription a few days 
ahead of this date. . 
2) Although it can be expensive, a good strategy is to make sure you 
have your medication in the key places you might be - for example, you 
might keep some in your bag or your pocket, some in a handy place in 
your room or house and also some in your car. 
In this way, on the occasions when you do feel symptoms, you will not 
have to worry that if they get worse, they might get out of hand, as you 
will always have your medication available, should you need it. 
Therefore you can have confidence about dealing with your asthma 
symptoms if they do get worse. 
b) Preparing for your reaction to known, unavoidable triggers. There 
might be situations where you cannot avoid going to places where you 
know there are things which trigger your asthma - for example, a 
friend·s house who has a cat you are allergic to. In this case, you can do 
two things: 
-double your dosage of Preventer medication for a week beforehand, 
if you are going to be exposed for any length of time (eg a holiday). 
- take two puffs of your Preventcr medication beforehand, if you are 
going to be exposed only for a short length of time (eg a passing 
visit). 
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c) Make sure those around you know what .. if anything - you want them 
to do to help when you are having trouble with your asthma. This could 
be your flatmates, your next--door-neighbour (if you live in residence) or a 
dose friend who you know you will usually be able to get hold of, should 
you need them. 
You might want them to leave you alone until you feel better, or to be 
near you just for reassurance, or you may want them to help you in 
another way - perhaps by calling a doctor if things get too bad. Whatever it 
is you would like them to do to help you feel better, you should make sure 
they know in advance what is likely to happel\ and how you would like 
them to help you deal with it. There is nothing worse than having 
fussing, panicking friends around when you are feeling unwell! Like you, 
they need preparing in advance so they can deal with the situation 
effecti vely. 
d) Try and identify your triggering factors, and get away from the 
triggering factor, if there ;s one. Many asthma sufferers find that their 
asthma is triggered by certain substances, or allergens. You should have a 
good idea of what these are, for you. Of course, the best policy is to avoid 
these triggers altogether where possible, but this is not always easy. 
If something unavoidable does trigger your asthma, the first thing you 
. should do is make sure you get away from it, if possible. In some cases, it 
might be embarrassing to move away from the trigger - for example, when 
you are visiting someone else's house and something there triggers your 
asthma. But remember, there is no need to be embarrassed about your 
condition, and your health is important, to y~u and to 'your friends. 
e) Know your dodor and nurses' contact numbers, should it become 
necessary to contact them. You should already know this because you 
have written them on page 3, so you are all prepared! 
QUESTION 
How can you help avoid panic? 
a) Hold my breath 
b) Plan ahead so I can cope effectively with my symptoms when they 
occur 
c) Make sure I know my doctor's phone number 
d) Ignore my asthma and don't think about it 
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ANSWER 
How can you avoid panic? 
a) Hold my breath. This is definitely NaT a good idea, and is probably the 
best way to aggravate your breathing even further! See the following 
section (pAl) for constructive things you could do, instead. 
b) Plan ahead so 1 can cope effectively with my symptoms when they 
occur. Yes, planning ahead will help you to have confidence in dealing 
with your asthma, so you will know what to do and need not panic when 
you feel symptoms. 
c) Make sure 1 kncrw my doctor's phone number. This is one thing which 
would help when planning ahead. Other things you might do are make 
sure you always have reliever medication handy, and make sure that 
those around you know how you would like them to help when you are 
having trouble with your asthma. 
d) Ignore my asthma and don" think about it. No! This is a sure way to 
encourage panic, since when you do start to feel symptoms, you will have 
no idea of how to deal with them. For asthma sufferers, vigilance and 
planning. but not obsession with their condition, is the name of the game. 
Ignoring your asthma will not make it go away, but will make it even 
harder to deal with it when it dOes cause you problems. 
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4) WHAT CAN I 00 IF 100 ALL TIllS AND STILLPANIC? 
Panic is a bad thing for asthma sufferers and should be avoided by forward 
planning, if at all possible. If, however, symptoms sometimes do still 
cause panic, you should teach yourself to reduce it, using the following 
techniques either to relax yourself or to distract yourself from the panic: 
RELAXATION TECHNIQUES· 
1. The "c.1ndle technique". Imagine a candle before you and try to gently 
blow the flame away from you. Breathe out slowly, and as fully as you 
can, with each breath you take. Do not try to blow the candle out - instead 
keep the breath you blowout at a steady rate. Try to breathe out slowly 
and steadily with ~ach breath you take, while reminding yourseU that you 
do know how to control your astluna and thinking clearly about how to 
do this, perhaps using some of the techniques you have just read about. 
2. The ''word technique". Every time you breathe out, repeat a word, 
under your breath· a one-syllable word with relaxing connotations, such 
as "calm" or "peace" is often helpful. Say it slowly and quietly every time 
you breathe out, and try to relax as you do so. 
DISfRACI10N TECHNIQUES 
t. Deseri bing your surroundings. Look around you and describe to 
yourself what you see at one side of your visual field. Work across 
towards the other side of your visual field, describing to yourself 
everything that you see. Do not speak out loud, however. during this 
exercise. It might be useful to count things as you do so - for example, you 
might say to yourself ttl see three trees, seven flowers, a house, .... tt or ") see 
four pictures, a television, three dirty mugs, .... ". 
2, Asking others to distrad you. You may want friends to talk to you or 
try to engage you in something which will prevent panicking. (Of course, 
you must tell them in advance how you wish them to do this, and when). 
IMPORTANT NOTE. Distraction techniques are to be used until the 
panic has subsided - NOT to distract you from then doing something 
constructive about dealing with your symptoms. 
QUESTION 
If I do everything I can, and still panic when I feel symptoms, I should: 
a) Stop trying to control my asthma. 
b) Try to stop the panic. 
c) Take more Reliever medication immediately. 
d) Think of a more constructive way to deal with the symptoms. 
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ANSWER 
If I do everything I can, and still panic when] feel asthma symptoms, ] 
should: 
a) Stop trying. NO - do not give up! Just because things go wrong once, it 
doesn't mean they always will. Concentrate on dealing with the panic and 
the symptoms you are feeling, and then, when they are gone, concentrate 
on planning how you will avoid panicking the next time. 
b) Try to stop the panic. Correct. You should try to stop the panic, 
perhaps using the "candle technique" described above, as it will only make 
your symptoms worse. Then, when you are calmer, you can think of 
something more constructive to do about the asthma. 
c) Take more Reliever medication immediately. This might not be the 
best thing to do, immediately. You must decide for yourself, but it will 
often be best to try and relax and get rid of the panic, before deciding 
whether you really need the drugs. Over·use of Reliever medication is 
not a good thing. 
d) Think about something more constructive to do to get rid oj the 
symptoms. This is correct, but first you might find it best to get rid of the 
panic you are feeling, as described above, since it stops you from being able 
to think clearly abou t things like this. 
.' • 0 • 
!.L t ' ...... " 
. 'SE[IION 3: 
. , . 
SUMMARY 
~ 4) 
Everybody's asthma is different, but we hope that at least some parts of 
this workbook will have been relevant to you and you will be able to use 
them to help you to control your asthma better. 
Here is a summary of the main points we have made: 
• Asthma is controll~ble • with the correct self-management, its 
symptoms can be prevented to a great extent and its effects on daily life 
can be minimised. Wen-controlled asthma is less likely to lead to 
complications in later life. 
• If astlunatic control is good, then 
(a) Peak flow measurements should be relatively constant 
(b) Few symptoms should be experienced 
(c) Little reliever medication should be used (ideally, a maximum 
of 1 puff per day) 
Cd) Daily life should be disrupted very little by the condition 
You need to monitor your asthma, making sure you are aware of 
these things, and act 'appropriately when your control decreases. A 
diary is a good way of doing this. 
• Although your doctor and asthma nurse are there to help you, it is 
you who is responsible for controlling your asthma on a day-to--day 
basis. 
• There are four main things you can do to improve your asthmatic 
control: 
(a) Take your Preventer medication regularly and day-to--day 
(b) Monitor your asthmatic control 
(c) Plan ahead 
(d) Deal effectively with panic, should it occur when you experience 
symptoms 
• The key to asthmatic control is Preventer medic~tion, which should 
be taken regularly, as advised by your doctor. If good control is 
attained, very little Reliever medication should be necessary. There are 
many reasons why sufferers do not take their Preventer medication as 
recommended, all of which can be overcome in some way. We have 
given some suggestions as to how you might go about this. 
• It is important to assess your own asthmatic control, using a diary to 
monitor your Peak Flow measurements, symptoms, Reliever 
medication use and disruption to your daily life due to asthma. You 
have had an introduction to this while completing this workbook. It 
should be useful for 
(a) checking your current asthmatic conlrol 
(b) assessing improvements in asthmatic control as you do more 
things to help your conditio1\. or when our doctor changes your 
medication 
(c) checking every so often that your asthma is still under control, 
once you have attained control initially. 
• Panicking when asthma symptoms are felt only makes them worse 
because it 
(a) constricts the airways even further 
(b) prevents you from doing other; more constructive things to 
decrease the symptoms. Panic should therefore be avoided by 
forward planning, and dealt with appropriately on the occasions 
where it does still occur. 
• Forward planning might include: 
(a) making sure you always have Reliever medication handy 
(b) making sure the people around you know how they can best 
help when you are suffering asthma symptoms 
(c) making sure you identify you triggering factors and get away 
from them as soon as possible. 
• Using all these methods, you really can get your asthma under 
control, which will leave you much healthier and less restricted by 
your condition. 
·"With this workbook you have also received a "summary card't which 
we would like you to keep in a prominent place, look at regularly and use 
the points to help you to control your asthma·" 
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SECTION 4: 
[ASE EIrIU()Y -
"[ONTROLLIN G MY 
ASTHMA REALLY VIV 
[HAN"G E MY LII?E 1" 
- . 
. " 
Just in case, after reading this far, you still have any doubts that gaining 
good control over your asthma will benefit you, read the story of Ruth, a 
20 year-old second year Arts student: 
"1 was diagnosed as having asthma when 1 was very young and 
from my early teens was prescribed Ventolin (Reliever medication) and 
Becotide (Preventer medication) by my doctor. However, my asthma was 
never really brought under control and twice during my 40' grade years 1 
had to be taken to hospital because I had such bad asthma attacks. During 
my school years, 1 never used to be able to lake part in sports classes 
properly, but I just got used to that and thought I never would be able to. 1 
guess I convinced myself that I didn't want to do these things. 
"At one point I was using up to one Ventolin inhaler every two 
weeks, but I thought this was the "trade-mark" of having asthma, and 1 
never really bothered about my Becotide. On the few occasions when I did 
make an effort to use it regularly - usually after my "hospital scares" - the 
Becotide gave me a terrible sore throat and 1 soon gave up again. 1 never 
saw any improvement in my asthma anyway, so 1 didn't beJieve it was 
worth it. 
"However, once I started university, things changed a bit. I was 
registered at a new Health Centre and there was a Practice Nurse there 
who was trained in asthma care who my doctor suggested I went to see. 
She gave me a Peak flow meter and explained to me how to assess my 
asthmatic control, and I went away and took readings for a week and kept 
them in an asthma diary. I was amazed to find that my lung function was 
'. " ~ fluctuating all over the place, and that when I actually wrote down the 
symptoms I was experiencing and how much Ventolin I was using, it was 
far greater than I had thought. Because the nurse had explained to me that 
poorly controlled asthma could make me very ill in later life, as well as 
making the really bad attacks more likely, I decided it was time to actually 
DO something about controlling my asthma. She stressed to me the 
importance of regular Preventer medication, which I'd never really 
understood ~fore, and although I didn't like the idea of taking medicine 
. on a long-term basis, I decided it would be worth it for my health, in the 
long-run. 
"1 told the nurse that I didn't like the Becotide as it made my throat 
sore, and she gave me a spacer which, although it made taking my inhaler 
more complicated, stopped the sore throats. J began to take my Becotide 
regularly, twice a day, and although at first 1 forgot quite often, 1 eventuaJly 
discovered that if I took it just before brushing my teeth, morning and 
night, it was much easier to remember. 1 kept diaries of my Peak Flow and 
symptoms and they really encouraged me because over the first few weeks 
I could actually see that my asthmatic control was improving. I was 
coughing a lot Jess and my Ventolin use dropped amazingly - J found I 
iust didn't need it any more! 
"All this was about a year and a half ago, and I've never looked 
back, although it hasn't been easy. I've been taking my Preventer 
medication pretty much every day since then, and have become much 
better at avoiding things which I know trigger my asthma, whereas before 
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I would just tolerate them and reach for the Ventolin when, inevitably, I 
started to wheeze. About 4 months ago I went to see the nurse again 
because my Peak flow, which I still measure for a week every couple of 
months or so, had stabilised for a few months, and she halved my 
Becotide dose and this has been enough, since then. Just next month I 
have another appointment and hopefully I might be able to reduce that 
dose, too, although, of course, I will still have to keep a careful track of my 
Peak Flow and symptoms and make sure I have Ventolin handy, just in 
case. I have also been recommended to take my Becotide and monitor my 
asthma for a while if I know I'm going to be near something unavoidable 
which triggers my asthma - for example, my friend's cats when I go to stay 
there. It took me a while to accept that reducing my medication wouldn't 
make my symptoms worse, but once we did it, I found that the opposite 
was true! By taking my Preventer medication regularly, my lungs were in 
better condition . 
... It happened so gradually that I hardly even noticed it, but as my 
asthma came under control and my symptoms went away I began to do 
more things that I never thought I'd be able to do, or at least, enjoy. For 
example, a group of my friends from my hall all became "'Swingnastics'" 
freaks and persuaded me to go along one day. It surprised me that they no 
longer thought of me as an invalid - probably because I wasn't using my 
VentoIin inhaler or wheezing nearly so much. They just expected me to 
join in as they did. So on I went - nervously, and with Ventolin tightly in 
hand, of course! To my surprise, I didn't even need to use it, although I 
did take it easy that day, of course. I have been going regularly ever since .. 
and putting in more effort! - and I've never had a problem at all. Of 
course, I feel much fitter for it Mum and Dad can't believe it - we never 
thought I'd be able to do this sort of thing, and I'd persuaded myself I 
wouldn't enjoy it even if I did. I guess I had no confidence, and "hid'" 
behind my asthma, for a long time. 
"Nowadays, though,. there's no hiding, for me! I'm determined to 
keep my asthma under control and not to let it interfere with my new life! 
It's a bit of an effort (although it's easier now it's more routine) but it's 
definitely worth itt" 
Ruth's story probably tells more about the benefits of asthmatic control 
than this workbook could ever tell. Only YOU can decide to get your 
asthma under control, but we hope that completing this workbook will at 
least have given you a few useful ideas as to how you might go about it. 
GOOIl LUCKIJ 
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